5-Fluorouracil
Based on 344 publication(s) in Google Scholar
5-Fluorouracil (5-FU) is an analogue of uracil and a potent antitumor agent. 5-Fluorouracil affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools. 5-Fluorouracil induces apoptosis and can be used as a chemical sensitizer. 5-Fluorouracil also inhibits HIV.
For research use only. We do not sell to patients.
- Purity: 99.99%
- CAS No.: 51-21-8
- Formula: C4H3FN2O2
- Molecular Weight:130.08
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) 5-Fluorouracil
More- Signal Transduct Target Ther. 2025 Dec 15;10(1):406. [Abstract]
- Cancer Cell. 2026 Mar 9;44(3):658-675.e12. [Abstract]
- Cancer Cell. 2025 Sep 25:S1535-6108(25)00393-9. [Abstract]
- Nature. 2024 Oct;634(8036):1229-1237. [Abstract]
- Nat Med. 2024 Mar;30(3):749-761. [Abstract]
- Cell. 2024 Apr 25;187(9):2288-2304.e27. [Abstract]
- Mol Cancer. 2024 Jan 10;23(1):12. [Abstract]
- Mol Cancer. 2024 Jan 24;23(1):23. [Abstract]
- Immunity. 2024 Feb 13;57(2):364-378.e9. [Abstract]
- Gastroenterology. 2021 Nov;161(5):1601-1614.e23. [Abstract]
- Adv Mater. 2026 Mar 15:e22617. [Abstract]
- Adv Mater. 2021 May;33(18):e2100949. [Abstract]
- Cancer Commun (Lond). 2024 Apr;44(4):469-490. [Abstract]
- JAMA Oncol. 2022 Jan 1;8(1):e215445. [Abstract]
- Cell Stem Cell. 2026 Apr 2;33(4):660-675.e5. [Abstract]
- Cancer Res. 2026 Mar 5. [Abstract]
- Cancer Res. 2025 May 14. [Abstract]
- Cancer Res. 2018 Oct 1;78(19):5586-5599. [Abstract]
- Drug Resist Updat. 2023 Mar:67:100926. [Abstract]
- Autophagy. 2025 Jul;21(7):1556-1577. [Abstract]
- Nat Commun. 2026 May 11. [Abstract]
- Nat Commun. 2026 May 28.
- ACS Nano. 2023 Nov 28;17(22):22901-22915. [Abstract]
- Redox Biol. 2026 Mar:90:104043. [Abstract]
- Mol Cell. 2025 Jul 17;85(14):2654-2672.e7. [Abstract]
- Gut Microbes. 2024 Jan-Dec;16(1):2333790. [Abstract]
- Theranostics. 2020 Jan 1;10(1):300-311. [Abstract]
- Theranostics. 2019 Jul 9;9(17):4878-4892. [Abstract]
- Acta Pharm Sin B. 2026 Jun 18.
- Acta Pharm Sin B. 2024 Apr;14(4):1677-1692. [Abstract]
- Acta Pharm Sin B. 2023 Nov;13(11):4621-4637. [Abstract]
- J Clin Invest. 2024 Mar 7;134(10):e172716. [Abstract]
- J Exp Clin Cancer Res. 2021 Apr 30;40(1):150. [Abstract]
- J Exp Clin Cancer Res. 2019 Aug 14;38(1):353. [Abstract]
- Adv Sci (Weinh). 2026 May;13(25):e21681. [Abstract]
- Adv Sci (Weinh). 2025 Jul;12(27):e2500271. [Abstract]
- Adv Sci (Weinh). 2025 Mar;12(12):e2408845. [Abstract]
- Adv Sci (Weinh). 2025 Jan;12(3):e2407519. [Abstract]
- Adv Sci (Weinh). 2023 Sep;10(27):e2302640. [Abstract]
- Adv Sci (Weinh). 2023 Apr;10(12):e2206004. [Abstract]
- Adv Sci (Weinh). 2022 Oct;9(30):e2200717. [Abstract]
- Adv Sci (Weinh). 2021 Nov;8(21):e2101936. [Abstract]
- MedComm (2020). 2021 Jun 3;2(3):467-480. [Abstract]
- Cell Rep Med. 2026 May 19;7(5):102757. [Abstract]
- Cell Rep Med. 2026 Mar 17;7(3):102686. [Abstract]
- Cell Rep Med. 2025 Oct 21;6(10):102401. [Abstract]
- Cell Rep Med. 2025 Apr 15;6(4):102053. [Abstract]
- Cell Death Differ. 2025 Apr 9. [Abstract]
- Biomaterials. 2024 Oct:310:122625. [Abstract]
- Plant Cell. 2024 May 29;36(6):2238-2252. [Abstract]
- Carbohydr Polym. 2024 Dec 15:346:122645. [Abstract]
- Research (Wash D C). 2025 Aug 25:8:0838. [Abstract]
- Asian J Pharm Sci. 2026 Jun 20.
- J Transl Int Med. 2026 Mar 26;14(2):237-258. [Abstract]
- Chem Eng J. 2025 Jun 6.
- Chem Eng J. 2023 Nov 17, 147466.
- Cell Death Dis. 2026 Apr 23;17(1):537. [Abstract]
- Cell Mol Biol Lett. 2025 Nov 7;30(1):133. [Abstract]
- Pharmacol Res. 2025 Dec:222:108027. [Abstract]
- Cell Death Dis. 2025 Mar 12;16(1):170. [Abstract]
- Cell Death Dis. 2025 Jan 18;16(1):28. [Abstract]
- Cell Death Dis. 2024 Oct 1;15(10):720. [Abstract]
- Cell Death Dis. 2024 Oct 27;15(10):779. [Abstract]
- Cell Death Dis. 2022 Feb 17;13(2):159. [Abstract]
- Cell Death Dis. 2021 Apr 1;12(4):338. [Abstract]
- Pharmacol Res. 2021 Jan:163:105232. [Abstract]
- Cell Death Dis. 2020 Jun 15;11(6):464. [Abstract]
- Pharmacol Res. 2020 Jun:156:104774. [Abstract]
- Cell Death Dis. 2019 Aug 13;10(8):615. [Abstract]
- Cancer Lett. 2026 Sep 28:656:218655. [Abstract]
- Cancer Lett. 2025 Dec 1:634:218064. [Abstract]
- Cancer Lett. 2026 Jan 28:638:218156. [Abstract]
- Cancer Lett. 2024 Oct 10:602:217214. [Abstract]
- Cancer Lett. 2023 May 28:562:216145. [Abstract]
- Cancer Lett. 2021 Nov 1:520:361-373. [Abstract]
- J Immunother Cancer. 2026 Jun 8;14(6):e015109. [Abstract]
- J Immunother Cancer. 2025 Nov 19;13(11):e012652. [Abstract]
- J Immunother Cancer. 2022 Aug;10(8):e004006. [Abstract]
- Int J Biol Sci. 2022 Apr 11;18(7):2882-2897. [Abstract]
- Int J Biol Sci. 2022 Feb 7;18(4):1724-1736. [Abstract]
- Cell Commun Signal. 2025 Oct 1;23(1):403. [Abstract]
- Cell Commun Signal. 2025 Jul 1;23(1):316. [Abstract]
- Cell Commun Signal. 2025 May 17;23(1):230. [Abstract]
- Phytomedicine. 2026 Jul:156:158180. [Abstract]
- Phytomedicine. 2026 Jul 25:157:158317. [Abstract]
- Phytomedicine. 2026 Jun:155:158113. [Abstract]
- Phytomedicine. 2026 Mar:152:157837. [Abstract]
- Phytomedicine. 2025 Aug:144:156958. [Abstract]
- Phytomedicine. 2025 Jul:142:156773. [Abstract]
- Phytomedicine. 2025 Jul 25:143:156925. [Abstract]
- Phytomedicine. 2024 Aug:131:155786. [Abstract]
- Phytomedicine. 2024 Jan:122:155079. [Abstract]
- Phytomedicine. 2023 Jul 25:116:154869. [Abstract]
- Phytomedicine. 2023 Jan:109:154563. [Abstract]
- Phytomedicine. 2021 Aug:89:153603. [Abstract]
- Phytomedicine. 2021 Jun:86:153553. [Abstract]
- Acta Biomater. 2026 Jul:218:244-260. [Abstract]
- Acta Pharmacol Sin. 2026 Jun 8. [Abstract]
- Cell Death Discov. 2022 May 2;8(1):238. [Abstract]
- NPJ Precis Oncol. 2024 Sep 30;8(1):214. [Abstract]
- Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2026813118. [Abstract]
- Oncogene. 2026 Jun 15. [Abstract]
- Oncogene. 2021 Dec;40(49):6666-6679. [Abstract]
- Int J Biol Macromol. 2026 May:361:151988. [Abstract]
- Int J Nanomedicine. 2024 Jul 19:19:7353-7365. [Abstract]
- Int J Nanomedicine. 2024 Jan 6:19:171-188. [Abstract]
- Int J Mol Med. 2022 Feb;49(2):21. [Abstract]
- Int J Mol Med. 2020 Jul;46(1):201-210. [Abstract]
- Mol Med. 2025 Feb 19;31(1):62. [Abstract]
- Arch Pharm Res. 2025 Dec;48(11-12):1362-1381. [Abstract]
- Phytother Res. 2025 Feb;39(2):581-592. [Abstract]
- View. 2023 Nov 15.
- Drug Deliv. 2026 Dec 31;33(1):2604086. [Abstract]
- Clin Transl Med. 2023 Nov;13(11):e1481. [Abstract]
- Clin Transl Med. 2022 Apr;12(4):e752. [Abstract]
- ACS Appl Mater Interfaces. 2026 Feb 11;18(5):7900-7909. [Abstract]
- ACS Appl Mater Interfaces. 2025 Jul 23;17(29):42394-42406. [Abstract]
- Cell Rep. 2026 May 22;45(6):117427. [Abstract]
- Cell Rep. 2025 Mar 25;44(4):115466. [Abstract]
- Cell Rep. 2025 Jan 13;44(1):115179. [Abstract]
- Cell Rep. 2023 Nov 14;42(11):113426. [Abstract]
- Cell Rep. 2023 Jan 31;42(1):111916. [Abstract]
- Cell Rep. 2022 Dec 20;41(12):111826. [Abstract]
- Cell Rep. 2022 Aug 16;40(7):111194. [Abstract]
- Cell Rep. 2021 Nov 30;37(9):110069. [Abstract]
- Cell Prolif. 2021 May;54(5):e13038. [Abstract]
- Chin J Nat Med. 2024.
- Chin J Nat Med. 2022 Mar;20(3):202-209. [Abstract]
- Chin Med. 2025 Mar 29;20(1):42. [Abstract]
- Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):440-452. [Abstract]
- Anal Chem. 2026 Jan 23. [Abstract]
- Int J Oncol. 2026 Jan;68(1):10. [Abstract]
- Int J Oncol. 2022 Nov;61(5):139. [Abstract]
- Int J Oncol. 2020 Aug;57(2):550-561. [Abstract]
- Anal Chem. 2016 Apr 5;88(7):3817-25. [Abstract]
- Cancer Cell Int. 2025 Oct 15;25(1):357. [Abstract]
- Cancer Cell Int. 2021 Jul 19;21(1):384. [Abstract]
- Cancer Cell Int. 2019 Jul 12:19:179. [Abstract]
- Mol Cancer Ther. 2025 Dec 4. [Abstract]
- Redox Rep. 2024 Dec;29(1):2313366. [Abstract]
- Mol Cancer Ther. 2021 Dec;20(12):2483-2494. [Abstract]
- Mol Cancer Ther. 2020 Mar;19(3):906-919. [Abstract]
- J Ethnopharmacol. 2026 Nov 15:370:121987. [Abstract]
- Cell Biosci. 2025 Jul 4;15(1):95. [Abstract]
- Cell Mol Life Sci. 2024 Nov 14;81(1):452. [Abstract]
- Food Biosci. 2025 Jan.
- Biomater Sci. 2025 Mar 19. [Abstract]
- Drug Des Devel Ther. 2024 Jun 20:18:2405-2420. [Abstract]
- Gastric Cancer. 2023 Nov;26(6):863-877. [Abstract]
- J Cell Biol. 2023 Jan 2;222(1):e202202110. [Abstract]
- Cells. 2026 Feb 28;15(5):430. [Abstract]
- Cells. 2026 Feb 23;15(4):383. [Abstract]
- ACS Biomater Sci Eng. 2025 Oct 13;11(10):5991-6003. [Abstract]
- Foods. 2025 Sep 30;14(19):3393. [Abstract]
- Oncogenesis. 2023 Feb 4;12(1):3. [Abstract]
- Pharm Biol. 2022 Dec;60(1):915-930. [Abstract]
- Foods. 2022 Nov 27;11(23):3823. [Abstract]
- J Biomed Inform. 2023 Jun:142:104383. [Abstract]
- Commun Biol. 2024 Dec 3;7(1):1612. [Abstract]
- Cell Rep Methods. 2023 Oct 23;3(10):100599. [Abstract]
- Front Bioeng Biotechnol. 2020 May 8:8:378. [Abstract]
- Pharmaceuticals (Basel). 2026 Apr 17;19(4):636. [Abstract]
- Eur J Pharmacol. 2026 Apr 10:1020:178785. [Abstract]
- Eur J Pharmacol. 2026 Jan 12:1011:178448. [Abstract]
- Eur J Pharmacol. 2025 Sep 15:1003:177942. [Abstract]
- Pharmaceuticals (Basel). 2022 Dec 12;15(12):1541. [Abstract]
- Int J Mol Sci. 2026 Mar 13;27(6):2646. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 2):115879. [Abstract]
- Int Immunopharmacol. 2025 Sep 6:165:115445. [Abstract]
- Int J Mol Sci. 2025 Mar 13;26(6):2578. [Abstract]
- Int Immunopharmacol. 2024 Nov 15:141:112955. [Abstract]
- Int Immunopharmacol. 2024 Jun 15:134:112197. [Abstract]
- Int Immunopharmacol. 2023 Aug 23;124(Pt A):110810. [Abstract]
- Mikrochim Acta. 2025 Dec 27;193(1):49. [Abstract]
- Front Pharmacol. 2022 Apr 8;13:879751. [Abstract]
- Front Pharmacol. 2020 Sep 18:11:576547. [Abstract]
- J Enzyme Inhib Med Chem. 2019 Dec;34(1):117-123. [Abstract]
- ACS Omega. 2025 Oct 30;10(44):52931-52943. [Abstract]
- Chem Biol Interact. 2019 May 1:304:148-157. [Abstract]
- Molecules. 2022 Oct 26;27(21):7255. [Abstract]
- BMC Chem. 2022 Oct 9;16(1):75. [Abstract]
- Molecules. 2022 May; 27(9): 2946. [Abstract]
- Molecules. 2020 Mar 5;25(5):1162. [Abstract]
- Mol Med Rep. 2025 Jun;31(6):165. [Abstract]
- Mol Med Rep. 2021 Dec;24(6):862. [Abstract]
- Mol Med Rep. 2019 Nov;20(5):4576-4586. [Abstract]
- J Mol Med (Berl). 2019 Aug;97(8):1183-1193. [Abstract]
- Sci Rep. 2026 May 31. [Abstract]
- Sci Rep. 2026 Feb 25;16(1):10467. [Abstract]
- Biol Proced Online. 2025 Jun 16;27(1):21. [Abstract]
- Sci Rep. 2025 May 28;15(1):18640. [Abstract]
- Sci Rep. 2025 Mar 17;15(1):9155. [Abstract]
- Sci Rep. 2024 Nov 29;14(1):29661. [Abstract]
- Transl Oncol. 2024 Sep:47:102054. [Abstract]
- Int J Cancer. 2020 Mar 15;146(6):1700-1716. [Abstract]
- Sci Rep. 2020 Feb 19;10(1):2935. [Abstract]
- Sci Rep. 2016 Dec 1:6:38267. [Abstract]
- Bioelectrochemistry. 2016 Jun:109:31-40. [Abstract]
- Eur J Med Res. 2025 Apr 10;30(1):265. [Abstract]
- Cancers (Basel). 2022 Nov 28;14(23):5854. [Abstract]
- Cell Signal. 2026 Oct:146:112668. [Abstract]
- Oncol Rep. 2025 Oct;54(4):133. [Abstract]
- Oncol Rep. 2025 Jul;54(1):82. [Abstract]
- J Cell Mol Med. 2025 Mar;29(6):e70470. [Abstract]
- Oncol Rep. 2021 Jan;45(1):107-118. [Abstract]
- Oncol Res. 2026 Jan 19;34(2):22. [Abstract]
- Mol Oncol. 2026 Jun 5. [Abstract]
- iScience. 2024 Dec 4;27(12):111437. [Abstract]
- iScience. 2022 Sep 6;25(10):105081. [Abstract]
- Biomedicines. 2022 Jan 10;10(1):143. [Abstract]
- BMC Complement Med Ther. 2025 Nov 3;25(1):405. [Abstract]
- BMC Complement Med Ther. 2025 Jul 2;25(1):217. [Abstract]
- FASEB J. 2019 Apr;33(4):5520-5534. [Abstract]
- Cancer Res Treat. 2023 Oct;55(4):1077-1086. [Abstract]
- Drug Dev Res. 2022 Nov;83(7):1683-1696. [Abstract]
- Fish Shellfish Immunol. 2022 Jan:120:648-657. [Abstract]
- Drug Dev Res. 2019 Dec;80(8):1040-1050. [Abstract]
- Drug Dev Res. 2019 Aug;80(5):573-584. [Abstract]
- Drug Dev Res. 2018 Sep;79(6):295-306. [Abstract]
- Epigenomes. 2026 Feb 23;10(1):14. [Abstract]
- BMC Cancer. 2025 Dec 31. [Abstract]
- Microbiol Spectr. 2025 Sep 2;13(9):e0182025. [Abstract]
- Curr Issues Mol Biol. 2025 Aug 26;47(9):687. [Abstract]
- Microbiol Spectr. 2022 Apr 27;10(2):e0272721. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2020 Oct;393(10):1987-1999. [Abstract]
- BMC Oral Health. 2023 Nov 9;23(1):846. [Abstract]
- Drug Metab Dispos. 2026 Apr;54(4):100274. [Abstract]
- J Biochem Mol Toxicol. 2026 Apr;40(4):e70819. [Abstract]
- J Biochem Mol Toxicol. 2025 Nov;39(11):e70541. [Abstract]
- PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007681. [Abstract]
- Cancer Med. 2026 May;15(5):e71898. [Abstract]
- Mol Carcinog. 2022 Dec;61(12):1177-1190. [Abstract]
- Arch Biochem Biophys. 2022 Jun 15;722:109216. [Abstract]
- Arch Pharm (Weinheim). 2021 Dec;354(12):e2100225. [Abstract]
- BMC Pharmacol Toxicol. 2021 Jan 6;22(1):1. [Abstract]
- Exp Cell Res. 2020 Aug 1;393(1):112054. [Abstract]
- Mol Carcinog. 2020 May;59(5):512-519. [Abstract]
- Bioorg Med Chem. 2019 Apr 15;27(8):1577-1587. [Abstract]
- Int J Biochem Cell Biol. 2018 Mar:96:9-19. [Abstract]
- Invest New Drugs. 2025 Jun;43(3):728-741. [Abstract]
- Reprod Toxicol. 2025 May:134:108895. [Abstract]
- Front Oncol. 2024 Dec 19:14:1501981. [Abstract]
- J Cancer. 2023 Aug 6;14(13):2481-2490. [Abstract]
- Front Oncol. 2022 Jul 29;12:871281. [Abstract]
- Front Oncol. 2021 Jul 13:11:704042. [Abstract]
- Chem Biol Drug Des. 2025 Nov;106(5):e70197. [Abstract]
- J Cancer Res Clin Oncol. 2023 Aug;149(10):7235-7246. [Abstract]
- BMC Gastroenterol. 2025 Jan 30;25(1):46. [Abstract]
- J Immunol Res. 2022 Sep 28;2022:6863240. [Abstract]
- Food Chem Toxicol. 2020 Dec:146:111843. [Abstract]
- Tissue Cell. 2026 May 28:103:103646. [Abstract]
- Chin J Integr Med. 2025 May 13. [Abstract]
- Oral Dis. 2025 Feb;31(2):468-481. [Abstract]
- J Appl Toxicol. 2023 Aug;43(8):1214-1224. [Abstract]
- In Vitro Model. 2025 Mar 5;4(1):31-44. [Abstract]
- J Cell Biochem. 2019 May;120(5):8447-8456. [Abstract]
- Int J Colorectal Dis. 2025 Aug 21;40(1):184. [Abstract]
- PeerJ. 2024 May 13:12:e17296. [Abstract]
- Biomed Res Int. 2020 Dec 8:2020:3042636. [Abstract]
- Discov Oncol. 2025 Aug 4;16(1):1468. [Abstract]
- Polycycl Aromat Compd. 2024 Oct 07.
- Technol Cancer Res Treat. 2020 Jan-Dec:19:1533033820962114. [Abstract]
- Biotechniques. 2019 Jul;67(1):11-15. [Abstract]
- Cancer Manag Res. 2019 Mar 22:11:2339-2348. [Abstract]
- Ther Clin Risk Manag. 2017 Feb 7:13:117-130. [Abstract]
- J Chromatogr B Analyt Technol Biomed Life Sci. 2026 Jun 16:1281:125188. [Abstract]
- Cancer Rep. 2025 Dec;8(12):e70401. [Abstract]
- Biochem Biophys Res Commun. 2024 May 28:710:149895. [Abstract]
- Biochem Biophys Res Commun. 2023 Aug 30:670:1-11. [Abstract]
- Biochem Biophys Res Commun. 2023 Jan 1:638:94-102. [Abstract]
- Anal Cell Pathol. 2022 Jun 16:2022:4484211. [Abstract]
- Biochem Biophys Res Commun. 2020 Nov 12;532(3):329-335. [Abstract]
- Biochem Biophys Res Commun. 2020 Sep 3;529(4):1086-1093. [Abstract]
- Biochem Biophys Res Commun. 2020 Jan 15;521(3):596-602. [Abstract]
- Med Sci Monit. 2018 Sep 21:24:6666-6672. [Abstract]
- Biochem Biophys Res Commun. 2018 Jun 27;501(3):636-642. [Abstract]
- Med Sci Monit. 2018 Jun 3:24:3710-3719. [Abstract]
- Onco Targets Ther. 2021 Oct 22;14:5131-5144. [Abstract]
- Onco Targets Ther. 2020 Oct 29:13:10995-11006. [Abstract]
- Arch Oral Biol. 2025 Sep 15:179:106396. [Abstract]
- Transl Cancer Res. 2026 Mar 31;15(3):190. [Abstract]
- J Pharmacol Toxicol Methods. 2020 Nov-Dec:106:106913. [Abstract]
- Oncol Lett. 2019 Aug;18(2):1337-1343. [Abstract]
- J Chemother. 2019 Jul;31(4):214-226. [Abstract]
- Biocell. 2026 Jan 23.
- J Med Food. 2021 Aug;24(8):806-816. [Abstract]
- J Int Med Res. 2019 Apr;47(4):1685-1695. [Abstract]
- Turk J Biol. 2026 Mar 13;50(2):170-184. [Abstract]
- Phytochem Lett. 27 May 2022.
- Mol Cell Toxicol (2019) 15:209-219
- Pharm Chem J. 2024 Aug.
- Res Sq. 2026 Jun 17.
- bioRxiv. 2026 May 23:2026.05.20.726695. [Abstract]
- bioRxiv. 2026 Apr 3.
- medRxiv. 2026 Apr 18.
- bioRxiv. 2026 Apr 7.
- bioRxiv. 2026 Mar 24.
- Res Sq. 2026 Mar 11.
- SSRN. 2026 Mar 5.
- bioRxiv. 2025 Sep 17.
- SSRN. 2025 Jul 26.
- SSRN. 2025 Jul 7.
- Res Sq. 2025 May 11.
- Environ Toxicol. 2025 Feb;40(2):204-221. [Abstract]
- Research Square Preprint. 2024 Nov 06.
- bioRxiv. 2024 July 24.
- Biomed Pharmacother. 2024 Nov:180:117576. [Abstract]
- bioRxiv. 2024 Oct 23:2024.10.20.619300. [Abstract]
- Biomed Pharmacother. 2024 Sep:178:117215. [Abstract]
- Comput Biol Med. 2024 Jul:177:108666. [Abstract]
- Heliyon. 2024 May 13.
- Heliyon. 2024 May 20;10(11):e31431. [Abstract]
- SSRN. 2024 Mar 20.
- Biomed Pharmacother. 2024 Jan:170:116086. [Abstract]
- Research Square Preprint. 2024 Jan 17.
- Research Square Preprint. 2024 Jan 3.
- Research Square Preprint. 2023 Aug 28.
- Biomed Pharmacother. 2023 Jul:163:114751. [Abstract]
- Patent. US20230129164A1.
- Research Square Preprint. 2023 Apr 3.
- Heliyon. 2023 Mar 21;9(4):e14655. [Abstract]
- bioRxiv. 2023 Feb 28.
- Research Square Print. 2023 Feb.
- Research Square Print. 23 Nov 2022.
- Biomed Pharmacother. 2022 Sep:153:113465. [Abstract]
- Research Square Print. 2022 Jun.
- Research Square Print. 2022 May.
- Research Square Preprint. 2022 May.
- Research Square Preprint. 2022 Feb.
- J Oncol. 2021 Nov 9:2021:9355555. [Abstract]
- Queen’s University. 2021 Oct.
- Research Square Preprint. 2021 Aug.
- Research Square Preprint. 2021 Apr.
- Environ Toxicol. 2021 Feb;36(2):276-286. [Abstract]
- Research Square Preprint. 2021 Feb.
- Research Square Preprint. 2020 Nov.
- Biomed Pharmacother. 2020 Aug:128:110262. [Abstract]
- Aging (Albany NY). 2020 Jul 20;12(16):16270-16293. [Abstract]
- Clinical Cancer Drugs. 2020 Apr.
- Masaryk University. 2020 Jan.
- Biomed Pharmacother. 2018 Jul:103:729-737. [Abstract]
- Oncotarget. 2017 Dec 15;8(70):115398-115412. [Abstract]
- Tumour Biol. 2016 Jul;37(7):8811-24. [Abstract]
- Drug Evaluation Research. 2016, 39(3): 367-371.
-
Cell Proliferation/Viability Assay
-
RT-PCR
-
Cell Proliferation/Viability Assay
-
Cell Proliferation/Viability Assay
-
IF
All Endogenous Metabolite Isoforms
More
Biological Activity
|
HIV |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 143B | IC50 |
13.01 μM
Compound: FUra
|
Cytotoxicity against human 143B cells after 72 hrs by SRB assay
Cytotoxicity against human 143B cells after 72 hrs by SRB assay
|
[PMID: 27073055] |
| 143B | IC50 |
16.31 μM
Compound: FUra
|
Cytotoxicity against human thymidine kinase deficient 143B cells after 72 hrs by SRB assay
Cytotoxicity against human thymidine kinase deficient 143B cells after 72 hrs by SRB assay
|
[PMID: 27073055] |
| 143B | IC50 |
25.216 μM
Compound: 5-FU
|
Antiproliferative activity against human 143B cells after 48 hrs by MTT assay
Antiproliferative activity against human 143B cells after 48 hrs by MTT assay
|
[PMID: 29223717] |
| 2008 | IC50 |
4.2 μM
Compound: 1, 5-FU
|
Growth inhibition of human 2008 cells by crystal violet assay
Growth inhibition of human 2008 cells by crystal violet assay
|
[PMID: 23075414] |
| 2008 | IC50 |
6 μM
Compound: 5FU
|
Cytotoxicity against human 2008 cells
Cytotoxicity against human 2008 cells
|
[PMID: 30035541] |
| 4T1 | IC50 |
23 μM
Compound: 5 Fluorouracil
|
Cytotoxicity against mouse 4T1 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against mouse 4T1 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212] |
| 4T1 | IC50 |
28.12 μM
Compound: 5-Fu
|
Anticancer activity against mouse 4T1 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
Anticancer activity against mouse 4T1 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31509699] |
| 786-0 | GI50 |
0.72 μM
Compound: 5-FU
|
Growth inhibition of human 786-0 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human 786-0 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| 786-0 | IC50 |
>10 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human 786-0 cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
Antiproliferative activity against human 786-0 cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
|
[PMID: 27295506] |
| 786-0 | GI50 |
0.72 μM
Compound: 5-FU
|
Anticancer activity against human 786-0 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human 786-0 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| 786-0 | IC50 |
0.72 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human 786-0 cells assessed as cell growth inhibition
Cytotoxicity against human 786-0 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| 786-0 | IC50 |
2.29 μM
Compound: 5-Fu
|
Antiproliferative activity against human 786-0 cells incubated for 72 hrs by SRB method
Antiproliferative activity against human 786-0 cells incubated for 72 hrs by SRB method
|
[PMID: 39054645] |
| 9L | IC50 |
1 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against 9L cells
Tested in vitro for anticancer activity against 9L cells
|
[PMID: 10072683] |
| A2780 | IC50 |
5 μM
Compound: 5-Fu
|
Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
|
[PMID: 16499317] |
| A2780 | IC50 |
0.65 μg/mL
Compound: 5-FU, 5-fluorouracil
|
Cytotoxicity against human A2780 cells by MTT assay
Cytotoxicity against human A2780 cells by MTT assay
|
[PMID: 18205316] |
| A2780 | IC50 |
7.21 μM
Compound: 5-FU
|
Antiproliferative activity against human A2780 cells expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against human A2780 cells expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| A2780 | IC50 |
0.2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human A2780 after 24 hrs by MTT assay
Cytotoxicity against human A2780 after 24 hrs by MTT assay
|
[PMID: 19338315] |
| A2780 | GI50 |
4.4 μM
Compound: 5-FU
|
Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 19664930] |
| A2780 | IC50 |
14 μM
Compound: 5-FU
|
Antiproliferative activity against human A2780 cells expressing p53 after 72 hrs by celltiter-glo assay
Antiproliferative activity against human A2780 cells expressing p53 after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| A2780 | GI50 |
3.5 μM
Compound: 5FU
|
Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human A2780 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| A2780 | IC50 |
5.1 μM
Compound: 1, 5-FU
|
Growth inhibition of human A2780 cells by crystal violet assay
Growth inhibition of human A2780 cells by crystal violet assay
|
[PMID: 23075414] |
| A2780 | IC50 |
5.4 μM
Compound: 5-Fu
|
Cytotoxicity against human A2780 cells by MTT method
Cytotoxicity against human A2780 cells by MTT method
|
[PMID: 23164710] |
| A2780 | IC50 |
32.11 μM
Compound: 1; 5-FU
|
Growth inhibition of human A2780 cells incubated for 1.5 hrs by MTT assay
Growth inhibition of human A2780 cells incubated for 1.5 hrs by MTT assay
|
[PMID: 38107178] |
| A2780 | IC50 |
36.29 μM
Compound: 1; 5-FU
|
Antiproliferative activity against human A2780 cells assessed as inhibition of cell growth incubated for 1.5 hrs by CCK-8 assay
Antiproliferative activity against human A2780 cells assessed as inhibition of cell growth incubated for 1.5 hrs by CCK-8 assay
|
[PMID: 38107178] |
| A2780 | IC50 |
12.93 μM
Compound: 5-Fu
|
Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| A2780 | IC50 |
3.932 μM
Compound: 5-Fu
|
Cytotoxicity against human A2780 cells assessed as cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human A2780 cells assessed as cell viability measured after 48 hrs by MTT assay
|
[PMID: 38964974] |
| A-375 | IC50 |
46.55 μM
Compound: 5-FU
|
Cytotoxicity against human A375 cells after 48 hrs by MTT assay
Cytotoxicity against human A375 cells after 48 hrs by MTT assay
|
[PMID: 22483608] |
| A-375 | IC50 |
21.09 μM
Compound: 5-Fu
|
Anticancer activity against human A375 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
Anticancer activity against human A375 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31509699] |
| A-375 | IC50 |
5.98 μM
Compound: 5-Fu
|
Antiproliferative activity against human A-375 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
Antiproliferative activity against human A-375 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
|
[PMID: 35797896] |
| A-375 | IC50 |
3.52 μM
Compound: 5-FU
|
Cytotoxicity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| A-375 | IC50 |
69.65 μM
Compound: 5-Fu
|
Antiproliferative activity against human A-375 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human A-375 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 39163776] |
| A-431 | ED50 |
44 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human A431 cells by MTT assay
Cytotoxicity against human A431 cells by MTT assay
|
[PMID: 12027771] |
| A-431 | IC50 |
0.018 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A431 cells after 48 hrs by MTT assay
Antiproliferative activity against human A431 cells after 48 hrs by MTT assay
|
[PMID: 19423198] |
| A-431 | IC50 |
2.17 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human A431 cells after 48 hrs by MTT assay
Cytotoxicity against human A431 cells after 48 hrs by MTT assay
|
[PMID: 20800480] |
| A498 | GI50 |
0.35 μM
Compound: 5-FU
|
Growth inhibition of human A498 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human A498 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| A498 | IC50 |
8.83 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human A498 cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
Antiproliferative activity against human A498 cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
|
[PMID: 27295506] |
| A498 | GI50 |
0.35 μM
Compound: 5-FU
|
Anticancer activity against human A498 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human A498 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| A498 | IC50 |
0.35 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A498 cells assessed as cell growth inhibition
Cytotoxicity against human A498 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| A549 | IC50 |
0.1 μg/mL
Compound: 5-fluorouracil
|
Antitumor activity against human A549 cells
Antitumor activity against human A549 cells
|
[PMID: 10579858] |
| A549 | IC50 |
0.26 μg/mL
Compound: 5-FU
|
Inhibitory concentration of compound for cytotoxicity against A459 human lung cells was determined
Inhibitory concentration of compound for cytotoxicity against A459 human lung cells was determined
|
[PMID: 11814824] |
| A549 | EC50 |
3.61 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 12027739] |
| A549 | IC50 |
50.5 μM
Compound: 5-FU
|
In vitro inhibitory concentration required against human lung carcinoma A-549 cell line was determined after 72 hrs of drug exposure using SRB method
In vitro inhibitory concentration required against human lung carcinoma A-549 cell line was determined after 72 hrs of drug exposure using SRB method
|
[PMID: 15380199] |
| A549 | ED50 |
0.4 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 16309328] |
| A549 | IC50 |
1.4 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
|
[PMID: 16499317] |
| A549 | IC50 |
3.1 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells by MTT microassay
Cytotoxicity against human A549 cells by MTT microassay
|
[PMID: 17320246] |
| A549 | IC50 |
9.2 μM
Compound: 5-FU
|
Cytotoxicity against A549 cells after 48 hrs by MTT assay
Cytotoxicity against A549 cells after 48 hrs by MTT assay
|
[PMID: 17604394] |
| A549 | IC50 |
0.18 μg/mL
Compound: 5-FU, 5-fluorouracil
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 18205316] |
| A549 | IC50 |
9.19 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 18440233] |
| A549 | IC50 |
3.1 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 18606546] |
| A549 | IC50 |
10.85 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 18644718] |
| A549 | IC50 |
50.5 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 72 hrs by SRB method
Cytotoxicity against human A549 cells after 72 hrs by SRB method
|
[PMID: 19324555] |
| A549 | IC50 |
0.2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human A549 after 24 hrs by MTT assay
Cytotoxicity against human A549 after 24 hrs by MTT assay
|
[PMID: 19338315] |
| A549 | IC50 |
20.8 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human A549 cells by SRB method
Cytotoxicity against human A549 cells by SRB method
|
[PMID: 19422203] |
| A549 | IC50 |
5.91 μM
Compound: 5-Fluoro uracil
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 19689125] |
| A549 | IC50 |
2 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells by SRB assay
Cytotoxicity against human A549 cells by SRB assay
|
[PMID: 19700322] |
| A549 | IC50 |
78 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by XTT method
Cytotoxicity against human A549 cells after 48 hrs by XTT method
|
[PMID: 20151671] |
| A549 | IC50 |
5.4 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 24 hrs by trypan blue exclusion assay
Antiproliferative activity against human A549 cells after 24 hrs by trypan blue exclusion assay
|
[PMID: 20403701] |
| A549 | EC50 |
100 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 20409617] |
| A549 | IC50 |
2.4 μM
Compound: 5-fluorouracil
|
Anticancer activity against human A549 cells assessed as cell viability after 48 hrs by SRB assay
Anticancer activity against human A549 cells assessed as cell viability after 48 hrs by SRB assay
|
[PMID: 21074444] |
| A549 | IC50 |
11.3 μM
Compound: 5-fluorouracil
|
Cytotoxicity in human A549 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity in human A549 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21250700] |
| A549 | IC50 |
>20 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21381696] |
| A549 | GI50 |
2.4 μM
Compound: 5FU
|
Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| A549 | IC50 |
13.7 μM
Compound: fluorouracil
|
Cytotoxicity against human A549 cells
Cytotoxicity against human A549 cells
|
[PMID: 21495659] |
| A549 | IC50 |
5.6 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 21515044] |
| A549 | IC50 |
52 μM
Compound: Fluorouracil
|
Cytotoxicity against human A549 cells
Cytotoxicity against human A549 cells
|
[PMID: 21774474] |
| A549 | IC50 |
0.42 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 3 days by MTT assay
Cytotoxicity against human A549 cells after 3 days by MTT assay
|
[PMID: 22000925] |
| A549 | IC50 |
3.2 x 10-1 μg/mL
Compound: fluorouracil
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 22011319] |
| A549 | IC50 |
5.64 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 22182926] |
| A549 | IC50 |
54.8 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 22244588] |
| A549 | IC50 |
35.05 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 22483608] |
| A549 | IC50 |
5.64 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells by after 48 hrs by MTT assay
Cytotoxicity against human A549 cells by after 48 hrs by MTT assay
|
[PMID: 22579780] |
| A549 | IC50 |
8.83 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| A549 | IC50 |
31.52 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 22801644] |
| A549 | IC50 |
35.41 μM
Compound: Fluorouracil
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 22809558] |
| A549 | IC50 |
12.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 22840493] |
| A549 | IC50 |
4.21 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed cell viability after 48 hrs by SRB assay
Cytotoxicity against human A549 cells assessed cell viability after 48 hrs by SRB assay
|
[PMID: 23044370] |
| A549 | IC50 |
88.9 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23067549] |
| A549 | IC50 |
1.54 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells by MTT method
Cytotoxicity against human A549 cells by MTT method
|
[PMID: 23164710] |
| A549 | IC50 |
5.64 μM
Compound: 5-Fu
|
Growth inhibition of human A549 cells after 48 hrs by MTT assay
Growth inhibition of human A549 cells after 48 hrs by MTT assay
|
[PMID: 23353737] |
| A549 | IC50 |
56 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23356786] |
| A549 | IC50 |
4.9 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23501113] |
| A549 | IC50 |
44.05 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| A549 | IC50 |
3.52 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 23665106] |
| A549 | IC50 |
8.71 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 23685571] |
| A549 | GI50 |
0.18 μM
Compound: 5-FU
|
Growth inhibition of human A549/ATCC cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human A549/ATCC cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| A549 | IC50 |
5.62 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23920246] |
| A549 | GI50 |
3.6 μM
Compound: fluorouracil
|
Cytotoxicity against human A549 cells after 72 hrs by SRB assay
Cytotoxicity against human A549 cells after 72 hrs by SRB assay
|
[PMID: 23964677] |
| A549 | IC50 |
34.33 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23988357] |
| A549 | IC50 |
44.05 μM
Compound: 5-Fu
|
Growth inhibition against human A549 cells after 48 hrs by MTT assay
Growth inhibition against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| A549 | IC50 |
1.1 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 24060486] |
| A549 | IC50 |
8.92 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells by MTT assay
Antiproliferative activity against human A549 cells by MTT assay
|
[PMID: 24095094] |
| A549 | IC50 |
34.33 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 3 days by MTT assay
Cytotoxicity against human A549 cells after 3 days by MTT assay
|
[PMID: 24095745] |
| A549 | IC50 |
20.13 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 24211021] |
| A549 | IC50 |
24.87 μg/mL
Compound: 5-F
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 24342667] |
| A549 | IC50 |
3.1 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human A549 cells after 4 days by MTT assay
Cytotoxicity against human A549 cells after 4 days by MTT assay
|
[PMID: 24359303] |
| A549 | IC50 |
1.9 μM
Compound: 5-Fluoro uracilc
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 24641975] |
| A549 | IC50 |
0.98 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as growth inhibition measured at 48 hrs by SRB assay
Cytotoxicity against human A549 cells assessed as growth inhibition measured at 48 hrs by SRB assay
|
[PMID: 24727462] |
| A549 | IC50 |
44.05 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 2 days by MTT assay
Cytotoxicity against human A549 cells after 2 days by MTT assay
|
[PMID: 24767839] |
| A549 | GI50 |
4.55 μM
Compound: 5-fluorouracil
|
Growth inhibition of human A549 cells after 48 hrs by SRB assay
Growth inhibition of human A549 cells after 48 hrs by SRB assay
|
[PMID: 24797798] |
| A549 | IC50 |
1.3 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 24835633] |
| A549 | IC50 |
34.34 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| A549 | IC50 |
4.21 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human A549 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 24956552] |
| A549 | IC50 |
1.65 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 24 to 48 hrs by sulforhodamine B assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 24 to 48 hrs by sulforhodamine B assay
|
[PMID: 24996138] |
| A549 | IC50 |
35.41 μM
Compound: Fluorouracil
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 25016234] |
| A549 | IC50 |
4.1 μg/mL
Compound: 5-Fu
|
Anticancer activity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
Anticancer activity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 25017036] |
| A549 | IC50 |
7.62 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 25113877] |
| A549 | IC50 |
51.64 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 25164762] |
| A549 | IC50 |
6.69 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as growth inhibition rate after 96 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition rate after 96 hrs by MTT assay
|
[PMID: 25203783] |
| A549 | IC50 |
0.01 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 25259515] |
| A549 | IC50 |
8.13 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation by CCK8 assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation by CCK8 assay
|
[PMID: 25442303] |
| A549 | IC50 |
38.23 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 2 days by MTT assay
Cytotoxicity against human A549 cells after 2 days by MTT assay
|
[PMID: 25841196] |
| A549 | IC50 |
36.34 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25841199] |
| A549 | IC50 |
7.51 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 25870131] |
| A549 | IC50 |
2.8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human A549 cells after 72 hrs by WST8 assay
Antiproliferative activity against human A549 cells after 72 hrs by WST8 assay
|
[PMID: 25919052] |
| A549 | IC50 |
40.38 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
|
[PMID: 25959813] |
| A549 | IC50 |
4.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay
|
[PMID: 26222449] |
| A549 | IC50 |
14.15 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 26227777] |
| A549 | IC50 |
2.13 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Anticancer activity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080] |
| A549 | IC50 |
44.05 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as induction of cell death incubated for 2 days by MTT assay
Cytotoxicity against human A549 cells assessed as induction of cell death incubated for 2 days by MTT assay
|
[PMID: 26259802] |
| A549 | IC50 |
7.244 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 26301558] |
| A549 | IC50 |
22.28 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 26363869] |
| A549 | IC50 |
6.76 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 26595184] |
| A549 | IC50 |
9 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells after 72 hrs by WST-8 assay
Antiproliferative activity against human A549 cells after 72 hrs by WST-8 assay
|
[PMID: 26606140] |
| A549 | IC50 |
1.1 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 26629861] |
| A549 | IC50 |
3.52 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTS assay
Antiproliferative activity against human A549 cells after 72 hrs by MTS assay
|
[PMID: 26703795] |
| A549 | IC50 |
31.33 μM
Compound: 5-FU
|
Cytotoxic activity against human A549 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxic activity against human A549 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26706349] |
| A549 | IC50 |
3.47 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 26735909] |
| A549 | IC50 |
8.13 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human A549 cells after 48 hrs by CCK8 assay
|
[PMID: 26786698] |
| A549 | IC50 |
1.4 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 26854375] |
| A549 | IC50 |
54.82 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 26873416] |
| A549 | IC50 |
34.27 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 26883148] |
| A549 | IC50 |
>50 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 26922223] |
| A549 | IC50 |
3.98 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 27092413] |
| A549 | IC50 |
35.41 μM
Compound: Fluorouracil
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 27128180] |
| A549 | IC50 |
21.58 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 27133593] |
| A549 | IC50 |
44.05 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 27189676] |
| A549 | IC50 |
10.5 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27262600] |
| A549 | IC50 |
2.8 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| A549 | IC50 |
16.96 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| A549 | IC50 |
24.66 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 27400887] |
| A549 | IC50 |
39.86 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27448774] |
| A549 | IC50 |
1.7 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 27528432] |
| A549 | IC50 |
6.8 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells measured after 72 hrs by MTT assay
Cytotoxicity against human A549 cells measured after 72 hrs by MTT assay
|
[PMID: 27537924] |
| A549 | IC50 |
8.13 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by CCK-8 assay
Antiproliferative activity against human A549 cells after 48 hrs by CCK-8 assay
|
[PMID: 27542307] |
| A549 | IC50 |
3.52 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTS assay
Antiproliferative activity against human A549 cells after 72 hrs by MTS assay
|
[PMID: 27575478] |
| A549 | IC50 |
30.47 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27614408] |
| A549 | IC50 |
13.95 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as growth inhibition by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition by MTT assay
|
[PMID: 27769034] |
| A549 | IC50 |
2.9 mM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27847140] |
| A549 | IC50 |
2.8 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 27875779] |
| A549 | IC50 |
16.63 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27913179] |
| A549 | IC50 |
1.16 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 27987485] |
| A549 | IC50 |
32.15 μM
Compound: 5-Fu
|
Cytotoxic activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay
|
[PMID: 28011223] |
| A549 | IC50 |
34.27 μM
Compound: 5FU
|
Cytotoxicity against human A549 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
Cytotoxicity against human A549 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
|
[PMID: 28038327] |
| A549 | IC50 |
10.5 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 28073676] |
| A549 | IC50 |
16.1 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 28117202] |
| A549 | IC50 |
1.2 μM
Compound: 5-F
|
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 28254697] |
| A549 | IC50 |
38.2 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 28371676] |
| A549 | IC50 |
10.65 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells incubated for 48 to 72 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 48 to 72 hrs by MTT assay
|
[PMID: 28395218] |
| A549 | GI50 |
2.09 μM
Compound: 5-FU
|
Growth inhibition of human A549 cells after 48 hrs by SRB assay
Growth inhibition of human A549 cells after 48 hrs by SRB assay
|
[PMID: 28400235] |
| A549 | IC50 |
15.1 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 28400238] |
| A549 | IC50 |
1.6 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 28431881] |
| A549 | IC50 |
4.7 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
|
[PMID: 28558970] |
| A549 | IC50 |
34.47 μM
Compound: 5-FU
|
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 28754470] |
| A549 | IC50 |
12.92 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 28863355] |
| A549 | GI50 |
4.2 μM
Compound: 5-Fluorouracil
|
Growth inhibition of human A549 cells after 48 hrs by SRB assay
Growth inhibition of human A549 cells after 48 hrs by SRB assay
|
[PMID: 28898082] |
| A549 | IC50 |
8.9 μM
Compound: 5-Fu
|
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 28987604] |
| A549 | IC50 |
11.2 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
|
[PMID: 29133037] |
| A549 | IC50 |
11.4 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133037] |
| A549 | IC50 |
2.8 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 29133046] |
| A549 | IC50 |
8.48 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 29133051] |
| A549 | IC50 |
15.93 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human A549 cells in presence of ubenimex after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells in presence of ubenimex after 48 hrs by MTT assay
|
[PMID: 29202398] |
| A549 | IC50 |
17.02 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 29202398] |
| A549 | IC50 |
66 μg/mL
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 29207336] |
| A549 | IC50 |
0.43 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 29254641] |
| A549 | IC50 |
55.7 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 29305189] |
| A549 | IC50 |
19.52 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 29486954] |
| A549 | IC50 |
36.8 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as decrease in cell viability by MTT assay
Cytotoxicity against human A549 cells assessed as decrease in cell viability by MTT assay
|
[PMID: 29489361] |
| A549 | IC50 |
13.18 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 29635165] |
| A549 | IC50 |
39.86 μM
Compound: 5-FU
|
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 29657100] |
| A549 | IC50 |
3.52 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells by MTS assay
Cytotoxicity against human A549 cells by MTS assay
|
[PMID: 29843103] |
| A549 | IC50 |
69.07 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 29958763] |
| A549 | IC50 |
55.73 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 30007564] |
| A549 | IC50 |
23.5 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 30108895] |
| A549 | IC50 |
71.09 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 30142612] |
| A549 | IC50 |
2.05 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 30243153] |
| A549 | IC50 |
7.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay
Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay
|
[PMID: 30248657] |
| A549 | IC50 |
4.3 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 30318440] |
| A549 | IC50 |
13.18 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30388465] |
| A549 | IC50 |
14.96 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 30472605] |
| A549 | IC50 |
23.57 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 30568759] |
| A549 | IC50 |
28.64 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| A549 | IC50 |
10.55 μM
Compound: 5-FU
|
Cytotoxicity against human A549 assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human A549 assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30709651] |
| A549 | IC50 |
38.7 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 30737134] |
| A549 | IC50 |
2.05 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757] |
| A549 | IC50 |
>100 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 31057737] |
| A549 | IC50 |
7.1 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as reduction in viability after 48 hrs by SRB assay
Cytotoxicity against human A549 cells assessed as reduction in viability after 48 hrs by SRB assay
|
[PMID: 31103402] |
| A549 | IC50 |
104.5 μM
Compound: 5-FU
|
Cytotoxicity in human A549 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
Cytotoxicity in human A549 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 31128448] |
| A549 | IC50 |
2.33 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992] |
| A549 | IC50 |
2.42 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197] |
| A549 | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells by MTT assay
Antiproliferative activity against human A549 cells by MTT assay
|
[PMID: 31546197] |
| A549 | IC50 |
50.43 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| A549 | IC50 |
8.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
|
[PMID: 31829592] |
| A549 | IC50 |
33.68 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human A549 cells assessed as cell growth inhibition by MTT assay
Antiproliferative activity against human A549 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 31945642] |
| A549 | IC50 |
6.8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured for 24 hrs
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured for 24 hrs
|
[PMID: 31945642] |
| A549 | IC50 |
0.69 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antiproliferative activity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 32485532] |
| A549 | IC50 |
>10 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
|
[PMID: 32659087] |
| A549 | GI50 |
19.76 μM
Compound: 4; 5-FU
|
Antiproliferative activity against human A549 cells measured after 48 hrs by SRB assay
Antiproliferative activity against human A549 cells measured after 48 hrs by SRB assay
|
[PMID: 32683166] |
| A549 | GI50 |
10.7 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
|
[PMID: 32832031] |
| A549 | IC50 |
17.3 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 32987314] |
| A549 | IC50 |
22.5 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 32987314] |
| A549 | IC50 |
25.3 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 32987314] |
| A549 | IC50 |
14.53 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 4 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 4 hrs by MTT assay
|
[PMID: 32992255] |
| A549 | IC50 |
34.47 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells by MTT assay
Antiproliferative activity against human A549 cells by MTT assay
|
[PMID: 33109400] |
| A549 | IC50 |
>30 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| A549 | IC50 |
>50 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33538581] |
| A549 | IC50 |
15.3 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Cytotoxicity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 33740546] |
| A549 | IC50 |
1.65 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as reduction in cell growth by CCK8 assay
Antiproliferative activity against human A549 cells assessed as reduction in cell growth by CCK8 assay
|
[PMID: 33964443] |
| A549 | IC50 |
2.36 μM
Compound: 5-Fluorouracil
|
Cytotoxicity activity against human A549 cells incubated for 48 hrs by SRB assay
Cytotoxicity activity against human A549 cells incubated for 48 hrs by SRB assay
|
[PMID: 34119830] |
| A549 | IC50 |
2.53 μM
Compound: 5-Fu
|
Antiproliferation activity against human A549 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
Antiproliferation activity against human A549 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
|
[PMID: 34186178] |
| A549 | IC50 |
15.14 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 34624825] |
| A549 | GI50 |
2.2 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human A549 cells assessed as reduction in cell growth
Antiproliferative activity against human A549 cells assessed as reduction in cell growth
|
[PMID: 34847410] |
| A549 | IC50 |
6.6 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 34883453] |
| A549 | IC50 |
100.02 μM
Compound: 5-FU
|
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35085721] |
| A549 | GI50 |
0.18 μM
Compound: 5-FU
|
Anticancer activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| A549 | IC50 |
3.85 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
|
[PMID: 35290844] |
| A549 | IC50 |
8.12 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 35609396] |
| A549 | IC50 |
11.42 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35635947] |
| A549 | IC50 |
31.41 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition
Cytotoxicity against human A549 cells assessed as cell growth inhibition
|
[PMID: 35809817] |
| A549 | IC50 |
1.65 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells
Antiproliferative activity against human A549 cells
|
[PMID: 35944853] |
| A549 | IC50 |
34.89 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition
Cytotoxicity against human A549 cells assessed as cell growth inhibition
|
[PMID: 35964428] |
| A549 | IC50 |
35.41 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth
|
[PMID: 36089111] |
| A549 | IC50 |
2.65 μM
Compound: 5-FU
|
Antitumor activity against human A549 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
Antitumor activity against human A549 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
|
[PMID: 36324491] |
| A549 | IC50 |
4.52 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| A549 | IC50 |
3.08 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 36335743] |
| A549 | IC50 |
29.17 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36336316] |
| A549 | IC50 |
108.7 μM
Compound: 5-FU
|
Anticancer activity against human A549 cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human A549 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| A549 | IC50 |
0.18 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition
Cytotoxicity against human A549 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| A549 | IC50 |
11.13 μM
Compound: 5-FU
|
Anticancer activity against human A549 cells assessed as cell growth inhibition by MTT assay
Anticancer activity against human A549 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 36481599] |
| A549 | IC50 |
11.3 μM
Compound: 5-FU
|
Anticancer activity against human A549 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Anticancer activity against human A549 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 36481599] |
| A549 | IC50 |
1.3 μM
Compound: 5-Fu
|
Cytotoxicity against human A549 cells assessed as cell inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell inhibition measured after 72 hrs by MTT assay
|
[PMID: 36774698] |
| A549 | IC50 |
32.4 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
Cytotoxicity against human A549 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
|
[PMID: 36970146] |
| A549 | IC50 |
7.6 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 37098306] |
| A549 | IC50 |
27.08 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
|
[PMID: 37122546] |
| A549 | GI50 |
2.2 μM
Compound: 5-FU
|
Growth inhibition of human A549 cells measured after 48 hrs by SRB colorimetric assay
Growth inhibition of human A549 cells measured after 48 hrs by SRB colorimetric assay
|
[PMID: 37137247] |
| A549 | IC50 |
25.36 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 37343499] |
| A549 | IC50 |
5.7 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 37859725] |
| A549 | IC50 |
34.86 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells by CCK8 assay
Antiproliferative activity against human A549 cells by CCK8 assay
|
[PMID: 37939862] |
| A549 | IC50 |
18.55 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 38107169] |
| A549 | IC50 |
>20 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 38897138] |
| A549 | IC50 |
22.8 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 39016216] |
| A549 | IC50 |
24.2 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
|
[PMID: 39045852] |
| A549 | IC50 |
36.3 μM
Compound: 5-FU
|
Antiproliferative activity against human A549 cells incubated for 24 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 24 hrs by MTT assay
|
[PMID: 39045852] |
| A549 | IC50 |
11.5 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells incubated for 72 hrs by SRB method
Antiproliferative activity against human A549 cells incubated for 72 hrs by SRB method
|
[PMID: 39054645] |
| A549 | IC50 |
3.9 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 39106494] |
| A549 | IC50 |
88.27 μM
Compound: 5-Fu
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 39163776] |
| A549 | IC50 |
>100 μM
Compound: 5-FU
|
Antitumor activity against Homo sapiens (human) A549 cells assessed as inhibition of cell viability after 72 hr by MTT assay
Antitumor activity against Homo sapiens (human) A549 cells assessed as inhibition of cell viability after 72 hr by MTT assay
|
10.1007/s00044-012-0283-8 |
| A549 | IC50 |
1.7 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of A-549 tumor cell line from lung.
Compound was tested for its inhibitory effect on the growth of A-549 tumor cell line from lung.
|
10.1016/0960-894X(96)00339-3 |
| A549 | IC50 |
0.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human A549 cells assessed as inhibition of cell growth after 48 hrs by sulforhodamine B assay
Cytotoxicity against human A549 cells assessed as inhibition of cell growth after 48 hrs by sulforhodamine B assay
|
10.1039/C5MD00289C |
| A549 | IC50 |
22.62 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
10.1039/C6MD00061D |
| A549 | IC50 |
26 μM
Compound: 5-FU
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
10.1039/C6MD00234J |
| A549 | IC50 |
10.32 μM
Compound: 5-FU
|
Antiproliferative activity in human A549 cells after 72 hrs by MTT assay
Antiproliferative activity in human A549 cells after 72 hrs by MTT assay
|
10.1039/C6MD00252H |
| A549/TR | IC50 |
112.23 μM
Compound: 5-FU
|
Cytotoxicity against human A549/TAX cells after 72 hrs by MTT assay
Cytotoxicity against human A549/TAX cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| A549/TR | IC50 |
84.28 μM
Compound: 5-FU
|
Cytotoxicity against human A549/T cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549/T cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| ACHN | IC50 |
9.874 μg/mL
Compound: 5-FU
|
Cytotoxicity against human ACHN cells after 24 hrs by MTT assay
Cytotoxicity against human ACHN cells after 24 hrs by MTT assay
|
[PMID: 23548704] |
| ACHN | GI50 |
0.29 μM
Compound: 5-FU
|
Growth inhibition of human ACHN cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human ACHN cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| ACHN | IC50 |
2.73 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human ACHN cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
Antiproliferative activity against human ACHN cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
|
[PMID: 27295506] |
| ACHN | GI50 |
0.27 μM
Compound: 5-FU
|
Anticancer activity against human ACHN cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human ACHN cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| ACHN | IC50 |
0.27 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human ACHN cells assessed as cell growth inhibition
Cytotoxicity against human ACHN cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| AGS | IC50 |
370 μM
Compound: 5-FU
|
Cytotoxicity against AGS cells after 48 hrs by MTT assay
Cytotoxicity against AGS cells after 48 hrs by MTT assay
|
[PMID: 17604394] |
| AGS | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human AGS cells after 72 hrs by SRB method
Cytotoxicity against human AGS cells after 72 hrs by SRB method
|
[PMID: 19324555] |
| AGS | GI50 |
25 μM
Compound: 5-Fu
|
Antiproliferative activity against human AGS cells after 48 hrs by MTT assay
Antiproliferative activity against human AGS cells after 48 hrs by MTT assay
|
[PMID: 28763647] |
| AGS | IC50 |
29.6 μM
Compound: 5-FU
|
Anti-proliferative activity against human AGS cells after 48 hrs by MTT assay
Anti-proliferative activity against human AGS cells after 48 hrs by MTT assay
|
[PMID: 28947149] |
| AGS | GI50 |
24.6 μM
Compound: 5-FU
|
Antiproliferative activity against human AGS cells after 48 hrs by MTT assay
Antiproliferative activity against human AGS cells after 48 hrs by MTT assay
|
[PMID: 29040954] |
| AGS | IC50 |
11.04 μM
Compound: 5-FU
|
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| AGS | IC50 |
23.24 μM
Compound: 5-Fu
|
Cytotoxicity against human AGS cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human AGS cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34628244] |
| AGS | IC50 |
58 μM
Compound: 5-Fu
|
Cytotoxicity against human AGS cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human AGS cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 35191714] |
| AGS | EC50 |
7.25 μM
Compound: 5FU
|
Cytotoxicity against human AGS cells assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
Cytotoxicity against human AGS cells assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
|
[PMID: 35939803] |
| ASPC1 | IC50 |
2.97 μM
Compound: 5-FU
|
Cytotoxicity against human Aspc-1 cells by crystal violet staining
Cytotoxicity against human Aspc-1 cells by crystal violet staining
|
[PMID: 20930123] |
| ASPC1 | IC50 |
98 μM
Compound: 5-FU
|
Cytotoxicity against human AsPC1 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human AsPC1 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27448774] |
| Astrocyte | IC50 |
>100 μM
Compound: 5FU
|
Cytotoxicity against rat astrocytes
Cytotoxicity against rat astrocytes
|
[PMID: 16970409] |
| AZ-521 cell line | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Cytotoxicity in human AZ-521 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity in human AZ-521 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21250700] |
| AZ-521 cell line | IC50 |
>20 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human AZ-521 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human AZ-521 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21381696] |
| B16 | IC50 |
8.73 μM
Compound: 5-FU
|
Cytotoxicity against mouse B16 cells by MTT assay
Cytotoxicity against mouse B16 cells by MTT assay
|
[PMID: 18644718] |
| B16 | IC50 |
2.6 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Mouse melanoma (B16) cell line.
In vitro inhibitory activity against Mouse melanoma (B16) cell line.
|
[PMID: 1995905] |
| B16 | IC50 |
33 μM
Compound: 5-fu
|
Cytotoxicity against mouse B16 cells after 48 hrs by MTT assay
Cytotoxicity against mouse B16 cells after 48 hrs by MTT assay
|
[PMID: 22304344] |
| B16 | IC50 |
4.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse B16 cells after 48 hrs by MTT assay
Cytotoxicity against mouse B16 cells after 48 hrs by MTT assay
|
[PMID: 24332497] |
| B16 | IC50 |
17.85 μM
Compound: 5-FU
|
Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay
Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay
|
[PMID: 25164762] |
| B16 | IC50 |
7.64 μM
Compound: 5-fluorouracil
|
Cytotoxicity against mouse B16 cells assessed as cell survival after 48 hrs by MTT assay
Cytotoxicity against mouse B16 cells assessed as cell survival after 48 hrs by MTT assay
|
[PMID: 25506718] |
| B16 | IC50 |
10.52 μM
Compound: 5-FU
|
Antiproliferative activity against mouse B16 cells after 72 hrs by MTT assay
Antiproliferative activity against mouse B16 cells after 72 hrs by MTT assay
|
[PMID: 25529742] |
| B16 | IC50 |
1.19 μM
Compound: 5-Fu
|
Cytotoxicity in mouse B16 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity in mouse B16 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 28987604] |
| B16 | IC50 |
12.62 μM
Compound: 5-Fu
|
Antiproliferative activity against mouse B16 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against mouse B16 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31877536] |
| B16-BL6 | IC50 |
0.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against mouse B16-BL6 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against mouse B16-BL6 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 11575942] |
| B16-BL6 | EC50 |
1.23 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay
Antiproliferative activity against mouse B16-BL6 cells after 72 hrs by MTT assay
|
[PMID: 12027739] |
| B16-BL6 | IC50 |
5.78 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay
Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay
|
[PMID: 18440233] |
| B16-BL6 | IC50 |
7.39 μM
Compound: 5-Fluoro uracil
|
Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay
Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay
|
[PMID: 19689125] |
| B16-F10 | IC50 |
21.41 μM
Compound: 5-Fluorouracil
|
Anticancer activity against mouse B16F10 cells assessed as cell survival measured after 48 hrs by MTT assay
Anticancer activity against mouse B16F10 cells assessed as cell survival measured after 48 hrs by MTT assay
|
[PMID: 23312949] |
| B16-F10 | IC50 |
0.87 μM
Compound: 5-Fu
|
Cytotoxicity against mouse B16F10 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Cytotoxicity against mouse B16F10 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25180925] |
| B16-F10 | IC50 |
1.43 μM
Compound: 5-Fu
|
Anticancer activity against mouse B16F10 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Anticancer activity against mouse B16F10 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25655718] |
| B16-F10 | IC50 |
6.29 μM
Compound: 5-Fu
|
Antiproliferative activity against mouse B16/F10 cells after 72 hrs by MTT assay
Antiproliferative activity against mouse B16/F10 cells after 72 hrs by MTT assay
|
[PMID: 29254641] |
| B16-F10 | IC50 |
4 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against mouse B16-F10 cells by MTT assay
Cytotoxicity against mouse B16-F10 cells by MTT assay
|
[PMID: 29280630] |
| BALB/3T3 | IC50 |
3.23 μM
Compound: FUra
|
Antiproliferative activity against mouse BALB/3T3 cells assessed as growth inhibition after 72 hrs by SRB method
Antiproliferative activity against mouse BALB/3T3 cells assessed as growth inhibition after 72 hrs by SRB method
|
[PMID: 25644674] |
| Bcap37 | IC50 |
5.33 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
|
[PMID: 22405648] |
| Bcap37 | IC50 |
5.58 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
|
[PMID: 24119869] |
| Bcap37 | IC50 |
5.18 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
|
[PMID: 25554922] |
| Bcap37 | IC50 |
5.58 μM
Compound: 5-Fu
|
Cytotoxicity against human Bcap37 cells assessed as induction of cell death incubated for 2 days by MTT assay
Cytotoxicity against human Bcap37 cells assessed as induction of cell death incubated for 2 days by MTT assay
|
[PMID: 26259802] |
| Bcap37 | IC50 |
47.09 μM
Compound: 5-Fu
|
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
|
[PMID: 26883148] |
| Bcap37 | IC50 |
15.47 μM
Compound: 5-Fu
|
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay
|
[PMID: 27133593] |
| Bcap37 | IC50 |
5.18 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Bcap37 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human Bcap37 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 27189676] |
| Bcap37 | IC50 |
37.09 μM
Compound: 5-Fu
|
Cytotoxicity against human Bcap37 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human Bcap37 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 27400887] |
| Bcap37 | IC50 |
47.1 μM
Compound: 5FU
|
Cytotoxicity against human Bcap37 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
Cytotoxicity against human Bcap37 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
|
[PMID: 28038327] |
| Bel-7402 | IC50 |
4.2 μM
Compound: 5-Fu
|
Cytotoxicity against human BEL-7402 cells after 96 hrs by MTT assay
Cytotoxicity against human BEL-7402 cells after 96 hrs by MTT assay
|
[PMID: 16499317] |
| Bel-7402 | IC50 |
23.21 μM
Compound: fluorouracil
|
Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay
Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay
|
[PMID: 17291040] |
| Bel-7402 | IC50 |
0.54 μg/mL
Compound: 5-FU, 5-fluorouracil
|
Cytotoxicity against human Bel 7402 cells by MTT assay
Cytotoxicity against human Bel 7402 cells by MTT assay
|
[PMID: 18205316] |
| Bel-7402 | IC50 |
14.41 μM
Compound: 5-FU
|
Cytotoxicity against human BEL-7402 cells by MTT assay
Cytotoxicity against human BEL-7402 cells by MTT assay
|
[PMID: 18644718] |
| Bel-7402 | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Bel7402 after 72 hrs by MTT assay
Cytotoxicity against human Bel7402 after 72 hrs by MTT assay
|
[PMID: 19233650] |
| Bel-7402 | IC50 |
4.7 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human Bel7402 cells after 24 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 24 hrs by MTT assay
|
[PMID: 19560842] |
| Bel-7402 | IC50 |
21.8 μM
Compound: fluorouracil
|
Cytotoxicity against human Bel7402 cells
Cytotoxicity against human Bel7402 cells
|
[PMID: 21495659] |
| Bel-7402 | IC50 |
8.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human Bel7402 cells by MTT assay
Antiproliferative activity against human Bel7402 cells by MTT assay
|
[PMID: 24095094] |
| Bel-7402 | IC50 |
5.5 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human Bel7402 cells after 4 days by MTT assay
Cytotoxicity against human Bel7402 cells after 4 days by MTT assay
|
[PMID: 24359303] |
| Bel-7402 | IC50 |
>500 μM
Compound: 5-FU
|
Cytotoxicity against human Bel7402 cells assessed as growth inhibition by MTT assay
Cytotoxicity against human Bel7402 cells assessed as growth inhibition by MTT assay
|
[PMID: 24684840] |
| Bel-7402 | IC50 |
11.12 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 24819956] |
| Bel-7402 | IC50 |
19.84 μM
Compound: 5-Fu
|
Antiproliferative activity against human Bel7402 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 25113877] |
| Bel-7402 | IC50 |
2.23 μM
Compound: 5-FU
|
Cytotoxicity against human Bel7402 cells assessed as growth inhibition rate after 96 hrs by MTT assay
Cytotoxicity against human Bel7402 cells assessed as growth inhibition rate after 96 hrs by MTT assay
|
[PMID: 25203783] |
| Bel-7402 | IC50 |
11.78 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 25529742] |
| Bel-7402 | IC50 |
19.91 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human Bel7402 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human Bel7402 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
|
[PMID: 25959813] |
| Bel-7402 | IC50 |
10.07 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 26227777] |
| Bel-7402 | IC50 |
>700 μM
Compound: 5-FU
|
Cytotoxicity against 5-fluorouracil-resistant human Bel7402 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against 5-fluorouracil-resistant human Bel7402 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 26320625] |
| Bel-7402 | IC50 |
2.25 μM
Compound: 5-Fu
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 28165738] |
| Bel-7402 | IC50 |
5.94 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by CCK-8 assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by CCK-8 assay
|
[PMID: 28301815] |
| Bel-7402 | IC50 |
20.93 μM
Compound: 5-Fu
|
Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay
Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay
|
[PMID: 29174813] |
| Bel-7402 | IC50 |
18.49 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 29407983] |
| Bel-7402 | IC50 |
18.49 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 29524728] |
| Bel-7402 | IC50 |
18.97 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 29635169] |
| Bel-7402 | IC50 |
18.65 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 30243153] |
| Bel-7402 | IC50 |
15.6 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells incubated for 48 hrs by MTT assay
|
[PMID: 30851694] |
| Bel-7402 | IC50 |
18.65 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757] |
| Bel-7402 | IC50 |
21.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113] |
| Bel-7402 | IC50 |
17.59 μM
Compound: 5-Fu
|
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992] |
| Bel-7402 | IC50 |
7.36 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402 incubated for 72 hrs by MTT assay
Antiproliferative activity against human Bel7402 incubated for 72 hrs by MTT assay
|
[PMID: 31553932] |
| Bel-7402 | IC50 |
53.33 μM
Compound: 5-FU
|
Cytotoxicity against human Bel7402 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human Bel7402 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| Bel-7402 | IC50 |
14.91 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
|
[PMID: 35290844] |
| Bel-7402 | IC50 |
36.52 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel-7402 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
Antiproliferative activity against human Bel-7402 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
|
[PMID: 37659196] |
| Bel-7402 | IC50 |
14.9 μM
Compound: 5-Fu
|
Antiproliferative activity against human Bel-7402 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human Bel-7402 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 39106494] |
| Bel-7402 | IC50 |
214.33 μM
Compound: 5-FU
|
Antiproliferative activity in 5-FU resistant human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity in 5-FU resistant human Bel7402 cells after 72 hrs by MTT assay
|
10.1039/C6MD00252H |
| Bel-7402 | IC50 |
7.57 μM
Compound: 5-FU
|
Antiproliferative activity in human Bel7402 cells after 72 hrs by MTT assay
Antiproliferative activity in human Bel7402 cells after 72 hrs by MTT assay
|
10.1039/C6MD00252H |
| Bel7402/5-FU | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by CCK-8 assay
Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by CCK-8 assay
|
[PMID: 28301815] |
| Bel7402/5-FU | IC50 |
>80 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by MTT assay
|
[PMID: 29407983] |
| Bel7402/5-FU | IC50 |
>80 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by MTT assay
Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by MTT assay
|
[PMID: 29524728] |
| Bel7402/5-FU | IC50 |
935.78 μM
Compound: 5-FU
|
Cytotoxicity against human Bel7402/5-FU cells after 72 hrs by MTT assay
Cytotoxicity against human Bel7402/5-FU cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| Bel7402/5-FU | IC50 |
61.7 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402/5-FU cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human Bel7402/5-FU cells incubated for 48 hrs by MTT assay
|
[PMID: 30851694] |
| Bel7402/5-FU | IC50 |
>400 μM
Compound: 5-FU
|
Antiproliferative activity against human Bel7402/5-FU incubated for 72 hrs by MTT assay
Antiproliferative activity against human Bel7402/5-FU incubated for 72 hrs by MTT assay
|
[PMID: 31553932] |
| Bel7402/5-FU | IC50 |
38.24 μM
Compound: 5-FU
|
Cytotoxicity against human Bel7402/5-FU cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human Bel7402/5-FU cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| BEL-7404 tumor cell line | IC50 |
0.2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human Bel7404 after 24 hrs by MTT assay
Cytotoxicity against human Bel7404 after 24 hrs by MTT assay
|
[PMID: 19338315] |
| BEL-7404 tumor cell line | IC50 |
26.8 μM
Compound: 5-FU
|
Cytotoxicity against human Bel7404 cells after 48 hrs by MTT assay
Cytotoxicity against human Bel7404 cells after 48 hrs by MTT assay
|
[PMID: 24565905] |
| BEL-7404 tumor cell line | IC50 |
30.23 μM
Compound: 5-FU
|
Cytotoxic activity against human Bel7404 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxic activity against human Bel7404 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26706349] |
| BEL-7404 tumor cell line | IC50 |
40.21 μM
Compound: 5-FU
|
Cytotoxicity against human Bel7404 cells after 48 hrs by MTT assay
Cytotoxicity against human Bel7404 cells after 48 hrs by MTT assay
|
[PMID: 30092368] |
| BGC-823 | IC50 |
5.4 μM
Compound: 5-Fu
|
Cytotoxicity against human BGC823 cells after 96 hrs by MTT assay
Cytotoxicity against human BGC823 cells after 96 hrs by MTT assay
|
[PMID: 16499317] |
| BGC-823 | IC50 |
31.16 μM
Compound: fluorouracil
|
Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 17291040] |
| BGC-823 | IC50 |
0.7 μg/mL
Compound: 5-FU, 5-fluorouracil
|
Cytotoxicity against human BGC 823 cells by MTT assay
Cytotoxicity against human BGC 823 cells by MTT assay
|
[PMID: 18205316] |
| BGC-823 | IC50 |
0.2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human BGC823 after 24 hrs by MTT assay
Cytotoxicity against human BGC823 after 24 hrs by MTT assay
|
[PMID: 19338315] |
| BGC-823 | EC50 |
17.37 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 21889345] |
| BGC-823 | IC50 |
100.02 μM
Compound: 5-FU
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 21962523] |
| BGC-823 | IC50 |
8.2 μg/mL
Compound: 5-FU
|
Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay
Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay
|
[PMID: 22647218] |
| BGC-823 | IC50 |
4.5 μM
Compound: 5-FU
|
Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay
Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay
|
[PMID: 22727445] |
| BGC-823 | IC50 |
15.65 μM
Compound: 5-Fu
|
Cytotoxicity against human BGC823 cells by MTT assay
Cytotoxicity against human BGC823 cells by MTT assay
|
[PMID: 22801644] |
| BGC-823 | IC50 |
1.52 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT method
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT method
|
[PMID: 23018096] |
| BGC-823 | IC50 |
3.84 μM
Compound: 5-Fu
|
Cytotoxicity against human BGC823 cells by MTT method
Cytotoxicity against human BGC823 cells by MTT method
|
[PMID: 23164710] |
| BGC-823 | IC50 |
7.48 μM
Compound: 5-FU
|
Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
Cytotoxicity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 24286761] |
| BGC-823 | IC50 |
35.6 μM
Compound: 5-Fu
|
Antiproliferative activity against human BGC823 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
|
[PMID: 25453794] |
| BGC-823 | IC50 |
34.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 28073676] |
| BGC-823 | IC50 |
17.37 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 28363444] |
| BGC-823 | IC50 |
34.8 μM
Compound: 5-FU
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 30108895] |
| BGC-823 | IC50 |
24.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
|
[PMID: 30527868] |
| BGC-823 | IC50 |
5.89 μM
Compound: 5-Fu
|
Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 32682202] |
| BGC-823 | IC50 |
15.4 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human BGC-823 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
Cytotoxicity against human BGC-823 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
|
[PMID: 33799070] |
| BGC-823 | IC50 |
14.02 μM
Compound: 5-Fu
|
Cytotoxicity against human BGC-823 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human BGC-823 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34628244] |
| BGC-823 | IC50 |
6.9 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36893627] |
| BGC-823 | IC50 |
37 μM
Compound: 5-Fu
|
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
Antiproliferative activity against human BGC823 cells after 48 hrs by MTT assay
|
10.1039/C5MD00382B |
| BGC-823 | IC50 |
8.82 μM
Compound: 5-FU
|
Cytotoxicity against human BGC823 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human BGC823 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
10.1039/C6MD00061D |
| BT-20 | IC50 |
47.3 μM
Compound: 5FU
|
Cytotoxicity against human BT20 cells incubated for 72 hrs by SRB assay
Cytotoxicity against human BT20 cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| BT-474 | IC50 |
72.9 μM
Compound: 5-Fu
|
Cytotoxicity against human BT474 cells after 3 days by MTT assay
Cytotoxicity against human BT474 cells after 3 days by MTT assay
|
[PMID: 22000925] |
| BT-549 | GI50 |
10.6 μM
Compound: 5-FU
|
Growth inhibition of human BT549 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human BT549 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| BT-549 | IC50 |
19.82 μM
Compound: 5-FU
|
Anticancer activity against human BT549 cells after 48 hrs by MTT assay
Anticancer activity against human BT549 cells after 48 hrs by MTT assay
|
[PMID: 26413726] |
| BT-549 | IC50 |
19.82 μM
Compound: 5-FU
|
Cytotoxicity against human BT549 cells after 48 hrs by MTT assay
Cytotoxicity against human BT549 cells after 48 hrs by MTT assay
|
[PMID: 27397498] |
| BT-549 | IC50 |
98.24 μM
Compound: Fluorouracil
|
Cytotoxicity against human BT549 cells after 48 hrs by MTT assay
Cytotoxicity against human BT549 cells after 48 hrs by MTT assay
|
[PMID: 28789892] |
| BT-549 | GI50 |
10.6 μM
Compound: 5-FU
|
Anticancer activity against human BT-549 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human BT-549 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| BT-549 | IC50 |
10.6 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human BT-549 cells assessed as cell growth inhibition
Cytotoxicity against human BT-549 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| BXPC-3 | GI50 |
8.2 μM
Compound: 5-Fu
|
Growth inhibition of human BxPC3 cells after 48 hrs by SRB assay
Growth inhibition of human BxPC3 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| BXPC-3 | GI50 |
2.9 nM
Compound: 5FU
|
Growth inhibition of human BxPC3 cells after 48 hrs by SRB assay
Growth inhibition of human BxPC3 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| BXPC-3 | EC50 |
0.14 μM
Compound: 1; 5-FU
|
Antiproliferative activity against human BxPC-3 cells assessed as reduction in cell viability measured after 5 days by PrestoBlue reagent based assay
Antiproliferative activity against human BxPC-3 cells assessed as reduction in cell viability measured after 5 days by PrestoBlue reagent based assay
|
[PMID: 34979089] |
| BXPC-3 | IC50 |
2.96 μM
Compound: 5-Fu
|
Antiproliferative activity against human BXPC-3 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human BXPC-3 cells incubated for 72 hrs by SRB assay
|
[PMID: 39054645] |
| C13 | IC50 |
8.5 μM
Compound: 1, 5-FU
|
Growth inhibition of cDDP-resistant human C13 cells by crystal violet assay
Growth inhibition of cDDP-resistant human C13 cells by crystal violet assay
|
[PMID: 23075414] |
| C13 | IC50 |
12.1 μM
Compound: 5FU
|
Cytotoxicity against human C13 cells after 72 hrs
Cytotoxicity against human C13 cells after 72 hrs
|
[PMID: 30035541] |
| C170 | IC50 |
0.3 μg/mL
Compound: 5-FU
|
Tested for cytotoxicity against C170 colorectal carcinoma cell line by [75Se]selenomethionine uptake assay, in vitro
Tested for cytotoxicity against C170 colorectal carcinoma cell line by [75Se]selenomethionine uptake assay, in vitro
|
[PMID: 8496926] |
| C170 | IC50 |
2 μM
Compound: 5-FU
|
Tested for cytotoxicity against C170 colorectal carcinoma cell line by [75Se]selenomethionine uptake assay, in vitro
Tested for cytotoxicity against C170 colorectal carcinoma cell line by [75Se]selenomethionine uptake assay, in vitro
|
[PMID: 8496926] |
| C-33-A | IC50 |
4.61 μM
Compound: 5-FU
|
Cytotoxicity against human C33A cells assessed as growth inhibition rate after 96 hrs by MTT assay
Cytotoxicity against human C33A cells assessed as growth inhibition rate after 96 hrs by MTT assay
|
[PMID: 25203783] |
| C6 | IC50 |
6.1 μM
Compound: 5FU
|
Cytotoxicity against rat C6 glioma cell line
Cytotoxicity against rat C6 glioma cell line
|
[PMID: 16970409] |
| Ca9-22 | CC50 |
262 μM
Compound: 5-FU
|
Cytotoxicity against human Ca9-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human Ca9-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 31532650] |
| Ca9-22 | CC50 |
13 μM
Compound: 5-FU
|
Cytotoxicity against human Ca9-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human Ca9-22 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32795767] |
| Caco-2 | CC50 |
384.4 μM
Compound: 5-FU
|
Cytotoxicity against human Caco-2 cells after 72 hrs
Cytotoxicity against human Caco-2 cells after 72 hrs
|
[PMID: 17337193] |
| Caco-2 | IC50 |
1.5 μM
Compound: 5-FU
|
Growth inhibition of human Caco-2 cells after 10 days
Growth inhibition of human Caco-2 cells after 10 days
|
[PMID: 17337193] |
| Caco-2 | CC50 |
384.4 μM
Compound: 5FU
|
Cytotoxicity against human Caco-2 cells after 72 hrs
Cytotoxicity against human Caco-2 cells after 72 hrs
|
[PMID: 17548129] |
| Caco-2 | IC50 |
1.5 μM
Compound: 5FU
|
Growth inhibition of human Caco-2 cells
Growth inhibition of human Caco-2 cells
|
[PMID: 17548129] |
| Caco-2 | CC50 |
384.4 μM
Compound: 5FU
|
Cytotoxicity against human Caco-2 cells after 72 hrs
Cytotoxicity against human Caco-2 cells after 72 hrs
|
[PMID: 17555969] |
| Caco-2 | IC50 |
1.5 μM
Compound: 5FU
|
Growth inhibition of human Caco-2 cells after 10 days
Growth inhibition of human Caco-2 cells after 10 days
|
[PMID: 17555969] |
| Caco-2 | CC50 |
384.4 μM
Compound: 5-Fu
|
Cytotoxicity against human Caco-2 cells after 72 hrs
Cytotoxicity against human Caco-2 cells after 72 hrs
|
[PMID: 18037195] |
| Caco-2 | IC50 |
1.5 μM
Compound: 5-Fu
|
Growth inhibition of human Caco-2 cells after 10 days
Growth inhibition of human Caco-2 cells after 10 days
|
[PMID: 18037195] |
| Caco-2 | GI50 |
2.2 μM
Compound: 5-FU
|
Antiproliferative activity against human Caco2 cells after 72 hrs by MTT-based Mosmann assay relative to control
Antiproliferative activity against human Caco2 cells after 72 hrs by MTT-based Mosmann assay relative to control
|
[PMID: 26539626] |
| Caco-2 | GI50 |
3.3 μM
Compound: 5-FU
|
Growth inhibition of human Caco2 cells measured after 72 hrs by MTT assay
Growth inhibition of human Caco2 cells measured after 72 hrs by MTT assay
|
[PMID: 27504537] |
| Caco-2 | IC50 |
31 μM
Compound: 5-FU
|
Cytotoxicity against human Caco2 cells assessed as cell viability after 24 hrs by MTT assay
Cytotoxicity against human Caco2 cells assessed as cell viability after 24 hrs by MTT assay
|
[PMID: 28463785] |
| Caco-2 | IC50 |
60 μM
Compound: 5-Fluorouracil
|
Cytotoxicity in human Caco2 cells after 72 hrs by MTT assay
Cytotoxicity in human Caco2 cells after 72 hrs by MTT assay
|
[PMID: 28793973] |
| Caco-2 | IC50 |
38.77 μM
Compound: 5-FU
|
Antiproliferative activity against human Caco2 cells after 72 hrs by MTT assay
Antiproliferative activity against human Caco2 cells after 72 hrs by MTT assay
|
[PMID: 29635169] |
| Caco-2 | IC50 |
10 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Caco2 cells
Cytotoxicity against human Caco2 cells
|
[PMID: 31200236] |
| Caco-2 | IC50 |
7.8 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human Caco2 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
Cytotoxicity against human Caco2 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
|
[PMID: 33799070] |
| Caco-2 | IC50 |
7.77 μM
Compound: 5-FU
|
Cytotoxicity against human Caco-2 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human Caco-2 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 34170142] |
| Caco-2 | IC50 |
0.277 μM
Compound: 5-FU
|
Cytotoxicity against human Caco-2 cells by MTT assay
Cytotoxicity against human Caco-2 cells by MTT assay
|
[PMID: 36335743] |
| Caco-2 | IC50 |
0.266 μM
Compound: 5-FU
|
Anticancer activity against human Caco-2 cells incubated for 72 hrs by MTT assay
Anticancer activity against human Caco-2 cells incubated for 72 hrs by MTT assay
|
[PMID: 36921275] |
| Caco-2 | IC50 |
4.75 μM
Compound: 5-FU
|
Antiproliferative activity against human Caco-2 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against human Caco-2 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 38626522] |
| Caco-2 | IC50 |
21 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against Homo sapiens (human) Caco2 cells after 48 hr by SRB assay
Cytotoxicity against Homo sapiens (human) Caco2 cells after 48 hr by SRB assay
|
10.1007/s00044-012-0424-0 |
| Caco-2 | IC50 |
21 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Caco2 cells assessed as inhibition of cell proliferation after 48 hrs by sulforhodamine-B assay
Cytotoxicity against human Caco2 cells assessed as inhibition of cell proliferation after 48 hrs by sulforhodamine-B assay
|
10.1039/C3MD00055A |
| CAKI-1 | GI50 |
0.07 μM
Compound: 5-FU
|
Growth inhibition of human CAKI-1 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human CAKI-1 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| CAKI-1 | GI50 |
0.07 μM
Compound: 5-FU
|
Anticancer activity against human CAKI-1 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human CAKI-1 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| CAKI-1 | IC50 |
0.07 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human CAKI-1 cells assessed as cell growth inhibition
Cytotoxicity against human CAKI-1 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| CAL-27 | IC50 |
0.5 μg/mL
Compound: 5-FU
|
Antiproliferative activity against human CAL-27 cells assessed as cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human CAL-27 cells assessed as cell viability measured after 72 hrs by MTT assay
|
[PMID: 34463097] |
| Calu-1 | IC50 |
>3.3 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human epidermoid carcinoma (Calu-1) cells
In vitro inhibitory activity against growth of Human epidermoid carcinoma (Calu-1) cells
|
[PMID: 1995901] |
| CAMA-1 | IC50 |
1.28 μM
Compound: 5FU
|
Cytotoxicity against human CAMA1 cells incubated for 72 hrs by SRB assay
Cytotoxicity against human CAMA1 cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| Cancer cell lines | IC50 |
6.8 x 10-5 M
Compound: 5-Fu
|
Inhibitory concentration against Human Gastric cancer cell (BGC) lines was determined.
Inhibitory concentration against Human Gastric cancer cell (BGC) lines was determined.
|
[PMID: 11229742] |
| Cancer cell lines | IC50 |
3.6 μM
Compound: 5-FU
|
Antiproliferative activity was evaluated against human prostate TSU cancer cell lines using the sulforhodamine B (STB) assay
Antiproliferative activity was evaluated against human prostate TSU cancer cell lines using the sulforhodamine B (STB) assay
|
[PMID: 15454213] |
| Cancer cell lines | IC50 |
6.4 μM
Compound: 5-FU
|
Antiproliferative activity was evaluated against human prostate PPC-1 cancer cell lines using the sulforhodamine B (STB) assay
Antiproliferative activity was evaluated against human prostate PPC-1 cancer cell lines using the sulforhodamine B (STB) assay
|
[PMID: 15454213] |
| Cancer cell lines | IC50 |
9.6 μM
Compound: 5-fluorouracil
|
Antiproliferative activity in MDA-MB 231 human breast cancer cells
Antiproliferative activity in MDA-MB 231 human breast cancer cells
|
[PMID: 15658875] |
| Cancer cell lines | GI50 |
5.75 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human colon cancer cells
Cytotoxicity against human colon cancer cells
|
[PMID: 17562365] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Growth inhibition of human prostate cancer cells after 48 hrs
Growth inhibition of human prostate cancer cells after 48 hrs
|
[PMID: 18950904] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Growth inhibition of human renal cancer cells after 48 hrs
Growth inhibition of human renal cancer cells after 48 hrs
|
[PMID: 18950904] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Growth inhibition of human ovarian cancer cells after 48 hrs
Growth inhibition of human ovarian cancer cells after 48 hrs
|
[PMID: 18950904] |
| Cancer cell lines | GI50 |
72.07 μM
Compound: 5-FU
|
Growth inhibition of human CNS cancer cells after 48 hrs
Growth inhibition of human CNS cancer cells after 48 hrs
|
[PMID: 18950904] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Growth inhibition of human breast cancer cells after 48 hrs
Growth inhibition of human breast cancer cells after 48 hrs
|
[PMID: 18950904] |
| Cancer cell lines | GI50 |
8.37 μM
Compound: 5-FU
|
Growth inhibition of human Colon cancer cells after 48 hrs
Growth inhibition of human Colon cancer cells after 48 hrs
|
[PMID: 18950904] |
| Cancer cell lines | GI50 |
>100 μM
Compound: 5-fu
|
Antitumor activity against human non small cell lung cancer cells after 48 hrs by SRB assay
Antitumor activity against human non small cell lung cancer cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-fu
|
Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay
Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-fu
|
Antitumor activity against human renal cancer cells after 48 hrs by SRB assay
Antitumor activity against human renal cancer cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-fu
|
Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay
Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-fu
|
Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay
Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-fu
|
Antitumor activity against human breast cancer cells after 48 hrs by SRB assay
Antitumor activity against human breast cancer cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-fu
|
Antitumor activity against human colon cancer cells after 48 hrs by SRB assay
Antitumor activity against human colon cancer cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Cytotoxicity against human prostate cancer cells after 48 hrs by coulter counting
Cytotoxicity against human prostate cancer cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Cytotoxicity against human renal cancer cells after 48 hrs by coulter counting
Cytotoxicity against human renal cancer cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Cytotoxicity against human ovarian cancer cells after 48 hrs by coulter counting
Cytotoxicity against human ovarian cancer cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-FU
|
Cytotoxicity against human CNS cancer cells after 48 hrs by coulter counting
Cytotoxicity against human CNS cancer cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Cytotoxicity against human breast cancer cells after 48 hrs by coulter counting
Cytotoxicity against human breast cancer cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-FU
|
Cytotoxicity against human colon cancer cells after 48 hrs by coulter counting
Cytotoxicity against human colon cancer cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Growth inhibition of human prostate cancer cells after 48 hrs by coulter counter method
Growth inhibition of human prostate cancer cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Growth inhibition of human renal cancer cells after 48 hrs by coulter counter method
Growth inhibition of human renal cancer cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Growth inhibition of human ovarian cancer cells after 48 hrs by coulter counter method
Growth inhibition of human ovarian cancer cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-FU
|
Growth inhibition of human CNS cancer cells after 48 hrs by coulter counter method
Growth inhibition of human CNS cancer cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Growth inhibition of human breast cancer cells after 48 hrs by coulter counter method
Growth inhibition of human breast cancer cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-FU
|
Growth inhibition of human colon cancer cells after 48 hrs by coulter counter method
Growth inhibition of human colon cancer cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Cancer cell lines | GI50 |
>100 μM
Compound: 5-fu
|
Antiproliferative activity against human non-small cell lung cancer cells after 48 hrs by cell counting analysis
Antiproliferative activity against human non-small cell lung cancer cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-fu
|
Antiproliferative activity against human prostate cancer cells after 48 hrs by cell counting analysis
Antiproliferative activity against human prostate cancer cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-fu
|
Antiproliferative activity against human renal cancer cells after 48 hrs by cell counting analysis
Antiproliferative activity against human renal cancer cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-fu
|
Antiproliferative activity against human ovarian cancer cells after 48 hrs by cell counting analysis
Antiproliferative activity against human ovarian cancer cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-fu
|
Antiproliferative activity against human CNS cancer cells after 48 hrs by cell counting analysis
Antiproliferative activity against human CNS cancer cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-fu
|
Antiproliferative activity against human breast cancer cells after 48 hrs by cell counting analysis
Antiproliferative activity against human breast cancer cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-fu
|
Antiproliferative activity against human colon cancer cells after 48 hrs by cell counting analysis
Antiproliferative activity against human colon cancer cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Cancer cell lines | GI50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human non-small cell lung cancer cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human non-small cell lung cancer cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Cytotoxicity against human prostate cancer cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human prostate cancer cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Cytotoxicity against human renal cancer cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human renal cancer cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Cytotoxicity against human ovarian cancer cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human ovarian cancer cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-FU
|
Cytotoxicity against human CNS cancer cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human CNS cancer cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Cytotoxicity against human breast cancer cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human breast cancer cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-FU
|
Cytotoxicity against human colon cancer cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human colon cancer cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Cancer cell lines | GI50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human non-small cell lung cancer cells after 48 hrs by coulter counter analysis
Cytotoxicity against human non-small cell lung cancer cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Cytotoxicity against human prostate cancer cells after 48 hrs by coulter counter analysis
Cytotoxicity against human prostate cancer cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Cytotoxicity against human renal cancer cells after 48 hrs by coulter counter analysis
Cytotoxicity against human renal cancer cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Cytotoxicity against human ovarian cancer cells after 48 hrs by coulter counter analysis
Cytotoxicity against human ovarian cancer cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-FU
|
Cytotoxicity against human CNS cancer cells after 48 hrs by coulter counter analysis
Cytotoxicity against human CNS cancer cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Cytotoxicity against human breast cancer cells after 48 hrs by coulter counter analysis
Cytotoxicity against human breast cancer cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-FU
|
Cytotoxicity against human colon cancer cells after 48 hrs by coulter counter analysis
Cytotoxicity against human colon cancer cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Cancer cell lines | GI50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human non-small cell lung cancer cells after 48 hrs by SRB assay
Cytotoxicity against human non-small cell lung cancer cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Cytotoxicity against human prostate cancer cells after 48 hrs by SRB assay
Cytotoxicity against human prostate cancer cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Cytotoxicity against human renal cancer cells after 48 hrs by SRB assay
Cytotoxicity against human renal cancer cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Cytotoxicity against human ovarian cancer cells after 48 hrs by SRB assay
Cytotoxicity against human ovarian cancer cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-FU
|
Cytotoxicity against human CNS cancer cells after 48 hrs by SRB assay
Cytotoxicity against human CNS cancer cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Cytotoxicity against human breast cancer cells after 48 hrs by SRB assay
Cytotoxicity against human breast cancer cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-FU
|
Cytotoxicity against human colon cancer cells after 48 hrs by SRB assay
Cytotoxicity against human colon cancer cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Cancer cell lines | GI50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human non-small cell lung cancer cells at 10 uM after 48 hrs
Cytotoxicity against human non-small cell lung cancer cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Cytotoxicity against human prostate cancer cells at 10 uM after 48 hrs
Cytotoxicity against human prostate cancer cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Cytotoxicity against human renal cancer cells at 10 uM after 48 hrs
Cytotoxicity against human renal cancer cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Cytotoxicity against human ovarian cancer cells at 10 uM after 48 hrs
Cytotoxicity against human ovarian cancer cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-FU
|
Cytotoxicity against human CNS cancer cells at 10 uM after 48 hrs
Cytotoxicity against human CNS cancer cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Cytotoxicity against human breast cancer cells at 10 uM after 48 hrs
Cytotoxicity against human breast cancer cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-FU
|
Cytotoxicity against human colon cancer cells at 10 uM after 48 hrs
Cytotoxicity against human colon cancer cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Cancer cell lines | GI50 |
>100 μM
Compound: 5-FU
|
Growth inhibition of human non-small cell lung cancer cells after 48 hrs by SRB assay
Growth inhibition of human non-small cell lung cancer cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Cancer cell lines | GI50 |
22.7 μM
Compound: 5-FU
|
Growth inhibition of human prostate cancer cells after 48 hrs by SRB assay
Growth inhibition of human prostate cancer cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Cancer cell lines | GI50 |
45.6 μM
Compound: 5-FU
|
Growth inhibition of human renal cancer cells after 48 hrs by SRB assay
Growth inhibition of human renal cancer cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Cancer cell lines | GI50 |
61.4 μM
Compound: 5-FU
|
Growth inhibition of human ovarian cancer cells after 48 hrs by SRB assay
Growth inhibition of human ovarian cancer cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Cancer cell lines | GI50 |
72.1 μM
Compound: 5-FU
|
Growth inhibition of human CNS cancer cells after 48 hrs by SRB assay
Growth inhibition of human CNS cancer cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Cancer cell lines | GI50 |
76.4 μM
Compound: 5-FU
|
Growth inhibition of human breast cancer cells after 48 hrs by SRB assay
Growth inhibition of human breast cancer cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Cancer cell lines | GI50 |
8.4 μM
Compound: 5-FU
|
Growth inhibition of human colon cancer cells after 48 hrs by SRB assay
Growth inhibition of human colon cancer cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Cancer cell lines | IC50 |
2.3 μM
Compound: 5-Florouracil
|
Anticancer activity against Homo sapiens (human) NCI lung cancer cell assessed as inhibition of cell proliferation after 24 hr by MTT assay
Anticancer activity against Homo sapiens (human) NCI lung cancer cell assessed as inhibition of cell proliferation after 24 hr by MTT assay
|
10.1007/s00044-012-0260-2 |
| CAPAN-1 | IC50 |
0.47 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human Capan-1 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human Capan-1 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay
|
[PMID: 32007666] |
| Capan-2 | IC50 |
54.247 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Capan2 cells incubated for 24 hrs by MTT assay
Cytotoxicity against human Capan2 cells incubated for 24 hrs by MTT assay
|
[PMID: 30904782] |
| CCD-18Co | IC50 |
9.26 μM
Compound: 5-Fu
|
Cytotoxicity against human CCD-18Co cells after 3 days by SRB assay
Cytotoxicity against human CCD-18Co cells after 3 days by SRB assay
|
[PMID: 24704691] |
| CCD-18Co | IC50 |
>200 μM
Compound: 5-FU
|
Cytotoxicity against human CCD-18Co cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human CCD-18Co cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32203786] |
| CCD-841CoN | IC50 |
>25 μM
Compound: 5-FU
|
Antiproliferative activity against human CRL1790 cells assessed as inhibition cell proliferation after 48 hrs by Sulforhodamine B assay
Antiproliferative activity against human CRL1790 cells assessed as inhibition cell proliferation after 48 hrs by Sulforhodamine B assay
|
[PMID: 23305919] |
| CCD-841CoN | GI50 |
10.3 μM
Compound: 5-FU
|
Cytotoxicity against human CRL1790 cells assessed as reduction in cell viability after 48 hrs by sulforhodamine B assay
Cytotoxicity against human CRL1790 cells assessed as reduction in cell viability after 48 hrs by sulforhodamine B assay
|
[PMID: 28716495] |
| CCD-841CoN | IC50 |
35.7 μM
Compound: 5-FU
|
Antiproliferative activity against human CCD-841-CoN cells after 72 hrs by MTT assay
Antiproliferative activity against human CCD-841-CoN cells after 72 hrs by MTT assay
|
[PMID: 30037494] |
| CCD-841CoN | IC50 |
18.7 μM
Compound: 5-FU
|
Cytotoxicity against human CRL1790 cells assessed as inhibition of cell growth
Cytotoxicity against human CRL1790 cells assessed as inhibition of cell growth
|
[PMID: 31864797] |
| CCD-841CoN | EC50 |
218 μM
Compound: 5FU
|
Cytotoxicity against human CCD-841CoN cells assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
Cytotoxicity against human CCD-841CoN cells assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
|
[PMID: 35939803] |
| CCRF-CEM | IC50 |
90.5 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against CEM cells
Tested in vitro for anticancer activity against CEM cells
|
[PMID: 10072683] |
| CCRF-CEM | IC50 |
8.9 μM
Compound: 5-Fluorouracil
|
Concentration required to inhibit 50% of cell growth on CEM lymphocytes.
Concentration required to inhibit 50% of cell growth on CEM lymphocytes.
|
[PMID: 11052798] |
| CCRF-CEM | IC50 |
1.2 μg/mL
Compound: 5-FU
|
Evaluated for the inhibition of tumor cell growth of Human T-Lymphocyte cells (CEM/0)
Evaluated for the inhibition of tumor cell growth of Human T-Lymphocyte cells (CEM/0)
|
[PMID: 11123990] |
| CCRF-CEM | IC50 |
9 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human CEM cells
Cytostatic activity against human CEM cells
|
[PMID: 17931862] |
| CCRF-CEM | IC50 |
9.23 μM
Compound: 5-FU
|
Antiproliferative activity against human CEM cells after 3 days by MTT assay
Antiproliferative activity against human CEM cells after 3 days by MTT assay
|
[PMID: 18424155] |
| CCRF-CEM | IC50 |
125 μM
Compound: 5-FU
|
Antiproliferative activity against human CEM cells after 72 hrs by MTT assay
Antiproliferative activity against human CEM cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| CCRF-CEM | IC50 |
40 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of cell growth of CCRF CEM leukemic cell lines in human.
Concentration required for 50% inhibition of cell growth of CCRF CEM leukemic cell lines in human.
|
[PMID: 1992123] |
| CCRF-CEM | IC50 |
2.1 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human acute lymphocytic leukemia (CCRF-CEM) cells
In vitro inhibitory activity against growth of Human acute lymphocytic leukemia (CCRF-CEM) cells
|
[PMID: 1995901] |
| CCRF-CEM | IC50 |
40 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human T-cell acute lymphoblastoid leukemia (CCRF CEM) cell line.
In vitro inhibitory activity against Human T-cell acute lymphoblastoid leukemia (CCRF CEM) cell line.
|
[PMID: 1995905] |
| CCRF-CEM | IC50 |
14 μM
Compound: 5-FU
|
Cytotoxicity against human CEM cells after 3 days by coulter counter analysis
Cytotoxicity against human CEM cells after 3 days by coulter counter analysis
|
[PMID: 21232828] |
| CCRF-CEM | IC50 |
14 μM
Compound: 5-FU
|
Cytostatic activity against human CEM cells after 3 days by coulter counting analysis
Cytostatic activity against human CEM cells after 3 days by coulter counting analysis
|
[PMID: 21330014] |
| CCRF-CEM | IC50 |
15 μM
Compound: 5-FU
|
Cytotoxicity against human CEM cells after 48 hrs by trypan blue assay
Cytotoxicity against human CEM cells after 48 hrs by trypan blue assay
|
[PMID: 21439690] |
| CCRF-CEM | IC50 |
30 μM
Compound: 5-FU
|
Cytotoxicity against human CEM cells after 72 hrs by MTT assay
Cytotoxicity against human CEM cells after 72 hrs by MTT assay
|
[PMID: 21439690] |
| CCRF-CEM | IC50 |
40 μM
Compound: 5-FU
|
Cytotoxicity against human CEM cells after 48 hrs by MTT assay
Cytotoxicity against human CEM cells after 48 hrs by MTT assay
|
[PMID: 21439690] |
| CCRF-CEM | IC50 |
8 μM
Compound: 5-FU
|
Cytotoxicity against human CEM cells after 72 hrs by trypan blue assay
Cytotoxicity against human CEM cells after 72 hrs by trypan blue assay
|
[PMID: 21439690] |
| CCRF-CEM | IC50 |
33.1 μM
Compound: 5-FU
|
Anticancer activity against human CCRF-CEM cells
Anticancer activity against human CCRF-CEM cells
|
[PMID: 21449610] |
| CCRF-CEM | IC50 |
12 μM
Compound: 1, 5-FU
|
Cytostatic activity against thymidine-kinase deficient human CEM cells after 72 hrs by cell counting
Cytostatic activity against thymidine-kinase deficient human CEM cells after 72 hrs by cell counting
|
[PMID: 21892829] |
| CCRF-CEM | IC50 |
18 μM
Compound: 1, 5-FU
|
Cytostatic activity against human CEM/0 cells after 72 hrs by cell counting
Cytostatic activity against human CEM/0 cells after 72 hrs by cell counting
|
[PMID: 21892829] |
| CCRF-CEM | IC50 |
18 μM
Compound: F-Uracil
|
Cytostatic activity against human CEM cells
Cytostatic activity against human CEM cells
|
[PMID: 21917363] |
| CCRF-CEM | IC50 |
18 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human CEM cells after 3 days by coulter counter analysis
Cytostatic activity against human CEM cells after 3 days by coulter counter analysis
|
[PMID: 22405290] |
| CCRF-CEM | IC50 |
32 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human CEM cells after 72 hrs by MTT assay
Cytotoxicity against human CEM cells after 72 hrs by MTT assay
|
[PMID: 23535322] |
| CCRF-CEM | IC50 |
2 μM
Compound: 5-FU
|
Effect on CCRF-CEM cells in culture
Effect on CCRF-CEM cells in culture
|
[PMID: 2362278] |
| CCRF-CEM | GI50 |
9.79 μM
Compound: 5-FU
|
Growth inhibition of human CCRF-CEM cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human CCRF-CEM cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| CCRF-CEM | IC50 |
18 μM
Compound: 5FU
|
Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell number after 72 hrs by cell counting assay
Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell number after 72 hrs by cell counting assay
|
[PMID: 24631358] |
| CCRF-CEM | IC50 |
18 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human CEM cells assessed as inhibition of proliferation after 72 hrs by Coulter cell counting method
Cytostatic activity against human CEM cells assessed as inhibition of proliferation after 72 hrs by Coulter cell counting method
|
[PMID: 24906510] |
| CCRF-CEM | IC50 |
18 μM
Compound: 5-FU
|
Cytostatic activity against human CEM cells after 72 hrs by Coulter counting
Cytostatic activity against human CEM cells after 72 hrs by Coulter counting
|
[PMID: 25435471] |
| CCRF-CEM | IC50 |
18 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human CEM cells assessed as inhibition of cell proliferation
Cytotoxicity against human CEM cells assessed as inhibition of cell proliferation
|
[PMID: 26001344] |
| CCRF-CEM | IC50 |
18 μM
Compound: 5-Fluorouracil
|
Anti-proliferative activity against human CEM cells measured after 72 hrs by coulter counter method
Anti-proliferative activity against human CEM cells measured after 72 hrs by coulter counter method
|
[PMID: 27750154] |
| CCRF-CEM | IC50 |
40 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of human T-cell acute lymphoblastoid leukemic CCRFCEM cell lines.
In vitro inhibitory effect on growth of human T-cell acute lymphoblastoid leukemic CCRFCEM cell lines.
|
[PMID: 3373480] |
| CCRF-CEM | GI50 |
9.97 μM
Compound: 5-FU
|
Anticancer activity against human CCRF-CEM cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human CCRF-CEM cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| CCRF-CEM | IC50 |
9.97 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human CCRF-CEM cells assessed as cell growth inhibition
Cytotoxicity against human CCRF-CEM cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| CCRF-CEM | IC50 |
5.0 x 10-6 M
Compound: FUra
|
Concentration required for the 50% inhibition of growth of CCRF-CEM human leukemia cells in culture
Concentration required for the 50% inhibition of growth of CCRF-CEM human leukemia cells in culture
|
[PMID: 7120290] |
| CCRF-CEM | IC50 |
2 μM
Compound: 5-FU
|
In vitro cytotoxic activity against CCRF-CEM human lymphoblastoid cells in culture.
In vitro cytotoxic activity against CCRF-CEM human lymphoblastoid cells in culture.
|
10.1016/0960-894X(96)00451-9 |
| CCRF-CEM | IC50 |
4 μg/mL
Compound: 5-FU
|
The compound was evaluated for antitumoral activity against human leukemia cell line CCRF CEM after 72 hr of incubation
The compound was evaluated for antitumoral activity against human leukemia cell line CCRF CEM after 72 hr of incubation
|
10.1016/S0960-894X(01)80742-3 |
| CCRF-CEM | IC50 |
0.95 μg/mL
Compound: 5-FU
|
Concentration at 50 percent inhibition of cell growth against human leukemia CCRF CEM cell line in vitro
Concentration at 50 percent inhibition of cell growth against human leukemia CCRF CEM cell line in vitro
|
10.1016/S0960-894X(01)81041-6 |
| CFPAC-1 | IC50 |
0.14 μM
Compound: 5-FU
|
Antiproliferative activity against human CFPAC-1 cells after 72 hrs by MTT assay
Antiproliferative activity against human CFPAC-1 cells after 72 hrs by MTT assay
|
[PMID: 27875779] |
| CFPAC-1 | IC50 |
0.14 μM
Compound: 5-FU
|
Antiproliferative activity against human CFPAC-1 cells after 72 hrs by MTT assay
Antiproliferative activity against human CFPAC-1 cells after 72 hrs by MTT assay
|
[PMID: 28525845] |
| CFPAC-1 | IC50 |
0.14 μM
Compound: 5-FU
|
Antiproliferative activity against human CFPAC-1 cells after 72 hrs by MTT assay
Antiproliferative activity against human CFPAC-1 cells after 72 hrs by MTT assay
|
[PMID: 29133046] |
| CFPAC-1 | IC50 |
41.221 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human CFPAC-1 cells incubated for 24 hrs by MTT assay
Cytotoxicity against human CFPAC-1 cells incubated for 24 hrs by MTT assay
|
[PMID: 30904782] |
| CFPAC-1 | IC50 |
0.14 μM
Compound: 5-FU
|
Antiproliferative activity against human CFPAC-1 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human CFPAC-1 cells incubated for 72 hrs by MTT assay
|
[PMID: 31734024] |
| CHO | IC50 |
12 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against CHO cells by MTT assay
Cytotoxicity against CHO cells by MTT assay
|
[PMID: 29280630] |
| CHO | IC50 |
5 μM
Compound: FU
|
Growth inhibitory activity against CHO cells in culture.
Growth inhibitory activity against CHO cells in culture.
|
[PMID: 7853342] |
| CHO-FU | IC50 |
100 μM
Compound: FU
|
Growth inhibitory activity against CHO/FU cells in culture.
Growth inhibitory activity against CHO/FU cells in culture.
|
[PMID: 7853342] |
| CNE | IC50 |
40.21 μM
Compound: 5-FU
|
Cytotoxicity against human CNE cells after 48 hrs by MTT assay
Cytotoxicity against human CNE cells after 48 hrs by MTT assay
|
[PMID: 24378217] |
| CNE | IC50 |
45.1 μM
Compound: 5-Fu
|
Cytotoxicity against human CNE cells after 48 hrs by MTT assay
Cytotoxicity against human CNE cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| CNE | IC50 |
15.07 μM
Compound: 5-Fu
|
Antiproliferative activity against human CNE cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Antiproliferative activity against human CNE cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 25113877] |
| CNE-2 | IC50 |
13.1 μM
Compound: 5-FU
|
Cytotoxicity against human CNE2 cells after 3 days by MTT assay
Cytotoxicity against human CNE2 cells after 3 days by MTT assay
|
[PMID: 21144621] |
| CNE-2 | IC50 |
17.2 μM
Compound: 5-FU
|
Antiproliferative activity against human CNE2 cells after 72 hrs by MTT assay
Antiproliferative activity against human CNE2 cells after 72 hrs by MTT assay
|
[PMID: 22079378] |
| CNE-2 | IC50 |
13.5 μM
Compound: Fluorouracil
|
Cytotoxicity against human CNE2 cells after 72 hrs ny MTT assay
Cytotoxicity against human CNE2 cells after 72 hrs ny MTT assay
|
[PMID: 22200404] |
| CNE-2 | IC50 |
15.1 μM
Compound: 5-FU
|
Cytotoxicity against human CNE2 cells after 72 hrs by MTT assay
Cytotoxicity against human CNE2 cells after 72 hrs by MTT assay
|
[PMID: 22749192] |
| COLO 205 | IC50 |
3.39 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human COLO205 cells
Cytotoxicity against human COLO205 cells
|
[PMID: 16996657] |
| COLO 205 | IC50 |
11.63 μM
Compound: 5-FU
|
Antiproliferative activity against p53 deficient human COLO205 cells after 72 hrs
Antiproliferative activity against p53 deficient human COLO205 cells after 72 hrs
|
[PMID: 18469809] |
| COLO 205 | IC50 |
21 μM
Compound: 5-FU
|
Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 19939522] |
| COLO 205 | IC50 |
0.1 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human colon adenocarcinoma (COLO 205) cells.
In vitro inhibitory activity against growth of Human colon adenocarcinoma (COLO 205) cells.
|
[PMID: 1995901] |
| COLO 205 | IC50 |
90 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient COLO205 cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient COLO205 cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| COLO 205 | IC50 |
4.17 μM
Compound: 5-FU
|
Anticancer activity against human COLO205 cells
Anticancer activity against human COLO205 cells
|
[PMID: 21449610] |
| COLO 205 | GI50 |
2.8 μM
Compound: 5FU
|
Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| COLO 205 | IC50 |
4.17 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human COLO205 cells
Cytotoxicity against human COLO205 cells
|
[PMID: 22409967] |
| COLO 205 | IC50 |
4.03 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
|
[PMID: 23352638] |
| COLO 205 | IC50 |
4.562 μg/mL
Compound: 5-FU
|
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
|
[PMID: 23548704] |
| COLO 205 | GI50 |
0.15 μM
Compound: 5-FU
|
Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human COLO205 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| COLO 205 | IC50 |
3.39 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human COLO205 cells assessed as inhibition of tumor growth after 24 hrs
Cytotoxicity against human COLO205 cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| COLO 205 | EC50 |
38.06 μM
Compound: 5-FU
|
Antiproliferative activity against human COLO205 cells after 24 hrs by MTT assay
Antiproliferative activity against human COLO205 cells after 24 hrs by MTT assay
|
[PMID: 25198997] |
| COLO 205 | IC50 |
1.8 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human COLO205 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human COLO205 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 26629861] |
| COLO 205 | CC50 |
>2512 μM
Compound: 5-Fu
|
Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| COLO 205 | IC50 |
14.8 μM
Compound: 5-Fu
|
Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| COLO 205 | IC50 |
1.9 μM
Compound: 5-F
|
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay
|
[PMID: 28254697] |
| COLO 205 | IC50 |
1.9 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human COLO205 cells by MTT assay
Antiproliferative activity against human COLO205 cells by MTT assay
|
[PMID: 29798826] |
| COLO 205 | IC50 |
27.7 μM
Compound: 5-FU
|
Cytotoxicity against human COLO 205 cells assessed as inhibition of cell growth incubated for 30 mins by SRB assay
Cytotoxicity against human COLO 205 cells assessed as inhibition of cell growth incubated for 30 mins by SRB assay
|
[PMID: 30114660] |
| COLO 205 | IC50 |
5.29 μM
Compound: 5-FU
|
Cytotoxicity against human COLO 205 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human COLO 205 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 34170142] |
| COLO 205 | GI50 |
0.15 μM
Compound: 5-FU
|
Anticancer activity against human COLO 205 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human COLO 205 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| COLO 205 | IC50 |
0.15 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human COLO 205 cells assessed as cell growth inhibition
Cytotoxicity against human COLO 205 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| COLO 205 | IC50 |
32 μM
Compound: 5-FU
|
Cytotoxicity against human COLO 205 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
Cytotoxicity against human COLO 205 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
|
[PMID: 38536967] |
| COLO 205 | IC50 |
4.54 μM
Compound: 5-Fu
|
Cytotoxicity against human COLO 205 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human COLO 205 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| COLO 205 | IC50 |
2.9 μM
Compound: 5-Fu
|
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
|
10.1007/s00044-010-9500-5 |
| COLO 320 | IC50 |
10 μM
Compound: 5-FU
|
Antiproliferative activity against human COLO320 cells after 48 hrs
Antiproliferative activity against human COLO320 cells after 48 hrs
|
[PMID: 21458113] |
| COLO 320 | IC50 |
8.7 μM
Compound: 5-FU
|
Antiproliferative activity against human COLO320 cells after 72 hrs
Antiproliferative activity against human COLO320 cells after 72 hrs
|
[PMID: 21458113] |
| COLO 320 | IC50 |
12.5 μM
Compound: 5-FU
|
Cytotoxicity against human COLO320 cells assessed as cell viability after 72 hrs by WST-1 assay
Cytotoxicity against human COLO320 cells assessed as cell viability after 72 hrs by WST-1 assay
|
[PMID: 22955095] |
| COLO 320DM | IC50 |
2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human COLO320DM cells after 48 hrs by MTT assay
Cytotoxicity against human COLO320DM cells after 48 hrs by MTT assay
|
[PMID: 23792352] |
| COLO 320DM | IC50 |
1.1 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of COLO 320DM tumor cell line from colon.
Compound was tested for its inhibitory effect on the growth of COLO 320DM tumor cell line from colon.
|
10.1016/0960-894X(96)00339-3 |
| COLO357 | IC50 |
2.05 μM
Compound: 5-FU
|
Cytotoxicity against human Colo-357 cells by crystal violet staining
Cytotoxicity against human Colo-357 cells by crystal violet staining
|
[PMID: 20930123] |
| Colon 26 | IC50 |
3.87 μM
Compound: 5-Fluorouracil
|
Dark toxicity against human Colon 26 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
Dark toxicity against human Colon 26 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
|
[PMID: 36561065] |
| Colon 26 | IC50 |
4.1 μM
Compound: 5-Fluorouracil
|
Phototoxicity against human Colon 26 cells assessed as inhibition of cell growth preincubated for 24 hrs followed by compound washout with replacement of fresh medium and irradiation with 50 W LED light by MTT assay
Phototoxicity against human Colon 26 cells assessed as inhibition of cell growth preincubated for 24 hrs followed by compound washout with replacement of fresh medium and irradiation with 50 W LED light by MTT assay
|
[PMID: 36561065] |
| COS-1 | IC50 |
110 μM
Compound: 5-FU
|
Cytotoxicity against african green monkey COS1 cells after 24 hrs by MTT assay
Cytotoxicity against african green monkey COS1 cells after 24 hrs by MTT assay
|
[PMID: 23202484] |
| CT26 | IC50 |
59.23 μM
Compound: 1; 5-FU
|
Growth inhibition of CT26 cells incubated for 1.5 hrs by MTT assay
Growth inhibition of CT26 cells incubated for 1.5 hrs by MTT assay
|
[PMID: 38107178] |
| CT26.WT | IC50 |
5 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against mouse CT26.WT cells by MTT assay
Cytotoxicity against mouse CT26.WT cells by MTT assay
|
[PMID: 29280630] |
| CWR22R | IC50 |
3.83 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human 22Rv1 cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
Antiproliferative activity against human 22Rv1 cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
|
[PMID: 27295506] |
| CWR22R | IC50 |
18.31 μM
Compound: 5-FU
|
Antiproliferative activity against human 22Rv1 cells assessed as cell growth inhibition by MTT assay
Antiproliferative activity against human 22Rv1 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 34000484] |
| DAN-G | IC50 |
4.38 μM
Compound: 5-FU
|
Cytotoxicity against human DAN-G cells by crystal violet staining
Cytotoxicity against human DAN-G cells by crystal violet staining
|
[PMID: 20930123] |
| DLD-1 | IC50 |
7.38 μM
Compound: 5-FU
|
Cytotoxicity against human DLD1 cells after 96 hrs by MTT assay
Cytotoxicity against human DLD1 cells after 96 hrs by MTT assay
|
[PMID: 15387639] |
| DLD-1 | IC50 |
4.5 μM
Compound: 5-FU
|
Growth inhibition of human DLD1 cells
Growth inhibition of human DLD1 cells
|
[PMID: 17553685] |
| DLD-1 | IC50 |
29.14 μM
Compound: 5-Fu
|
Cytotoxicity against human DLD1 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Cytotoxicity against human DLD1 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 24583355] |
| DLD-1 | EC50 |
16.3 μM
Compound: 5-FU
|
Antiproliferative activity against human DLD1 cells after 24 hrs by MTT assay
Antiproliferative activity against human DLD1 cells after 24 hrs by MTT assay
|
[PMID: 25198997] |
| DLD-1 | IC50 |
33 μM
Compound: 5-FU
|
Antiproliferative activity against human DLD1 cells after 72 hrs by MTT assay
Antiproliferative activity against human DLD1 cells after 72 hrs by MTT assay
|
[PMID: 30037494] |
| DLD-1 | IC50 |
33 μM
Compound: 5-FU
|
Antiproliferative activity against human DLD1 cells after 72 hrs by MTT assay
Antiproliferative activity against human DLD1 cells after 72 hrs by MTT assay
|
[PMID: 30429977] |
| DLD-1 | IC50 |
11.4 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human DLD-1 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human DLD-1 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
|
[PMID: 32387836] |
| DLD-1 | IC50 |
11 μM
Compound: 5-FU
|
Induction of apoptosis in human DLD-1 cells in presence of EGCG at 50 uM
Induction of apoptosis in human DLD-1 cells in presence of EGCG at 50 uM
|
[PMID: 36780831] |
| DLD-1 | IC50 |
150 μM
Compound: 5-FU
|
Antiproliferative activity against human DLD-1 cells assessed as reduction in cell growth incubated for 24 hrs by MTT assay
Antiproliferative activity against human DLD-1 cells assessed as reduction in cell growth incubated for 24 hrs by MTT assay
|
[PMID: 36780831] |
| DLD-1 | IC50 |
4.16 μM
Compound: 5-FU
|
Inhibition of human DLD-1 cell spheroids incubated for 7 days by luciferase based assay
Inhibition of human DLD-1 cell spheroids incubated for 7 days by luciferase based assay
|
[PMID: 36780832] |
| DLD-1 | IC50 |
6 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of DLD-1 tumor cell line from colon.
Compound was tested for its inhibitory effect on the growth of DLD-1 tumor cell line from colon.
|
10.1016/0960-894X(96)00339-3 |
| DMS-114 | GI50 |
100 μM
Compound: 5-Fu
|
Growth inhibition of human DMS114 cells after 48 hrs by SRB assay
Growth inhibition of human DMS114 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| DU-145 | IC50 |
11.9 μM
Compound: 5-FU
|
Concentration required to inhibit proliferation of DU-145 prostate cancer cell lines
Concentration required to inhibit proliferation of DU-145 prostate cancer cell lines
|
[PMID: 15341952] |
| DU-145 | IC50 |
11.9 μM
Compound: 5-FU
|
Antiproliferative activity was evaluated against human prostate DU-145 cancer cell lines using the sulforhodamine B (STB) assay
Antiproliferative activity was evaluated against human prostate DU-145 cancer cell lines using the sulforhodamine B (STB) assay
|
[PMID: 15454213] |
| DU-145 | IC50 |
11.9 μM
Compound: 5-FU
|
Antiproliferative activity against prostate cancer DU-145 cell line using sulforhodamine B(SRB) assay
Antiproliferative activity against prostate cancer DU-145 cell line using sulforhodamine B(SRB) assay
|
[PMID: 15801848] |
| DU-145 | IC50 |
11.9 μM
Compound: 5-FU
|
Antiproliferative activity against human prostate cancer DU-145 cell line by sulforhodamine B assay
Antiproliferative activity against human prostate cancer DU-145 cell line by sulforhodamine B assay
|
[PMID: 16005217] |
| DU-145 | GI50 |
15.4 μM
Compound: 5FU
|
Cytotoxicity against human DU145 cells after 48 hrs
Cytotoxicity against human DU145 cells after 48 hrs
|
[PMID: 18798609] |
| DU-145 | GI50 |
5.3 μM
Compound: 5FU
|
Cytotoxicity against human DU145 cells
Cytotoxicity against human DU145 cells
|
[PMID: 20356752] |
| DU-145 | IC50 |
2.19 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
|
[PMID: 20494492] |
| DU-145 | IC50 |
4.8 μM
Compound: 5-fluorouracil
|
Anticancer activity against human DU145 cells assessed as cell viability after 48 hrs by SRB assay
Anticancer activity against human DU145 cells assessed as cell viability after 48 hrs by SRB assay
|
[PMID: 21074444] |
| DU-145 | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Cytotoxicity in human DU145 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity in human DU145 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21250700] |
| DU-145 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells by MTT assay
Cytotoxicity against human DU145 cells by MTT assay
|
[PMID: 21689869] |
| DU-145 | IC50 |
3.3 μM
Compound: Fluorouracil
|
Cytotoxicity against human DU145 cells
Cytotoxicity against human DU145 cells
|
[PMID: 21774474] |
| DU-145 | GI50 |
9.37 μM
Compound: 5-Fu
|
Growth inhibition of human DU145 cells after 48 hrs by SRB assay
Growth inhibition of human DU145 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| DU-145 | IC50 |
12.32 μM
Compound: 5-Fu
|
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| DU-145 | GI50 |
20 nM
Compound: 5FU
|
Growth inhibition of human DU145 cells after 48 hrs by SRB assay
Growth inhibition of human DU145 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| DU-145 | GI50 |
0.36 μM
Compound: 5-FU
|
Growth inhibition of human DU145 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human DU145 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| DU-145 | IC50 |
1.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
|
[PMID: 24060486] |
| DU-145 | IC50 |
3.4 μM
Compound: Fluorouracil
|
Cytotoxic activity against human DU145 cells
Cytotoxic activity against human DU145 cells
|
[PMID: 24195466] |
| DU-145 | IC50 |
1.9 μM
Compound: 5-Fluoro uracilc
|
Cytotoxicity against human DU145 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human DU145 cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 24641975] |
| DU-145 | IC50 |
1.5 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
Cytotoxicity against human DU145 cells after 24 hrs by MTT assay
|
[PMID: 24835633] |
| DU-145 | IC50 |
6.37 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 25870131] |
| DU-145 | IC50 |
6.072 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 26301558] |
| DU-145 | GI50 |
1 μg/mL
Compound: 5FU
|
Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay method
Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay method
|
[PMID: 26383125] |
| DU-145 | IC50 |
39.17 μM
Compound: 5-FU
|
Anticancer activity against human DU145 cells after 48 hrs by MTT assay
Anticancer activity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 26413726] |
| DU-145 | IC50 |
39.17 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 27397498] |
| DU-145 | IC50 |
24.2 μM
Compound: 5 Fluorouracil
|
Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212] |
| DU-145 | IC50 |
1.7 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 27528432] |
| DU-145 | IC50 |
26.1 μM
Compound: 5-Fu
|
Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 27561718] |
| DU-145 | IC50 |
1.6 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human DU145 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human DU145 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27561719] |
| DU-145 | IC50 |
40.58 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27614408] |
| DU-145 | GI50 |
5.82 μM
Compound: 5-FU
|
Growth inhibition of human DU145 cells after 48 hrs by SRB assay
Growth inhibition of human DU145 cells after 48 hrs by SRB assay
|
[PMID: 28400235] |
| DU-145 | IC50 |
2.18 μM
Compound: 5-FU
|
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 28431881] |
| DU-145 | IC50 |
2.18 μM
Compound: 5-FU
|
Cytotoxicity in human DU145 cells incubated for 48 hrs by MTT assay
Cytotoxicity in human DU145 cells incubated for 48 hrs by MTT assay
|
[PMID: 28923381] |
| DU-145 | IC50 |
39.17 μM
Compound: 5-FU
|
Cytotoxicity in human DU145 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human DU145 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 29657100] |
| DU-145 | IC50 |
25.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 30527868] |
| DU-145 | IC50 |
2.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human DU145 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human DU145 cells incubated for 72 hrs by MTT assay
|
[PMID: 31829592] |
| DU-145 | GI50 |
0.36 μM
Compound: 5-FU
|
Anticancer activity against human DU-145 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human DU-145 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| DU-145 | IC50 |
0.36 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human DU-145 cells assessed as cell growth inhibition
Cytotoxicity against human DU-145 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| DU-145 | IC50 |
8.58 μM
Compound: 5-Fu
|
Antiproliferative activity against human DU-145 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human DU-145 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36931124] |
| DU-145 | IC50 |
2.95 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) DU145 cells by MTT assay
Cytotoxicity against Homo sapiens (human) DU145 cells by MTT assay
|
10.1007/s00044-010-9395-1 |
| DU-145 | IC50 |
2.95 μM
Compound: 5-FU
|
Antitumor activity against Homo sapiens (human) DU145 cells assessed as inhibition of cell viability after 72 hr by MTT assay
Antitumor activity against Homo sapiens (human) DU145 cells assessed as inhibition of cell viability after 72 hr by MTT assay
|
10.1007/s00044-012-0283-8 |
| DU-145 | IC50 |
38 μM
Compound: 5-Fu
|
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
|
10.1039/C5MD00382B |
| E0771 | IC50 |
0.28 μM
Compound: 5-Fu
|
Cytotoxicity against mouse E0771 cells after 3 days by SRB assay
Cytotoxicity against mouse E0771 cells after 3 days by SRB assay
|
[PMID: 24704691] |
| EC9706 | IC50 |
20.3 μM
Compound: 5-Fu
|
Antitumor activity against human EC9706 cells after 72 hrs by MTT assay
Antitumor activity against human EC9706 cells after 72 hrs by MTT assay
|
[PMID: 21486694] |
| EC9706 | IC50 |
0.32 μM
Compound: 5-Fu
|
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
|
[PMID: 23644193] |
| EC9706 | IC50 |
9.45 μM
Compound: 5-Fu
|
Antiproliferative activity against human EC9706 cells after 48 hrs by MTT assay
Antiproliferative activity against human EC9706 cells after 48 hrs by MTT assay
|
[PMID: 24835817] |
| EC9706 | IC50 |
8.07 μM
Compound: 5-Fu
|
Anticancer activity against human EC9706 cells after 72 hrs by MTT assay
Anticancer activity against human EC9706 cells after 72 hrs by MTT assay
|
[PMID: 25001482] |
| EC9706 | IC50 |
4.7 μM
Compound: 5-Fu
|
Anticancer activity against human EC9706 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Anticancer activity against human EC9706 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 25086915] |
| EC9706 | IC50 |
15.67 μM
Compound: 5-Fu
|
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
|
[PMID: 25707012] |
| EC9706 | IC50 |
23.26 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human EC9706 cells after 48 hrs by MTT assay
Antiproliferative activity against human EC9706 cells after 48 hrs by MTT assay
|
[PMID: 28119200] |
| EC9706 | IC50 |
5.13 μM
Compound: 5-Fu
|
Antiproliferative activity against human EC9706 cells after 72 hrs by MTT assay
Antiproliferative activity against human EC9706 cells after 72 hrs by MTT assay
|
[PMID: 29475156] |
| EC9706 | IC50 |
2.45 μM
Compound: 5-FU
|
Antiproliferative activity against human EC9706 assessed as reduction in cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human EC9706 assessed as reduction in cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 37859725] |
| ECa-109 cell line | IC50 |
3.34 μM
Compound: 5-Fu
|
Cytotoxicity against human EC109 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human EC109 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 23353743] |
| ECa-109 cell line | IC50 |
10.61 μM
Compound: 5-Fu
|
Cytotoxicity against human EC109 cells after 72 hrs by MTT assay
Cytotoxicity against human EC109 cells after 72 hrs by MTT assay
|
[PMID: 23792764] |
| ECa-109 cell line | IC50 |
10.61 μM
Compound: 5-Fu
|
Cytotoxicity against human EC109 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human EC109 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 24077182] |
| ECa-109 cell line | IC50 |
24.14 μM
Compound: 5-Fu
|
Cytotoxicity against human EC109 cells after 72 hrs by MTT assay
Cytotoxicity against human EC109 cells after 72 hrs by MTT assay
|
[PMID: 24798098] |
| ECa-109 cell line | IC50 |
10.81 μM
Compound: 5-Fu
|
Cytotoxicity against human EC109 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Cytotoxicity against human EC109 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25180925] |
| ECa-109 cell line | IC50 |
11.61 μM
Compound: 5-Fu
|
Anticancer activity against human EC109 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Anticancer activity against human EC109 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25655718] |
| ECa-109 cell line | IC50 |
3.17 μM
Compound: 5-Fu
|
Antiproliferative activity against human EC109 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human EC109 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27105028] |
| ECa-109 cell line | IC50 |
10.3 μM
Compound: 5-FU
|
Cytotoxicity against human EC109 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human EC109 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27423479] |
| ECa-109 cell line | IC50 |
25.99 μM
Compound: 5-FU
|
Cytotoxicity against human EC109 cells assessed as growth inhibition by MTT assay
Cytotoxicity against human EC109 cells assessed as growth inhibition by MTT assay
|
[PMID: 27769034] |
| ECa-109 cell line | IC50 |
10.59 μM
Compound: 5-Fu
|
Antiproliferative activity against human EC109 cells after 72 hrs by MTT assay
Antiproliferative activity against human EC109 cells after 72 hrs by MTT assay
|
[PMID: 27771599] |
| ECa-109 cell line | IC50 |
10.3 μM
Compound: 5-FU
|
Cytotoxicity against human EC109 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Cytotoxicity against human EC109 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 28038329] |
| ECa-109 cell line | IC50 |
30.25 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human ECA109 cells after 48 hrs by MTT assay
Antiproliferative activity against human ECA109 cells after 48 hrs by MTT assay
|
[PMID: 28119200] |
| ECa-109 cell line | IC50 |
5.01 μM
Compound: 5-FU
|
Antiproliferative activity against human EC109 cells after 72 hrs by MTT assay
Antiproliferative activity against human EC109 cells after 72 hrs by MTT assay
|
[PMID: 28759876] |
| ECa-109 cell line | IC50 |
56.2 μM
Compound: 5-FU
|
Antiproliferative activity against human EC109 cells after 48 hrs by MTT assay
Antiproliferative activity against human EC109 cells after 48 hrs by MTT assay
|
[PMID: 28763643] |
| ECa-109 cell line | IC50 |
6.21 μM
Compound: 5-FU
|
Antiproliferative activity against human EC109 cells after 48 hrs by MTT assay
Antiproliferative activity against human EC109 cells after 48 hrs by MTT assay
|
[PMID: 28838695] |
| ECa-109 cell line | IC50 |
6.21 μM
Compound: 5-FU
|
Antiproliferative activity against human EC109 cells after 48 hrs by MTT assay
Antiproliferative activity against human EC109 cells after 48 hrs by MTT assay
|
[PMID: 28863355] |
| ECa-109 cell line | IC50 |
6.21 μM
Compound: 5-Fu
|
Antiproliferative activity against human EC109 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human EC109 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 29113745] |
| ECa-109 cell line | IC50 |
6.02 μM
Compound: 5-Fu
|
Antiproliferative activity against human EC109 cells after 72 hrs by MTT assay
Antiproliferative activity against human EC109 cells after 72 hrs by MTT assay
|
[PMID: 29475156] |
| ECa-109 cell line | IC50 |
6.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human EC109 cells by MTT assay
Antiproliferative activity against human EC109 cells by MTT assay
|
[PMID: 31546197] |
| ECa-109 cell line | IC50 |
21.21 μM
Compound: 5-FU
|
Antiproliferative activity against human EC109 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human EC109 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 31740251] |
| ECa-109 cell line | IC50 |
11.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human EC109 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human EC109 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 34455358] |
| ECa-109 cell line | IC50 |
11.37 μM
Compound: 5-FU
|
Antiproliferative activity against human EC109 cells assessed as inhibition of cell growth by SRB assay
Antiproliferative activity against human EC109 cells assessed as inhibition of cell growth by SRB assay
|
[PMID: 35594653] |
| ECa-109 cell line | IC50 |
15.9 μM
Compound: 5-Fu
|
Cytotoxicity against human EC109 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human EC109 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
10.1039/C5MD00240K |
| Ehrlich | CC50 |
90.55 μM
Compound: 5-FU
|
Growth inhibition of EAC cells after 3 hrs
Growth inhibition of EAC cells after 3 hrs
|
[PMID: 17239491] |
| Ehrlich | ED50 |
58 uL
Compound: 5FU
|
Antitumor activity against mouse EAC cells tansplanted in Swiss albino mouse assessed as dead cells at 50 to 250 mg/kg/day, ip by tyrpan blue assay
Antitumor activity against mouse EAC cells tansplanted in Swiss albino mouse assessed as dead cells at 50 to 250 mg/kg/day, ip by tyrpan blue assay
|
[PMID: 19527933] |
| Ehrlich | ED50 |
58 μL
Compound: 5FU
|
Antitumor activity against mouse EAC cells tansplanted in Swiss albino mouse assessed as dead cells at 50 to 250 mg/kg/day, ip by tyrpan blue assay
Antitumor activity against mouse EAC cells tansplanted in Swiss albino mouse assessed as dead cells at 50 to 250 mg/kg/day, ip by tyrpan blue assay
|
[PMID: 19527933] |
| Ehrlich | IC50 |
1.5 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against mouse EAC cells assessed as cell viability using trypan blue staining after 2 hrs by hemocytometer analysis
Cytotoxicity against mouse EAC cells assessed as cell viability using trypan blue staining after 2 hrs by hemocytometer analysis
|
[PMID: 21353349] |
| Ehrlich | ED50 |
38.6 ug
Compound: 5-FU
|
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
|
[PMID: 23022735] |
| Ehrlich | ED50 |
38.6 μg
Compound: 5-FU
|
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
|
[PMID: 23022735] |
| Ehrlich | IC50 |
97.3 ug
Compound: 5-FU
|
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
|
[PMID: 23022735] |
| Ehrlich | IC50 |
97.3 μg
Compound: 5-FU
|
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
Cytotoxicity against mouse EAC after 2 hrs by trypan blue staining based hemocytometer analysis
|
[PMID: 23022735] |
| Ehrlich | IC50 |
14.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse EAC cells after 48 hrs by MTT assay
Cytotoxicity against mouse EAC cells after 48 hrs by MTT assay
|
[PMID: 24534537] |
| Ehrlich | IC50 |
16.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse EAC cells after 48 hrs by LDH release assay
Cytotoxicity against mouse EAC cells after 48 hrs by LDH release assay
|
[PMID: 24534537] |
| Ehrlich | IC50 |
16.4 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse EAC cells after 48 hrs by trypan blue exclusion assay
Cytotoxicity against mouse EAC cells after 48 hrs by trypan blue exclusion assay
|
[PMID: 24534537] |
| Ehrlich | IC50 |
14.6 μM
Compound: 5-fluorouracil
|
Cytotoxicity against mouse EAC cells after 48 hrs by trypan blue dye exclusion method
Cytotoxicity against mouse EAC cells after 48 hrs by trypan blue dye exclusion method
|
[PMID: 25261825] |
| Ehrlich | IC50 |
15.4 μM
Compound: 5-fluorouracil
|
Cytotoxicity against mouse EAC cells after 48 hrs by LDH release assay
Cytotoxicity against mouse EAC cells after 48 hrs by LDH release assay
|
[PMID: 25261825] |
| Ehrlich | IC50 |
16.3 μM
Compound: 5-fluorouracil
|
Cytotoxicity against mouse EAC cells after 48 hrs by MTT method
Cytotoxicity against mouse EAC cells after 48 hrs by MTT method
|
[PMID: 25261825] |
| Ehrlich | IC50 |
9.2 μM
Compound: 5-fluorouracil
|
Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133037] |
| Ehrlich | IC50 |
9.6 μM
Compound: 5-fluorouracil
|
Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
|
[PMID: 29133037] |
| Ehrlich | IC50 |
0.38 μM
Compound: 5-fluorouracil
|
Anticancer activity against mouse EAC cells assessed as reduction in cell viability
Anticancer activity against mouse EAC cells assessed as reduction in cell viability
|
[PMID: 33276991] |
| Ehrlich | CC50 |
37.36 μM
Compound: 5-FU
|
Cytotoxicity against mouse EAC cell assessed as reduction in cell viability incubated for 3 hrs by tryphan blue dye based assay
Cytotoxicity against mouse EAC cell assessed as reduction in cell viability incubated for 3 hrs by tryphan blue dye based assay
|
[PMID: 33540356] |
| Ehrlich | ED50 |
96.3 mM
Compound: 5-flu
|
Cytotoxicity against Mus musculus (mouse) EAC assessed as cell viability by trypan blue exclusion assay
Cytotoxicity against Mus musculus (mouse) EAC assessed as cell viability by trypan blue exclusion assay
|
10.1007/s00044-009-9199-3 |
| Ehrlich | ED50 |
63 μg/cm3
Compound: 5-FU
|
In vitro antitumor activity against Mus musculus (mouse) Ehrlich ascites cell assessed as dead tumor cells by trypan blue exclusion test
In vitro antitumor activity against Mus musculus (mouse) Ehrlich ascites cell assessed as dead tumor cells by trypan blue exclusion test
|
10.1007/s00044-012-0336-z |
| Ehrlich | IC50 |
0.38 μM
Compound: 5-FU
|
Antitumor activity against mouse EAC cells by trypan blue exclusion assay
Antitumor activity against mouse EAC cells by trypan blue exclusion assay
|
10.1007/s00044-013-0859-y |
| EKVX | GI50 |
61.8 μM
Compound: 5-FU
|
Growth inhibition of human EKVX cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human EKVX cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| ES-2 | IC50 |
25.92 μM
Compound: 5-FU
|
Antiproliferative activity against human ES2 cells
Antiproliferative activity against human ES2 cells
|
[PMID: 38716896] |
| Fibroblast | IC50 |
11 μM
Compound: 5-FU
|
Antiproliferative activity against human fibroblasts after 48 hrs by resazurin reduction test
Antiproliferative activity against human fibroblasts after 48 hrs by resazurin reduction test
|
[PMID: 21530016] |
| Fibroblast | IC50 |
>50 μM
Compound: 5-FU
|
Cytotoxicity against human skin fibroblast cells incubated for 72 hrs by MTT assay
Cytotoxicity against human skin fibroblast cells incubated for 72 hrs by MTT assay
|
[PMID: 35367708] |
| FM3A | IC50 |
0.02 μg/mL
Compound: 5-FU
|
Evaluated for the inhibition of tumor cell growth of murine mammary carcinoma malignant tumor cell line (FM3A/0)
Evaluated for the inhibition of tumor cell growth of murine mammary carcinoma malignant tumor cell line (FM3A/0)
|
[PMID: 11123990] |
| FM3A | IC50 |
0.18 μM
Compound: 5-FU
|
Cytostatic activity against mouse FM3A cells after 2 days by coulter counting analysis
Cytostatic activity against mouse FM3A cells after 2 days by coulter counting analysis
|
[PMID: 21330014] |
| G-292 | IC50 |
>3.3 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human osteogenic sarcoma (G-292) cells
In vitro inhibitory activity against growth of Human osteogenic sarcoma (G-292) cells
|
[PMID: 1995901] |
| GES1 | IC50 |
30.9 μM
Compound: 5-Fu
|
Cytotoxicity against human GES-1 cells after 48 hrs by MTT assay
Cytotoxicity against human GES-1 cells after 48 hrs by MTT assay
|
[PMID: 25462264] |
| GES1 | IC50 |
13.75 μM
Compound: 5-FU
|
Cytotoxicity against human GES-1 cells assessed as growth inhibition after 72 hrs by CCK8 assay
Cytotoxicity against human GES-1 cells assessed as growth inhibition after 72 hrs by CCK8 assay
|
[PMID: 27597411] |
| GES1 | IC50 |
8.59 μM
Compound: 5-FU
|
Cytotoxicity against human GES-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human GES-1 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 28759876] |
| GES1 | IC50 |
9.02 μM
Compound: 5-FU
|
Antiproliferative activity against human GES-1 cells after 48 hrs by MTT assay
Antiproliferative activity against human GES-1 cells after 48 hrs by MTT assay
|
[PMID: 28863355] |
| GES1 | IC50 |
12.51 μM
Compound: 5-Fu
|
Antiproliferative activity against human GES-1 cells after 72 hrs by MTT assay
Antiproliferative activity against human GES-1 cells after 72 hrs by MTT assay
|
[PMID: 29635165] |
| GES1 | IC50 |
12.51 μM
Compound: 5-Fu
|
Cytotoxicity against human GES-1 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human GES-1 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30388465] |
| GES1 | IC50 |
3.69 μM
Compound: 5-FU
|
Antiproliferative activity against human GES-1 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human GES-1 cells incubated for 72 hrs by MTT assay
|
[PMID: 31404863] |
| GES1 | IC50 |
10.21 μM
Compound: 5-FU
|
Cytotoxicity against human GES1 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human GES1 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 31577977] |
| GES1 | IC50 |
2.37 μM
Compound: 5-Fu
|
Cytotoxicity against human GES1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human GES1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 32682202] |
| GES1 | IC50 |
2.45 μM
Compound: 5-Fu
|
Antiproliferative activity against human GES1 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human GES1 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33385852] |
| GES1 | IC50 |
19.27 μM
Compound: 5-FU
|
Cytotoxicity against human GES1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human GES1 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 34302974] |
| GES1 | IC50 |
38.5 μM
Compound: 5-Fu
|
Cytotoxicity against human GES1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human GES1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34628244] |
| GES1 | IC50 |
78.4 μM
Compound: 5-FU
|
Toxicity in human GES1 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Toxicity in human GES1 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35085721] |
| GES1 | IC50 |
>100 μM
Compound: 5-Fu
|
Cytotoxicity against human GES1 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human GES1 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 35191714] |
| GES1 | IC50 |
49.6 μM
Compound: 5-FU
|
Antiproliferative activity against human GES1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human GES1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 35286954] |
| GES1 | IC50 |
7.22 μM
Compound: 5-Fu
|
Cytotoxicity against human GES-1 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human GES-1 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
10.1039/C6MD00169F |
| GTL 16 cell line | IC50 |
0.84 μM
Compound: 5-FU
|
Antitumor activity against human GTL 16 cell line assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
Antitumor activity against human GTL 16 cell line assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
|
[PMID: 36324491] |
| H4 | CC50 |
3843.8 μM
Compound: 5-FU
|
Cytotoxicity against human H4 cells after 72 hrs
Cytotoxicity against human H4 cells after 72 hrs
|
[PMID: 17337193] |
| H4 | CC50 |
3843.8 μM
Compound: 5FU
|
Cytotoxicity against human H4 cells after 72 hrs
Cytotoxicity against human H4 cells after 72 hrs
|
[PMID: 17548129] |
| H4 | CC50 |
3843.8 μM
Compound: 5FU
|
Cytotoxicity against human H4 cells after 72 hrs
Cytotoxicity against human H4 cells after 72 hrs
|
[PMID: 17555969] |
| H4 | CC50 |
10 μM
Compound: 5-Fu
|
Tumor selectivity index, ratio of CC50 for human H4 cells to CC50 for human Caco-2 cells
Tumor selectivity index, ratio of CC50 for human H4 cells to CC50 for human Caco-2 cells
|
[PMID: 18037195] |
| H4 | CC50 |
3843.8 μM
Compound: 5-Fu
|
Cytotoxicity against human H4 cells after 72 hrs
Cytotoxicity against human H4 cells after 72 hrs
|
[PMID: 18037195] |
| H4 | CC50 |
83.4 μM
Compound: 5-Fu
|
Tumor selectivity index, ratio of CC50 for human H4 cells to CC50 for human melanoma cells
Tumor selectivity index, ratio of CC50 for human H4 cells to CC50 for human melanoma cells
|
[PMID: 18037195] |
| H69AR | GI50 |
100 μM
Compound: 5-Fu
|
Growth inhibition of human H69AR cells after 48 hrs by SRB assay
Growth inhibition of human H69AR cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| HaCaT | IC50 |
0.4 μM
Compound: 5-FU
|
Growth inhibition of human HaCaT cells after 72 hrs by MTT assay
Growth inhibition of human HaCaT cells after 72 hrs by MTT assay
|
[PMID: 18640746] |
| HaCaT | IC50 |
0.3 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human HaCaT cells after 72 hrs by MTT assay
Cytostatic activity against human HaCaT cells after 72 hrs by MTT assay
|
[PMID: 22405290] |
| HaCaT | IC50 |
15.26 μM
Compound: 5-Fluorouracil
|
Cytotoxic activity against human HaCaT cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Cytotoxic activity against human HaCaT cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080] |
| HaCaT | IC50 |
16.15 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HaCaT cells after 48 hrs by MTT assay
Antiproliferative activity against human HaCaT cells after 48 hrs by MTT assay
|
[PMID: 27092413] |
| HBL-100 | GI50 |
5.5 μM
Compound: 5-FU
|
Growth inhibition of human HBL100 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HBL100 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 19664930] |
| HBL-100 | GI50 |
5.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HBL100 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HBL100 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 25752525] |
| HBL-100 | GI50 |
5.5 μM
Compound: 5-FU
|
Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
|
[PMID: 28728108] |
| HBL-100 | GI50 |
5.5 μM
Compound: 5-FU
|
Antiproliferative activity against human HBL100 cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human HBL100 cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 31376562] |
| HBL-100 | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HBL100 cells by MTT assay
Antiproliferative activity against human HBL100 cells by MTT assay
|
[PMID: 31546197] |
| HBL-100 | GI50 |
4.4 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HBL-100 cells assessed as reduction in cell growth
Antiproliferative activity against human HBL-100 cells assessed as reduction in cell growth
|
[PMID: 34847410] |
| HBL-100 | GI50 |
5.5 μM
Compound: 5-FU
|
Growth inhibition of human HBL-100 cells measured after 48 hrs by SRB colorimetric assay
Growth inhibition of human HBL-100 cells measured after 48 hrs by SRB colorimetric assay
|
[PMID: 37137247] |
| HCC 2998 | IC50 |
5.75 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HCC2998 cells
Cytotoxicity against human HCC2998 cells
|
[PMID: 16996657] |
| HCC 2998 | IC50 |
13.5 μM
Compound: 5-FU
|
Anticancer activity against human HCC2998 cells
Anticancer activity against human HCC2998 cells
|
[PMID: 21449610] |
| HCC 2998 | IC50 |
13.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCC2998 cells
Cytotoxicity against human HCC2998 cells
|
[PMID: 22409967] |
| HCC 2998 | GI50 |
0.05 μM
Compound: 5-FU
|
Growth inhibition of human HCC2998 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HCC2998 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| HCC 2998 | IC50 |
5.75 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCC2998 cells assessed as inhibition of tumor growth after 24 hrs
Cytotoxicity against human HCC2998 cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| HCC 2998 | CC50 |
>2512 μM
Compound: 5-Fu
|
Cytotoxicity against human HCC2998 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCC2998 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HCC 2998 | IC50 |
14.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HCC2998 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCC2998 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HCC 2998 | GI50 |
0.05 μM
Compound: 5-FU
|
Anticancer activity against human HCC 2998 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HCC 2998 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| HCC 2998 | IC50 |
12.6 μM
Compound: 5-FU
|
Cytotoxicity against human HCC 2998 cells assessed as inhibition of cell viability incubated for 72 hrs under hypoxia condition by MTT assay
Cytotoxicity against human HCC 2998 cells assessed as inhibition of cell viability incubated for 72 hrs under hypoxia condition by MTT assay
|
[PMID: 35182815] |
| HCC 2998 | IC50 |
0.05 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCC 2998 cells assessed as cell growth inhibition
Cytotoxicity against human HCC 2998 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HCC1937 | IC50 |
25.94 μM
Compound: 5-FU
|
Antitumor activity against human HCC1937 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
Antitumor activity against human HCC1937 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
|
[PMID: 36324491] |
| HCCLM3 | IC50 |
1.84 mM
Compound: 5-FU
|
Antiproliferative activity against human HCCLM3 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
Antiproliferative activity against human HCCLM3 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
|
[PMID: 28073674] |
| HCCLM9 | IC50 |
27.21 μM
Compound: 5-FU
|
Antiproliferative activity against human HCCLM9 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human HCCLM9 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 37182331] |
| HCT-116 | ED50 |
0.48 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human HCT116 cells by MTT assay
Cytotoxicity against human HCT116 cells by MTT assay
|
[PMID: 11908984] |
| HCT-116 | IC50 |
4.93 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 96 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 96 hrs by MTT assay
|
[PMID: 15387639] |
| HCT-116 | IC50 |
2.04 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HCT116 cells
Cytotoxicity against human HCT116 cells
|
[PMID: 16996657] |
| HCT-116 | IC50 |
300 μM
Compound: 5-FU
|
Growth inhibition in HCT116 cells assessed as inhibition of [3H]thymidine incorporation
Growth inhibition in HCT116 cells assessed as inhibition of [3H]thymidine incorporation
|
[PMID: 17411027] |
| HCT-116 | IC50 |
2.8 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs
Antiproliferative activity against human HCT116 cells after 72 hrs
|
[PMID: 17548198] |
| HCT-116 | IC50 |
6.36 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against human HCT116 cells expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| HCT-116 | IC50 |
2.6 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| HCT-116 | IC50 |
3.03 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells after 24 hrs by trypan blue exclusion assay
Cytotoxicity against human HCT116 cells after 24 hrs by trypan blue exclusion assay
|
[PMID: 20163895] |
| HCT-116 | IC50 |
4 μM
Compound: 5-FU
|
Antitumor activity against human HCT116 cells after 24 hrs by MTT assay
Antitumor activity against human HCT116 cells after 24 hrs by MTT assay
|
[PMID: 20211564] |
| HCT-116 | IC50 |
1.93 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 20494492] |
| HCT-116 | IC50 |
12 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells expressing p53 after 72 hrs by celltiter-glo assay
Antiproliferative activity against human HCT116 cells expressing p53 after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| HCT-116 | IC50 |
8.51 μM
Compound: 5-FU
|
Anticancer activity against human HCT116 cells
Anticancer activity against human HCT116 cells
|
[PMID: 21449610] |
| HCT-116 | IC50 |
4 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 22130132] |
| HCT-116 | IC50 |
6 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 22154835] |
| HCT-116 | IC50 |
4 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human HCT116 cells after 72 hrs by MTT assay
Cytostatic activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 22405290] |
| HCT-116 | IC50 |
6 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay
Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay
|
[PMID: 22409771] |
| HCT-116 | IC50 |
8.51 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells
Cytotoxicity against human HCT116 cells
|
[PMID: 22409967] |
| HCT-116 | IC50 |
31.72 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 22483608] |
| HCT-116 | GI50 |
9.9 μM
Compound: 5-Fu
|
Growth inhibition of human HCT116 cells after 48 hrs by SRB assay
Growth inhibition of human HCT116 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| HCT-116 | IC50 |
18.7 μM
Compound: 5FU
|
Cytotoxicity against human HCT116 cells incubated for 72 hrs by SRB assay
Cytotoxicity against human HCT116 cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| HCT-116 | IC50 |
36.4 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 23067549] |
| HCT-116 | GI50 |
8.8 nM
Compound: 5FU
|
Growth inhibition of human HCT116 cells after 48 hrs by SRB assay
Growth inhibition of human HCT116 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| HCT-116 | IC50 |
3.56 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells assessed as inhibition cell proliferation after 48 hrs by Sulforhodamine B assay
Antiproliferative activity against human HCT116 cells assessed as inhibition cell proliferation after 48 hrs by Sulforhodamine B assay
|
[PMID: 23305919] |
| HCT-116 | IC50 |
27.76 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HCT-116 | IC50 |
4.52 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCT116 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23644215] |
| HCT-116 | IC50 |
5.53 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 23665106] |
| HCT-116 | IC50 |
3.24 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 23685571] |
| HCT-116 | IC50 |
10.1 μM
Compound: 5-FU
|
Synergistic antitumor activity against siRNA-mediated luciferase knockout human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs (Rvb = 13.8 microM)
Synergistic antitumor activity against siRNA-mediated luciferase knockout human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs (Rvb = 13.8 microM)
|
[PMID: 23814490] |
| HCT-116 | IC50 |
3.2 μM
Compound: 5-FU
|
Synergistic antitumor activity against siRNA-mediated Pim-1 knockout human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs (Rvb = 13.8 microM)
Synergistic antitumor activity against siRNA-mediated Pim-1 knockout human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs (Rvb = 13.8 microM)
|
[PMID: 23814490] |
| HCT-116 | GI50 |
0.22 μM
Compound: 5-FU
|
Growth inhibition of human HCT116 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HCT116 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| HCT-116 | IC50 |
27.76 μM
Compound: 5-Fu
|
Growth inhibition against human HCT116 cells after 48 hrs by MTT assay
Growth inhibition against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| HCT-116 | IC50 |
8.32 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 24211021] |
| HCT-116 | IC50 |
5.78 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 24378217] |
| HCT-116 | IC50 |
24.43 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 24565905] |
| HCT-116 | IC50 |
10.54 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 24819956] |
| HCT-116 | IC50 |
10.05 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| HCT-116 | IC50 |
4.8 μg/mL
Compound: 5-Fu
|
Anticancer activity against human HCT116 cells assessed as growth inhibition after 48 hrs by MTT assay
Anticancer activity against human HCT116 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 25017036] |
| HCT-116 | IC50 |
0.5 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTS assay
|
[PMID: 25066282] |
| HCT-116 | EC50 |
>50 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 24 hrs by MTT assay
|
[PMID: 25198997] |
| HCT-116 | IC50 |
36.2 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
|
[PMID: 25453794] |
| HCT-116 | IC50 |
6 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay
Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay
|
[PMID: 25462277] |
| HCT-116 | IC50 |
29.58 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25841199] |
| HCT-116 | IC50 |
4.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human HCT116 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay
|
[PMID: 26222449] |
| HCT-116 | IC50 |
5.53 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTS assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTS assay
|
[PMID: 26703795] |
| HCT-116 | IC50 |
24.58 μM
Compound: 5-FU
|
Cytotoxic activity against human HCT116 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxic activity against human HCT116 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26706349] |
| HCT-116 | CC50 |
>2512 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT116 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCT116 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HCT-116 | IC50 |
14.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT116 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCT116 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HCT-116 | IC50 |
2.3 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 26854375] |
| HCT-116 | IC50 |
38.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 26922223] |
| HCT-116 | IC50 |
>50 μM
Compound: 5-FU
|
Anticancer activity against human HCT116 cells assessed as inhibition of cell growth after 24 hrs by MTT assay
Anticancer activity against human HCT116 cells assessed as inhibition of cell growth after 24 hrs by MTT assay
|
[PMID: 26922233] |
| HCT-116 | IC50 |
>50 μM
Compound: 5-FU
|
Anticancer activity against human HCT116 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Anticancer activity against human HCT116 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26922233] |
| HCT-116 | IC50 |
27.8 μM
Compound: 5-FU
|
Anticancer activity against human HCT116 cells assessed as inhibition of cell growth after 72 hrs by MTT assay
Anticancer activity against human HCT116 cells assessed as inhibition of cell growth after 72 hrs by MTT assay
|
[PMID: 26922233] |
| HCT-116 | IC50 |
56.96 μM
Compound: 5-Fuorouracil
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 27017265] |
| HCT-116 | IC50 |
68.71 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells measured after 48 hrs by MTT assay
|
[PMID: 27287368] |
| HCT-116 | IC50 |
84.9 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HCT-116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| HCT-116 | IC50 |
15.38 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27448774] |
| HCT-116 | IC50 |
29.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 27503679] |
| HCT-116 | IC50 |
5.53 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTS assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTS assay
|
[PMID: 27575478] |
| HCT-116 | IC50 |
2.5 μM
Compound: 5-FU
|
Growth inhibition of human HCT116 cells after 72 hrs by MTS assay
Growth inhibition of human HCT116 cells after 72 hrs by MTS assay
|
[PMID: 27704811] |
| HCT-116 | IC50 |
2 mM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27847140] |
| HCT-116 | IC50 |
29.2 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 28073676] |
| HCT-116 | IC50 |
38.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 28110871] |
| HCT-116 | IC50 |
18.4 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay
Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay
|
[PMID: 28219046] |
| HCT-116 | IC50 |
0.041 mM
Compound: 5-Fluorouracil
|
Cytotoxicity in human HCT116 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity in human HCT116 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 28334654] |
| HCT-116 | IC50 |
26.2 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 28400238] |
| HCT-116 | IC50 |
9.9 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells
Cytotoxicity against human HCT116 cells
|
[PMID: 28431341] |
| HCT-116 | IC50 |
4.16 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 28458133] |
| HCT-116 | IC50 |
41.9 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 28532669] |
| HCT-116 | IC50 |
4 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 28623814] |
| HCT-116 | IC50 |
17.01 μM
Compound: 5-Fu
|
Cytotoxic activity against human HCT116 cells
Cytotoxic activity against human HCT116 cells
|
[PMID: 28697923] |
| HCT-116 | GI50 |
5.47 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT116 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 28716495] |
| HCT-116 | IC50 |
8.62 μM
Compound: 5-FU
|
Cytotoxicity in human HCT116 cells incubated for 48 hrs by MTT assay
Cytotoxicity in human HCT116 cells incubated for 48 hrs by MTT assay
|
[PMID: 28923381] |
| HCT-116 | IC50 |
44.06 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HCT116 cells in presence of ubenimex after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells in presence of ubenimex after 48 hrs by MTT assay
|
[PMID: 29202398] |
| HCT-116 | IC50 |
53.84 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 29202398] |
| HCT-116 | IC50 |
201 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 29207336] |
| HCT-116 | IC50 |
8.638 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 29223717] |
| HCT-116 | IC50 |
29.5 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 29232583] |
| HCT-116 | IC50 |
11.29 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 29316536] |
| HCT-116 | IC50 |
4 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
Antiproliferative activity against human HCT116 cells after 72 hrs by SRB assay
|
[PMID: 29326016] |
| HCT-116 | IC50 |
17.25 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 29486954] |
| HCT-116 | IC50 |
5.53 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells by MTS assay
Cytotoxicity against human HCT116 cells by MTS assay
|
[PMID: 29843103] |
| HCT-116 | IC50 |
37.6 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 30108895] |
| HCT-116 | IC50 |
18.4 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay
Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay
|
[PMID: 30108969] |
| HCT-116 | IC50 |
38.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 30142612] |
| HCT-116 | IC50 |
11.56 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 30318440] |
| HCT-116 | IC50 |
5.53 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 30472605] |
| HCT-116 | IC50 |
0.54 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability by SRB assay
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability by SRB assay
|
[PMID: 30660827] |
| HCT-116 | IC50 |
15.52 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HCT116 assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30709651] |
| HCT-116 | IC50 |
24.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113] |
| HCT-116 | IC50 |
4.42 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells expressing wild type p53 incubated for 72 hrs by MTS assay
Cytotoxicity against human HCT116 cells expressing wild type p53 incubated for 72 hrs by MTS assay
|
[PMID: 31158748] |
| HCT-116 | IC50 |
4.69 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells deficient in p53 incubated for 72 hrs by MTS assay
Cytotoxicity against human HCT116 cells deficient in p53 incubated for 72 hrs by MTS assay
|
[PMID: 31158748] |
| HCT-116 | IC50 |
17.3 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT116 cells
Cytotoxicity against human HCT116 cells
|
[PMID: 31200236] |
| HCT-116 | IC50 |
63.9 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
Cytotoxicity against human HCT116 cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
|
[PMID: 31416740] |
| HCT-116 | IC50 |
20.4 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 31471102] |
| HCT-116 | IC50 |
26.14 μM
Compound: 5-Fu
|
Anticancer activity against human HCT116 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
Anticancer activity against human HCT116 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31509699] |
| HCT-116 | IC50 |
5.2 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HCT-116 cells
Cytotoxicity against human HCT-116 cells
|
[PMID: 31761383] |
| HCT-116 | IC50 |
13 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HCT116 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells incubated for 72 hrs by MTT assay
|
[PMID: 31829592] |
| HCT-116 | IC50 |
4.02 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells assessed as inhibition of cell growth
Cytotoxicity against human HCT116 cells assessed as inhibition of cell growth
|
[PMID: 31864797] |
| HCT-116 | IC50 |
6.86 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31877536] |
| HCT-116 | IC50 |
6.86 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell growth after 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell growth after 72 hrs by MTT assay
|
[PMID: 31883693] |
| HCT-116 | IC50 |
6.5 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HCT116 cells after 48 hrs by CellTiter-Glo assay
Cytotoxicity against human HCT116 cells after 48 hrs by CellTiter-Glo assay
|
[PMID: 31999116] |
| HCT-116 | IC50 |
26042.5 nM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 32203786] |
| HCT-116 | IC50 |
26042.5 x 10-3 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 32203786] |
| HCT-116 | IC50 |
12.31 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
|
[PMID: 32387836] |
| HCT-116 | IC50 |
13.8 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32682200] |
| HCT-116 | GI50 |
>10 μM
Compound: 4; 5-FU
|
Antiproliferative activity against human HCT-116 cells measured after 48 hrs by SRB assay
Antiproliferative activity against human HCT-116 cells measured after 48 hrs by SRB assay
|
[PMID: 32683166] |
| HCT-116 | IC50 |
6.1 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| HCT-116 | IC50 |
1.7 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 33321421] |
| HCT-116 | IC50 |
4.3 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells harboring p53 knock out gene assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human HCT-116 cells harboring p53 knock out gene assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 33321421] |
| HCT-116 | IC50 |
10.81 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33538581] |
| HCT-116 | IC50 |
13.9 μM
Compound: 1; 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs in presence of 5 mM GSH by SRB assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs in presence of 5 mM GSH by SRB assay
|
[PMID: 33819035] |
| HCT-116 | IC50 |
14.9 μM
Compound: 1; 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
|
[PMID: 33819035] |
| HCT-116 | IC50 |
4.6 μM
Compound: 5-FU
|
Anticancer activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 33940466] |
| HCT-116 | IC50 |
37.22 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 34157389] |
| HCT-116 | IC50 |
7.38 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 34170142] |
| HCT-116 | EC50 |
>1000 μM
Compound: 5-FU
|
Reversal of 5-FU resistance against human HCT-116 cells overexpressing DPD assessed as inhibition of cell proliferation measured after 72 hrs in presence of 5-FU by MTT assay
Reversal of 5-FU resistance against human HCT-116 cells overexpressing DPD assessed as inhibition of cell proliferation measured after 72 hrs in presence of 5-FU by MTT assay
|
[PMID: 34411894] |
| HCT-116 | IC50 |
5.3 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells
Cytotoxicity against human HCT-116 cells
|
[PMID: 34655985] |
| HCT-116 | EC50 |
>1000 μM
Compound: 5-FU
|
Antiproliferative activity against 5-FU resistant DPD expressed human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against 5-FU resistant DPD expressed human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 34688013] |
| HCT-116 | IC50 |
19.27 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 34715305] |
| HCT-116 | EC50 |
0.5 μM
Compound: 1; 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 5 days by PrestoBlue reagent based assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 5 days by PrestoBlue reagent based assay
|
[PMID: 34979089] |
| HCT-116 | IC50 |
91.73 μM
Compound: 5-FU
|
Cytotoxicity in human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35085721] |
| HCT-116 | GI50 |
0.22 μM
Compound: 5-FU
|
Anticancer activity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| HCT-116 | IC50 |
5.78 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT-116 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells after 72 hrs by MTT assay
|
[PMID: 35609396] |
| HCT-116 | IC50 |
9.88 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35635947] |
| HCT-116 | IC50 |
7.77 μM
Compound: 5-FU
|
Antitumor activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 35777102] |
| HCT-116 | IC50 |
30.72 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth
|
[PMID: 36089111] |
| HCT-116 | IC50 |
6.5 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by MTT assay
|
[PMID: 36209705] |
| HCT-116 | IC50 |
21.54 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 36269639] |
| HCT-116 | IC50 |
4.89 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| HCT-116 | IC50 |
32.26 μM
Compound: 5-FU
|
Anticancer activity against human HCT-116 cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human HCT-116 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| HCT-116 | IC50 |
0.22 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HCT-116 | IC50 |
40 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell growth incubated for 24 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell growth incubated for 24 hrs by MTT assay
|
[PMID: 36780831] |
| HCT-116 | IC50 |
5 μM
Compound: 5-FU
|
Induction of apoptosis in human HCT-116 cells in presence of EGCG at 50 uM
Induction of apoptosis in human HCT-116 cells in presence of EGCG at 50 uM
|
[PMID: 36780831] |
| HCT-116 | IC50 |
12 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
Cytotoxicity against human HCT-116 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
|
[PMID: 37243616] |
| HCT-116 | IC50 |
16.58 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 37343499] |
| HCT-116 | IC50 |
14.29 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
|
[PMID: 37360398] |
| HCT-116 | IC50 |
8.2 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth measured after 48 to 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth measured after 48 to 72 hrs by MTT assay
|
[PMID: 37902628] |
| HCT-116 | IC50 |
16.72 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 38107169] |
| HCT-116 | IC50 |
24.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by MTS assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability by MTS assay
|
[PMID: 38107170] |
| HCT-116 | IC50 |
13.01 μM
Compound: 1; 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 1.5 hrs by CCK-8 assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 1.5 hrs by CCK-8 assay
|
[PMID: 38107178] |
| HCT-116 | IC50 |
9.93 μM
Compound: 1; 5-FU
|
Growth inhibition of human HCT-116 cells incubated for 1.5 hrs by MTT assay
Growth inhibition of human HCT-116 cells incubated for 1.5 hrs by MTT assay
|
[PMID: 38107178] |
| HCT-116 | IC50 |
6 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
|
[PMID: 38107180] |
| HCT-116 | IC50 |
5.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| HCT-116 | IC50 |
14.43 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112] |
| HCT-116 | IC50 |
4.1 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
|
[PMID: 38688437] |
| HCT-116 | IC50 |
9.63 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38759254] |
| HCT-116 | IC50 |
8.03 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-116 cells incubated for 72 hrs by MTS assay
Cytotoxicity against human HCT-116 cells incubated for 72 hrs by MTS assay
|
[PMID: 38843656] |
| HCT-116 | IC50 |
>20 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 38897138] |
| HCT-116 | IC50 |
8.75 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 39016216] |
| HCT-116 | IC50 |
19.7 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by MTT assay
|
[PMID: 39045852] |
| HCT-116 | IC50 |
29.6 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-116 cells incubated for 24 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells incubated for 24 hrs by MTT assay
|
[PMID: 39045852] |
| HCT-116 | IC50 |
13.89 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by SRB method
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by SRB method
|
[PMID: 39054645] |
| HCT-116 | IC50 |
1.93 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HCT116 cells by MTT assay
Cytotoxicity against Homo sapiens (human) HCT116 cells by MTT assay
|
10.1007/s00044-010-9395-1 |
| HCT-116 | IC50 |
0.0462 mM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HCT116 cells assessed as growth inhibition after 72 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HCT116 cells assessed as growth inhibition after 72 hr by MTT assay
|
10.1007/s00044-012-0181-0 |
| HCT-116 | IC50 |
19.2 μM
Compound: 5-FU
|
Anticancer activity against Homo sapiens (human) HCT116 cells assessed as inhibition of cell proliferation after 72 hr by MTT assay
Anticancer activity against Homo sapiens (human) HCT116 cells assessed as inhibition of cell proliferation after 72 hr by MTT assay
|
10.1007/s00044-012-0240-6 |
| HCT-116 | IC50 |
1.93 μM
Compound: 5-FU
|
Antitumor activity against Homo sapiens (human) HCT116 cells assessed as inhibition of cell viability after 72 hr by MTT assay
Antitumor activity against Homo sapiens (human) HCT116 cells assessed as inhibition of cell viability after 72 hr by MTT assay
|
10.1007/s00044-012-0283-8 |
| HCT-116 | IC50 |
19.2 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HCT116 cells assessed as growth inhibition after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HCT116 cells assessed as growth inhibition after 48 hr by MTT assay
|
10.1007/s00044-012-0461-8 |
| HCT-116 | GI50 |
9.51 μM
Compound: 5-FU
|
Cytotoxicity against human HCT116 cells after 48 hrs by SRB assay
Cytotoxicity against human HCT116 cells after 48 hrs by SRB assay
|
10.1007/s00044-013-0798-7 |
| HCT-116 | IC50 |
4.9 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
10.1039/C4MD00209A |
| HCT-116 | IC50 |
4.3 μM
Compound: 5-FU
|
Antiproliferative activity in human HCT116 cells after 72 hrs by MTT assay
Antiproliferative activity in human HCT116 cells after 72 hrs by MTT assay
|
10.1039/C6MD00252H |
| HCT-15 | IC50 |
0.11 μg/mL
Compound: 5-FU
|
Inhibitory concentration of compound for cytotoxicity against HCT15 human colon cells was determined
Inhibitory concentration of compound for cytotoxicity against HCT15 human colon cells was determined
|
[PMID: 11814824] |
| HCT-15 | IC50 |
6.61 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HCT15 cells
Cytotoxicity against human HCT15 cells
|
[PMID: 16996657] |
| HCT-15 | IC50 |
300 μM
Compound: 5-FU
|
Growth inhibition in HCT15 cells assessed as inhibition of [3H]thymidine incorporation
Growth inhibition in HCT15 cells assessed as inhibition of [3H]thymidine incorporation
|
[PMID: 17411027] |
| HCT-15 | IC50 |
18.24 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT15 cells expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against human HCT15 cells expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| HCT-15 | IC50 |
48 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT15 cells expressing p53 after 72 hrs by celltiter-glo assay
Antiproliferative activity against human HCT15 cells expressing p53 after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| HCT-15 | IC50 |
3.6 μM
Compound: 5-fluorouracil
|
Anticancer activity against human HCT15 cells assessed as cell viability after 48 hrs by SRB assay
Anticancer activity against human HCT15 cells assessed as cell viability after 48 hrs by SRB assay
|
[PMID: 21074444] |
| HCT-15 | IC50 |
9.71 μM
Compound: 5-FU
|
Anticancer activity against human HCT15 cells
Anticancer activity against human HCT15 cells
|
[PMID: 21449610] |
| HCT-15 | IC50 |
9.71 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT15 cells
Cytotoxicity against human HCT15 cells
|
[PMID: 22409967] |
| HCT-15 | GI50 |
21 μM
Compound: 5-Fu
|
Growth inhibition of human HCT15 cells after 48 hrs by SRB assay
Growth inhibition of human HCT15 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| HCT-15 | GI50 |
21.1 nM
Compound: 5FU
|
Growth inhibition of human HCT15 cells after 48 hrs by SRB assay
Growth inhibition of human HCT15 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| HCT-15 | IC50 |
45.01 μM
Compound: 5-FU
|
Cytotoxicity against human HCT15 cells after 24 hrs by MTT assay
Cytotoxicity against human HCT15 cells after 24 hrs by MTT assay
|
[PMID: 23202484] |
| HCT-15 | GI50 |
0.11 μM
Compound: 5-FU
|
Growth inhibition of human HCT15 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HCT15 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| HCT-15 | IC50 |
6.61 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT15 cells assessed as inhibition of tumor growth after 24 hrs
Cytotoxicity against human HCT15 cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| HCT-15 | IC50 |
4.5 μM
Compound: 5-FU
|
Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 24910974] |
| HCT-15 | CC50 |
>2512 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HCT-15 | IC50 |
14.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HCT-15 | IC50 |
45.01 μM
Compound: 5-FU
|
Growth inhibition of human HCT15 cells after 24 hrs by MTT assay
Growth inhibition of human HCT15 cells after 24 hrs by MTT assay
|
[PMID: 28011220] |
| HCT-15 | IC50 |
7.53 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT15 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT15 cells after 48 hrs by MTT assay
|
[PMID: 29174813] |
| HCT-15 | IC50 |
11.87 μM
Compound: 5-FU
|
Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
|
[PMID: 30318440] |
| HCT-15 | IC50 |
7.53 μM
Compound: 5-FU
|
Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| HCT-15 | IC50 |
33.68 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HCT-15 cells assessed as cell growth inhibition by MTT assay
Antiproliferative activity against human HCT-15 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 31945642] |
| HCT-15 | IC50 |
10.86 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-15 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
|
[PMID: 32387836] |
| HCT-15 | GI50 |
0.11 μM
Compound: 5-FU
|
Anticancer activity against human HCT-15 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HCT-15 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| HCT-15 | IC50 |
8.24 μM
Compound: 5-FU
|
Anticancer activity against human HCT-15 cells incubated for 72 hrs by MTT assay
Anticancer activity against human HCT-15 cells incubated for 72 hrs by MTT assay
|
[PMID: 35367708] |
| HCT-15 | IC50 |
8.23 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-15 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-15 cells incubated for 72 hrs by MTT assay
|
[PMID: 36209705] |
| HCT-15 | IC50 |
0.11 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT-15 cells assessed as cell growth inhibition
Cytotoxicity against human HCT-15 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HCT-15 | IC50 |
12 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-15 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
Cytotoxicity against human HCT-15 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
|
[PMID: 37243616] |
| HCT-15 | IC50 |
5.7 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of HCT-15 tumor cell line from colon.
Compound was tested for its inhibitory effect on the growth of HCT-15 tumor cell line from colon.
|
10.1016/0960-894X(96)00339-3 |
| HCT-8 | IC50 |
4.2 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
|
[PMID: 16499317] |
| HCT-8 | IC50 |
0.54 μg/mL
Compound: 5-FU, 5-fluorouracil
|
Cytotoxicity against human HCT8 cells by MTT assay
Cytotoxicity against human HCT8 cells by MTT assay
|
[PMID: 18205316] |
| HCT-8 | IC50 |
0.2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human HCT8 after 24 hrs by MTT assay
Cytotoxicity against human HCT8 after 24 hrs by MTT assay
|
[PMID: 19338315] |
| HCT-8 | IC50 |
5.38 μM
Compound: 5-Fu
|
Cytotoxicity against human HCT8 cells by MTT method
Cytotoxicity against human HCT8 cells by MTT method
|
[PMID: 23164710] |
| HCT-8 | IC50 |
6.92 μM
Compound: 5-Fu
|
Antiproliferative activity against human HCT8 cells by MTT assay
Antiproliferative activity against human HCT8 cells by MTT assay
|
[PMID: 24095094] |
| HCT-8 | IC50 |
3.54 μM
Compound: 5-FU
|
Cytotoxicity against human HCT8 cells assessed as growth inhibition rate after 96 hrs by MTT assay
Cytotoxicity against human HCT8 cells assessed as growth inhibition rate after 96 hrs by MTT assay
|
[PMID: 25203783] |
| HCT-8 | IC50 |
0.91 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT8 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Antiproliferative activity against human HCT8 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 25675144] |
| HCT-8 | IC50 |
36.638 μM
Compound: 5-FU
|
Antiproliferative activity against 5-FU resistant human HCT8 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Antiproliferative activity against 5-FU resistant human HCT8 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 25675144] |
| HCT-8 | IC50 |
6.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay
|
[PMID: 26227777] |
| HCT-8 | IC50 |
32.31 μM
Compound: 5-FU
|
Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HCT8 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 26873416] |
| HCT-8 | IC50 |
28.9 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay
|
[PMID: 30037494] |
| HCT-8 | IC50 |
28.9 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay
Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay
|
[PMID: 30429977] |
| HCT-8 | IC50 |
2.2 μM
Compound: 5-FU
|
Cytotoxicity against human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 33321421] |
| HCT-8 | IC50 |
47 μM
Compound: 5-FU
|
Cytotoxicity against 5-FU resistant human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against 5-FU resistant human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 33321421] |
| HCT-8 | IC50 |
11.18 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-8 cells assessed as cell growth inhibition
Antiproliferative activity against human HCT-8 cells assessed as cell growth inhibition
|
[PMID: 33930801] |
| HCT-8 | IC50 |
4.7 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-8 cells assessed as cell growth inhibition in presence of piperlongumine
Antiproliferative activity against human HCT-8 cells assessed as cell growth inhibition in presence of piperlongumine
|
[PMID: 33930801] |
| HCT-8 | IC50 |
>20 μM
Compound: 5-FU
|
Antiproliferative activity against human HCT-8 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-8 cells incubated for 72 hrs by MTT assay
|
[PMID: 36209705] |
| HEK293 | IC50 |
42.9 μM
Compound: 5-FU
|
Cytotoxicity against human HEK293 cells after 2 days by alamar blue assay
Cytotoxicity against human HEK293 cells after 2 days by alamar blue assay
|
[PMID: 22093761] |
| HEK293 | IC50 |
48.7 μM
Compound: 5-FU
|
Antiproliferative activity against HEK293 cells after 24 hrs by MTT assay
Antiproliferative activity against HEK293 cells after 24 hrs by MTT assay
|
[PMID: 25198997] |
| HEK293 | IC50 |
40 μM
Compound: 5 Fluorouracil
|
Cytotoxicity against human HEK293 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human HEK293 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212] |
| HEK293 | IC50 |
19.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HEK293 cells by MTT assay
Antiproliferative activity against human HEK293 cells by MTT assay
|
[PMID: 29798826] |
| HEK293 | IC50 |
79.32 μM
Compound: 5-FU
|
Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 32203786] |
| HEK293 | IC50 |
41.01 μM
Compound: 5-Fu
|
Antiproliferative activity against human HEK293 cells after 72 hrs by MTT assay
Antiproliferative activity against human HEK293 cells after 72 hrs by MTT assay
|
[PMID: 35609396] |
| HEK293 | IC50 |
5.11 μM
Compound: 1; 5-FU
|
Cytotoxicity against HEK293 cells assessed as inhibition of cell growth incubated 1.5 hrs by MTT assay
Cytotoxicity against HEK293 cells assessed as inhibition of cell growth incubated 1.5 hrs by MTT assay
|
[PMID: 38107178] |
| HEK293 | IC50 |
2.15 μM
Compound: 5-Florouracil
|
Cytotoxicity against Homo sapiens (human) HEK293 cells assessed as inhibition of cell proliferation after 24 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HEK293 cells assessed as inhibition of cell proliferation after 24 hr by MTT assay
|
10.1007/s00044-012-0260-2 |
| HEK-293T | IC50 |
>100 μM
Compound: 5-FU
|
Growth inhibition of HEK293T cells after 24 hrs by MTT assay
Growth inhibition of HEK293T cells after 24 hrs by MTT assay
|
[PMID: 28011220] |
| HEK-293T | IC50 |
4.07 μM
Compound: 5-FU
|
Antiproliferative activity against HEK293T cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against HEK293T cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 38626522] |
| HEK-293T | IC50 |
17.57 μM
Compound: 5-FU
|
Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112] |
| HEK-293T | IC50 |
56.21 μM
Compound: 5-FU
|
Antiproliferative activity against HEK293T
Antiproliferative activity against HEK293T
|
[PMID: 38716896] |
| HEL | IC50 |
32.27 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HEL cells after 48 hrs by MTT assay
Antiproliferative activity against human HEL cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| HEL | IC50 |
15.98 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HEL cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HEL cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133049] |
| HeLa | IC50 |
0.44 μg/mL
Compound: 5FU
|
Cytotoxicity against human HeLa S3 cells
Cytotoxicity against human HeLa S3 cells
|
[PMID: 10425135] |
| HeLa | IC50 |
1.0 x 10-6 M
Compound: 5-Fu
|
Inhibitory concentration against Hella cancer cell lines was determined.
Inhibitory concentration against Hella cancer cell lines was determined.
|
[PMID: 11229742] |
| HeLa | EC50 |
0.23 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 12027739] |
| HeLa | IC50 |
16 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 3 days by MTT assay
Antiproliferative activity against human HeLa cells after 3 days by MTT assay
|
[PMID: 18424155] |
| HeLa | IC50 |
0.77 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 18440233] |
| HeLa | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against p53 deficient human HeLa cells after 72 hrs
Antiproliferative activity against p53 deficient human HeLa cells after 72 hrs
|
[PMID: 18469809] |
| HeLa | IC50 |
4 μM
Compound: 5-FU
|
Growth inhibition of human HeLa cells after 72 hrs by MTT assay
Growth inhibition of human HeLa cells after 72 hrs by MTT assay
|
[PMID: 18640746] |
| HeLa | GI50 |
10 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 19572613] |
| HeLa | IC50 |
10 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 19618920] |
| HeLa | GI50 |
19 μM
Compound: 5-FU
|
Growth inhibition of human HeLa cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HeLa cells after 48 hrs by sulforhodamine B assay
|
[PMID: 19664930] |
| HeLa | IC50 |
0.44 μM
Compound: 5-Fluoro uracil
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 19689125] |
| HeLa | IC50 |
10 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 19795843] |
| HeLa | IC50 |
10 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 19919065] |
| HeLa | IC50 |
1.01 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by SRB assay
Cytotoxicity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 19932530] |
| HeLa | IC50 |
64.2 μM
Compound: 5-Fu
|
Antitumor activity against human HeLa cells by MTT assay
Antitumor activity against human HeLa cells by MTT assay
|
[PMID: 20171096] |
| HeLa | IC50 |
10 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 20405881] |
| HeLa | EC50 |
79.79 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 20409617] |
| HeLa | IC50 |
9.7 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 20494492] |
| HeLa | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient HeLa cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient HeLa cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| HeLa | IC50 |
0.57 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 4 days by coulter counter analysis
Cytotoxicity against human HeLa cells after 4 days by coulter counter analysis
|
[PMID: 21232828] |
| HeLa | IC50 |
0.18 μM
Compound: 5-FU
|
Cytostatic activity against human HeLa cells in presence of 20 uM 2'-deoxyuridine
Cytostatic activity against human HeLa cells in presence of 20 uM 2'-deoxyuridine
|
[PMID: 21330014] |
| HeLa | IC50 |
0.45 μM
Compound: 5-FU
|
Cytostatic activity against human HeLa cells after 3 days by coulter counting analysis
Cytostatic activity against human HeLa cells after 3 days by coulter counting analysis
|
[PMID: 21330014] |
| HeLa | IC50 |
1 μM
Compound: 5-FU
|
Cytostatic activity against human HeLa cells in presence of 500 uM uracil
Cytostatic activity against human HeLa cells in presence of 500 uM uracil
|
[PMID: 21330014] |
| HeLa | IC50 |
1.1 μM
Compound: 5-FU
|
Cytostatic activity against human HeLa cells in presence of 500 uM uridine
Cytostatic activity against human HeLa cells in presence of 500 uM uridine
|
[PMID: 21330014] |
| HeLa | IC50 |
1.5 μM
Compound: 5-FU
|
Cytostatic activity against human HeLa cells in presence of 20 uM thymidine
Cytostatic activity against human HeLa cells in presence of 20 uM thymidine
|
[PMID: 21330014] |
| HeLa | IC50 |
41.46 μM
Compound: 5-Fu
|
Antitumor activity against human HeLa cells after 72 hrs by MTT assay
Antitumor activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 21486694] |
| HeLa | IC50 |
16.1 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 21515044] |
| HeLa | IC50 |
10.31 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 21524829] |
| HeLa | IC50 |
4 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 3 days by MTT assay
Cytotoxicity against human HeLa cells after 3 days by MTT assay
|
[PMID: 21612935] |
| HeLa | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 21689869] |
| HeLa | EC50 |
31.02 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 21889345] |
| HeLa | IC50 |
0.23 μM
Compound: 1, 5-FU
|
Cytostatic activity against thymidine-kinase deficient human HeLa cells after 72 hrs by cell counting
Cytostatic activity against thymidine-kinase deficient human HeLa cells after 72 hrs by cell counting
|
[PMID: 21892829] |
| HeLa | IC50 |
0.54 μM
Compound: 1, 5-FU
|
Cytostatic activity against human HeLa cells after 72 hrs by cell counting
Cytostatic activity against human HeLa cells after 72 hrs by cell counting
|
[PMID: 21892829] |
| HeLa | IC50 |
0.54 μM
Compound: F-Uracil
|
Cytostatic activity against human HeLa cells
Cytostatic activity against human HeLa cells
|
[PMID: 21917363] |
| HeLa | IC50 |
110.16 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 21962523] |
| HeLa | IC50 |
1.4 x 10-1 μg/mL
Compound: fluorouracil
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 22011319] |
| HeLa | IC50 |
16.32 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 22182926] |
| HeLa | IC50 |
82.2 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 48 hrs by CCK-8 assay
Cytotoxicity against human HeLa cells after 48 hrs by CCK-8 assay
|
[PMID: 22244588] |
| HeLa | IC50 |
108 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells
Cytotoxicity against human HeLa cells
|
[PMID: 22283451] |
| HeLa | IC50 |
43 μM
Compound: 5-fu
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 22304344] |
| HeLa | IC50 |
0.54 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human HeLa cells after 3 days by coulter counter analysis
Cytostatic activity against human HeLa cells after 3 days by coulter counter analysis
|
[PMID: 22405290] |
| HeLa | IC50 |
14.93 μM
Compound: 5-Fluoruracil
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 22555152] |
| HeLa | IC50 |
16.32 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells by after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells by after 48 hrs by MTT assay
|
[PMID: 22579780] |
| HeLa | IC50 |
15.99 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| HeLa | IC50 |
0.04 mg/mL
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 3 days MTT assay
Cytotoxicity against human HeLa cells after 3 days MTT assay
|
[PMID: 22796042] |
| HeLa | IC50 |
10.36 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 22801644] |
| HeLa | IC50 |
0.28 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 22959518] |
| HeLa | IC50 |
9.5 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23002924] |
| HeLa | IC50 |
3.25 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT method
Antiproliferative activity against human HeLa cells after 48 hrs by MTT method
|
[PMID: 23018096] |
| HeLa | IC50 |
63.4 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23067549] |
| HeLa | IC50 |
14.78 μM
Compound: 5-FU
|
Antitumor activity against human HeLa cells assessed as growth inhibition measured after 48 hrs by MTT assay
Antitumor activity against human HeLa cells assessed as growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 23313635] |
| HeLa | IC50 |
1.28 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 23352638] |
| HeLa | IC50 |
16.32 μM
Compound: 5-Fu
|
Growth inhibition of human HeLa cells after 48 hrs by MTT assay
Growth inhibition of human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23353737] |
| HeLa | IC50 |
142.6 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23356786] |
| HeLa | IC50 |
7.34 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HeLa | IC50 |
43.71 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 23665106] |
| HeLa | IC50 |
3.4 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 23792763] |
| HeLa | IC50 |
6.23 μM
Compound: FUra
|
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay
|
[PMID: 23867603] |
| HeLa | IC50 |
16.52 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23920246] |
| HeLa | IC50 |
0.8 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 23994872] |
| HeLa | IC50 |
7.34 μM
Compound: 5-Fu
|
Growth inhibition against human HeLa cells after 48 hrs by MTT assay
Growth inhibition against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| HeLa | IC50 |
0.887 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 24021891] |
| HeLa | IC50 |
1.1 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 24060486] |
| HeLa | IC50 |
35.34 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 24378217] |
| HeLa | IC50 |
2.3 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 24547794] |
| HeLa | IC50 |
80.48 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 24565905] |
| HeLa | IC50 |
0.54 μM
Compound: 5FU
|
Cytotoxicity against human HeLa cells assessed as reduction in cell number after 72 hrs by cell counting assay
Cytotoxicity against human HeLa cells assessed as reduction in cell number after 72 hrs by cell counting assay
|
[PMID: 24631358] |
| HeLa | IC50 |
1.8 μM
Compound: 5-Fluoro uracilc
|
Cytotoxicity against human HeLa cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 24641975] |
| HeLa | IC50 |
7.34 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 2 days by MTT assay
Cytotoxicity against human HeLa cells after 2 days by MTT assay
|
[PMID: 24767839] |
| HeLa | IC50 |
1.3 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 24835633] |
| HeLa | IC50 |
0.54 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human HeLa cells assessed as inhibition of proliferation after 72 hrs by Coulter cell counting method
Cytostatic activity against human HeLa cells assessed as inhibition of proliferation after 72 hrs by Coulter cell counting method
|
[PMID: 24906510] |
| HeLa | IC50 |
4.9 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay
|
[PMID: 24910974] |
| HeLa | GI50 |
30.21 μM
Compound: 5-Fu
|
Antiproliferative activity against human HeLa cells after 24 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 24934992] |
| HeLa | IC50 |
2.78 μM
Compound: FU
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 24941129] |
| HeLa | IC50 |
23.33 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| HeLa | IC50 |
5.7 μg/mL
Compound: 5-Fu
|
Anticancer activity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
Anticancer activity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 25017036] |
| HeLa | IC50 |
12 μM
Compound: 5-Fu
|
Anticancer activity against human HeLa cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Anticancer activity against human HeLa cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 25086915] |
| HeLa | IC50 |
35.34 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 25151580] |
| HeLa | IC50 |
2.6 μM
Compound: 5-FU
|
Cytostatic activity against human HeLa cells after 72 hrs by Coulter counting
Cytostatic activity against human HeLa cells after 72 hrs by Coulter counting
|
[PMID: 25435471] |
| HeLa | IC50 |
18.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human HeLa cells assessed as cell-growth inhibition after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as cell-growth inhibition after 48 hrs by MTT assay
|
[PMID: 25453794] |
| HeLa | IC50 |
36.53 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 25462253] |
| HeLa | IC50 |
13.45 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells assessed as cell survival after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as cell survival after 48 hrs by MTT assay
|
[PMID: 25506718] |
| HeLa | IC50 |
9.09 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 25529742] |
| HeLa | GI50 |
15 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
|
[PMID: 25752525] |
| HeLa | IC50 |
5.8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HeLa cells after 72 hrs by WST8 assay
Antiproliferative activity against human HeLa cells after 72 hrs by WST8 assay
|
[PMID: 25919052] |
| HeLa | IC50 |
8.93 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
|
[PMID: 25959813] |
| HeLa | IC50 |
0.54 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation
Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation
|
[PMID: 26001344] |
| HeLa | IC50 |
4.6 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Anticancer activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080] |
| HeLa | IC50 |
66.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells incubated for 72 hrs by MTT assay
|
[PMID: 26291038] |
| HeLa | IC50 |
8.317 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 26301558] |
| HeLa | IC50 |
6.4 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells after 72 hrs by WST-8 assay
Antiproliferative activity against human HeLa cells after 72 hrs by WST-8 assay
|
[PMID: 26606140] |
| HeLa | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 26617970] |
| HeLa | IC50 |
1.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human HeLa cells assessed as cell growth inhibition by MTT assay
|
[PMID: 26629861] |
| HeLa | IC50 |
43.71 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTS assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTS assay
|
[PMID: 26703795] |
| HeLa | IC50 |
17.21 μM
Compound: 5-Fu
|
Antiproliferative activity against human HeLa cells after 48 hrs by CCK8 assay
Antiproliferative activity against human HeLa cells after 48 hrs by CCK8 assay
|
[PMID: 26786698] |
| HeLa | IC50 |
82.27 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 26873416] |
| HeLa | IC50 |
26.18 μM
Compound: 5-Fu
|
Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 26922223] |
| HeLa | IC50 |
6.23 μM
Compound: FUra
|
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay
|
[PMID: 27073055] |
| HeLa | IC50 |
10.72 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27262600] |
| HeLa | IC50 |
57.17 μM
Compound: 5-Fu
|
Antiproliferative activity against human HeLa cells measured after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells measured after 48 hrs by MTT assay
|
[PMID: 27287368] |
| HeLa | IC50 |
5.8 μM
Compound: 5-FU
|
Antiproliferation activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferation activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| HeLa | IC50 |
132.99 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| HeLa | IC50 |
6.23 μM
Compound: FUra
|
Cytotoxicity against human HeLa cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
Cytotoxicity against human HeLa cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
|
[PMID: 27501415] |
| HeLa | IC50 |
1.8 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 27528432] |
| HeLa | IC50 |
17.21 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 48 hrs by CCK-8 assay
Antiproliferative activity against human HeLa cells after 48 hrs by CCK-8 assay
|
[PMID: 27542307] |
| HeLa | IC50 |
28.2 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 27561718] |
| HeLa | IC50 |
1.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human HeLa cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27561719] |
| HeLa | IC50 |
1.6 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human HeLa cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27720296] |
| HeLa | IC50 |
0.54 μM
Compound: 5-Fluorouracil
|
Anti-proliferative activity against human HeLa cells measured after 4 days by coulter counter method
Anti-proliferative activity against human HeLa cells measured after 4 days by coulter counter method
|
[PMID: 27750154] |
| HeLa | IC50 |
8.81 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 27875779] |
| HeLa | IC50 |
62.2 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay
|
[PMID: 28152430] |
| HeLa | IC50 |
1.4 μM
Compound: 5-F
|
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 28254697] |
| HeLa | IC50 |
9.02 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 28363444] |
| HeLa | IC50 |
1.86 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 28431881] |
| HeLa | IC50 |
13.9 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST8 assay
|
[PMID: 28488862] |
| HeLa | IC50 |
8.81 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 28525845] |
| HeLa | IC50 |
5.3 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by WST8 assay
|
[PMID: 28558970] |
| HeLa | GI50 |
15 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 28728108] |
| HeLa | IC50 |
2.9 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 28838694] |
| HeLa | IC50 |
3.82 μg/mL
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 29100732] |
| HeLa | IC50 |
8.81 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 29133046] |
| HeLa | IC50 |
30.2 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 29305189] |
| HeLa | IC50 |
28 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as decrease in cell viability by MTT assay
Cytotoxicity against human HeLa cells assessed as decrease in cell viability by MTT assay
|
[PMID: 29489361] |
| HeLa | IC50 |
3.2 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 96 hrs
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 96 hrs
|
[PMID: 29673982] |
| HeLa | IC50 |
1.8 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells by MTT assay
Antiproliferative activity against human HeLa cells by MTT assay
|
[PMID: 29798826] |
| HeLa | IC50 |
7 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by MTT assay
|
[PMID: 29908443] |
| HeLa | IC50 |
30.21 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 30007564] |
| HeLa | IC50 |
10.75 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 30318440] |
| HeLa | IC50 |
>20 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 30472605] |
| HeLa | IC50 |
28.22 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 30568759] |
| HeLa | IC50 |
10.72 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HeLa assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30709651] |
| HeLa | IC50 |
50 μM
Compound: 5-Fu
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 31057737] |
| HeLa | IC50 |
120.4 μM
Compound: 5-FU
|
Cytotoxicity in human HeLa cells assessed as growth inhibition incubated for 24 hrs by MTT assay
Cytotoxicity in human HeLa cells assessed as growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 31128448] |
| HeLa | IC50 |
10 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells
Cytotoxicity against human HeLa cells
|
[PMID: 31200236] |
| HeLa | GI50 |
15 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 31376562] |
| HeLa | IC50 |
20.4 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
Cytotoxicity against human HeLa cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
|
[PMID: 31416740] |
| HeLa | IC50 |
1.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 31546197] |
| HeLa | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells by MTT assay
Antiproliferative activity against human HeLa cells by MTT assay
|
[PMID: 31546197] |
| HeLa | IC50 |
8.81 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells incubated for 72 hrs by MTT assay
|
[PMID: 31734024] |
| HeLa | IC50 |
13.9 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLa cells incubated for 72 hrs by WST-8 assay
Cytotoxicity against human HeLa cells incubated for 72 hrs by WST-8 assay
|
[PMID: 32125158] |
| HeLa | IC50 |
15.02 μM
Compound: 5-FLU
|
Cytotoxicity against human HeLa cells assessed as growth inhibition by MTT assay
Cytotoxicity against human HeLa cells assessed as growth inhibition by MTT assay
|
[PMID: 32331934] |
| HeLa | IC50 |
12.7 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 32987314] |
| HeLa | IC50 |
15.5 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 32987314] |
| HeLa | IC50 |
20.6 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 32987314] |
| HeLa | IC50 |
13.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HeLa cells assessed as decrease in cell viability measured after 72 hrs by WST-8 assay
Cytotoxicity against human HeLa cells assessed as decrease in cell viability measured after 72 hrs by WST-8 assay
|
[PMID: 33383442] |
| HeLa | IC50 |
>50 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33538581] |
| HeLa | IC50 |
12.3 μM
Compound: 5-FU
|
Anticancer activity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Anticancer activity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 33940466] |
| HeLa | IC50 |
42.74 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability by MTT assay
|
[PMID: 34157389] |
| HeLa | GI50 |
16 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell growth
Antiproliferative activity against human HeLa cells assessed as reduction in cell growth
|
[PMID: 34847410] |
| HeLa | IC50 |
32.1 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 34883453] |
| HeLa | IC50 |
24.34 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth by SRB assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth by SRB assay
|
[PMID: 35594653] |
| HeLa | IC50 |
49.77 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition
Cytotoxicity against human HeLa cells assessed as cell growth inhibition
|
[PMID: 35809817] |
| HeLa | IC50 |
0.113 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition
Cytotoxicity against human HeLa cells assessed as cell growth inhibition
|
[PMID: 35964428] |
| HeLa | IC50 |
30.71 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth by MTT assay
|
[PMID: 36089111] |
| HeLa | IC50 |
5.78 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 36242987] |
| HeLa | IC50 |
1.94 μM
Compound: 5-FU
|
Antitumor activity against human HeLa cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
Antitumor activity against human HeLa cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
|
[PMID: 36324491] |
| HeLa | IC50 |
>20 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| HeLa | IC50 |
0.199 μM
Compound: 5-FU
|
Anticancer activity against human HeLa cells incubated for 72 hrs by MTT assay
Anticancer activity against human HeLa cells incubated for 72 hrs by MTT assay
|
[PMID: 36921275] |
| HeLa | GI50 |
15 μM
Compound: 5-FU
|
Growth inhibition of human HeLa cells measured after 48 hrs by SRB colorimetric assay
Growth inhibition of human HeLa cells measured after 48 hrs by SRB colorimetric assay
|
[PMID: 37137247] |
| HeLa | IC50 |
18.82 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 37859725] |
| HeLa | IC50 |
15.69 μM
Compound: 1; 5-FU
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 1.5 hrs by CCK-8 assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 1.5 hrs by CCK-8 assay
|
[PMID: 38107178] |
| HeLa | IC50 |
17.35 μM
Compound: 1; 5-FU
|
Growth inhibition of human HeLa cells incubated for 1.5 hrs by MTT assay
Growth inhibition of human HeLa cells incubated for 1.5 hrs by MTT assay
|
[PMID: 38107178] |
| HeLa | IC50 |
7.79 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 38626522] |
| HeLa | IC50 |
9.75 μM
Compound: 5-FU
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 39016216] |
| HeLa | IC50 |
6 μg
Compound: 5-fluorouracil
|
Compound was tested in vitro for cytotoxicity against HeLa cells.
Compound was tested in vitro for cytotoxicity against HeLa cells.
|
[PMID: 8709115] |
| HeLa | IC50 |
9.7 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HeLa cells by MTT assay
Cytotoxicity against Homo sapiens (human) HeLa cells by MTT assay
|
10.1007/s00044-010-9395-1 |
| HeLa | IC50 |
3 μg/mL
Compound: 5-Fluorouracil
|
In vitro inhibitory concentration for cytotoxic activity was tested against HeLa cells
In vitro inhibitory concentration for cytotoxic activity was tested against HeLa cells
|
10.1016/S0960-894X(97)00365-X |
| HeLa | IC50 |
4.71 μM
Compound: 5-Fu
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
10.1039/C4MD00209A |
| HeLa | IC50 |
56.5 μM
Compound: 5-FU
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
10.1039/C6MD00234J |
| HeLa S3 | IC50 |
5.4 μM
Compound: Fluorouracil
|
Cytotoxicity against human HeLaS3 cells after 72 hrs by WST1 assay
Cytotoxicity against human HeLaS3 cells after 72 hrs by WST1 assay
|
[PMID: 15387656] |
| HeLa S3 | IC50 |
5.4 μM
Compound: fluorouracil
|
Cytotoxicity against human HeLaS3 cells by WST1 assay
Cytotoxicity against human HeLaS3 cells by WST1 assay
|
[PMID: 15568771] |
| HeLa S3 | ED50 |
2.47 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human HeLaS3 cells after 3 days by trypan blue exclusion technique
Cytotoxicity against human HeLaS3 cells after 3 days by trypan blue exclusion technique
|
[PMID: 1800632] |
| Hep 3B2 | ED50 |
7.15 x 10-2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 11908984] |
| Hep 3B2 | IC50 |
7.2 x 10-2 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 16038565] |
| Hep 3B2 | ED50 |
0.6 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 16309328] |
| Hep 3B2 | IC50 |
0.6 μM
Compound: 5-Fu
|
Cytotoxicity against human Hep 3B cells by MTT microassay
Cytotoxicity against human Hep 3B cells by MTT microassay
|
[PMID: 17320246] |
| Hep 3B2 | IC50 |
0.6 μM
Compound: 5-Fu
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 18606546] |
| Hep 3B2 | IC50 |
1.5 μM
Compound: 5-Fu
|
Cytotoxicity against human Hep3B cells assessed as induction of cell death incubated for 2 days by MTT assay
Cytotoxicity against human Hep3B cells assessed as induction of cell death incubated for 2 days by MTT assay
|
[PMID: 26259802] |
| Hep 3B2 | IC50 |
10.53 μM
Compound: 5-Fu
|
Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay
Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay
|
[PMID: 26883148] |
| Hep 3B2 | IC50 |
17.53 μM
Compound: 5-Fu
|
Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay
Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay
|
[PMID: 27133593] |
| Hep 3B2 | IC50 |
22.99 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Hep3B cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human Hep3B cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 27189676] |
| Hep 3B2 | IC50 |
9.36 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Hep3B cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human Hep3B cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27913179] |
| Hep 3B2 | IC50 |
10.53 μM
Compound: 5-Fu
|
Cytotoxic activity against human Hep3B cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxic activity against human Hep3B cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 27993516] |
| Hep 3B2 | IC50 |
10.53 μM
Compound: 5FU
|
Cytotoxicity against human Hep3B cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
Cytotoxicity against human Hep3B cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
|
[PMID: 28038327] |
| Hep 3B2 | IC50 |
49.72 μM
Compound: 5-FU
|
Cytotoxicity against human Hep3B cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human Hep3B cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 28174107] |
| Hep 3B2 | IC50 |
2.66 μM
Compound: 5-FU
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 28262527] |
| Hep 3B2 | IC50 |
11.9 μM
Compound: 5-FU
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 28371676] |
| Hep 3B2 | IC50 |
5.11 μM
Compound: 5-FU
|
Antiproliferative activity against human Hep3B cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against human Hep3B cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 38626522] |
| HEp-2 | IC50 |
128.7 μM
Compound: 5-FU
|
Antiproliferative activity against human Hep2 cells after 72 hrs by MTT method
Antiproliferative activity against human Hep2 cells after 72 hrs by MTT method
|
[PMID: 17524655] |
| HEp-2 | IC50 |
0.3 μM
Compound: 5-fluorouracil
|
Anticancer activity against human Hep2 cells assessed as cell viability after 48 hrs by SRB assay
Anticancer activity against human Hep2 cells assessed as cell viability after 48 hrs by SRB assay
|
[PMID: 21074444] |
| HEp-2 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human Hep2 cells after 72 hrs by MTT assay
Antiproliferative activity against human Hep2 cells after 72 hrs by MTT assay
|
[PMID: 21524829] |
| HEp-2 | IC50 |
24.58 μM
Compound: 5-Fu
|
Cytotoxicity against human Hep2 cells by MTT assay
Cytotoxicity against human Hep2 cells by MTT assay
|
[PMID: 22801644] |
| HEp-2 | IC50 |
4.5 μM
Compound: 5-FU
|
Antiproliferative activity against human Hep2 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human Hep2 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23501113] |
| HEp-2 | IC50 |
128.7 μM
Compound: 5-Fu
|
Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay
Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay
|
[PMID: 23792763] |
| HEp-2 | IC50 |
2 μM
Compound: 5-Fu
|
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
|
10.1007/s00044-010-9500-5 |
| HepG2 | IC50 |
37.9 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against HepG2 cells
Tested in vitro for anticancer activity against HepG2 cells
|
[PMID: 10072683] |
| HepG2 | ED50 |
3.3 x 10-2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 11908984] |
| HepG2 | IC50 |
1.3 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 16499328] |
| HepG2 | IC50 |
18.7 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HepG2 cells
Cytotoxicity against human HepG2 cells
|
[PMID: 18302336] |
| HepG2 | IC50 |
9.2 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 3 days by MTT assay
Antiproliferative activity against human HepG2 cells after 3 days by MTT assay
|
[PMID: 18424155] |
| HepG2 | EC50 |
52.43 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 20409617] |
| HepG2 | IC50 |
25 μg/mL
Compound: 5FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by SRB assay
Cytotoxicity against human HepG2 cells after 48 hrs by SRB assay
|
[PMID: 21115211] |
| HepG2 | IC50 |
8.6 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as loss of cell monolayers after 96 hrs
Cytotoxicity against human HepG2 cells assessed as loss of cell monolayers after 96 hrs
|
[PMID: 21130542] |
| HepG2 | IC50 |
2.78 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 21131104] |
| HepG2 | IC50 |
18.85 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 after 48 hrs by MTT assay
Cytotoxicity against human HepG2 after 48 hrs by MTT assay
|
[PMID: 21486698] |
| HepG2 | IC50 |
109 μM
Compound: Fluorouracil
|
Cytotoxicity against human HepG2 cells
Cytotoxicity against human HepG2 cells
|
[PMID: 21774474] |
| HepG2 | EC50 |
23.31 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 21889345] |
| HepG2 | IC50 |
110.01 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 21962523] |
| HepG2 | IC50 |
2.7 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 3 days by MTT assay
Cytotoxicity against human HepG2 cells after 3 days by MTT assay
|
[PMID: 22000925] |
| HepG2 | IC50 |
8.2 ng/mL
Compound: fluorouracil
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 22011319] |
| HepG2 | IC50 |
8.2 x 10-3 μg/mL
Compound: fluorouracil
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 22011319] |
| HepG2 | IC50 |
76.7 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 2 days by alamar blue assay
Cytotoxicity against human HepG2 cells after 2 days by alamar blue assay
|
[PMID: 22093761] |
| HepG2 | IC50 |
8.6 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 96 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 96 hrs by MTT assay
|
[PMID: 22204901] |
| HepG2 | IC50 |
15.92 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 22209486] |
| HepG2 | IC50 |
108 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells
Cytotoxicity against human HepG2 cells
|
[PMID: 22283451] |
| HepG2 | IC50 |
34 μM
Compound: 5-fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 22304344] |
| HepG2 | IC50 |
5 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay
Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay
|
[PMID: 22409771] |
| HepG2 | IC50 |
46.31 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 22483608] |
| HepG2 | IC50 |
56.2 μM
Compound: 5-Fluoruracil
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 22555152] |
| HepG2 | IC50 |
9.3 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 22647218] |
| HepG2 | IC50 |
32.22 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| HepG2 | IC50 |
4.8 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 22727445] |
| HepG2 | IC50 |
10.45 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 22801644] |
| HepG2 | IC50 |
46.83 μM
Compound: Fluorouracil
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 22809558] |
| HepG2 | IC50 |
5.7 μM
Compound: 5FU
|
Cytotoxicity against human HepG2 cells incubated for 72 hrs by SRB assay
Cytotoxicity against human HepG2 cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| HepG2 | IC50 |
1.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT method
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT method
|
[PMID: 23018096] |
| HepG2 | IC50 |
9.1 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 96 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 96 hrs by MTT assay
|
[PMID: 23022735] |
| HepG2 | IC50 |
51.5 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 23067549] |
| HepG2 | IC50 |
29.87 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 23202484] |
| HepG2 | IC50 |
21.9 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 23279864] |
| HepG2 | IC50 |
>100 μM
Compound: 5-FU
|
Antitumor activity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
Antitumor activity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 23313635] |
| HepG2 | IC50 |
22.8 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 23490159] |
| HepG2 | IC50 |
40.34 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HepG2 | IC50 |
24.96 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 23685571] |
| HepG2 | IC50 |
10 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 23800391] |
| HepG2 | IC50 |
29.98 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 23988357] |
| HepG2 | IC50 |
40.34 μM
Compound: 5-Fu
|
Growth inhibition against human HepG2 cells after 48 hrs by MTT assay
Growth inhibition against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| HepG2 | IC50 |
12.48 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by CCK-8 assay
Cytotoxicity against human HepG2 cells after 48 hrs by CCK-8 assay
|
[PMID: 24013415] |
| HepG2 | IC50 |
29.98 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 3 days by MTT assay
Cytotoxicity against human HepG2 cells after 3 days by MTT assay
|
[PMID: 24095745] |
| HepG2 | IC50 |
4.35 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 24119869] |
| HepG2 | IC50 |
19.45 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 24211021] |
| HepG2 | IC50 |
7.43 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 24286761] |
| HepG2 | IC50 |
29.98 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 24378217] |
| HepG2 | IC50 |
7.6 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 24547794] |
| HepG2 | IC50 |
26.98 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 24565905] |
| HepG2 | IC50 |
86.87 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition by MTT assay
|
[PMID: 24684840] |
| HepG2 | IC50 |
38.34 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| HepG2 | IC50 |
46.83 μM
Compound: Fluorouracil
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 25016234] |
| HepG2 | IC50 |
29.98 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 25151580] |
| HepG2 | IC50 |
5.86 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human HepG2 cells assessed as cell survival after 48 hrs by MTT assay
Anticancer activity against human HepG2 cells assessed as cell survival after 48 hrs by MTT assay
|
[PMID: 25812966] |
| HepG2 | IC50 |
31.98 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 2 days by MTT assay
Cytotoxicity against human HepG2 cells after 2 days by MTT assay
|
[PMID: 25841196] |
| HepG2 | IC50 |
30.79 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25841199] |
| HepG2 | IC50 |
8 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 25969171] |
| HepG2 | IC50 |
16.42 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 26227777] |
| HepG2 | IC50 |
40.34 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as induction of cell death incubated for 2 days by MTT assay
Cytotoxicity against human HepG2 cells assessed as induction of cell death incubated for 2 days by MTT assay
|
[PMID: 26259802] |
| HepG2 | IC50 |
55.2 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
|
[PMID: 26291038] |
| HepG2 | IC50 |
>150 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 26320625] |
| HepG2 | IC50 |
46.83 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 26363869] |
| HepG2 | IC50 |
35.99 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 26546214] |
| HepG2 | IC50 |
41.62 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 26873416] |
| HepG2 | IC50 |
49.72 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 26883148] |
| HepG2 | EC50 |
2.21 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 26883149] |
| HepG2 | IC50 |
49.02 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 26922223] |
| HepG2 | IC50 |
174.5 μM
Compound: 5-Fuorouracil
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 27017265] |
| HepG2 | IC50 |
6.6 μM
Compound: FUra
|
Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay
Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay
|
[PMID: 27073055] |
| HepG2 | IC50 |
46.83 μM
Compound: Fluorouracil
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 27128180] |
| HepG2 | IC50 |
25.17 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 27133593] |
| HepG2 | IC50 |
40.34 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 27189676] |
| HepG2 | IC50 |
9.23 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27262600] |
| HepG2 | IC50 |
46.83 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
|
[PMID: 27287368] |
| HepG2 | IC50 |
13.54 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| HepG2 | IC50 |
8 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 27343853] |
| HepG2 | IC50 |
39.74 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 27400887] |
| HepG2 | IC50 |
205.19 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell growth after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell growth after 48 hrs by MTT assay
|
[PMID: 27422336] |
| HepG2 | IC50 |
6.6 μM
Compound: FUra
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
|
[PMID: 27501415] |
| HepG2 | IC50 |
1.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27561719] |
| HepG2 | GI50 |
7 μM
Compound: 5-FU
|
Hepatotoxicity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
Hepatotoxicity against human HepG2 cells assessed as growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 27688184] |
| HepG2 | IC50 |
>10 μM
Compound: 5-FU
|
Growth inhibition of human HepG2 cells after 72 hrs by MTS assay
Growth inhibition of human HepG2 cells after 72 hrs by MTS assay
|
[PMID: 27704811] |
| HepG2 | IC50 |
1.8 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27720296] |
| HepG2 | IC50 |
8.9 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 27875779] |
| HepG2 | IC50 |
5 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 27987485] |
| HepG2 | IC50 |
32.6 μM
Compound: 5-Fu
|
Cytotoxic activity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxic activity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 27993516] |
| HepG2 | IC50 |
32.87 μM
Compound: 5-FU
|
Growth inhibition of human HepG2 cells after 24 hrs by MTT assay
Growth inhibition of human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 28011220] |
| HepG2 | IC50 |
10.17 μM
Compound: 5FU
|
Cytotoxicity against human HepG2 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
Cytotoxicity against human HepG2 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
|
[PMID: 28038327] |
| HepG2 | IC50 |
49.02 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 28110871] |
| HepG2 | IC50 |
17.2 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 28117202] |
| HepG2 | IC50 |
10.53 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 28174107] |
| HepG2 | IC50 |
1.4 μM
Compound: 5-F
|
Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 28254697] |
| HepG2 | IC50 |
2.1 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 28262527] |
| HepG2 | IC50 |
0.061 mM
Compound: 5-Fluorouracil
|
Cytotoxicity in human HepG2 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity in human HepG2 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 28334654] |
| HepG2 | IC50 |
13.31 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 28363444] |
| HepG2 | IC50 |
32.6 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 28371676] |
| HepG2 | IC50 |
17.44 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay
|
[PMID: 28395218] |
| HepG2 | IC50 |
20.1 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 28400238] |
| HepG2 | IC50 |
8.1 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells
Cytotoxicity against human HepG2 cells
|
[PMID: 28431341] |
| HepG2 | IC50 |
29.07 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 28458133] |
| HepG2 | IC50 |
29.1 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 28494251] |
| HepG2 | IC50 |
8.9 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 28525845] |
| HepG2 | IC50 |
5.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 28623814] |
| HepG2 | IC50 |
28.8 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 28756264] |
| HepG2 | IC50 |
6.9 μM
Compound: 5-Fluorouracil
|
Antitumor activity against human HepG2 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
Antitumor activity against human HepG2 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
|
[PMID: 28926764] |
| HepG2 | IC50 |
10.4 μM
Compound: 5-Fu
|
Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 28987604] |
| HepG2 | IC50 |
30.48 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells treated for 24 hrs measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells treated for 24 hrs measured after 72 hrs by MTT assay
|
[PMID: 29037951] |
| HepG2 | IC50 |
2.24 μg/mL
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 29100732] |
| HepG2 | IC50 |
14.52 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HepG2 cells in presence of ubenimex after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells in presence of ubenimex after 48 hrs by MTT assay
|
[PMID: 29202398] |
| HepG2 | IC50 |
18.35 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 29202398] |
| HepG2 | IC50 |
237 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 29207336] |
| HepG2 | IC50 |
36.6 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 29305189] |
| HepG2 | IC50 |
5 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 72 hrs by SRB assay
Antiproliferative activity against human HepG2 cells after 72 hrs by SRB assay
|
[PMID: 29326016] |
| HepG2 | IC50 |
23.6 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 29486954] |
| HepG2 | IC50 |
76.9 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability by MTT assay
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability by MTT assay
|
[PMID: 29489361] |
| HepG2 | IC50 |
15.74 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 24 hrs by CCK-8 assay
Antiproliferative activity against human HepG2 cells after 24 hrs by CCK-8 assay
|
[PMID: 29499490] |
| HepG2 | IC50 |
8.6 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 96 hrs
Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 96 hrs
|
[PMID: 29673982] |
| HepG2 | IC50 |
12 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HepG2 cells after 6 days by MTT assay
Cytotoxicity against human HepG2 cells after 6 days by MTT assay
|
[PMID: 29786436] |
| HepG2 | IC50 |
1.7 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells by MTT assay
Antiproliferative activity against human HepG2 cells by MTT assay
|
[PMID: 29798826] |
| HepG2 | IC50 |
59.12 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 29958763] |
| HepG2 | IC50 |
36.62 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 30007564] |
| HepG2 | IC50 |
31.98 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 30092368] |
| HepG2 | IC50 |
31.98 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 30108826] |
| HepG2 | IC50 |
63.37 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 30108924] |
| HepG2 | IC50 |
47.97 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 30142612] |
| HepG2 | IC50 |
15.92 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells by MTT assay
Antiproliferative activity against human HepG2 cells by MTT assay
|
[PMID: 30359819] |
| HepG2 | IC50 |
30.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 30527868] |
| HepG2 | IC50 |
31.7 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 30739827] |
| HepG2 | IC50 |
66.42 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 30826506] |
| HepG2 | IC50 |
3.6 μM
Compound: Fluorouracil
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 31013087] |
| HepG2 | IC50 |
68 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 31057737] |
| HepG2 | IC50 |
112.1 μM
Compound: 5-FU
|
Cytotoxicity in human HePG2 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
Cytotoxicity in human HePG2 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 31128448] |
| HepG2 | IC50 |
8.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 31276896] |
| HepG2 | IC50 |
60.73 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 31401008] |
| HepG2 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
Cytotoxicity against human HepG2 cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
|
[PMID: 31416740] |
| HepG2 | IC50 |
1.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 31546197] |
| HepG2 | IC50 |
7.22 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells by MTT assay
Antiproliferative activity against human HepG2 cells by MTT assay
|
[PMID: 31546197] |
| HepG2 | IC50 |
8.9 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
|
[PMID: 31734024] |
| HepG2 | IC50 |
7.9 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells
Cytotoxicity against human HepG2 cells
|
[PMID: 31761383] |
| HepG2 | IC50 |
2.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
|
[PMID: 31829592] |
| HepG2 | IC50 |
32.57 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31877536] |
| HepG2 | IC50 |
32.57 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell growth after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell growth after 72 hrs by MTT assay
|
[PMID: 31883693] |
| HepG2 | IC50 |
8.02 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth by MTT assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth by MTT assay
|
[PMID: 31884408] |
| HepG2 | IC50 |
33.68 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition by MTT assay
Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 31945642] |
| HepG2 | IC50 |
0.52 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 32485532] |
| HepG2 | IC50 |
8.69 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 32791397] |
| HepG2 | IC50 |
33.5 μg/mL
Compound: 5-FU
|
Anticancer activity against human HepG2 cells
Anticancer activity against human HepG2 cells
|
[PMID: 32795767] |
| HepG2 | IC50 |
>30 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| HepG2 | IC50 |
18.9 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 33740546] |
| HepG2 | IC50 |
66.42 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 33831559] |
| HepG2 | IC50 |
2.98 μM
Compound: 5-Fu
|
Antiproliferation activity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
Antiproliferation activity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
|
[PMID: 34186178] |
| HepG2 | IC50 |
18.98 μM
Compound: 5-FU
|
Anticancer activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Anticancer activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 34425478] |
| HepG2 | IC50 |
6.69 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 34624825] |
| HepG2 | IC50 |
5.3 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells
Cytotoxicity against human HepG2 cells
|
[PMID: 34655985] |
| HepG2 | IC50 |
72.33 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34838335] |
| HepG2 | IC50 |
20.4 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 35092899] |
| HepG2 | IC50 |
11.68 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 35259487] |
| HepG2 | IC50 |
18.98 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 35609396] |
| HepG2 | IC50 |
0.004 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition
Cytotoxicity against human HepG2 cells assessed as cell growth inhibition
|
[PMID: 35964428] |
| HepG2 | IC50 |
29.81 μM
Compound: 5-Fu
|
Antitumor activity human HepG2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity human HepG2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36216031] |
| HepG2 | IC50 |
36.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
|
[PMID: 36288556] |
| HepG2 | IC50 |
2.88 μM
Compound: 5-FU
|
Antitumor activity against human HepG2 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
Antitumor activity against human HepG2 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
|
[PMID: 36324491] |
| HepG2 | IC50 |
8.66 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| HepG2 | IC50 |
36.74 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36336316] |
| HepG2 | IC50 |
15.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HepG2 cells assessed as cell inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell inhibition measured after 72 hrs by MTT assay
|
[PMID: 36774698] |
| HepG2 | IC50 |
0.178 μM
Compound: 5-FU
|
Anticancer activity against human HepG2 cells incubated for 72 hrs by MTT assay
Anticancer activity against human HepG2 cells incubated for 72 hrs by MTT assay
|
[PMID: 36921275] |
| HepG2 | IC50 |
11.68 μM
Compound: 5-Fu
|
Antitumor activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36931124] |
| HepG2 | IC50 |
17.57 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
|
[PMID: 37122546] |
| HepG2 | IC50 |
29.38 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 37182331] |
| HepG2 | IC50 |
0.37 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
|
[PMID: 37360398] |
| HepG2 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
|
[PMID: 37659196] |
| HepG2 | IC50 |
16.42 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 37859723] |
| HepG2 | IC50 |
66.82 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 37859725] |
| HepG2 | IC50 |
33.79 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells by CCK8 assay
Antiproliferative activity against human HepG2 cells by CCK8 assay
|
[PMID: 37939862] |
| HepG2 | IC50 |
25.48 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells incubated for 48 hrs by MTT assay
|
[PMID: 37972528] |
| HepG2 | IC50 |
4.07 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 38626522] |
| HepG2 | IC50 |
5.46 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112] |
| HepG2 | IC50 |
23.45 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay
|
[PMID: 38784474] |
| HepG2 | IC50 |
12.94 μM
Compound: 5-FU
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 39016216] |
| HepG2 | IC50 |
3.09 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by SRB method
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by SRB method
|
[PMID: 39054645] |
| HepG2 | IC50 |
24.733 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 39163776] |
| HepG2 | IC50 |
0.07 mM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell survival after 96 hr
Cytotoxicity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell survival after 96 hr
|
10.1007/s00044-012-0201-0 |
| HepG2 | IC50 |
19.2 μM
Compound: 5-FU
|
Antitumor activity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell viability after 72 hr by MTT assay
Antitumor activity against Homo sapiens (human) HepG2 cells assessed as inhibition of cell viability after 72 hr by MTT assay
|
10.1007/s00044-012-0283-8 |
| HepG2 | IC50 |
85 μM
Compound: 5-flurouracil
|
Compound was evaluated for the inhibition of cell proliferation of human hepatocellular carcinoma, HepG2 (ATCC HB8065).
Compound was evaluated for the inhibition of cell proliferation of human hepatocellular carcinoma, HepG2 (ATCC HB8065).
|
10.1016/0960-894X(96)00418-0 |
| HepG2 | IC50 |
40.18 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
10.1039/C5MD00163C |
| HepG2 | IC50 |
55.74 μM
Compound: 5-FU
|
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
10.1039/C6MD00061D |
| HepG2 | IC50 |
10.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
10.1039/C6MD00169F |
| HepG2 | IC50 |
5.82 μM
Compound: 5-FU
|
Antiproliferative activity in human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity in human HepG2 cells after 72 hrs by MTT assay
|
10.1039/C6MD00252H |
| HGC-27 | IC50 |
14.72 μM
Compound: 5-FU
|
Cytotoxicity against human HGC27 cells after 48 hrs by MTT assay
Cytotoxicity against human HGC27 cells after 48 hrs by MTT assay
|
[PMID: 28431881] |
| HGC-27 | IC50 |
8.22 μM
Compound: 5-Fu
|
Antiproliferative activity against human HGC27 cells after 72 hrs by MTT assay
Antiproliferative activity against human HGC27 cells after 72 hrs by MTT assay
|
[PMID: 28456031] |
| HGC-27 | IC50 |
11.02 μM
Compound: 5-FU
|
Antiproliferative activity against human HGC27 cells after 72 hrs by MTT assay
Antiproliferative activity against human HGC27 cells after 72 hrs by MTT assay
|
[PMID: 28759876] |
| HGC-27 | IC50 |
8.22 μM
Compound: 5-FU
|
Antiproliferative activity against human HGC27 cells after 72 hrs by MTT assay
Antiproliferative activity against human HGC27 cells after 72 hrs by MTT assay
|
[PMID: 30108876] |
| HGC-27 | IC50 |
18 μM
Compound: 5-FU
|
Cytotoxicity against human HGC27 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human HGC27 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 31029946] |
| HGC-27 | IC50 |
4.28 μM
Compound: 5-FU
|
Anticancer activity against human HGC-27 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Anticancer activity against human HGC-27 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 31577977] |
| HGC-27 | IC50 |
5.75 μM
Compound: 5-Fu
|
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 32682202] |
| HGC-27 | IC50 |
>30 μM
Compound: 5-FU
|
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| HGC-27 | IC50 |
27.5 μM
Compound: 5-Fu
|
Cytotoxicity against human HGC-27 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human HGC-27 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34628244] |
| HGC-27 | IC50 |
76.62 μM
Compound: 5-FU
|
Cytotoxicity in human HGC-27 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human HGC-27 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35085721] |
| HGC-27 | IC50 |
45.2 μM
Compound: 5-FU
|
Antiproliferative activity against human HGC-27 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 35286954] |
| HGC-27 | IC50 |
0.5 μM
Compound: 5-Fu
|
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
|
[PMID: 37360398] |
| HL-60 | IC50 |
1.0 x 10-6 M
Compound: 5-Fu
|
Inhibitory concentration against Human leukemia cancer cell (HL-60)lines was determined.
Inhibitory concentration against Human leukemia cancer cell (HL-60)lines was determined.
|
[PMID: 11229742] |
| HL-60 | IC50 |
1.5 μM
Compound: 5-flurouracil
|
In vitro inhibitory concentration against proliferation of HL60 cells
In vitro inhibitory concentration against proliferation of HL60 cells
|
[PMID: 12877593] |
| HL-60 | IC50 |
65.3 μM
Compound: 5-FU
|
In vitro inhibitory concentration required against human leukemic HL-60 cell line was determined after 48 hrs of drug exposure using MTT method
In vitro inhibitory concentration required against human leukemic HL-60 cell line was determined after 48 hrs of drug exposure using MTT method
|
[PMID: 15380199] |
| HL-60 | IC50 |
85.1 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HL60 (TB) cells
Cytotoxicity against human HL60 (TB) cells
|
[PMID: 16996657] |
| HL-60 | IC50 |
0.16 μM
Compound: fluorouracil
|
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 17291040] |
| HL-60 | GI50 |
3.8 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 3 days by trypan blue staining
Antiproliferative activity against human HL60 cells after 3 days by trypan blue staining
|
[PMID: 18491866] |
| HL-60 | IC50 |
21.38 μM
Compound: 5-FU
|
Cytotoxicity against human HL60 cells by MTT assay
Cytotoxicity against human HL60 cells by MTT assay
|
[PMID: 18644718] |
| HL-60 | IC50 |
65.3 μM
Compound: 5-FU
|
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 19324555] |
| HL-60 | IC50 |
1.33 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human promyelocytic leukemia (HL-60) cells
In vitro inhibitory activity against growth of Human promyelocytic leukemia (HL-60) cells
|
[PMID: 1995901] |
| HL-60 | IC50 |
1.3 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human promyelocytic leukemia (HL-60) cell line.
In vitro inhibitory activity against Human promyelocytic leukemia (HL-60) cell line.
|
[PMID: 1995905] |
| HL-60 | CC50 |
0.07 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HL60 cells after 5 days by MTT assay
Cytotoxicity against human HL60 cells after 5 days by MTT assay
|
[PMID: 20227144] |
| HL-60 | IC50 |
9.5 μM
Compound: 5-fluorouracil
|
Cytotoxicity in human HL60 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity in human HL60 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21250700] |
| HL-60 | IC50 |
9.1 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21381696] |
| HL-60 | IC50 |
>100 μM
Compound: 5-FU
|
Anticancer activity against human HL60 cells
Anticancer activity against human HL60 cells
|
[PMID: 21449610] |
| HL-60 | IC50 |
2.7 pM
Compound: 5-FU
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 21640594] |
| HL-60 | IC50 |
68.3 μM
Compound: 5-Fu
|
Cytotoxicity against human HL60 cells after 48 hrs by CCK-8 assay
Cytotoxicity against human HL60 cells after 48 hrs by CCK-8 assay
|
[PMID: 22244588] |
| HL-60 | IC50 |
266 μM
Compound: 5-Fu
|
Antiproliferative activity against human HL60 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HL60 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 22424614] |
| HL-60 | IC50 |
0.06 μM
Compound: 5-FU
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 22959518] |
| HL-60 | IC50 |
10.05 μM
Compound: 5-Fu
|
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HL-60 | IC50 |
22.3 μM
Compound: 5-FU
|
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 23867385] |
| HL-60 | IC50 |
10.05 μM
Compound: 5-Fu
|
Growth inhibition against human HL60 cells after 48 hrs by MTT assay
Growth inhibition against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| HL-60 | IC50 |
27.01 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 25164762] |
| HL-60 | IC50 |
10.45 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 25529742] |
| HL-60 | IC50 |
22.54 μM
Compound: FUra
|
Antiproliferative activity against human HL60 cells assessed as growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 25644674] |
| HL-60 | IC50 |
27.43 μM
Compound: 5-Fu
|
Antiproliferative activity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 26922223] |
| HL-60 | IC50 |
1.62 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 48 hrs by MTS assay
Antiproliferative activity against human HL60 cells after 48 hrs by MTS assay
|
[PMID: 28152430] |
| HL-60 | IC50 |
2.8 μM
Compound: 5-Fu
|
Cytotoxic activity against human HL60 cells
Cytotoxic activity against human HL60 cells
|
[PMID: 28697923] |
| HL-60 | IC50 |
3.69 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells treated for 24 hrs measured after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells treated for 24 hrs measured after 72 hrs by MTT assay
|
[PMID: 29037951] |
| HL-60 | IC50 |
2.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human HL60 cells after 72 hrs by tryphan blue staining based hematocytometric method
Antiproliferative activity against human HL60 cells after 72 hrs by tryphan blue staining based hematocytometric method
|
[PMID: 29131616] |
| HL-60 | IC50 |
>30 μM
Compound: 5-FU
|
Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 29133061] |
| HL-60 | IC50 |
67.2 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 29305189] |
| HL-60 | IC50 |
2.37 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 29407983] |
| HL-60 | IC50 |
2.37 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 29524728] |
| HL-60 | IC50 |
3.46 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 29635169] |
| HL-60 | IC50 |
54.54 μM
Compound: 5-Fu
|
Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
Antiproliferative activity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 29958763] |
| HL-60 | IC50 |
2.45 μM
Compound: 5-FU
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757] |
| HL-60 | IC50 |
42.8 μM
Compound: 5-FU
|
Cytotoxicity against human HL60 cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay
Cytotoxicity against human HL60 cells assessed as reduction in cell viability measured after 48 hrs by CCK8 assay
|
[PMID: 31253531] |
| HL-60 | IC50 |
38.13 μM
Compound: 5-FU
|
Antiproliferative activity against human HL-60 cells assessed as cell growth inhibition in presence of piperlongumine
Antiproliferative activity against human HL-60 cells assessed as cell growth inhibition in presence of piperlongumine
|
[PMID: 33930801] |
| HL-60 | IC50 |
84.68 μM
Compound: 5-FU
|
Antiproliferative activity against human HL-60 cells assessed as cell growth inhibition
Antiproliferative activity against human HL-60 cells assessed as cell growth inhibition
|
[PMID: 33930801] |
| HL-60 | IC50 |
81.13 μM
Compound: 5-FU
|
Cytotoxicity in human HL-60 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human HL-60 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35085721] |
| HL-60 | IC50 |
25.4 μg/mL
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HL60 cells by MTT assay
Cytotoxicity against Homo sapiens (human) HL60 cells by MTT assay
|
10.1007/s00044-009-9193-9 |
| HL-60 | IC50 |
266 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HL60 cells after 96 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HL60 cells after 96 hr by MTT assay
|
10.1007/s00044-011-9778-y |
| HL-60 | IC50 |
5.4 μM
Compound: 5-FU
|
Anticancer activity against Homo sapiens (human) HL60 cells assessed as inhibition of cell proliferation after 72 hr by MTT assay
Anticancer activity against Homo sapiens (human) HL60 cells assessed as inhibition of cell proliferation after 72 hr by MTT assay
|
10.1007/s00044-012-0240-6 |
| HL-60(TB) | IC50 |
>2512 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HL-60(TB) cells
Cytotoxicity against human HL-60(TB) cells
|
[PMID: 22409967] |
| HL-60(TB) | GI50 |
100 μM
Compound: 5-Fu
|
Growth inhibition of human HL-60(TB) cells after 48 hrs by SRB assay
Growth inhibition of human HL-60(TB) cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| HL-60(TB) | GI50 |
100 nM
Compound: 5FU
|
Growth inhibition of human HL-60(TB) cells after 48 hrs by SRB assay
Growth inhibition of human HL-60(TB) cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| HL-60(TB) | GI50 |
2.3 μM
Compound: 5-FU
|
Growth inhibition of human HL-60(TB) cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HL-60(TB) cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| HL-60(TB) | IC50 |
85.1 μM
Compound: 5-Fluorouracil
|
Antileukemic activity against human HL-60(TB) cells assessed as inhibition of tumor growth after 24 hrs
Antileukemic activity against human HL-60(TB) cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| HL-60(TB) | GI50 |
2.3 μM
Compound: 5-FU
|
Anticancer activity against human HL-60(TB) cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HL-60(TB) cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| HL-60(TB) | IC50 |
2.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HL-60(TB) cells assessed as cell growth inhibition
Cytotoxicity against human HL-60(TB) cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HOP-62 | GI50 |
4.1 μM
Compound: 5FU
|
Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| HOP-62 | GI50 |
0.39 μM
Compound: 5-FU
|
Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HOP62 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| HOP-62 | GI50 |
0.39 μM
Compound: 5-FU
|
Anticancer activity against human HOP-62 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HOP-62 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| HOP-62 | IC50 |
0.39 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HOP-62 cells assessed as cell growth inhibition
Cytotoxicity against human HOP-62 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HOP-92 | GI50 |
77.9 μM
Compound: 5-FU
|
Growth inhibition of human HOP92 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HOP92 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| HOP-92 | GI50 |
77.9 μM
Compound: 5-FU
|
Anticancer activity against human HOP-92 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HOP-92 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| HOP-92 | IC50 |
77.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HOP-92 cells assessed as cell growth inhibition
Cytotoxicity against human HOP-92 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HOS | IC50 |
0.79 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human osteogenic sarcoma (HOS) cells
In vitro inhibitory activity against growth of Human osteogenic sarcoma (HOS) cells
|
[PMID: 1995901] |
| Hs-578T | GI50 |
9.77 μM
Compound: 5-FU
|
Growth inhibition of human Hs 578T cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human Hs 578T cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| Hs-578T | GI50 |
9.77 μM
Compound: 5-FU
|
Anticancer activity against human Hs-578T cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human Hs-578T cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| Hs-578T | IC50 |
9.77 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Hs-578T cells assessed as cell growth inhibition
Cytotoxicity against human Hs-578T cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HSC-2 | CC50 |
47 μM
Compound: 5-FU
|
Cytotoxicity against human HSC2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HSC2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 31532650] |
| HSC-2 | CC50 |
13 μM
Compound: 5-FU
|
Cytotoxicity against human HSC-2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HSC-2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32795767] |
| HSC-2 | CC50 |
>1000 μM
Compound: 5-FU
|
Cytotoxicity against human HSC-2 cells incubated for 48 hrs by MTT assay
Cytotoxicity against human HSC-2 cells incubated for 48 hrs by MTT assay
|
[PMID: 33744685] |
| HSC-3 | CC50 |
13 μM
Compound: 5-FU
|
Cytotoxicity against human HSC-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HSC-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32795767] |
| HSC-4 | CC50 |
25 μM
Compound: 5-FU
|
Cytotoxicity against human HSC4 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HSC4 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 31532650] |
| HT-1080 | ED50 |
8 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HT1080 cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide assay
Cytotoxicity against human HT1080 cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide assay
|
[PMID: 11141109] |
| HT-1080 | ED50 |
8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HT1080 cells by MTT assay
Antiproliferative activity against human HT1080 cells by MTT assay
|
[PMID: 11277741] |
| HT-1080 | ED50 |
8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HT1080 cells by MTT assay
Antiproliferative activity against human HT1080 cells by MTT assay
|
[PMID: 11325233] |
| HT-1080 | ED50 |
0.48 μg/mL
Compound: 5-fluorouracil
|
Antiproliferative activity against human HT1080 cells after 4 days by MTT assay
Antiproliferative activity against human HT1080 cells after 4 days by MTT assay
|
[PMID: 11374950] |
| HT-1080 | ED50 |
8 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HT1080 cells by MTT assay
Cytotoxicity against human HT1080 cells by MTT assay
|
[PMID: 11430002] |
| HT-1080 | IC50 |
1.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HT1080 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HT1080 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 11575942] |
| HT-1080 | EC50 |
1.38 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay
|
[PMID: 12027739] |
| HT-1080 | EC50 |
0.29 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HT1080 cells by MTT assay
Antiproliferative activity against human HT1080 cells by MTT assay
|
[PMID: 12444707] |
| HT-1080 | IC50 |
3700 nM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay
Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay
|
[PMID: 14640513] |
| HT-1080 | IC50 |
9.45 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
|
[PMID: 18440233] |
| HT-1080 | IC50 |
8.58 μM
Compound: 5-Fluoro uracil
|
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
|
[PMID: 19689125] |
| HT-1080 | IC50 |
5.2 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay
|
[PMID: 19919052] |
| HT-1080 | IC50 |
3.06 μM
Compound: 5-Fu
|
Cytotoxicity against human HT1080 cells by MTT assay
Cytotoxicity against human HT1080 cells by MTT assay
|
[PMID: 22801644] |
| HT-1080 | IC50 |
15.2 μM
Compound: 5-FU
|
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
|
[PMID: 23067549] |
| HT-1080 | IC50 |
35.62 μM
Compound: 5-Fu
|
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HT-1080 | IC50 |
70.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HT1080 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human HT1080 cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 23647462] |
| HT-1080 | IC50 |
35.62 μM
Compound: 5-Fu
|
Growth inhibition against human HT1080 cells after 48 hrs by MTT assay
Growth inhibition against human HT1080 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| HT-1080 | IC50 |
6 μM
Compound: 5-FU
|
Cytotoxicity against human HT-1080 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human HT-1080 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 37098306] |
| HT-1376 | IC50 |
0.58 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human bladder carcinoma (HT1376) cells
In vitro inhibitory activity against growth of Human bladder carcinoma (HT1376) cells
|
[PMID: 1995901] |
| HT-22 | CC50 |
8.1 μM
Compound: 5-Fu
|
Cytotoxicity against mouse HT22 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against mouse HT22 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32832031] |
| HT-29 | IC50 |
0.1 μg/mL
Compound: 5-fluorouracil
|
Antitumor activity against human HT-29 cells
Antitumor activity against human HT-29 cells
|
[PMID: 10579858] |
| HT-29 | ED50 |
7.4 x 10-2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human HT-29 cells by MTT assay
Cytotoxicity against human HT-29 cells by MTT assay
|
[PMID: 11908984] |
| HT-29 | ED50 |
0.2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human HT-29 cells by MTT assay
Cytotoxicity against human HT-29 cells by MTT assay
|
[PMID: 16309328] |
| HT-29 | IC50 |
7.3 μM
Compound: 5-FU
|
Antiproliferative activity against HT29 cells
Antiproliferative activity against HT29 cells
|
[PMID: 17110105] |
| HT-29 | IC50 |
0.6 μM
Compound: 5-Fu
|
Cytotoxicity against human HT29 cells by MTT microassay
Cytotoxicity against human HT29 cells by MTT microassay
|
[PMID: 17320246] |
| HT-29 | IC50 |
540 μM
Compound: 5-FU
|
Cytotoxicity against HT29 cells after 48 hrs by MTT assay
Cytotoxicity against HT29 cells after 48 hrs by MTT assay
|
[PMID: 17604394] |
| HT-29 | IC50 |
0.6 μM
Compound: 5-Fu
|
Cytotoxicity against human HT29 cells by MTT assay
Cytotoxicity against human HT29 cells by MTT assay
|
[PMID: 18606546] |
| HT-29 | GI50 |
8.9 μM
Compound: 5FU
|
Cytotoxicity against human HT29 cells after 48 hrs
Cytotoxicity against human HT29 cells after 48 hrs
|
[PMID: 18798609] |
| HT-29 | GI50 |
14.9 μM
Compound: 5FU
|
Cytotoxicity against human HT-29 cells
Cytotoxicity against human HT-29 cells
|
[PMID: 20356752] |
| HT-29 | IC50 |
10.2 μM
Compound: 5-FU
|
Anticancer activity against human HT-29 cells
Anticancer activity against human HT-29 cells
|
[PMID: 21449610] |
| HT-29 | IC50 |
1.08 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells after 6 days by SRB colorimetric assay
Cytotoxicity against human HT-29 cells after 6 days by SRB colorimetric assay
|
[PMID: 21684047] |
| HT-29 | IC50 |
10.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HT-29 cells
Cytotoxicity against human HT-29 cells
|
[PMID: 22409967] |
| HT-29 | IC50 |
7.3 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as growth inhibition after 144 hrs by crystal violet staining method
Antiproliferative activity against human HT-29 cells assessed as growth inhibition after 144 hrs by crystal violet staining method
|
[PMID: 22450132] |
| HT-29 | IC50 |
7.3 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells after 72 hrs by crystal violet staining method
Antiproliferative activity against human HT-29 cells after 72 hrs by crystal violet staining method
|
[PMID: 22765897] |
| HT-29 | IC50 |
7.3 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells after 72 hrs by crystal violet staining
Cytotoxicity against human HT-29 cells after 72 hrs by crystal violet staining
|
[PMID: 22959205] |
| HT-29 | IC50 |
6.35 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HT-29 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23644215] |
| HT-29 | IC50 |
24.5 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
|
[PMID: 23665106] |
| HT-29 | GI50 |
0.17 μM
Compound: 5-FU
|
Growth inhibition of human HT-29 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HT-29 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| HT-29 | ED50 |
7.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HT-29 cells by Alamar blue assay
Cytotoxicity against human HT-29 cells by Alamar blue assay
|
[PMID: 24128077] |
| HT-29 | IC50 |
24.87 μM
Compound: 5-Fu
|
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay
|
[PMID: 24583355] |
| HT-29 | IC50 |
2.58 μM
Compound: 5-Fu
|
Cytotoxicity against human HT-29 cells after 3 days by SRB assay
Cytotoxicity against human HT-29 cells after 3 days by SRB assay
|
[PMID: 24704691] |
| HT-29 | IC50 |
17.2 μM
Compound: 5-Fu
|
Cytotoxicity against human HT-29 cells after 2 days by MTT assay
Cytotoxicity against human HT-29 cells after 2 days by MTT assay
|
[PMID: 24767839] |
| HT-29 | IC50 |
0.15 μM
Compound: 5-fluorouracil
|
Antitumor activity against colon carcinoma cell line (HT-29)
Antitumor activity against colon carcinoma cell line (HT-29)
|
[PMID: 2547068] |
| HT-29 | IC50 |
25.08 μM
Compound: FUra
|
Antiproliferative activity against human HT-29 cells assessed as growth inhibition after 72 hrs by SRB method
Antiproliferative activity against human HT-29 cells assessed as growth inhibition after 72 hrs by SRB method
|
[PMID: 25644674] |
| HT-29 | GI50 |
0.4 μg/mL
Compound: 5FU
|
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 48 hrs by SRB assay method
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 48 hrs by SRB assay method
|
[PMID: 26383125] |
| HT-29 | IC50 |
15.83 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 48 hrs by WST-1 assay
Cytotoxicity against human HT-29 cells assessed as growth inhibition after 48 hrs by WST-1 assay
|
[PMID: 26413725] |
| HT-29 | IC50 |
24.5 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells after 72 hrs by MTS assay
Antiproliferative activity against human HT-29 cells after 72 hrs by MTS assay
|
[PMID: 26703795] |
| HT-29 | CC50 |
>2512 μM
Compound: 5-Fu
|
Cytotoxicity against human HT-29 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HT-29 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HT-29 | IC50 |
14.8 μM
Compound: 5-Fu
|
Cytotoxicity against human HT-29 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human HT-29 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| HT-29 | IC50 |
5.3 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
Antiproliferative activity against human HT-29 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
|
[PMID: 26731300] |
| HT-29 | IC50 |
>50 μM
Compound: 5-FU
|
Anticancer activity against human HT-29 cells assessed as inhibition of cell growth after 24 hrs by MTT assay
Anticancer activity against human HT-29 cells assessed as inhibition of cell growth after 24 hrs by MTT assay
|
[PMID: 26922233] |
| HT-29 | IC50 |
25 μM
Compound: 5-FU
|
Anticancer activity against human HT-29 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Anticancer activity against human HT-29 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26922233] |
| HT-29 | IC50 |
6.3 μM
Compound: 5-FU
|
Anticancer activity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay
Anticancer activity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay
|
[PMID: 26922233] |
| HT-29 | IC50 |
2.8 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
|
[PMID: 27092413] |
| HT-29 | IC50 |
690 nM
Compound: Fluorouracil
|
Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
|
[PMID: 2778449] |
| HT-29 | IC50 |
4.9 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
|
[PMID: 28494251] |
| HT-29 | IC50 |
7.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HT-29 cells incubated for 72 hrs by alamar blue assay
Cytotoxicity against human HT-29 cells incubated for 72 hrs by alamar blue assay
|
[PMID: 28648460] |
| HT-29 | IC50 |
4.6 μM
Compound: 5-Fluorouracil
|
Antitumor activity against human HT-29 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
Antitumor activity against human HT-29 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
|
[PMID: 28926764] |
| HT-29 | IC50 |
8.3 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 29133061] |
| HT-29 | IC50 |
22.23 μM
Compound: 5-Fu
|
Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
|
[PMID: 29958763] |
| HT-29 | IC50 |
6.5 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30368201] |
| HT-29 | IC50 |
9.99 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 30472605] |
| HT-29 | IC50 |
146.2 μM
Compound: 5-FU
|
Cytotoxicity in human HT-29 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
Cytotoxicity in human HT-29 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 31128448] |
| HT-29 | IC50 |
2.42 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197] |
| HT-29 | IC50 |
>10 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32127259] |
| HT-29 | IC50 |
13.37 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
|
[PMID: 32387836] |
| HT-29 | GI50 |
12.6 μM
Compound: 5-Fu
|
Antiproliferative activity against human HT-29 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells incubated for 48 hrs by MTT assay
|
[PMID: 32832031] |
| HT-29 | IC50 |
12.67 μM
Compound: 5-Fu
|
Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition incubated for 4 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition incubated for 4 hrs by MTT assay
|
[PMID: 32992255] |
| HT-29 | IC50 |
14.9 μM
Compound: 1; 5-FU
|
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
|
[PMID: 33819035] |
| HT-29 | IC50 |
5.2 μM
Compound: 1; 5-FU
|
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs in presence of 5 mM GSH by SRB assay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs in presence of 5 mM GSH by SRB assay
|
[PMID: 33819035] |
| HT-29 | IC50 |
25.9 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human HT-29 cells cultured as 3D spheroids assessed as inhibition of spheroid formation measured after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells cultured as 3D spheroids assessed as inhibition of spheroid formation measured after 48 hrs by MTT assay
|
[PMID: 33872002] |
| HT-29 | IC50 |
16.07 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 34157389] |
| HT-29 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity in human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35085721] |
| HT-29 | GI50 |
0.17 μM
Compound: 5-FU
|
Anticancer activity against human HT-29 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human HT-29 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| HT-29 | IC50 |
15.96 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
|
[PMID: 35290844] |
| HT-29 | IC50 |
23.9 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35635947] |
| HT-29 | IC50 |
12.2 μM
Compound: 5-FU
|
Antitumor activity against human HT-29 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human HT-29 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 35777102] |
| HT-29 | IC50 |
9.19 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells incubated for 72 hrs by MTT assay
|
[PMID: 36209705] |
| HT-29 | IC50 |
18.77 nM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 36269639] |
| HT-29 | IC50 |
17.48 μM
Compound: 5-FU
|
Anticancer activity against human HT-29 cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human HT-29 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| HT-29 | IC50 |
0.17 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition
Cytotoxicity against human HT-29 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| HT-29 | IC50 |
80.6 μM
Compound: 5-FU
|
Anticancer activity against human HT-29 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
Anticancer activity against human HT-29 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay
|
[PMID: 36481599] |
| HT-29 | IC50 |
5.31 μM
Compound: 5-FU
|
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
|
[PMID: 36923920] |
| HT-29 | IC50 |
12 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
Cytotoxicity against human HT-29 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
|
[PMID: 37243616] |
| HT-29 | IC50 |
22.12 μM
Compound: 5-FU
|
Cytotoxicity against human HT-29 cells incubated for 72 hrs by MTS assay
Cytotoxicity against human HT-29 cells incubated for 72 hrs by MTS assay
|
[PMID: 38843656] |
| HT-29 | IC50 |
10.26 μg/mL
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) HT-29 cells by MTT assay
Cytotoxicity against Homo sapiens (human) HT-29 cells by MTT assay
|
10.1007/s00044-009-9193-9 |
| HT-29 | IC50 |
9.72 μM
Compound: 5-Fu
|
Cytotoxicity against Homo sapiens (human) HT-29 cells after 72 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HT-29 cells after 72 hr by MTT assay
|
10.1007/s00044-011-9549-9 |
| HT-29 | IC50 |
3.24 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against Homo sapiens (human) HT-29 cells assessed as inhibition of cell growth after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HT-29 cells assessed as inhibition of cell growth after 48 hr by MTT assay
|
10.1007/s00044-012-0209-5 |
| HT-29 | IC50 |
>100 μM
Compound: 5-Fu
|
Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay
|
10.1039/C5MD00163C |
| hTERT-BJ | GI50 |
5.5 μM
Compound: 5-FU
|
Antiproliferative activity against human hTERT-BJ cells after 48 hrs by SRB assay
Antiproliferative activity against human hTERT-BJ cells after 48 hrs by SRB assay
|
[PMID: 28728108] |
| hTERT-BJ | GI50 |
5.5 μM
Compound: 5-FU
|
Cytotoxicity against human hTERT-BJ cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human hTERT-BJ cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 31376562] |
| hTERT-BJ | IC50 |
5.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity activity against human hTERT-BJ cells by MTT assay
Cytotoxicity activity against human hTERT-BJ cells by MTT assay
|
[PMID: 31546197] |
| hTERT-BJ | GI50 |
5.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human hTERT-BJ cells assessed as reduction in cell growth
Antiproliferative activity against human hTERT-BJ cells assessed as reduction in cell growth
|
[PMID: 34847410] |
| Huh-7 | IC50 |
30.7 μM
Compound: 5-Fu
|
Cytotoxicity against human HuH7 cells after 72 hrs by SRB assay
Cytotoxicity against human HuH7 cells after 72 hrs by SRB assay
|
[PMID: 22409771] |
| Huh-7 | IC50 |
30.7 μM
Compound: 5FU
|
Cytotoxicity against human HuH7 cells incubated for 72 hrs by SRB assay
Cytotoxicity against human HuH7 cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| Huh-7 | IC50 |
15.85 μM
Compound: 5-Fu
|
Growth inhibition of human HuH7 cells after 48 hrs by MTT assay
Growth inhibition of human HuH7 cells after 48 hrs by MTT assay
|
[PMID: 23353737] |
| Huh-7 | IC50 |
20.03 μg/mL
Compound: 5-F
|
Cytotoxicity against human HuH7 cells after 48 hrs by MTT assay
Cytotoxicity against human HuH7 cells after 48 hrs by MTT assay
|
[PMID: 24342667] |
| Huh-7 | IC50 |
30.7 μM
Compound: 5-FU
|
Cytotoxicity against human HuH7 cells after 72 hrs by SRB assay
Cytotoxicity against human HuH7 cells after 72 hrs by SRB assay
|
[PMID: 25462277] |
| Huh-7 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human HuH7 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HuH7 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 26320625] |
| Huh-7 | IC50 |
10.41 μg/mL
Compound: 5-FU
|
Cytotoxicity against human HuH7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human HuH7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 26546214] |
| Huh-7 | IC50 |
390 μM
Compound: 5-FU
|
Cytotoxicity against human HuH7 cells assessed as reduction in cell growth after 48 hrs by MTT assay
Cytotoxicity against human HuH7 cells assessed as reduction in cell growth after 48 hrs by MTT assay
|
[PMID: 27422336] |
| Huh-7 | IC50 |
2.98 mM
Compound: 5-FU
|
Antiproliferative activity against human HuH7 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
Antiproliferative activity against human HuH7 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
|
[PMID: 28073674] |
| Huh-7 | IC50 |
21 μM
Compound: 5-FU
|
Cytotoxicity against human HuH7 cells assessed as growth inhibition after 72 hrs by SRB assay
Cytotoxicity against human HuH7 cells assessed as growth inhibition after 72 hrs by SRB assay
|
[PMID: 28219046] |
| Huh-7 | IC50 |
5.63 μM
Compound: 5-FU
|
Antiproliferative activity against human HuH7 cells after 72 hrs by MTT assay
Antiproliferative activity against human HuH7 cells after 72 hrs by MTT assay
|
[PMID: 29316536] |
| Huh-7 | IC50 |
30 μM
Compound: 5-FU
|
Antiproliferative activity against human HuH7 cells after 72 hrs by SRB assay
Antiproliferative activity against human HuH7 cells after 72 hrs by SRB assay
|
[PMID: 29326016] |
| Huh-7 | IC50 |
21 μM
Compound: 5-FU
|
Cytotoxicity against human HuH7 cells after 72 hrs by SRB assay
Cytotoxicity against human HuH7 cells after 72 hrs by SRB assay
|
[PMID: 30108969] |
| Huh-7 | IC50 |
30.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human Huh-7 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
Antiproliferative activity against human Huh-7 cells assessed as reduction in cell viability after 48 hr by CCK-8 assay
|
[PMID: 36288556] |
| Huh-7 | IC50 |
1.06 μM
Compound: 5-FU
|
Anticancer activity against human Huh-7 cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human Huh-7 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| Huh-7 | IC50 |
8.98 μM
Compound: 5-FU
|
Antiproliferative activity against human Huh-7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human Huh-7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 37182331] |
| Huh-7 | IC50 |
30.7 μM
Compound: 5-FU
|
Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
|
[PMID: 38107180] |
| Huh-7 | IC50 |
30.6 μM
Compound: 5-FU
|
Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
Cytotoxicity against human Huh-7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
|
[PMID: 38688437] |
| Huh-7 | IC50 |
28.53 μM
Compound: 5-Fu
|
Cytotoxicity against human Huh-7 cells assessed as cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human Huh-7 cells assessed as cell viability measured after 48 hrs by MTT assay
|
[PMID: 38964974] |
| Huh-7 | IC50 |
30.7 μM
Compound: 5FU
|
Cytotoxicity against human HuH7 cells assessed as inhibition of cell proliferation by sulforhodamine B assay
Cytotoxicity against human HuH7 cells assessed as inhibition of cell proliferation by sulforhodamine B assay
|
10.1039/C4MD00306C |
| HuTu80 | GI50 |
0.4 μg/mL
Compound: 5FU
|
Cytotoxicity against human HuTu 80 cells assessed as growth inhibition after 48 hrs by SRB assay method
Cytotoxicity against human HuTu 80 cells assessed as growth inhibition after 48 hrs by SRB assay method
|
[PMID: 26383125] |
| HuTu80 | IC50 |
65.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HuTu80 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
Cytotoxicity against human HuTu80 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
|
[PMID: 36970146] |
| HUVEC | GI50 |
9.72 μM
Compound: 5-Fu
|
Growth inhibition of HUVEC cells after 48 hrs by SRB assay
Growth inhibition of HUVEC cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| HUVEC | GI50 |
3.6 nM
Compound: 5FU
|
Growth inhibition of human HUVEC cells after 48 hrs by SRB assay
Growth inhibition of human HUVEC cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| HUVEC | IC50 |
56 μM
Compound: 5-FU
|
Cytotoxicity against human HUVEC after 48 hrs by MTT assay
Cytotoxicity against human HUVEC after 48 hrs by MTT assay
|
[PMID: 24378217] |
| HUVEC | IC50 |
24.12 μM
Compound: 5-Fu
|
Cytotoxicity against HUVEC after 48 hrs by MTT assay
Cytotoxicity against HUVEC after 48 hrs by MTT assay
|
[PMID: 24953029] |
| HUVEC | IC50 |
56 μM
Compound: 5-FU
|
Cytotoxicity against human HUVEC cells after 48 hrs by MTT assay
Cytotoxicity against human HUVEC cells after 48 hrs by MTT assay
|
[PMID: 25151580] |
| HUVEC | IC50 |
56.37 μM
Compound: 5-Fu
|
Cytotoxicity against human HUVEC cells after 2 days by MTT assay
Cytotoxicity against human HUVEC cells after 2 days by MTT assay
|
[PMID: 25841196] |
| HUVEC | IC50 |
79.6 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against HUVEC assessed as cell growth inhibition by MTT assay
Cytotoxicity against HUVEC assessed as cell growth inhibition by MTT assay
|
[PMID: 27720296] |
| HUVEC | IC50 |
56 μM
Compound: 5-FU
|
Cytotoxicity in HUVEC cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in HUVEC cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 28754470] |
| HUVEC | IC50 |
11.65 μM
Compound: 5-FU
|
Cytotoxicity against HUVEC
Cytotoxicity against HUVEC
|
[PMID: 30746067] |
| HUVEC | IC50 |
>200 μM
Compound: 5-FLU
|
Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 34606997] |
| HUVEC | IC50 |
96 μM
Compound: 5-FLU
|
Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against HUVEC assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 34606997] |
| HUVEC | IC50 |
0.43 μM
Compound: 1; 5-FU
|
Cytotoxicity against human HUVEC cells assessed as inhibition of cell growth incubated 1.5 hrs by MTT assay
Cytotoxicity against human HUVEC cells assessed as inhibition of cell growth incubated 1.5 hrs by MTT assay
|
[PMID: 38107178] |
| IEC-6 | IC50 |
0.66 μM
Compound: 5-FU
|
Cytotoxicity against rat IEC-6 cells after 6 days by SRB colorimetric assay
Cytotoxicity against rat IEC-6 cells after 6 days by SRB colorimetric assay
|
[PMID: 21684047] |
| IGROV-1 | GI50 |
9.1 μM
Compound: 5-Fu
|
Growth inhibition of human IGROV1 cells after 48 hrs by SRB assay
Growth inhibition of human IGROV1 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| IGROV-1 | GI50 |
8.12 nM
Compound: 5FU
|
Growth inhibition of human IGROV1 cells after 48 hrs by SRB assay
Growth inhibition of human IGROV1 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| IGROV-1 | GI50 |
1.22 μM
Compound: 5-FU
|
Growth inhibition of human IGROV1 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human IGROV1 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| IGROV-1 | IC50 |
10.6 μM
Compound: 5FU
|
Cytotoxicity against human IGROV1 cells after 72 hrs
Cytotoxicity against human IGROV1 cells after 72 hrs
|
[PMID: 30035541] |
| IGROV-1 | GI50 |
1.22 μM
Compound: 5-FU
|
Anticancer activity against human IGROV-1 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human IGROV-1 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| IGROV-1 | IC50 |
1.22 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human IGROV-1 cells assessed as cell growth inhibition
Cytotoxicity against human IGROV-1 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| IM-9 | IC50 |
0.34 μg/mL
Compound: 5-F-Ura
|
In vitro antitumor activity in IM-9 cell lines
In vitro antitumor activity in IM-9 cell lines
|
[PMID: 8648611] |
| IMR-32 | IC50 |
18 μM
Compound: 5-fluorouracil
|
Anticancer activity against human IMR32 cells assessed as cell viability after 48 hrs by SRB assay
Anticancer activity against human IMR32 cells assessed as cell viability after 48 hrs by SRB assay
|
[PMID: 21074444] |
| IMR-32 | IC50 |
1.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human IMR32 cells after 48 hrs by SRB assay
Cytotoxicity against human IMR32 cells after 48 hrs by SRB assay
|
[PMID: 24056146] |
| IMR-32 | IC50 |
1.3 μM
Compound: 5-FU
|
Cytotoxicity against human IMR32 cells after 48 hrs by SRB assay
Cytotoxicity against human IMR32 cells after 48 hrs by SRB assay
|
[PMID: 25176329] |
| IMR-32 | IC50 |
5.7 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human IMR32 cells after 48 hrs by CellTiter-Glo assay
Cytotoxicity against human IMR32 cells after 48 hrs by CellTiter-Glo assay
|
[PMID: 31999116] |
| IMR-90 | IC50 |
136.4 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human IMR90 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human IMR90 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 26629861] |
| Ishikawa | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human Ishikawa cells assessed as reduction in cell viability
Antiproliferative activity against human Ishikawa cells assessed as reduction in cell viability
|
[PMID: 38911148] |
| Jurkat | IC50 |
87.73 μM
Compound: 5-FU
|
Antiproliferative activity against p53 deficient human Jurkat cells after 72 hrs by proliferative assay
Antiproliferative activity against p53 deficient human Jurkat cells after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| Jurkat | IC50 |
87 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient Jurkat cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient Jurkat cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| K562 | IC50 |
126 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human K562 cells
Cytotoxicity against human K562 cells
|
[PMID: 16996657] |
| K562 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against p53 deficient human K562 cells after 72 hrs
Antiproliferative activity against p53 deficient human K562 cells after 72 hrs
|
[PMID: 18469809] |
| K562 | GI50 |
16.7 μM
Compound: 5FU
|
Cytotoxicity against human K562 cells after 48 hrs
Cytotoxicity against human K562 cells after 48 hrs
|
[PMID: 18798609] |
| K562 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 19324555] |
| K562 | IC50 |
3.8 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of cell growth of K562 leukemic cell lines in human.
Concentration required for 50% inhibition of cell growth of K562 leukemic cell lines in human.
|
[PMID: 1992123] |
| K562 | IC50 |
2.2 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human chronic myelogenous leukemia (K562 cells
In vitro inhibitory activity against growth of Human chronic myelogenous leukemia (K562 cells
|
[PMID: 1995901] |
| K562 | GI50 |
89.9 μM
Compound: 5FU
|
Cytotoxicity against human K562 cells
Cytotoxicity against human K562 cells
|
[PMID: 20356752] |
| K562 | IC50 |
45.4 μM
Compound: 5-FU
|
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 20494492] |
| K562 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient K562 cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient K562 cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| K562 | IC50 |
38 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 21131104] |
| K562 | IC50 |
2.4 μM
Compound: 5-FU
|
Anticancer activity against human K562 cells
Anticancer activity against human K562 cells
|
[PMID: 21449610] |
| K562 | IC50 |
2.4 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human K562 cells
Cytotoxicity against human K562 cells
|
[PMID: 22409967] |
| K562 | IC50 |
2.1 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 22537362] |
| K562 | IC50 |
114.5 μM
Compound: 5-Fu
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 23356786] |
| K562 | IC50 |
28 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 23535322] |
| K562 | IC50 |
23.55 μM
Compound: 5-Fu
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| K562 | GI50 |
3.58 μM
Compound: 5-FU
|
Growth inhibition of human K562 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human K562 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| K562 | IC50 |
23.55 μM
Compound: 5-Fu
|
Growth inhibition against human K562 cells after 48 hrs by MTT assay
Growth inhibition against human K562 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| K562 | ED50 |
16.22 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human K562 cells after 6 hrs by Alamar Blue assay
Cytotoxicity against human K562 cells after 6 hrs by Alamar Blue assay
|
[PMID: 24020806] |
| K562 | ED50 |
21 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human K562 cells by Alamar blue assay
Cytotoxicity against human K562 cells by Alamar blue assay
|
[PMID: 24128077] |
| K562 | IC50 |
126 μM
Compound: 5-Fluorouracil
|
Antileukemic activity against human K562 cells assessed as inhibition of tumor growth after 24 hrs
Antileukemic activity against human K562 cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| K562 | IC50 |
31.6 μM
Compound: 5-Fu
|
Anticancer activity against human K562 cells after 48 hrs by MTT assay
Anticancer activity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 25462264] |
| K562 | GI50 |
0.9 μg/mL
Compound: 5FU
|
Cytotoxicity against human K562 cells assessed as growth inhibition after 48 hrs by SRB assay method
Cytotoxicity against human K562 cells assessed as growth inhibition after 48 hrs by SRB assay method
|
[PMID: 26383125] |
| K562 | IC50 |
38.58 μM
Compound: 5-FU
|
Growth inhibition of human K562 cells after 48 hrs by WST1 assay
Growth inhibition of human K562 cells after 48 hrs by WST1 assay
|
[PMID: 28126436] |
| K562 | IC50 |
3.54 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 28165738] |
| K562 | IC50 |
30.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human K562 cells incubated for 72 hrs by alamar blue assay
Cytotoxicity against human K562 cells incubated for 72 hrs by alamar blue assay
|
[PMID: 28648460] |
| K562 | GI50 |
19 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 28763647] |
| K562 | GI50 |
18.5 μM
Compound: 5-FU
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 29040954] |
| K562 | IC50 |
9.49 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human K562 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human K562 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133049] |
| K562 | IC50 |
8.48 μg/mL
Compound: 5-FU
|
Anti-leukemia activity in human K562 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Anti-leukemia activity in human K562 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
|
[PMID: 30114660] |
| K562 | IC50 |
12.21 μM
Compound: 5-FU
|
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| K562 | IC50 |
20.7 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
Antiproliferative activity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 30737134] |
| K562 | IC50 |
3.86 μM
Compound: 5-FU
|
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757] |
| K562 | IC50 |
32.92 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human K562 cells by disk diffusion soft agar colony formation assay
Cytotoxicity against human K562 cells by disk diffusion soft agar colony formation assay
|
[PMID: 31117520] |
| K562 | IC50 |
4.02 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992] |
| K562 | IC50 |
41.66 μM
Compound: 5-FU
|
Cytotoxicity against human K562 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human K562 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| K562 | IC50 |
3.94 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31877536] |
| K562 | IC50 |
3.94 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells assessed as reduction in cell growth after 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as reduction in cell growth after 72 hrs by MTT assay
|
[PMID: 31883693] |
| K562 | IC50 |
38.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human K562 cells by MTT reduction assay
Antiproliferative activity against human K562 cells by MTT reduction assay
|
[PMID: 33421712] |
| K562 | IC50 |
38 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of human chronic myelogenous leukemic K562 cell lines.
In vitro inhibitory effect on growth of human chronic myelogenous leukemic K562 cell lines.
|
[PMID: 3373480] |
| K562 | IC50 |
20.21 μM
Compound: 5-FU
|
Cytotoxicity against human K562 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Cytotoxicity against human K562 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 33740546] |
| K562 | GI50 |
3.58 μM
Compound: 5-FU
|
Anticancer activity against human K562 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human K562 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| K562 | IC50 |
3.58 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human K562 cells assessed as cell growth inhibition
Cytotoxicity against human K562 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| K562 | IC50 |
38.58 μM
Compound: 5-FU
|
Anticancer activity against human K562 cells assessed as cell growth inhibition measured after 48 hrs by WST-1 assay
Anticancer activity against human K562 cells assessed as cell growth inhibition measured after 48 hrs by WST-1 assay
|
[PMID: 36481599] |
| K562 | IC50 |
38.58 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells assessed as inhibition of cell growth
Antiproliferative activity against human K562 cells assessed as inhibition of cell growth
|
[PMID: 36543034] |
| K562 | IC50 |
5.18 μM
Compound: 5-Fu
|
Antiproliferative activity against human K562 cells by CCK8 assay
Antiproliferative activity against human K562 cells by CCK8 assay
|
[PMID: 37939862] |
| K562 | IC50 |
>20 μM
Compound: 5-Fu
|
Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| K562 | IC50 |
4.3 μg/mL
Compound: 5-F-Ura
|
In vitro antitumor activity in K-562 cell lines
In vitro antitumor activity in K-562 cell lines
|
[PMID: 8648611] |
| K562 | IC50 |
45.4 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) K562 cells by MTT assay
Cytotoxicity against Homo sapiens (human) K562 cells by MTT assay
|
10.1007/s00044-010-9395-1 |
| K562/Adr | IC50 |
31.9 μM
Compound: 5-FU
|
Cytotoxicity against human K562/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human K562/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| KATO III stomach cancer cell line | EC50 |
21.4 μM
Compound: 5FU
|
Cytotoxicity against human KATO III stomach cancer cell line assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
Cytotoxicity against human KATO III stomach cancer cell line assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
|
[PMID: 35939803] |
| KB | IC50 |
2.3 μM
Compound: 5-Fluorouracil
|
In vitro cytotoxicity against human oral epidermoid carcinoma KB cells.
In vitro cytotoxicity against human oral epidermoid carcinoma KB cells.
|
[PMID: 10229634] |
| KB | IC50 |
0.93 μg/mL
Compound: 5FU
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 10425135] |
| KB | IC50 |
3.5 x 10-6 M
Compound: 5-Fu
|
Inhibitory concentration against KB cancer cell lines was determined.
Inhibitory concentration against KB cancer cell lines was determined.
|
[PMID: 11229742] |
| KB | IC50 |
>10 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human KB cells after 2 to 7 days by neutral red assay
Cytotoxicity against human KB cells after 2 to 7 days by neutral red assay
|
[PMID: 11374943] |
| KB | IC50 |
13.4 μM
Compound: 5-fu
|
Cytotoxicity against human KB cells after 48 hrs
Cytotoxicity against human KB cells after 48 hrs
|
[PMID: 17000031] |
| KB | ED50 |
1.25 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human KB cells after 3 days by trypan blue exclusion technique
Cytotoxicity against human KB cells after 3 days by trypan blue exclusion technique
|
[PMID: 1800632] |
| KB | IC50 |
4.46 nM
Compound: Fluorouracil
|
Cytotoxicity against human KB cells by MTT assay
Cytotoxicity against human KB cells by MTT assay
|
[PMID: 19345581] |
| KB | IC50 |
4.46 x 10-3 μM
Compound: Fluorouracil
|
Cytotoxicity against human KB cells by MTT assay
Cytotoxicity against human KB cells by MTT assay
|
[PMID: 19345581] |
| KB | IC50 |
12.5 μM
Compound: fluorouracil
|
Cytotoxicity against human KB cells after 72 hrs MTT assay
Cytotoxicity against human KB cells after 72 hrs MTT assay
|
[PMID: 19846302] |
| KB | IC50 |
12.1 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human oral epidermoid carcinoma (KB) cell line.
In vitro inhibitory activity against Human oral epidermoid carcinoma (KB) cell line.
|
[PMID: 1995905] |
| KB | IC50 |
4.46 μM
Compound: Fluorouracil
|
Cytotoxicity against human KB cells after 3 days by MTT assay
Cytotoxicity against human KB cells after 3 days by MTT assay
|
[PMID: 20356655] |
| KB | IC50 |
2.16 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human KB cells after 48 hrs by MTT assay
Cytotoxicity against human KB cells after 48 hrs by MTT assay
|
[PMID: 21131104] |
| KB | IC50 |
11.9 μM
Compound: 5-FU
|
Cytotoxicity against human KB cells after 3 days by MTT assay
Cytotoxicity against human KB cells after 3 days by MTT assay
|
[PMID: 21144621] |
| KB | IC50 |
15.9 μM
Compound: Flurouracil
|
Cytotoxicity against human KB cells after 72 hrs by MTT assay
Cytotoxicity against human KB cells after 72 hrs by MTT assay
|
[PMID: 21273072] |
| KB | GI50 |
5.2 μM
Compound: 5FU
|
Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human KB cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| KB | IC50 |
7.7 pM
Compound: 5-FU
|
Cytotoxicity against human KB cells after 72 hrs by MTT assay
Cytotoxicity against human KB cells after 72 hrs by MTT assay
|
[PMID: 21640594] |
| KB | IC50 |
12.5 μM
Compound: Fluorouracil
|
Cytotoxicity against human KB cells after 3 days by MTT assay
Cytotoxicity against human KB cells after 3 days by MTT assay
|
[PMID: 21843939] |
| KB | IC50 |
9.85 μM
Compound: 5-FU
|
Antiproliferative activity against human KB cells after 72 hrs by MTT assay
Antiproliferative activity against human KB cells after 72 hrs by MTT assay
|
[PMID: 22079378] |
| KB | IC50 |
9 μM
Compound: Fluorouracil
|
Cytotoxicity against human KB cells after 72 hrs ny MTT assay
Cytotoxicity against human KB cells after 72 hrs ny MTT assay
|
[PMID: 22200404] |
| KB | IC50 |
6.8 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human KB cells after 48 hrs by MTT assay
Cytotoxicity against human KB cells after 48 hrs by MTT assay
|
[PMID: 22537362] |
| KB | IC50 |
8.28 μM
Compound: 5-FU
|
Cytotoxicity against human KB cells after 72 hrs by MTT assay
Cytotoxicity against human KB cells after 72 hrs by MTT assay
|
[PMID: 22749192] |
| KB | IC50 |
4.84 μM
Compound: FUra
|
Cytotoxicity against human KB cells after 72 hrs by SRB assay
Cytotoxicity against human KB cells after 72 hrs by SRB assay
|
[PMID: 23867603] |
| KB | IC50 |
8.1 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human KB cells after 4 days by MTT assay
Cytotoxicity against human KB cells after 4 days by MTT assay
|
[PMID: 24359303] |
| KB | IC50 |
1.23 μM
Compound: 5-Fu
|
Cytotoxicity against human KB cells after 48 hrs by MTT assay
Cytotoxicity against human KB cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| KB | IC50 |
53.52 μM
Compound: 5-FU
|
Antiproliferative activity against human KB cells after 48 hrs by MTT assay
Antiproliferative activity against human KB cells after 48 hrs by MTT assay
|
[PMID: 25164762] |
| KB | IC50 |
4.84 μM
Compound: FUra
|
Cytotoxicity against human KB cells after 72 hrs by SRB assay
Cytotoxicity against human KB cells after 72 hrs by SRB assay
|
[PMID: 27073055] |
| KB | IC50 |
4.84 μM
Compound: FUra
|
Cytotoxicity against human KB cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
Cytotoxicity against human KB cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
|
[PMID: 27501415] |
| KB | IC50 |
12.1 μg/mL
Compound: 5-FU
|
Concentration at 50 percent inhibition of cell growth against human cancer KB cell line in vitro
Concentration at 50 percent inhibition of cell growth against human cancer KB cell line in vitro
|
10.1016/S0960-894X(01)81041-6 |
| KCL-22 | IC50 |
3.52 μM
Compound: FU
|
Antiproliferative activity against human KCL22 cells after 48 hrs by MTT assay
Antiproliferative activity against human KCL22 cells after 48 hrs by MTT assay
|
[PMID: 24941129] |
| KG-1 | IC50 |
82.97 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human KG1 cells after 48 hrs by MTT assay
Antiproliferative activity against human KG1 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| KKLS | IC50 |
6.2 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of KKLS tumor cell line from stomach.
Compound was tested for its inhibitory effect on the growth of KKLS tumor cell line from stomach.
|
10.1016/0960-894X(96)00339-3 |
| KM12 | IC50 |
7.94 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human KM12 cells
Cytotoxicity against human KM12 cells
|
[PMID: 16996657] |
| KM12 | IC50 |
8.32 μM
Compound: 5-FU
|
Anticancer activity against human KM12 cells
Anticancer activity against human KM12 cells
|
[PMID: 21449610] |
| KM12 | IC50 |
8.32 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human KM12 cells
Cytotoxicity against human KM12 cells
|
[PMID: 22409967] |
| KM12 | GI50 |
0.21 μM
Compound: 5-FU
|
Growth inhibition of human KM12 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human KM12 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| KM12 | IC50 |
7.94 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human KM12 cells assessed as inhibition of tumor growth after 24 hrs
Cytotoxicity against human KM12 cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| KM12 | CC50 |
>2512 μM
Compound: 5-Fu
|
Cytotoxicity against human KM12 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human KM12 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| KM12 | IC50 |
14.8 μM
Compound: 5-Fu
|
Cytotoxicity against human KM12 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human KM12 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| KM12 | IC50 |
12.26 μM
Compound: 5-FU
|
Anticancer activity against human KM12 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Anticancer activity against human KM12 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 34438126] |
| KM12 | GI50 |
0.21 μM
Compound: 5-FU
|
Anticancer activity against human KM12 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human KM12 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| KM12 | IC50 |
0.21 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human KM12 cells assessed as cell growth inhibition
Cytotoxicity against human KM12 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| KYSE-270 | IC50 |
7.73 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human KYSE-270 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human KYSE-270 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36893627] |
| KYSE-450 | IC50 |
32.58 μM
Compound: 5-FU
|
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38759254] |
| KYSE-510 | IC50 |
7.73 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human KYSE-510 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human KYSE-510 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36893627] |
| L02 | IC50 |
56 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human L02 cells after 48 hrs by MTT assay
Cytotoxicity against human L02 cells after 48 hrs by MTT assay
|
[PMID: 21131104] |
| L02 | IC50 |
46.57 μM
Compound: 5-Fu
|
Cytotoxicity against human L02 cells by after 48 hrs by MTT assay
Cytotoxicity against human L02 cells by after 48 hrs by MTT assay
|
[PMID: 22579780] |
| L02 | IC50 |
46.57 μM
Compound: 5-Fu
|
Growth inhibition of human L02 cells after 48 hrs by MTT assay
Growth inhibition of human L02 cells after 48 hrs by MTT assay
|
[PMID: 23353737] |
| L02 | IC50 |
95.36 μM
Compound: 5-FU
|
Cytotoxicity against human HL-7702 cells assessed as growth inhibition by MTT assay
Cytotoxicity against human HL-7702 cells assessed as growth inhibition by MTT assay
|
[PMID: 24684840] |
| L02 | IC50 |
58.74 μM
Compound: 5-FU
|
Cytotoxicity against human HL7702 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human HL7702 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25841199] |
| L02 | IC50 |
25.9 μM
Compound: 5-FU
|
Cytotoxicity against human L02 cells after 72 hrs by MTT assay
Cytotoxicity against human L02 cells after 72 hrs by MTT assay
|
[PMID: 26595184] |
| L02 | IC50 |
>10 μM
Compound: 5-Fu
|
Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
Cytotoxicity against human LO2 cells after 48 hrs by MTT assay
|
[PMID: 26714048] |
| L02 | IC50 |
14.53 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human HL7702 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HL7702 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27262600] |
| L02 | IC50 |
25.9 μM
Compound: 5-FU
|
Cytotoxicity against human L02 measured after 72 hrs by MTT assay
Cytotoxicity against human L02 measured after 72 hrs by MTT assay
|
[PMID: 27537924] |
| L02 | IC50 |
12.85 μM
Compound: 5-FU
|
Cytotoxicity against human HL-7702 cells assessed as growth inhibition after 72 hrs by CCK8 assay
Cytotoxicity against human HL-7702 cells assessed as growth inhibition after 72 hrs by CCK8 assay
|
[PMID: 27597411] |
| L02 | IC50 |
32.546 μM
Compound: 5-FU
|
Antiproliferative activity against human LO2 cells after 72 hrs by CCK-8 assay
Antiproliferative activity against human LO2 cells after 72 hrs by CCK-8 assay
|
[PMID: 28301815] |
| L02 | IC50 |
46 μM
Compound: 5-FU
|
Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
|
[PMID: 28756264] |
| L02 | IC50 |
19.1 μM
Compound: 5-FU
|
Anti-proliferative activity against human L02 cells after 48 hrs by MTT assay
Anti-proliferative activity against human L02 cells after 48 hrs by MTT assay
|
[PMID: 28947149] |
| L02 | IC50 |
58.74 μM
Compound: 5-FU
|
Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
|
[PMID: 30092368] |
| L02 | IC50 |
58.74 μM
Compound: 5-FU
|
Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay
|
[PMID: 30108826] |
| L02 | IC50 |
19.12 μM
Compound: 5-Fu
|
Cytotoxicity in human L02 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human L02 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113] |
| L02 | IC50 |
10.6 μM
Compound: Fluorouracil
|
Cytotoxicity against human LO2 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human LO2 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 31013087] |
| L02 | IC50 |
>50 μM
Compound: 5-Fu
|
Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992] |
| L02 | IC50 |
29.53 μM
Compound: 5-Fu
|
Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31509699] |
| L02 | IC50 |
>200 μM
Compound: 5-FU
|
Cytotoxicity against human LO2 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human LO2 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| L02 | IC50 |
>50 μM
Compound: 5-Fu
|
Cytotoxicity against human L02 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 31877536] |
| L02 | IC50 |
>40 μM
Compound: 5-Fu
|
Antiproliferative activity against human L02 cells assessed as reduction in cell growth after 72 hrs by MTT assay
Antiproliferative activity against human L02 cells assessed as reduction in cell growth after 72 hrs by MTT assay
|
[PMID: 31883693] |
| L02 | IC50 |
46.45 μM
Compound: 5-FU
|
Cytotoxicity against human L02 cells assessed as cell growth inhibition
Cytotoxicity against human L02 cells assessed as cell growth inhibition
|
[PMID: 35809817] |
| L02 | IC50 |
44.05 μM
Compound: 5-FU
|
Antiproliferative activity against human L02 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
Antiproliferative activity against human L02 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
|
[PMID: 37122546] |
| L02 | IC50 |
54.45 μM
Compound: 5-Fu
|
Cytotoxicity against human L02 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Cytotoxicity against human L02 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
|
[PMID: 37360398] |
| L02 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human L02 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
Antiproliferative activity against human L02 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
|
[PMID: 37659196] |
| L1210 | IC50 |
0.62 μM
Compound: 5-Fluorouracil
|
In vitro cytotoxicity against murine Leukemia L1210 cells.
In vitro cytotoxicity against murine Leukemia L1210 cells.
|
[PMID: 10229634] |
| L1210 | IC50 |
0.28 μM
Compound: 5-Fluorouracil
|
Concentration required to inhibit 50% of cell growth on murine L1210 cells.
Concentration required to inhibit 50% of cell growth on murine L1210 cells.
|
[PMID: 11052798] |
| L1210 | IC50 |
125 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 48 hr
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 48 hr
|
[PMID: 11063625] |
| L1210 | IC50 |
220 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 24 hr
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 24 hr
|
[PMID: 11063625] |
| L1210 | IC50 |
2200 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 2 hr
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 2 hr
|
[PMID: 11063625] |
| L1210 | IC50 |
630 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 8 hr
Growth inhibition in L1210 mouse Leukemia cells for a treatment time of 8 hr
|
[PMID: 11063625] |
| L1210 | IC50 |
0.04 μg/mL
Compound: 5-FU
|
Evaluated for the inhibition of tumor cell growth of murine leukemia malignant tumor cell line (L1210/0)
Evaluated for the inhibition of tumor cell growth of murine leukemia malignant tumor cell line (L1210/0)
|
[PMID: 11123990] |
| L1210 | IC50 |
1010 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse leukemia cells after 8 h treatment
Growth inhibition in L1210 mouse leukemia cells after 8 h treatment
|
[PMID: 11728193] |
| L1210 | IC50 |
200 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse leukemia cells after 48 hr treatment
Growth inhibition in L1210 mouse leukemia cells after 48 hr treatment
|
[PMID: 11728193] |
| L1210 | IC50 |
2500 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse leukemia cells after 2 hr treatment
Growth inhibition in L1210 mouse leukemia cells after 2 hr treatment
|
[PMID: 11728193] |
| L1210 | IC50 |
360 nM
Compound: 5-FU
|
Growth inhibition in L1210 mouse leukemia cells after 24 h treatment
Growth inhibition in L1210 mouse leukemia cells after 24 h treatment
|
[PMID: 11728193] |
| L1210 | IC50 |
0.28 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against mouse L1210 cells
Cytostatic activity against mouse L1210 cells
|
[PMID: 17931862] |
| L1210 | ED50 |
1.41 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against mouse L1210 cells after 3 days by trypan blue exclusion technique
Cytotoxicity against mouse L1210 cells after 3 days by trypan blue exclusion technique
|
[PMID: 1800632] |
| L1210 | IC50 |
0.69 μM
Compound: 5-FU
|
Antiproliferative activity against mouse L1210 cells after 2 days by MTT assay
Antiproliferative activity against mouse L1210 cells after 2 days by MTT assay
|
[PMID: 18424155] |
| L1210 | IC50 |
0.32 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of cell growth of L1210 leukemic cell lines in mouse.
Concentration required for 50% inhibition of cell growth of L1210 leukemic cell lines in mouse.
|
[PMID: 1992123] |
| L1210 | IC50 |
0.56 μM
Compound: 5-FU
|
Cytotoxicity against mouse L1210 cells after 2 days by coulter counter analysis
Cytotoxicity against mouse L1210 cells after 2 days by coulter counter analysis
|
[PMID: 21232828] |
| L1210 | IC50 |
>500 μM
Compound: 5-FU
|
Inhibition of DNA synthesis in mouse L1210 cells assessed as [methyl-3H]thymidine incorporation in to DNA by liquid scintillation counting
Inhibition of DNA synthesis in mouse L1210 cells assessed as [methyl-3H]thymidine incorporation in to DNA by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
>500 μM
Compound: 5-FU
|
Inhibition of DNA synthesis in mouse L1210 cells assessed as [methyl-3H]thymidine incorporation in to DNA preincubated for 24 hrs by liquid scintillation counting
Inhibition of DNA synthesis in mouse L1210 cells assessed as [methyl-3H]thymidine incorporation in to DNA preincubated for 24 hrs by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
0.02 μM
Compound: 5-FU
|
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 24 hrs by liquid scintillation counting
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 24 hrs by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
0.06 μM
Compound: 5-FU
|
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 24 hrs by liquid scintillation counting
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 24 hrs by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
0.22 μM
Compound: 5-FU
|
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 4 hrs by liquid scintillation counting
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 4 hrs by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
0.37 μM
Compound: 5-FU
|
Inhibition of DNA synthesis in mouse L1210 cells assessed as [6-3H]2'-deoxyuridine incorporation in to DNA preincubated for 24 hrs by liquid scintillation counting
Inhibition of DNA synthesis in mouse L1210 cells assessed as [6-3H]2'-deoxyuridine incorporation in to DNA preincubated for 24 hrs by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
0.47 μM
Compound: 5-FU
|
Cytostatic activity against mouse L1210 cells in presence of 500 uM uracil
Cytostatic activity against mouse L1210 cells in presence of 500 uM uracil
|
[PMID: 21330014] |
| L1210 | IC50 |
0.56 μM
Compound: 5-FU
|
Cytostatic activity against mouse L1210 cells after 2 days by coulter counting analysis
Cytostatic activity against mouse L1210 cells after 2 days by coulter counting analysis
|
[PMID: 21330014] |
| L1210 | IC50 |
0.6 μM
Compound: 5-FU
|
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 4 hrs by liquid scintillation counting
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 4 hrs by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
0.62 μM
Compound: 5-FU
|
Cytostatic activity against mouse L1210 cells in presence of 500 uM uridine
Cytostatic activity against mouse L1210 cells in presence of 500 uM uridine
|
[PMID: 21330014] |
| L1210 | IC50 |
0.97 μM
Compound: 5-FU
|
Inhibition of DNA synthesis in mouse L1210 cells assessed as [6-3H]2'-deoxyuridine incorporation in to DNA by liquid scintillation counting
Inhibition of DNA synthesis in mouse L1210 cells assessed as [6-3H]2'-deoxyuridine incorporation in to DNA by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
1.3 μM
Compound: 5-FU
|
Cytostatic activity against mouse L1210 cells in presence of 20 uM 2'-deoxyuridine
Cytostatic activity against mouse L1210 cells in presence of 20 uM 2'-deoxyuridine
|
[PMID: 21330014] |
| L1210 | IC50 |
21 μM
Compound: 5-FU
|
Cytostatic activity against mouse L1210 cells in presence of 20 uM thymidine
Cytostatic activity against mouse L1210 cells in presence of 20 uM thymidine
|
[PMID: 21330014] |
| L1210 | IC50 |
4.9 μM
Compound: 5-FU
|
Inhibition of RNA synthesis in mouse L1210 cells assessed as [5-3H]uridine incorporation in to RNA preincubated for 24 hrs by liquid scintillation counting
Inhibition of RNA synthesis in mouse L1210 cells assessed as [5-3H]uridine incorporation in to RNA preincubated for 24 hrs by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
51 μM
Compound: 5-FU
|
Inhibition of RNA synthesis in mouse L1210 cells assessed as [5-3H]uridine incorporation in to RNA by liquid scintillation counting
Inhibition of RNA synthesis in mouse L1210 cells assessed as [5-3H]uridine incorporation in to RNA by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
7 μM
Compound: 5-FU
|
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 15 mins by liquid scintillation counting
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 15 mins by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
≥10 μM
Compound: 5-FU
|
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 15 mins by liquid scintillation counting
Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxycytidine after preincubation for 15 mins by liquid scintillation counting
|
[PMID: 21330014] |
| L1210 | IC50 |
1.1 pM
Compound: 5-FU
|
Cytotoxicity against mouse L1210 cells after 72 hrs by MTT assay
Cytotoxicity against mouse L1210 cells after 72 hrs by MTT assay
|
[PMID: 21640594] |
| L1210 | IC50 |
0.32 μM
Compound: 1, 5-FU
|
Cytostatic activity against thymidine-kinase deficient mouse L1210 cells after 48 hrs by cell counting
Cytostatic activity against thymidine-kinase deficient mouse L1210 cells after 48 hrs by cell counting
|
[PMID: 21892829] |
| L1210 | IC50 |
0.49 μM
Compound: F-Uracil
|
Cytostatic activity against mouse L1210 cells
Cytostatic activity against mouse L1210 cells
|
[PMID: 21917363] |
| L1210 | IC50 |
0.49 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against mouse L1210 cells after 2 days by coulter counter analysis
Cytostatic activity against mouse L1210 cells after 2 days by coulter counter analysis
|
[PMID: 22405290] |
| L1210 | IC50 |
0.3 μM
Compound: 5-FU
|
Effect on L1210/0 cells in culture
Effect on L1210/0 cells in culture
|
[PMID: 2362278] |
| L1210 | IC50 |
0.33 μM
Compound: 5FU
|
Cytotoxicity against mouse L1210 cells assessed as reduction in cell number after 48 hrs by cell counting assay
Cytotoxicity against mouse L1210 cells assessed as reduction in cell number after 48 hrs by cell counting assay
|
[PMID: 24631358] |
| L1210 | IC50 |
0.33 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against mouse L1210 cells assessed as inhibition of proliferation after 48 hrs by Coulter cell counting method
Cytostatic activity against mouse L1210 cells assessed as inhibition of proliferation after 48 hrs by Coulter cell counting method
|
[PMID: 24906510] |
| L1210 | IC50 |
0.33 μM
Compound: 5-FU
|
Cytostatic activity against mouse L1210 cells after 48 hrs by Coulter counting
Cytostatic activity against mouse L1210 cells after 48 hrs by Coulter counting
|
[PMID: 25435471] |
| L1210 | IC50 |
0.33 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse L1210 cells assessed as inhibition of cell proliferation
Cytotoxicity against mouse L1210 cells assessed as inhibition of cell proliferation
|
[PMID: 26001344] |
| L1210 | IC50 |
0.33 μM
Compound: 5-Fluorouracil
|
Anti-proliferative activity against mouse L1210 cells measured after 48 hrs by coulter counter method
Anti-proliferative activity against mouse L1210 cells measured after 48 hrs by coulter counter method
|
[PMID: 27750154] |
| L1210 | IC50 |
1.0 x 10-7 M
Compound: FUra
|
Inhibition of cell growth of L1210 mouse Leukemia cells
Inhibition of cell growth of L1210 mouse Leukemia cells
|
[PMID: 2967375] |
| L1210 | IC50 |
0.32 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of mouse leukemic L1210 cell lines.
In vitro inhibitory effect on growth of mouse leukemic L1210 cell lines.
|
[PMID: 3373480] |
| L1210 | ED50 |
1.94 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against mouse L1210 cells
Cytotoxicity against mouse L1210 cells
|
[PMID: 3443857] |
| L1210 | IC50 |
5.0 x 10-7 M
Compound: FUra
|
Concentration required for the 50% inhibition of growth of L1210 mouse leukemia cells in culture
Concentration required for the 50% inhibition of growth of L1210 mouse leukemia cells in culture
|
[PMID: 7120290] |
| L1210 | IC50 |
0.12 μM
Compound: 5-fluorouracil
|
In vitro growth inhibition of L1210 cells 48 hours after administration of compound
In vitro growth inhibition of L1210 cells 48 hours after administration of compound
|
[PMID: 7629806] |
| L1210 | IC50 |
0.22 μM
Compound: 5-fluorouracil
|
In vitro growth inhibition of L1210 cells 24 hours after administration of compound
In vitro growth inhibition of L1210 cells 24 hours after administration of compound
|
[PMID: 7629806] |
| L1210 | IC50 |
0.63 μM
Compound: 5-fluorouracil
|
In vitro growth inhibition of L1210 cells 8 hours after administration of compound
In vitro growth inhibition of L1210 cells 8 hours after administration of compound
|
[PMID: 7629806] |
| L1210 | IC50 |
2.2 μM
Compound: 5-fluorouracil
|
In vitro growth inhibition of L1210 cells 2 hours after administration of compound
In vitro growth inhibition of L1210 cells 2 hours after administration of compound
|
[PMID: 7629806] |
| L1210 | IC50 |
0.36 μg/mL
Compound: 5-FU
|
Concentration at 50 percent inhibition of cell growth against mouse leukemia 1210 cell line in vitro
Concentration at 50 percent inhibition of cell growth against mouse leukemia 1210 cell line in vitro
|
10.1016/S0960-894X(01)81041-6 |
| L1210/C | IC50 |
0.2 μg/mL
Compound: 5-FU
|
The compound was evaluated for antitumoral activity against mouse leukemia cell line L1210/c after 72 hr of incubation
The compound was evaluated for antitumoral activity against mouse leukemia cell line L1210/c after 72 hr of incubation
|
10.1016/S0960-894X(01)80742-3 |
| L929 | IC50 |
1.38 μM
Compound: 5-Fu
|
Cytotoxicity against mouse L929 cells after 72 hrs by MTT assay
Cytotoxicity against mouse L929 cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| L929 | IC50 |
2.98 μM
Compound: 5-Fu
|
Antiproliferative activity against mouse L929 cells after 48 hrs by CCK8 assay
Antiproliferative activity against mouse L929 cells after 48 hrs by CCK8 assay
|
[PMID: 26786698] |
| L929 | IC50 |
>100 μM
Compound: 5-Fu
|
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation by MTT assay
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36336316] |
| Leukemia cell | GI50 |
52.5 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human leukemia cells
Cytotoxicity against human leukemia cells
|
[PMID: 17562365] |
| Leukemia cell | GI50 |
15.09 μM
Compound: 5-FU
|
Growth inhibition of human leukemia cells after 48 hrs
Growth inhibition of human leukemia cells after 48 hrs
|
[PMID: 18950904] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-fu
|
Antitumor activity against human leukemia cells after 48 hrs by SRB assay
Antitumor activity against human leukemia cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-FU
|
Cytotoxicity against human leukemia cells after 48 hrs by coulter counting
Cytotoxicity against human leukemia cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-FU
|
Growth inhibition of human leukemia cells after 48 hrs by coulter counter method
Growth inhibition of human leukemia cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-fu
|
Antiproliferative activity against human leukemia cells after 48 hrs by cell counting analysis
Antiproliferative activity against human leukemia cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-FU
|
Cytotoxicity against human leukemia cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human leukemia cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-FU
|
Cytotoxicity against human leukemia cells after 48 hrs by coulter counter analysis
Cytotoxicity against human leukemia cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Leukemia cell | GI50 |
1.51 μM
Compound: 5-FU
|
Cytotoxicity against human leukemia cells after 48 hrs by SRB assay
Cytotoxicity against human leukemia cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-FU
|
Cytotoxicity against human leukemia cells at 10 uM after 48 hrs
Cytotoxicity against human leukemia cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Leukemia cell | GI50 |
15.1 μM
Compound: 5-FU
|
Growth inhibition of human leukemia cells after 48 hrs by SRB assay
Growth inhibition of human leukemia cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| Lewis lung carcinoma cell line | IC50 |
2.59 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay
Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay
|
[PMID: 18440233] |
| Lewis lung carcinoma cell line | IC50 |
2.9 μg/mL
Compound: 5-Fu
|
Anticancer activity against mouse LL/2 cells assessed as growth inhibition after 48 hrs by MTT assay
Anticancer activity against mouse LL/2 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 25017036] |
| LFCl2A | IC50 |
28.5 μM
Compound: 5-fluoro uracil
|
In vitro cytotoxic activity against LFCl2A cell line derived from an hepatocarcinoma induced in the commentary rat by dimethylaminoazobenzene
In vitro cytotoxic activity against LFCl2A cell line derived from an hepatocarcinoma induced in the commentary rat by dimethylaminoazobenzene
|
10.1016/S0960-894X(00)80263-2 |
| LFCl2A | IC50 |
28.5 μM
Compound: 5-fluoro uracil
|
In vitro cytotoxicity against LFCl2A (rat hepatocarcinoma) cells.
In vitro cytotoxicity against LFCl2A (rat hepatocarcinoma) cells.
|
10.1016/S0960-894X(01)81055-6 |
| LNCaP | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against LNCaP cells
Tested in vitro for anticancer activity against LNCaP cells
|
[PMID: 10072683] |
| LNCaP | IC50 |
4.9 μM
Compound: 5-FU
|
Concentration required to inhibit proliferation of LNCaP prostate cancer cell lines
Concentration required to inhibit proliferation of LNCaP prostate cancer cell lines
|
[PMID: 15341952] |
| LNCaP | IC50 |
4.9 μM
Compound: 5-FU
|
Antiproliferative activity was evaluated against human prostate LNCaP cancer cell lines using the sulforhodamine B (STB) assay
Antiproliferative activity was evaluated against human prostate LNCaP cancer cell lines using the sulforhodamine B (STB) assay
|
[PMID: 15454213] |
| LNCaP | IC50 |
4.9 μM
Compound: 5-FU
|
Antiproliferative activity against prostate cancer LNCaP Cell line using sulforhodamine B(SRB) assay
Antiproliferative activity against prostate cancer LNCaP Cell line using sulforhodamine B(SRB) assay
|
[PMID: 15801848] |
| LNCaP | IC50 |
4.9 μM
Compound: 5-FU
|
Antiproliferative activity against human prostate cancer LNCaP cell line by sulforhodamine B assay
Antiproliferative activity against human prostate cancer LNCaP cell line by sulforhodamine B assay
|
[PMID: 16005217] |
| LNCaP | IC50 |
0.03 μM
Compound: 5-FU
|
Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay
Cytotoxicity against human LNCAP cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay
|
[PMID: 27156770] |
| LNCaP | IC50 |
47.18 μM
Compound: F
|
Cytotoxicity against human LNCAP cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human LNCAP cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 27210438] |
| LNCaP | IC50 |
5.21 μM
Compound: 5-FU
|
Antiproliferative activity against human LNCAP cells after 48 hrs by MTT assay
Antiproliferative activity against human LNCAP cells after 48 hrs by MTT assay
|
[PMID: 28666860] |
| LNCaP | IC50 |
7.93 μM
Compound: 5-Fu
|
Antiproliferative activity against human LNCaP cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antiproliferative activity against human LNCaP cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36931124] |
| LNCaP C4-2B | IC50 |
5.64 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human C4-2B cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
Antiproliferative activity against human C4-2B cells assessed as inhibition of cell viability after 48 hrs by MTT reduction assay
|
[PMID: 27295506] |
| LNCaP C4-2B | IC50 |
38.2 μM
Compound: 5-FU
|
Antiproliferative activity against human C4-2B cells after 48 hrs by MTT assay
Antiproliferative activity against human C4-2B cells after 48 hrs by MTT assay
|
[PMID: 30108895] |
| LoVo | IC50 |
3.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human LoVo cells after 48 hrs by MTT assay
Antiproliferative activity against human LoVo cells after 48 hrs by MTT assay
|
[PMID: 22840493] |
| LoVo | IC50 |
12.7 μM
Compound: 5-Fu
|
Antiproliferative activity against human LoVo cells assessed as cell-growth inhibition after 48 hrs by MTT assay
Antiproliferative activity against human LoVo cells assessed as cell-growth inhibition after 48 hrs by MTT assay
|
[PMID: 25453794] |
| LoVo | IC50 |
4.69 μM
Compound: FUra
|
Antiproliferative activity against human LoVo cells assessed as growth inhibition after 72 hrs by SRB method
Antiproliferative activity against human LoVo cells assessed as growth inhibition after 72 hrs by SRB method
|
[PMID: 25644674] |
| LoVo | IC50 |
11.5 μM
Compound: 5-FU
|
Growth inhibition of human LoVo cells after 48 hrs by CCK-8 assay
Growth inhibition of human LoVo cells after 48 hrs by CCK-8 assay
|
[PMID: 30106289] |
| LoVo | IC50 |
2.7 μM
Compound: 5-FU
|
Antiproliferative activity against human LoVo cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human LoVo cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32127259] |
| LoVo | IC50 |
8.35 μM
Compound: 5-FU
|
Antitumor activity against human LoVo cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human LoVo cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 35777102] |
| LoVo | IC50 |
12.6 μM
Compound: 5-FU
|
Anticancer activity against human LoVo cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human LoVo cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| LoVo | IC50 |
9.89 μM
Compound: 5-Fu
|
Cytotoxicity against human LoVo cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human LoVo cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| LOX IMVI | GI50 |
0.24 μM
Compound: 5-FU
|
Growth inhibition of human LOXIMVI cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human LOXIMVI cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| LS-1034 | IC50 |
0.11 μM
Compound: 5-FU
|
Inhibition of human LS1034 cell spheroids incubated for 7 days by luciferase based assay
Inhibition of human LS1034 cell spheroids incubated for 7 days by luciferase based assay
|
[PMID: 36780832] |
| LS180 | IC50 |
38.92 μM
Compound: FUra
|
Antiproliferative activity against human LS180 cells assessed as growth inhibition after 72 hrs by SRB method
Antiproliferative activity against human LS180 cells assessed as growth inhibition after 72 hrs by SRB method
|
[PMID: 25644674] |
| LS180 | IC50 |
3.4 μM
Compound: 5-Fu
|
Cytotoxicity against human LS180 cells assessed as cell inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human LS180 cells assessed as cell inhibition measured after 72 hrs by MTT assay
|
[PMID: 36774698] |
| LS-513 | IC50 |
84 μM
Compound: 5-FU
|
Cytotoxicity against human LS-513 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
Cytotoxicity against human LS-513 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
|
[PMID: 38536967] |
| LX-2 | IC50 |
0.178 μM
Compound: 5-FU
|
Antiproliferative activity against human LX2 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against human LX2 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 38626522] |
| M14 | GI50 |
22.4 μM
Compound: 5FU
|
Cytotoxicity against human M14 cells after 48 hrs
Cytotoxicity against human M14 cells after 48 hrs
|
[PMID: 18798609] |
| M14 | GI50 |
32.4 μM
Compound: 5FU
|
Cytotoxicity against human M14 cells
Cytotoxicity against human M14 cells
|
[PMID: 20356752] |
| M14 | GI50 |
0.98 μM
Compound: 5-FU
|
Growth inhibition of human M14 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human M14 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| M14 | GI50 |
0.7 μg/mL
Compound: 5FU
|
Cytotoxicity against human M14 cells assessed as growth inhibition after 48 hrs by SRB assay method
Cytotoxicity against human M14 cells assessed as growth inhibition after 48 hrs by SRB assay method
|
[PMID: 26383125] |
| M14 | GI50 |
0.98 μM
Compound: 5-FU
|
Anticancer activity against human M14 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human M14 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| M14 | IC50 |
0.98 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human M14 cells assessed as cell growth inhibition
Cytotoxicity against human M14 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| Mahlavu | IC50 |
10 μM
Compound: 5-Fu
|
Cytotoxicity against human Mahlavu cells after 72 hrs by SRB assay
Cytotoxicity against human Mahlavu cells after 72 hrs by SRB assay
|
[PMID: 22409771] |
| Mahlavu | IC50 |
10 μM
Compound: 5-FU
|
Antiproliferative activity against human Mahlavu cells after 72 hrs by SRB assay
Antiproliferative activity against human Mahlavu cells after 72 hrs by SRB assay
|
[PMID: 29326016] |
| Malme-3M | GI50 |
0.05 μM
Compound: 5-FU
|
Growth inhibition of human MALME-3M cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human MALME-3M cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| Malme-3M | GI50 |
0.05 μM
Compound: 5-FU
|
Anticancer activity against human Malme-3M cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human Malme-3M cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| Malme-3M | IC50 |
0.05 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human Malme-3M cells assessed as cell growth inhibition
Cytotoxicity against human Malme-3M cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| MCF-10A | IC50 |
0.73 μM
Compound: 5-FU
|
Cytotoxicity against human MCF10A cells after 6 days by SRB colorimetric assay
Cytotoxicity against human MCF10A cells after 6 days by SRB colorimetric assay
|
[PMID: 21684047] |
| MCF-10A | IC50 |
8.06 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF10A cells after 3 days by SRB assay
Cytotoxicity against human MCF10A cells after 3 days by SRB assay
|
[PMID: 24704691] |
| MCF-10A | IC50 |
>20 μM
Compound: 5-FU
|
Cytotoxicity against human MCF10A cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human MCF10A cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 30472605] |
| MCF-10A | IC50 |
39.7 μM
Compound: 5-FU
|
Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33166925] |
| MCF-10A | IC50 |
17.2 μM
Compound: 5-FU
|
Antiproliferation activity against human MCF-10A cells assessed as reduction in cell viability under hypoxic conditions by MTT assay
Antiproliferation activity against human MCF-10A cells assessed as reduction in cell viability under hypoxic conditions by MTT assay
|
[PMID: 33965860] |
| MCF-10A | IC50 |
>20 μM
Compound: 5-FU
|
Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human MCF-10A cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| MCF-10A | IC50 |
19.5 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF-10A cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human MCF-10A cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 38897138] |
| MCF-10A | IC50 |
5.09 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF-10A cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF-10A cells incubated for 72 hrs by SRB assay
|
[PMID: 39054645] |
| MCF7 | IC50 |
41 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against MCF-7 cells
Tested in vitro for anticancer activity against MCF-7 cells
|
[PMID: 10072683] |
| MCF7 | IC50 |
4.8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity in MCF-7 human breast cancer cells
Antiproliferative activity in MCF-7 human breast cancer cells
|
[PMID: 15658875] |
| MCF7 | IC50 |
0.12 x 10-2 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 16038565] |
| MCF7 | ED50 |
0.2 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 16309328] |
| MCF7 | IC50 |
1.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells by MTT microassay
Cytotoxicity against human MCF7 cells by MTT microassay
|
[PMID: 17320246] |
| MCF7 | IC50 |
4.8 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells after 72 hrs
Cytotoxicity against human MCF7 cells after 72 hrs
|
[PMID: 17336074] |
| MCF7 | CC50 |
768.8 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs
Cytotoxicity against human MCF7 cells after 72 hrs
|
[PMID: 17337193] |
| MCF7 | CC50 |
768.8 μM
Compound: 5FU
|
Cytotoxicity against human MCF7 cells after 72 hrs
Cytotoxicity against human MCF7 cells after 72 hrs
|
[PMID: 17548129] |
| MCF7 | IC50 |
0.3 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs
Antiproliferative activity against human MCF7 cells after 72 hrs
|
[PMID: 17548198] |
| MCF7 | CC50 |
5 μM
Compound: 5-Fu
|
Tumor selectivity index, ratio of CC50 for human H4 cells to CC50 for human MCF7 cells
Tumor selectivity index, ratio of CC50 for human H4 cells to CC50 for human MCF7 cells
|
[PMID: 18037195] |
| MCF7 | CC50 |
768.8 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs
Cytotoxicity against human MCF7 cells after 72 hrs
|
[PMID: 18037195] |
| MCF7 | IC50 |
4.32 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 3 days by SRB assay
Antiproliferative activity against human MCF7 cells after 3 days by SRB assay
|
[PMID: 18069093] |
| MCF7 | IC50 |
4.32 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells
Antiproliferative activity against human MCF7 cells
|
[PMID: 18194866] |
| MCF7 | IC50 |
4.5 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 3 days by MTT assay
Antiproliferative activity against human MCF7 cells after 3 days by MTT assay
|
[PMID: 18424155] |
| MCF7 | IC50 |
26.67 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against human MCF7 cells expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| MCF7 | IC50 |
1.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 18606546] |
| MCF7 | IC50 |
15 μM
Compound: 5-FU
|
Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
Growth inhibition of human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 18640746] |
| MCF7 | GI50 |
6.5 μM
Compound: 5FU
|
Cytotoxicity against human MCF7 cells after 48 hrs
Cytotoxicity against human MCF7 cells after 48 hrs
|
[PMID: 18798609] |
| MCF7 | IC50 |
4.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 after 72 hrs by MTT assay
Cytotoxicity against human MCF7 after 72 hrs by MTT assay
|
[PMID: 19233650] |
| MCF7 | GI50 |
>10 μM
Compound: 5-Fu
|
Growth inhibition of human MCF7 cells after 72 hrs by Alamar Blue assay
Growth inhibition of human MCF7 cells after 72 hrs by Alamar Blue assay
|
[PMID: 19406645] |
| MCF7 | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 19560842] |
| MCF7 | GI50 |
15 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 19572613] |
| MCF7 | IC50 |
15 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 19618920] |
| MCF7 | IC50 |
0.3 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| MCF7 | IC50 |
15 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 19795843] |
| MCF7 | IC50 |
15 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 19919065] |
| MCF7 | IC50 |
0.67 μg/mL
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
|
[PMID: 19932530] |
| MCF7 | IC50 |
15 μM
Compound: 5-FU
|
Antitumor activity against human MCF7 cells after 24 hrs by MTT assay
Antitumor activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 20211564] |
| MCF7 | GI50 |
4.5 μM
Compound: 5FU
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 20356752] |
| MCF7 | IC50 |
15.2 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 24 hrs by trypan blue exclusion assay
Antiproliferative activity against human MCF7 cells after 24 hrs by trypan blue exclusion assay
|
[PMID: 20403701] |
| MCF7 | GI50 |
8.3 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 48 hrs by SRB assay
Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 48 hrs by SRB assay
|
[PMID: 20438092] |
| MCF7 | IC50 |
64 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells expressing p53 after 72 hrs by celltiter-glo assay
Antiproliferative activity against human MCF7 cells expressing p53 after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| MCF7 | IC50 |
34 μg/mL
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 36 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 36 hrs by MTT assay
|
[PMID: 20961091] |
| MCF7 | IC50 |
14.1 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 21109433] |
| MCF7 | IC50 |
4.32 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells expressing wild type p53 and ras mutant after 3 days by SRB assay
Cytotoxicity against human MCF7 cells expressing wild type p53 and ras mutant after 3 days by SRB assay
|
[PMID: 21126804] |
| MCF7 | IC50 |
2.3 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as loss of cell monolayers after 96 hrs
Cytotoxicity against human MCF7 cells assessed as loss of cell monolayers after 96 hrs
|
[PMID: 21130542] |
| MCF7 | IC50 |
15.2 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 3 days by MTT assay
Cytotoxicity against human MCF7 cells after 3 days by MTT assay
|
[PMID: 21144621] |
| MCF7 | IC50 |
9.6 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs
|
[PMID: 21295381] |
| MCF7 | IC50 |
7.54 μM
Compound: 5-Fu
|
Antitumor activity against human MCF7 cells after 72 hrs by MTT assay
Antitumor activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 21486694] |
| MCF7 | GI50 |
2.8 μM
Compound: 5FU
|
Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| MCF7 | IC50 |
42.01 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 21524829] |
| MCF7 | IC50 |
15 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by resazurin reduction test
Antiproliferative activity against human MCF7 cells after 48 hrs by resazurin reduction test
|
[PMID: 21530016] |
| MCF7 | IC50 |
4.32 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 6 days by SRB colorimetric assay
Cytotoxicity against human MCF7 cells after 6 days by SRB colorimetric assay
|
[PMID: 21684047] |
| MCF7 | IC50 |
31 μM
Compound: Fluorouracil
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 21774474] |
| MCF7 | IC50 |
2.2 x 10-1 μg/mL
Compound: fluorouracil
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 22011319] |
| MCF7 | IC50 |
9.67 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 22079378] |
| MCF7 | IC50 |
14 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 22130132] |
| MCF7 | IC50 |
0.67 μg/mL
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 22154835] |
| MCF7 | IC50 |
2.3 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
|
[PMID: 22204901] |
| MCF7 | IC50 |
31 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 22283451] |
| MCF7 | IC50 |
35 μM
Compound: 5-fu
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 22304344] |
| MCF7 | IC50 |
15 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human MCF7 cells after 72 hrs by MTT assay
Cytostatic activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 22405290] |
| MCF7 | IC50 |
3.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
|
[PMID: 22409771] |
| MCF7 | IC50 |
4.7 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 144 hrs by crystal violet staining method
Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 144 hrs by crystal violet staining method
|
[PMID: 22450132] |
| MCF7 | GI50 |
9.9 μM
Compound: 5-Fu
|
Growth inhibition of human MCF7 cells after 48 hrs by SRB assay
Growth inhibition of human MCF7 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| MCF7 | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 22537362] |
| MCF7 | IC50 |
66.91 μM
Compound: 5-Fluoruracil
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 22555152] |
| MCF7 | IC50 |
12.5 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 22727445] |
| MCF7 | IC50 |
14.2 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 22749192] |
| MCF7 | IC50 |
4.7 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by crystal violet staining method
Antiproliferative activity against human MCF7 cells after 72 hrs by crystal violet staining method
|
[PMID: 22765897] |
| MCF7 | IC50 |
0.69 mg/mL
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 3 days MTT assay
Cytotoxicity against human MCF7 cells after 3 days MTT assay
|
[PMID: 22796042] |
| MCF7 | IC50 |
24.58 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 22801644] |
| MCF7 | IC50 |
16.2 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 22840493] |
| MCF7 | IC50 |
3.5 μM
Compound: 5FU
|
Cytotoxicity against human MCF7 cells incubated for 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| MCF7 | IC50 |
4.7 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by crystal violet staining
Cytotoxicity against human MCF7 cells after 72 hrs by crystal violet staining
|
[PMID: 22959205] |
| MCF7 | IC50 |
2.5 μg/mL
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
|
[PMID: 23022735] |
| MCF7 | IC50 |
78.6 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23067549] |
| MCF7 | GI50 |
14.5 nM
Compound: 5FU
|
Growth inhibition of human MCF7 cells after 48 hrs by SRB assay
Growth inhibition of human MCF7 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| MCF7 | IC50 |
17.2 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 23279864] |
| MCF7 | IC50 |
>100 μM
Compound: 5-FU
|
Antitumor activity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
Antitumor activity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 23313635] |
| MCF7 | IC50 |
7.54 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 23353743] |
| MCF7 | IC50 |
16.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23490159] |
| MCF7 | IC50 |
11.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| MCF7 | IC50 |
7.33 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 23644193] |
| MCF7 | IC50 |
32.18 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 23665106] |
| MCF7 | IC50 |
10.14 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 23685571] |
| MCF7 | IC50 |
3.6 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 23792763] |
| MCF7 | IC50 |
7.54 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 23792764] |
| MCF7 | IC50 |
5 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23800391] |
| MCF7 | IC50 |
6.53 μM
Compound: FUra
|
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
|
[PMID: 23867603] |
| MCF7 | GI50 |
0.07 μM
Compound: 5-FU
|
Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| MCF7 | IC50 |
11.5 μM
Compound: 5-Fu
|
Growth inhibition against human MCF7 cells after 48 hrs by MTT assay
Growth inhibition against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| MCF7 | IC50 |
1.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 24060486] |
| MCF7 | IC50 |
7.54 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 24077182] |
| MCF7 | IC50 |
9.79 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 24286761] |
| MCF7 | IC50 |
3.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 24332497] |
| MCF7 | IC50 |
1.8 μM
Compound: 5-Fluoro uracilc
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 24641975] |
| MCF7 | IC50 |
2.86 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 3 days by SRB assay
Cytotoxicity against human MCF7 cells after 3 days by SRB assay
|
[PMID: 24704691] |
| MCF7 | IC50 |
11.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 2 days by MTT assay
Cytotoxicity against human MCF7 cells after 2 days by MTT assay
|
[PMID: 24767839] |
| MCF7 | IC50 |
7.76 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 24798098] |
| MCF7 | IC50 |
7.08 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 24819956] |
| MCF7 | IC50 |
1.4 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 24835633] |
| MCF7 | IC50 |
3.52 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 24835817] |
| MCF7 | IC50 |
7.12 μM
Compound: 5-Fu
|
Anticancer activity against human MCF7 cells after 72 hrs by MTT assay
Anticancer activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 25001482] |
| MCF7 | IC50 |
39.88 μM
Compound: Fluorouracil
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 25016234] |
| MCF7 | IC50 |
12.1 μg/mL
Compound: 5-Fu
|
Anticancer activity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 25017036] |
| MCF7 | IC50 |
4.6 μM
Compound: 5-Fu
|
Anticancer activity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 25086915] |
| MCF7 | IC50 |
8.93 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25180925] |
| MCF7 | IC50 |
14.26 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation by CCK8 assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation by CCK8 assay
|
[PMID: 25442303] |
| MCF7 | IC50 |
16.3 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
|
[PMID: 25453794] |
| MCF7 | IC50 |
26.9 μM
Compound: 5-Fu
|
Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
Anticancer activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 25462264] |
| MCF7 | IC50 |
34.48 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by WST-1 assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by WST-1 assay
|
[PMID: 25466196] |
| MCF7 | IC50 |
9.12 μM
Compound: 5-Fu
|
Anticancer activity against human MCF7 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25655718] |
| MCF7 | IC50 |
12.24 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 25707012] |
| MCF7 | IC50 |
9.56 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
|
[PMID: 25959813] |
| MCF7 | IC50 |
2.36 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080] |
| MCF7 | IC50 |
11.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as induction of cell death incubated for 2 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as induction of cell death incubated for 2 days by MTT assay
|
[PMID: 26259802] |
| MCF7 | IC50 |
5.012 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 26301558] |
| MCF7 | IC50 |
19.39 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 26363869] |
| MCF7 | GI50 |
0.3 μg/mL
Compound: 5FU
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay method
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay method
|
[PMID: 26383125] |
| MCF7 | IC50 |
0.09 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 26617970] |
| MCF7 | IC50 |
32.18 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTS assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTS assay
|
[PMID: 26703795] |
| MCF7 | IC50 |
5.2 x 10-1 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by CCK8 assay
Cytotoxicity against human MCF7 cells after 72 hrs by CCK8 assay
|
[PMID: 26725029] |
| MCF7 | IC50 |
5.2 x 10-7 M
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by CCK8 assay
Cytotoxicity against human MCF7 cells after 72 hrs by CCK8 assay
|
[PMID: 26725029] |
| MCF7 | IC50 |
0.9 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
Antiproliferative activity against human MCF7 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
|
[PMID: 26731300] |
| MCF7 | IC50 |
2 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 26854375] |
| MCF7 | IC50 |
42.78 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 26883148] |
| MCF7 | IC50 |
26.14 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 26922223] |
| MCF7 | IC50 |
222.6 μM
Compound: 5-Fuorouracil
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 27017265] |
| MCF7 | IC50 |
6.53 μM
Compound: FUra
|
Cytotoxicity against human MCF7cells after 72 hrs by SRB assay
Cytotoxicity against human MCF7cells after 72 hrs by SRB assay
|
[PMID: 27073055] |
| MCF7 | IC50 |
7.61 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27105028] |
| MCF7 | IC50 |
30.41 μM
Compound: Fluorouracil
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 27128180] |
| MCF7 | IC50 |
13.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 27133593] |
| MCF7 | IC50 |
11.5 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 27189676] |
| MCF7 | IC50 |
32.27 μM
Compound: F
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 27210438] |
| MCF7 | IC50 |
11.1 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell survivability after 24 hrs by crystal violet staining based microscopic analysis
Cytotoxicity against human MCF7 cells assessed as cell survivability after 24 hrs by crystal violet staining based microscopic analysis
|
[PMID: 27234893] |
| MCF7 | IC50 |
10.8 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27262600] |
| MCF7 | IC50 |
71.49 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| MCF7 | IC50 |
3 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 27343853] |
| MCF7 | IC50 |
32.18 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 27400887] |
| MCF7 | IC50 |
15 μM
Compound: 5 Fluorouracil
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212] |
| MCF7 | IC50 |
6.53 μM
Compound: FUra
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
|
[PMID: 27501415] |
| MCF7 | GI50 |
3.6 μM
Compound: 5-FU
|
Growth inhibition of human MCF7 cells measured after 72 hrs by MTT assay
Growth inhibition of human MCF7 cells measured after 72 hrs by MTT assay
|
[PMID: 27504537] |
| MCF7 | IC50 |
1.9 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 27528432] |
| MCF7 | IC50 |
32.18 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTS assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTS assay
|
[PMID: 27575478] |
| MCF7 | IC50 |
4.8 μg/mL
Compound: 5-flourouracil
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27597407] |
| MCF7 | IC50 |
13.19 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by CCK8 assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by CCK8 assay
|
[PMID: 27597411] |
| MCF7 | GI50 |
4.5 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 27688184] |
| MCF7 | IC50 |
9.25 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 27771599] |
| MCF7 | IC50 |
7.12 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 27987485] |
| MCF7 | IC50 |
42.78 μM
Compound: 5FU
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
|
[PMID: 28038327] |
| MCF7 | IC50 |
19.2 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 28073676] |
| MCF7 | IC50 |
26.14 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 28110871] |
| MCF7 | IC50 |
78.28 μM
Compound: 5-FU
|
Growth inhibition of human MCF7 cells after 48 hrs by WST1 assay
Growth inhibition of human MCF7 cells after 48 hrs by WST1 assay
|
[PMID: 28126436] |
| MCF7 | IC50 |
1.75 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 28165738] |
| MCF7 | IC50 |
1.4 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by SRB assay
|
[PMID: 28219046] |
| MCF7 | IC50 |
0.0415 mM
Compound: 5-Fluorouracil
|
Cytotoxicity in human MCF7 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity in human MCF7 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 28334654] |
| MCF7 | IC50 |
30 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 28371676] |
| MCF7 | IC50 |
7.67 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells incubated for 48 to 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells incubated for 48 to 72 hrs by MTT assay
|
[PMID: 28395218] |
| MCF7 | GI50 |
1.67 μM
Compound: 5-FU
|
Growth inhibition of human MCF7 cells after 48 hrs by SRB assay
Growth inhibition of human MCF7 cells after 48 hrs by SRB assay
|
[PMID: 28400235] |
| MCF7 | IC50 |
7.9 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 28431341] |
| MCF7 | IC50 |
28.73 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 28458133] |
| MCF7 | IC50 |
5.6 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
|
[PMID: 28558970] |
| MCF7 | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 28623814] |
| MCF7 | IC50 |
3.18 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 28666860] |
| MCF7 | IC50 |
38.5 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 28756264] |
| MCF7 | IC50 |
7.21 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 28759876] |
| MCF7 | IC50 |
5.2 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 28759877] |
| MCF7 | IC50 |
5.7 μM
Compound: 5-Fluorouracil
|
Antitumor activity against human MCF7 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
Antitumor activity against human MCF7 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
|
[PMID: 28926764] |
| MCF7 | IC50 |
14.7 μM
Compound: 5-Fu
|
Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 28987604] |
| MCF7 | IC50 |
2.19 μg/mL
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 29100732] |
| MCF7 | IC50 |
10.2 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133037] |
| MCF7 | IC50 |
10.6 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
|
[PMID: 29133037] |
| MCF7 | IC50 |
28.97 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 29174813] |
| MCF7 | IC50 |
178 μg/mL
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 29207336] |
| MCF7 | IC50 |
2.35 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 29223098] |
| MCF7 | IC50 |
32.626 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 29223717] |
| MCF7 | IC50 |
6.11 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 29254641] |
| MCF7 | IC50 |
3 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
|
[PMID: 29326016] |
| MCF7 | IC50 |
18.75 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 29475156] |
| MCF7 | IC50 |
15.78 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 29486954] |
| MCF7 | IC50 |
26.91 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 29635169] |
| MCF7 | IC50 |
16.7 μM
Compound: 5-FU
|
Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 29657100] |
| MCF7 | IC50 |
2.3 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 96 hrs
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 96 hrs
|
[PMID: 29673982] |
| MCF7 | IC50 |
1.8 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells by MTT assay
Antiproliferative activity against human MCF7 cells by MTT assay
|
[PMID: 29798826] |
| MCF7 | IC50 |
63 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 72 hrs by MTT assay
|
[PMID: 29908443] |
| MCF7 | IC50 |
29.4 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 30108895] |
| MCF7 | IC50 |
57.09 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 30108924] |
| MCF7 | IC50 |
1.4 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
|
[PMID: 30108969] |
| MCF7 | IC50 |
26.14 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 30142612] |
| MCF7 | IC50 |
27.89 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 30243153] |
| MCF7 | IC50 |
7.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 3 days by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells after 3 days by sulforhodamine B assay
|
[PMID: 30248657] |
| MCF7 | IC50 |
32.18 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 30472605] |
| MCF7 | IC50 |
22.6 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 30527868] |
| MCF7 | IC50 |
29.41 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 30568759] |
| MCF7 | IC50 |
26.57 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| MCF7 | IC50 |
26.34 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30709651] |
| MCF7 | IC50 |
16.28 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 30981113] |
| MCF7 | IC50 |
57 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 31057737] |
| MCF7 | IC50 |
136.5 μM
Compound: 5-FU
|
Cytotoxicity in human MCF-7 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
Cytotoxicity in human MCF-7 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 31128448] |
| MCF7 | IC50 |
9.74 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 31200236] |
| MCF7 | IC50 |
5.4 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 31276896] |
| MCF7 | IC50 |
41.51 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 31401008] |
| MCF7 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
Cytotoxicity against human MCF7 cells assessed as increase in growth inhibition by measuring decrease in cell viability incubated for 72 hrs and measured after 2 hrs by microplate reader based WST-1 assay
|
[PMID: 31416740] |
| MCF7 | IC50 |
3.2 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 31471102] |
| MCF7 | IC50 |
31.04 μM
Compound: 5-Fu
|
Anticancer activity against human MCF7 cells overexpressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
Anticancer activity against human MCF7 cells overexpressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31509699] |
| MCF7 | IC50 |
30 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells by MTT assay
Antiproliferative activity against human MCF7 cells by MTT assay
|
[PMID: 31546197] |
| MCF7 | IC50 |
7.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31546197] |
| MCF7 | IC50 |
17.11 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 31577977] |
| MCF7 | IC50 |
52.07 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| MCF7 | IC50 |
5.5 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 31761383] |
| MCF7 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against drug-resistant TCCD-induced human MCF7 cells overexpressing CYP1B1 assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against drug-resistant TCCD-induced human MCF7 cells overexpressing CYP1B1 assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31803401] |
| MCF7 | IC50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31803401] |
| MCF7 | IC50 |
26.65 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31877536] |
| MCF7 | IC50 |
26.65 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth after 72 hrs by MTT assay
|
[PMID: 31883693] |
| MCF7 | IC50 |
5.5 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 31926469] |
| MCF7 | IC50 |
>40 μM
Compound: 5-fluorouracil
|
Anticancer activity against human MCF7 cells
Anticancer activity against human MCF7 cells
|
[PMID: 31945642] |
| MCF7 | IC50 |
16.27 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
|
[PMID: 32135407] |
| MCF7 | IC50 |
3.15 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay
|
[PMID: 32311607] |
| MCF7 | IC50 |
0.59 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF-7 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antiproliferative activity against human MCF-7 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 32485532] |
| MCF7 | IC50 |
4.55 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
|
[PMID: 32619887] |
| MCF7 | IC50 |
4.76 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 32682202] |
| MCF7 | IC50 |
30 μg/mL
Compound: 5-FU
|
Anticancer activity against human MCF7 cells
Anticancer activity against human MCF7 cells
|
[PMID: 32795767] |
| MCF7 | IC50 |
10.4 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 32987314] |
| MCF7 | IC50 |
12.6 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 32987314] |
| MCF7 | IC50 |
8.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 32987314] |
| MCF7 | IC50 |
5.8 μM
Compound: 5-FU
|
Cytotoxicity against ERalpha-dependent human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against ERalpha-dependent human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33166925] |
| MCF7 | IC50 |
13.16 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| MCF7 | IC50 |
5.32 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33385852] |
| MCF7 | IC50 |
78.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MCF7 cells by MTT reduction assay
Antiproliferative activity against human MCF7 cells by MTT reduction assay
|
[PMID: 33421712] |
| MCF7 | IC50 |
18.58 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 33740546] |
| MCF7 | IC50 |
12.3 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
|
[PMID: 33799070] |
| MCF7 | IC50 |
20.09 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 33894490] |
| MCF7 | IC50 |
12.5 μM
Compound: 5-FU
|
Antiproliferation activity against human MCF7 cells assessed as reduction in cell viability under hypoxic conditions by MTT assay
Antiproliferation activity against human MCF7 cells assessed as reduction in cell viability under hypoxic conditions by MTT assay
|
[PMID: 33965860] |
| MCF7 | IC50 |
1.7 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 34000484] |
| MCF7 | IC50 |
22.439 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 34000485] |
| MCF7 | IC50 |
2.13 μM
Compound: 5-Fluorouracil
|
Cytotoxicity activity against human MCF7 cells incubated for 48 hrs by SRB assay
Cytotoxicity activity against human MCF7 cells incubated for 48 hrs by SRB assay
|
[PMID: 34119830] |
| MCF7 | IC50 |
18.13 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 34157389] |
| MCF7 | IC50 |
5.44 μM
Compound: 5-Fu
|
Antiproliferation activity against human MCF-7 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
Antiproliferation activity against human MCF-7 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
|
[PMID: 34186178] |
| MCF7 | IC50 |
8.77 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 34302974] |
| MCF7 | IC50 |
>200 μM
Compound: 5-FLU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 34606997] |
| MCF7 | IC50 |
166 μM
Compound: 5-FLU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 34606997] |
| MCF7 | IC50 |
9.49 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 34624825] |
| MCF7 | IC50 |
2.46 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| MCF7 | IC50 |
2.2 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells measured after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells measured after 24 hrs by MTT assay
|
[PMID: 34875389] |
| MCF7 | IC50 |
22.8 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 34883453] |
| MCF7 | GI50 |
0.07 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| MCF7 | IC50 |
15.14 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 35259487] |
| MCF7 | IC50 |
10.92 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
|
[PMID: 35290844] |
| MCF7 | IC50 |
29.5 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells incubated for 72 hrs by MTT assay
Anticancer activity against human MCF7 cells incubated for 72 hrs by MTT assay
|
[PMID: 35367708] |
| MCF7 | IC50 |
16.32 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth by SRB assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth by SRB assay
|
[PMID: 35594653] |
| MCF7 | IC50 |
8.41 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 35609396] |
| MCF7 | IC50 |
21.11 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35635947] |
| MCF7 | IC50 |
5.4 μM
Compound: 5-Fu
|
Anticancer activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35694689] |
| MCF7 | IC50 |
7.42 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
|
[PMID: 35797896] |
| MCF7 | IC50 |
48.45 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition
|
[PMID: 35809817] |
| MCF7 | IC50 |
21.06 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
|
[PMID: 36089111] |
| MCF7 | IC50 |
5.05 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 36242987] |
| MCF7 | IC50 |
4.42 μM
Compound: 5-FU
|
Antitumor activity against human MCF7 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
Antitumor activity against human MCF7 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
|
[PMID: 36324491] |
| MCF7 | IC50 |
>20 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| MCF7 | IC50 |
0.07 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| MCF7 | IC50 |
45.04 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells assessed as cell growth inhibition by MTT assay
Anticancer activity against human MCF7 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 36481599] |
| MCF7 | IC50 |
45.04 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 36481599] |
| MCF7 | IC50 |
78.28 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells assessed as cell growth inhibition measured after 48 hrs by WST-1 assay
Anticancer activity against human MCF7 cells assessed as cell growth inhibition measured after 48 hrs by WST-1 assay
|
[PMID: 36481599] |
| MCF7 | IC50 |
78.28 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
|
[PMID: 36543034] |
| MCF7 | IC50 |
0.235 μM
Compound: 5-FU
|
Anticancer activity against human MCF7 cells incubated for 72 hrs by MTT assay
Anticancer activity against human MCF7 cells incubated for 72 hrs by MTT assay
|
[PMID: 36921275] |
| MCF7 | IC50 |
15.14 μM
Compound: 5-Fu
|
Antitumor activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36931124] |
| MCF7 | IC50 |
24.5 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 37098306] |
| MCF7 | IC50 |
24.78 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 37343499] |
| MCF7 | IC50 |
12.23 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells measured after 72 hrs by MTT assay
|
[PMID: 37379957] |
| MCF7 | IC50 |
5.167 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT reagent based ELISA
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT reagent based ELISA
|
[PMID: 37556946] |
| MCF7 | IC50 |
10 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 37859725] |
| MCF7 | IC50 |
25.44 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 37859725] |
| MCF7 | IC50 |
>50 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells by CCK8 assay
Antiproliferative activity against human MCF7 cells by CCK8 assay
|
[PMID: 37939862] |
| MCF7 | IC50 |
15.22 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 38107169] |
| MCF7 | IC50 |
3.5 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
|
[PMID: 38107180] |
| MCF7 | IC50 |
35.32 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 48 hrs by Alamar blue dye based assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 48 hrs by Alamar blue dye based assay
|
[PMID: 38171252] |
| MCF7 | IC50 |
6.51 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 38626522] |
| MCF7 | IC50 |
23.9 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112] |
| MCF7 | IC50 |
3.5 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
Cytotoxicity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by SRB assay
|
[PMID: 38688437] |
| MCF7 | IC50 |
11.62 μM
Compound: 5-FU
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 39016216] |
| MCF7 | IC50 |
11 μM
Compound: 5-Fu
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 39106494] |
| MCF7 | IC50 |
2.9 μM
Compound: 5-Fu
|
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
|
10.1007/s00044-010-9500-5 |
| MCF7 | IC50 |
0.0052 mM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) MCF7 cells assessed as growth inhibition after 72 hr by MTT assay
Cytotoxicity against Homo sapiens (human) MCF7 cells assessed as growth inhibition after 72 hr by MTT assay
|
10.1007/s00044-012-0181-0 |
| MCF7 | IC50 |
0.02 mM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) MCF7 cells assessed as inhibition of cell survival after 96 hr
Cytotoxicity against Homo sapiens (human) MCF7 cells assessed as inhibition of cell survival after 96 hr
|
10.1007/s00044-012-0201-0 |
| MCF7 | IC50 |
1.25 μM
Compound: 5-Florouracil
|
Anticancer activity against Homo sapiens (human) MCF7 cells assessed as inhibition of cell proliferation after 24 hr by MTT assay
Anticancer activity against Homo sapiens (human) MCF7 cells assessed as inhibition of cell proliferation after 24 hr by MTT assay
|
10.1007/s00044-012-0260-2 |
| MCF7 | GI50 |
8.4 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
|
10.1007/s00044-013-0798-7 |
| MCF7 | IC50 |
13.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
10.1039/C5MD00240K |
| MCF7 | IC50 |
21.47 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
10.1039/C6MD00061D |
| MCF7 | IC50 |
79.3 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
10.1039/C6MD00234J |
| MCF7 | IC50 |
4.32 μM
Compound: 5-FU
|
Antiproliferative activity in human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity in human MCF7 cells after 72 hrs by MTT assay
|
10.1039/C6MD00252H |
| MDA-MB-231 | IC50 |
9.6 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs
Cytotoxicity against human MDA-MB-231 cells after 72 hrs
|
[PMID: 17336074] |
| MDA-MB-231 | IC50 |
3.5 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA231 cells after 24 hrs by trypan blue exclusion assay
Antiproliferative activity against human MDA231 cells after 24 hrs by trypan blue exclusion assay
|
[PMID: 20403701] |
| MDA-MB-231 | GI50 |
54 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against estrogen receptor deficient human MDA-MB-231 cells after 48 hrs by SRB assay
Antiproliferative activity against estrogen receptor deficient human MDA-MB-231 cells after 48 hrs by SRB assay
|
[PMID: 20438092] |
| MDA-MB-231 | IC50 |
4.7 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs
|
[PMID: 21295381] |
| MDA-MB-231 | IC50 |
59 μM
Compound: Fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells
Cytotoxicity against human MDA-MB-231 cells
|
[PMID: 21774474] |
| MDA-MB-231 | IC50 |
62 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-231 cells
Cytotoxicity against human MDA-MB-231 cells
|
[PMID: 22283451] |
| MDA-MB-231 | IC50 |
9.6 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells assessed as growth inhibition after 144 hrs by crystal violet staining method
Antiproliferative activity against human MDA-MB-231 cells assessed as growth inhibition after 144 hrs by crystal violet staining method
|
[PMID: 22450132] |
| MDA-MB-231 | IC50 |
13.65 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-231 cells by after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells by after 48 hrs by MTT assay
|
[PMID: 22579780] |
| MDA-MB-231 | IC50 |
9.6 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by crystal violet staining method
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by crystal violet staining method
|
[PMID: 22765897] |
| MDA-MB-231 | IC50 |
31.57 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA231 cells by MTT assay
Cytotoxicity against human MDA231 cells by MTT assay
|
[PMID: 22801644] |
| MDA-MB-231 | IC50 |
9.6 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by crystal violet staining
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by crystal violet staining
|
[PMID: 22959205] |
| MDA-MB-231 | GI50 |
6.6 μM
Compound: 5-FU
|
Growth inhibition of human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| MDA-MB-231 | IC50 |
13.65 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 23920246] |
| MDA-MB-231 | IC50 |
18.12 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-231 cells after 3 days by SRB assay
Cytotoxicity against human MDA-MB-231 cells after 3 days by SRB assay
|
[PMID: 24704691] |
| MDA-MB-231 | IC50 |
2.45 μM
Compound: FU
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 24941129] |
| MDA-MB-231 | IC50 |
24.6 μM
Compound: Fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 25016234] |
| MDA-MB-231 | IC50 |
77.28 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by WST-1 assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by WST-1 assay
|
[PMID: 25466196] |
| MDA-MB-231 | IC50 |
5.82 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 25870131] |
| MDA-MB-231 | IC50 |
5.2 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by WST8 assay
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by WST8 assay
|
[PMID: 25919052] |
| MDA-MB-231 | IC50 |
45.43 μM
Compound: 5-FU
|
Anticancer activity against human MDA-MB-231 cells after 48 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 26413726] |
| MDA-MB-231 | IC50 |
1.1 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by WST-8 assay
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by WST-8 assay
|
[PMID: 26606140] |
| MDA-MB-231 | IC50 |
24.6 μM
Compound: Fluorouracil
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 27128180] |
| MDA-MB-231 | IC50 |
5.2 μM
Compound: 5-FU
|
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| MDA-MB-231 | IC50 |
22.53 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| MDA-MB-231 | IC50 |
45.43 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 27397498] |
| MDA-MB-231 | IC50 |
35.91 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27448774] |
| MDA-MB-231 | IC50 |
19 μM
Compound: 5 Fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212] |
| MDA-MB-231 | IC50 |
1.8 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27561719] |
| MDA-MB-231 | IC50 |
35.98 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27614408] |
| MDA-MB-231 | IC50 |
1.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27720296] |
| MDA-MB-231 | IC50 |
5 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
|
[PMID: 27987485] |
| MDA-MB-231 | IC50 |
4.33 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 28431881] |
| MDA-MB-231 | IC50 |
24.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 28759877] |
| MDA-MB-231 | IC50 |
53.47 μM
Compound: Fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 28789892] |
| MDA-MB-231 | IC50 |
17.74 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133049] |
| MDA-MB-231 | IC50 |
35.91 μM
Compound: 5-FU
|
Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 29657100] |
| MDA-MB-231 | IC50 |
21.05 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
|
[PMID: 30318440] |
| MDA-MB-231 | IC50 |
>20 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTS assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTS assay
|
[PMID: 30472605] |
| MDA-MB-231 | IC50 |
1.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 31546197] |
| MDA-MB-231 | IC50 |
7.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31546197] |
| MDA-MB-231 | IC50 |
93.8 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31803401] |
| MDA-MB-231 | IC50 |
9.89 μM
Compound: 5-Fu
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 4 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 4 hrs by MTT assay
|
[PMID: 32992255] |
| MDA-MB-231 | IC50 |
29.38 μM
Compound: 5-Fu
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by WST-1 assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by WST-1 assay
|
[PMID: 33129590] |
| MDA-MB-231 | IC50 |
66.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 24 hrs
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability after 24 hrs
|
[PMID: 33139111] |
| MDA-MB-231 | IC50 |
4.75 μM
Compound: 5-fluoro uracil
|
Cytotoxicity against human MDA-MB-231 cells incubated for 3 days by MTT assay
Cytotoxicity against human MDA-MB-231 cells incubated for 3 days by MTT assay
|
[PMID: 33152379] |
| MDA-MB-231 | IC50 |
15.74 μM
Compound: 5-FU
|
Cytotoxicity against Non-ERalpha-dependent human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against Non-ERalpha-dependent human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33166925] |
| MDA-MB-231 | IC50 |
25.31 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 33894490] |
| MDA-MB-231 | IC50 |
13 μM
Compound: 5-FU
|
Anticancer activity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 33940466] |
| MDA-MB-231 | IC50 |
16.117 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells assessed as growth inhibition measured after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as growth inhibition measured after 72 hrs by MTT assay
|
[PMID: 34000485] |
| MDA-MB-231 | IC50 |
25 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
[PMID: 34171512] |
| MDA-MB-231 | IC50 |
5.85 μM
Compound: 5-Fu
|
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay
|
[PMID: 34186178] |
| MDA-MB-231 | IC50 |
15 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent assay
|
[PMID: 34516133] |
| MDA-MB-231 | IC50 |
3.5 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| MDA-MB-231 | GI50 |
6.6 μM
Compound: 5-FU
|
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| MDA-MB-231 | IC50 |
26.73 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 35797901] |
| MDA-MB-231 | IC50 |
97.04 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition
|
[PMID: 35964428] |
| MDA-MB-231 | IC50 |
7.75 μM
Compound: 5-FU
|
Antitumor activity against human MDA-MB-231 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
Antitumor activity against human MDA-MB-231 cells assessed as inhibit cell proliferation incubated for 72 hrs by CCK-8 assay
|
[PMID: 36324491] |
| MDA-MB-231 | IC50 |
10.22 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| MDA-MB-231 | IC50 |
21.838 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-231 cells by MTT assay
Cytotoxicity against human MDA-MB-231 cells by MTT assay
|
[PMID: 36335743] |
| MDA-MB-231 | IC50 |
6.6 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| MDA-MB-231 | IC50 |
67.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell inhibition measured after 72 hrs by MTT assay
|
[PMID: 36774698] |
| MDA-MB-231 | IC50 |
1.58 μM
Compound: 5-Fu
|
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
|
[PMID: 37360398] |
| MDA-MB-231 | IC50 |
8.704 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT reagent based ELISA
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT reagent based ELISA
|
[PMID: 37556946] |
| MDA-MB-231 | IC50 |
13.86 μM
Compound: 5Fu
|
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 37837671] |
| MDA-MB-231 | IC50 |
>50 μM
Compound: 5-Fu
|
Antiproliferative activity against human MDA-MB-231 cells by CCK8 assay
Antiproliferative activity against human MDA-MB-231 cells by CCK8 assay
|
[PMID: 37939862] |
| MDA-MB-231 | IC50 |
6.81 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth measured after 48 hrs by Alamar blue dye based assay
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth measured after 48 hrs by Alamar blue dye based assay
|
[PMID: 38171252] |
| MDA-MB-231 | IC50 |
16.37 μM
Compound: 5-Fu
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by SRB assay
|
[PMID: 39054645] |
| MDA-MB-231 | IC50 |
2.72 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against Homo sapiens (human) MDA231 cells assessed as inhibition of cell growth after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) MDA231 cells assessed as inhibition of cell growth after 48 hr by MTT assay
|
10.1007/s00044-012-0209-5 |
| MDA-MB-231 | IC50 |
20 μM
Compound: 5-Fu
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
10.1039/C5MD00382B |
| MDA-MB-435 | GI50 |
0.07 μM
Compound: 5-FU
|
Growth inhibition of human MDA-MB-435 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human MDA-MB-435 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| MDA-MB-435 | IC50 |
25.6 μg/mL
Compound: 5-F
|
Cytotoxicity against human MDA-MB-435 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-435 cells after 48 hrs by MTT assay
|
[PMID: 24342667] |
| MDA-MB-435 | IC50 |
1.95 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-435 cells assessed as cell growth inhibition in presence of piperlongumine
Antiproliferative activity against human MDA-MB-435 cells assessed as cell growth inhibition in presence of piperlongumine
|
[PMID: 33930801] |
| MDA-MB-435 | IC50 |
9.19 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-435 cells assessed as cell growth inhibition
Antiproliferative activity against human MDA-MB-435 cells assessed as cell growth inhibition
|
[PMID: 33930801] |
| MDA-MB-435 | GI50 |
0.07 μM
Compound: 5-FU
|
Anticancer activity against human MDA-MB-435 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MDA-MB-435 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| MDA-MB-435 | IC50 |
0.07 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MDA-MB-435 cells assessed as cell growth inhibition
Cytotoxicity against human MDA-MB-435 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| MDA-MB-435S | IC50 |
14.5 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-435S cells after 72 hrs by MTT method
Antiproliferative activity against human MDA-MB-435S cells after 72 hrs by MTT method
|
[PMID: 17524655] |
| MDA-MB-435S | IC50 |
14.5 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-435S cells after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-435S cells after 72 hrs by MTT assay
|
[PMID: 23792763] |
| MDA-MB-435S | IC50 |
15.19 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-435S cells after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-435S cells after 72 hrs by MTT assay
|
[PMID: 26595184] |
| MDA-MB-435S | IC50 |
15.2 μM
Compound: 5-FU
|
Cytotoxicity against human MDA-MB-435S cells measured after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-435S cells measured after 72 hrs by MTT assay
|
[PMID: 27537924] |
| MDA-MB-453 | IC50 |
>50 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by MTT assay
|
[PMID: 22079378] |
| MDA-MB-453 | IC50 |
7.4 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-453 cells
Antiproliferative activity against human MDA-MB-453 cells
|
[PMID: 34655985] |
| MDA-MB-468 | IC50 |
95.69 μM
Compound: Fluorouracil
|
Cytotoxicity against human MDA-MB-468 cells after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-468 cells after 48 hrs by MTT assay
|
[PMID: 28789892] |
| MDA-MB-468 | IC50 |
44.6 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay
|
[PMID: 29133037] |
| MDA-MB-468 | IC50 |
44.9 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133037] |
| MDA-MB-468 | IC50 |
7.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31546197] |
| MDA-MB-468 | IC50 |
>20 μM
Compound: 5-Fu
|
Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent assay
Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability incubated for 24 hrs by CellTiter-Glo luminescent assay
|
[PMID: 34516133] |
| MDA-MB-468 | IC50 |
>200 μM
Compound: 5-FU
|
Antiproliferative activity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-468 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 35797901] |
| MDCK | EC50 |
23 μg/mL
Compound: 18b
|
Antiviral activity against Influenza B virus Florida/4/2006 infected in MDCK cells
Antiviral activity against Influenza B virus Florida/4/2006 infected in MDCK cells
|
[PMID: 20674371] |
| MDCK | EC50 |
26 μg/mL
Compound: 18b
|
Antiviral activity against Influenza A virus H5N1 Vietnam/1203/2004H infected in MDCK cells
Antiviral activity against Influenza A virus H5N1 Vietnam/1203/2004H infected in MDCK cells
|
[PMID: 20674371] |
| MDCK | IC50 |
>100 μg/mL
Compound: 18b
|
Cytotoxicity against MDCK cells
Cytotoxicity against MDCK cells
|
[PMID: 20674371] |
| ME-180 | IC50 |
4.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human ME180 cells after 48 hrs by MTT assay
Cytotoxicity against human ME180 cells after 48 hrs by MTT assay
|
[PMID: 24332497] |
| Melanoma cell | CC50 |
46.1 μM
Compound: 5-FU
|
Cytotoxicity against human skin melanoma cells after 72 hrs
Cytotoxicity against human skin melanoma cells after 72 hrs
|
[PMID: 17337193] |
| Melanoma cell | CC50 |
46.1 μM
Compound: 5FU
|
Cytotoxicity against human melanoma cells after 72 hrs
Cytotoxicity against human melanoma cells after 72 hrs
|
[PMID: 17548129] |
| Melanoma cell | CC50 |
46.1 μM
Compound: 5-Fu
|
Cytotoxicity against human melanoma cells after 72 hrs
Cytotoxicity against human melanoma cells after 72 hrs
|
[PMID: 18037195] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Growth inhibition of human melanoma cells after 48 hrs
Growth inhibition of human melanoma cells after 48 hrs
|
[PMID: 18950904] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-fu
|
Antitumor activity against human melanoma cells after 48 hrs by SRB assay
Antitumor activity against human melanoma cells after 48 hrs by SRB assay
|
[PMID: 20350811] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Cytotoxicity against human melanoma cells after 48 hrs by coulter counting
Cytotoxicity against human melanoma cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Growth inhibition of human Melanoma cells after 48 hrs by coulter counter method
Growth inhibition of human Melanoma cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-fu
|
Antiproliferative activity against human melanoma cells after 48 hrs by cell counting analysis
Antiproliferative activity against human melanoma cells after 48 hrs by cell counting analysis
|
[PMID: 22995621] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Cytotoxicity against human melanoma cells after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human melanoma cells after 48 hrs by sulphorhodamine B assay
|
[PMID: 23474899] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Cytotoxicity against human melanoma cells after 48 hrs by coulter counter analysis
Cytotoxicity against human melanoma cells after 48 hrs by coulter counter analysis
|
[PMID: 23683592] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Cytotoxicity against human melanoma cells after 48 hrs by SRB assay
Cytotoxicity against human melanoma cells after 48 hrs by SRB assay
|
[PMID: 23994328] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Cytotoxicity against human melanoma cells at 10 uM after 48 hrs
Cytotoxicity against human melanoma cells at 10 uM after 48 hrs
|
[PMID: 24469112] |
| Melanoma cell | GI50 |
70.6 μM
Compound: 5-FU
|
Growth inhibition of human melanoma cells after 48 hrs by SRB assay
Growth inhibition of human melanoma cells after 48 hrs by SRB assay
|
[PMID: 27554444] |
| MES-SA | IC50 |
1.1 μM
Compound: 5-FU
|
Antiproliferative activity against human MES-SA cells after 72 hrs by MTT assay
Antiproliferative activity against human MES-SA cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| MeWo | IC50 |
8 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human MeWo cells by MTT assay
Cytotoxicity against human MeWo cells by MTT assay
|
[PMID: 29280630] |
| MFE-296 | IC50 |
30.68 μM
Compound: 5FU
|
Cytotoxicity against human MFE296 cells incubated for 72 hrs by SRB assay
Cytotoxicity against human MFE296 cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| MG-63 | IC50 |
8 μM
Compound: 5-FU
|
Cytotoxicity against human MG63 cells after 3 days by MTT assay
Cytotoxicity against human MG63 cells after 3 days by MTT assay
|
[PMID: 21612935] |
| MGC-803 | IC50 |
12.6 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells after 3 days by MTT assay
Cytotoxicity against human MGC803 cells after 3 days by MTT assay
|
[PMID: 21144621] |
| MGC-803 | IC50 |
16.6 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 22079378] |
| MGC-803 | IC50 |
3.42 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 22405648] |
| MGC-803 | IC50 |
18.5 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 22749192] |
| MGC-803 | IC50 |
7.01 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 23353743] |
| MGC-803 | IC50 |
7.14 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 23644193] |
| MGC-803 | IC50 |
6.92 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 23792764] |
| MGC-803 | IC50 |
6.92 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 24077182] |
| MGC-803 | IC50 |
3.68 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 24119869] |
| MGC-803 | IC50 |
15.32 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 24211021] |
| MGC-803 | IC50 |
8.13 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 24798098] |
| MGC-803 | IC50 |
11.34 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 24835817] |
| MGC-803 | IC50 |
46.93 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| MGC-803 | IC50 |
3.45 μM
Compound: 5-Fu
|
Anticancer activity against human MGC803 cells after 72 hrs by MTT assay
Anticancer activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 25001482] |
| MGC-803 | IC50 |
10 μM
Compound: 5-Fu
|
Anticancer activity against human MGC803 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Anticancer activity against human MGC803 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 25086915] |
| MGC-803 | IC50 |
7.76 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 25113877] |
| MGC-803 | IC50 |
46.93 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 25151580] |
| MGC-803 | IC50 |
7.69 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25180925] |
| MGC-803 | IC50 |
30.45 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 25462253] |
| MGC-803 | IC50 |
3.71 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 25554922] |
| MGC-803 | IC50 |
8.43 μM
Compound: 5-Fu
|
Anticancer activity against human MGC803 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
Anticancer activity against human MGC803 cells assessed as inhibition of proliferation after 72 hrs by MTT assay
|
[PMID: 25655718] |
| MGC-803 | IC50 |
10.72 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 25707012] |
| MGC-803 | IC50 |
3.58 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human MGC803 cells assessed as cell survival after 48 hrs by MTT assay
Anticancer activity against human MGC803 cells assessed as cell survival after 48 hrs by MTT assay
|
[PMID: 25812966] |
| MGC-803 | IC50 |
47.39 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 2 days by MTT assay
Cytotoxicity against human MGC803 cells after 2 days by MTT assay
|
[PMID: 25841196] |
| MGC-803 | IC50 |
40.94 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25841199] |
| MGC-803 | IC50 |
68.3 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 26714048] |
| MGC-803 | EC50 |
3.35 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 26883149] |
| MGC-803 | IC50 |
1.25 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27105028] |
| MGC-803 | IC50 |
7.21 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27423479] |
| MGC-803 | IC50 |
10.64 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells assessed as growth inhibition after 72 hrs by CCK8 assay
Cytotoxicity against human MGC803 cells assessed as growth inhibition after 72 hrs by CCK8 assay
|
[PMID: 27597411] |
| MGC-803 | IC50 |
10.14 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells assessed as growth inhibition by MTT assay
Cytotoxicity against human MGC803 cells assessed as growth inhibition by MTT assay
|
[PMID: 27769034] |
| MGC-803 | IC50 |
7.35 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 27771599] |
| MGC-803 | IC50 |
7.21 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 28038329] |
| MGC-803 | IC50 |
3.12 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 28165738] |
| MGC-803 | IC50 |
6.56 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 28456031] |
| MGC-803 | IC50 |
6.89 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 28759876] |
| MGC-803 | IC50 |
9.79 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 28763643] |
| MGC-803 | IC50 |
7.52 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 28838695] |
| MGC-803 | IC50 |
7.52 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 28863355] |
| MGC-803 | IC50 |
1.8 μg/mL
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 29100732] |
| MGC-803 | IC50 |
7.52 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 29113745] |
| MGC-803 | IC50 |
14.15 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 29133051] |
| MGC-803 | IC50 |
>50 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 29174813] |
| MGC-803 | IC50 |
25.54 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 29316536] |
| MGC-803 | IC50 |
7.86 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 29407946] |
| MGC-803 | IC50 |
9.24 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 29475156] |
| MGC-803 | IC50 |
8.66 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 29635165] |
| MGC-803 | IC50 |
6.56 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 30108876] |
| MGC-803 | IC50 |
74.39 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 30108924] |
| MGC-803 | IC50 |
31.04 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 30142612] |
| MGC-803 | IC50 |
8.66 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30388465] |
| MGC-803 | IC50 |
>50 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| MGC-803 | IC50 |
14 μM
Compound: 5-FU
|
Cytotoxicity against human MGC803 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human MGC803 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 31029946] |
| MGC-803 | IC50 |
58 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay
|
[PMID: 31057737] |
| MGC-803 | IC50 |
3.38 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells incubated for 72 hrs by MTT assay
|
[PMID: 31404863] |
| MGC-803 | IC50 |
6.5 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MGC803 cells by MTT assay
Antiproliferative activity against human MGC803 cells by MTT assay
|
[PMID: 31546197] |
| MGC-803 | IC50 |
6.82 μM
Compound: 5-FU
|
Anticancer activity against human MGC-803 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Anticancer activity against human MGC-803 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 31577977] |
| MGC-803 | IC50 |
9.79 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC803 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human MGC803 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 31740251] |
| MGC-803 | IC50 |
18.63 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells measured after 48 hrs by MTT assay
|
[PMID: 32135407] |
| MGC-803 | IC50 |
6.52 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
|
[PMID: 32619887] |
| MGC-803 | IC50 |
6.82 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32682200] |
| MGC-803 | IC50 |
3.79 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 32682202] |
| MGC-803 | IC50 |
24.803 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells by MTT assay
Antiproliferative activity against human MGC-803 cells by MTT assay
|
[PMID: 32810752] |
| MGC-803 | IC50 |
34.85 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells by MTT assay
Antiproliferative activity against human MGC-803 cells by MTT assay
|
[PMID: 33109400] |
| MGC-803 | IC50 |
29.15 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| MGC-803 | IC50 |
4.55 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33385852] |
| MGC-803 | IC50 |
7.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MGC-803 cells
Antiproliferative activity against human MGC-803 cells
|
[PMID: 33421712] |
| MGC-803 | IC50 |
9.05 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 34302974] |
| MGC-803 | IC50 |
6.22 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 34455358] |
| MGC-803 | IC50 |
12.14 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 34624825] |
| MGC-803 | IC50 |
62.51 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34628244] |
| MGC-803 | IC50 |
10.36 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells
Antiproliferative activity against human MGC-803 cells
|
[PMID: 34655985] |
| MGC-803 | IC50 |
93.53 μM
Compound: 5-FU
|
Cytotoxicity in human MGC-803 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human MGC-803 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 35085721] |
| MGC-803 | IC50 |
39.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 35092899] |
| MGC-803 | IC50 |
10.14 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 35259487] |
| MGC-803 | IC50 |
28.6 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 35286954] |
| MGC-803 | IC50 |
>50 μM
Compound: 5-FU
|
Anticancer activity against human MGC-803 cells incubated for 72 hrs by MTT assay
Anticancer activity against human MGC-803 cells incubated for 72 hrs by MTT assay
|
[PMID: 35367708] |
| MGC-803 | IC50 |
10.27 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by SRB assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by SRB assay
|
[PMID: 35594653] |
| MGC-803 | IC50 |
38.49 μM
Compound: 5-FU
|
Cytotoxicity against human MGC-803 cells assessed as cell growth inhibition
Cytotoxicity against human MGC-803 cells assessed as cell growth inhibition
|
[PMID: 35809817] |
| MGC-803 | IC50 |
62.5 μM
Compound: 5-FU
|
Cytotoxicity against human MGC-803 cells assessed as cell growth inhibition
Cytotoxicity against human MGC-803 cells assessed as cell growth inhibition
|
[PMID: 35964428] |
| MGC-803 | IC50 |
7.21 μM
Compound: 5-Fu
|
Antitumor activity human MGC-803 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity human MGC-803 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36216031] |
| MGC-803 | IC50 |
5.81 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 36242987] |
| MGC-803 | IC50 |
7.54 μM
Compound: 5-FU
|
Cytotoxicity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| MGC-803 | IC50 |
6.06 μM
Compound: 5-FU
|
Anticancer activity against human MGC-803 cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human MGC-803 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| MGC-803 | IC50 |
14.1 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36893627] |
| MGC-803 | IC50 |
6.9 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth by MTT assay
|
[PMID: 36893627] |
| MGC-803 | IC50 |
10.14 μM
Compound: 5-Fu
|
Antitumor activity against human MGC-803 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human MGC-803 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36931124] |
| MGC-803 | IC50 |
27.56 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
|
[PMID: 37122546] |
| MGC-803 | IC50 |
9.95 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC-803 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells measured after 72 hrs by MTT assay
|
[PMID: 37379957] |
| MGC-803 | IC50 |
15.7 μM
Compound: 5-FU
|
Cytotoxicity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 37859725] |
| MGC-803 | IC50 |
26.35 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 37859725] |
| MGC-803 | IC50 |
34.85 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by MTT assay
|
[PMID: 37972528] |
| MGC-803 | IC50 |
3.88 μM
Compound: 5-FU
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 38759254] |
| MGC-803 | IC50 |
44.05 μM
Compound: 5-fluorouracil
|
Inhibition of cell proliferation in human MGC-803 cells incubated for 72 hrs by MTT assay
Inhibition of cell proliferation in human MGC-803 cells incubated for 72 hrs by MTT assay
|
[PMID: 39285177] |
| MGC-803 | IC50 |
9.2 μM
Compound: 5-Fu
|
Cytotoxicity against human MGC803 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
10.1039/C5MD00240K |
| MGC-803 | IC50 |
7.22 μM
Compound: 5-Fu
|
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
|
10.1039/C6MD00169F |
| M-HeLa | IC50 |
62 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human HelaM cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
Cytotoxicity against human HelaM cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
|
[PMID: 36970146] |
| MIA PaCa-2 | IC50 |
6.5 μM
Compound: 5-FU
|
Antiproliferative activity against human MiaPaCa2 cells after 3 days by MTT assay
Antiproliferative activity against human MiaPaCa2 cells after 3 days by MTT assay
|
[PMID: 18424155] |
| MIA PaCa-2 | IC50 |
10 μM
Compound: 5-FU
|
Growth inhibition of human MIAPaCa2 cells after 72 hrs by MTT assay
Growth inhibition of human MIAPaCa2 cells after 72 hrs by MTT assay
|
[PMID: 18640746] |
| MIA PaCa-2 | GI50 |
>10 μM
Compound: 5-Fu
|
Growth inhibition of human MIAPaCa2 cells after 72 hrs by Alamar Blue assay
Growth inhibition of human MIAPaCa2 cells after 72 hrs by Alamar Blue assay
|
[PMID: 19406645] |
| MIA PaCa-2 | IC50 |
14 μM
Compound: 5-FU
|
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs
|
[PMID: 21458113] |
| MIA PaCa-2 | IC50 |
7.4 μM
Compound: 5-FU
|
Antiproliferative activity against human MIAPaCa2 cells after 72 hrs
Antiproliferative activity against human MIAPaCa2 cells after 72 hrs
|
[PMID: 21458113] |
| MIA PaCa-2 | IC50 |
11.45 μM
Compound: 5-FU
|
Antiproliferative activity against human MIAPaCa2 cells after 72 hrs by MTT assay
Antiproliferative activity against human MIAPaCa2 cells after 72 hrs by MTT assay
|
[PMID: 21524829] |
| MIA PaCa-2 | GI50 |
30 μM
Compound: 5-Fu
|
Growth inhibition of human MIAPaCa2 cells after 48 hrs by SRB assay
Growth inhibition of human MIAPaCa2 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| MIA PaCa-2 | IC50 |
11.67 μM
Compound: 5-Fluoruracil
|
Antiproliferative activity against human MIAPaCa2 cells after 72 hrs by MTT assay
Antiproliferative activity against human MIAPaCa2 cells after 72 hrs by MTT assay
|
[PMID: 22555152] |
| MIA PaCa-2 | GI50 |
30.6 nM
Compound: 5FU
|
Growth inhibition of human MIAPaCa2 cells after 48 hrs by SRB assay
Growth inhibition of human MIAPaCa2 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| MIA PaCa-2 | IC50 |
11.67 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MIAPaCa2 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human MIAPaCa2 cells incubated for 72 hrs by MTT assay
|
[PMID: 26291038] |
| MIA PaCa-2 | IC50 |
3.5 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human MIAPaCa2 cells assessed as decrease in cell viability after 96 hrs
Cytotoxicity against human MIAPaCa2 cells assessed as decrease in cell viability after 96 hrs
|
[PMID: 29673982] |
| MIA PaCa-2 | IC50 |
24.267 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MIAPaCa2 cells incubated for 24 hrs by MTT assay
Cytotoxicity against human MIAPaCa2 cells incubated for 24 hrs by MTT assay
|
[PMID: 30904782] |
| MKN-1 | IC50 |
3.88 μM
Compound: 5-Fu
|
Antiproliferative activity against human MKN-1 cells incubated for 72 hrs by SRB method
Antiproliferative activity against human MKN-1 cells incubated for 72 hrs by SRB method
|
[PMID: 39054645] |
| MKN-28 | IC50 |
9.67 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human MKN28 cells assessed as cell survival after 48 hrs by MTT assay
Cytotoxicity against human MKN28 cells assessed as cell survival after 48 hrs by MTT assay
|
[PMID: 25506718] |
| MKN-28 | IC50 |
6.9 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MKN28 cells by MTT assay
Antiproliferative activity against human MKN28 cells by MTT assay
|
[PMID: 31546197] |
| MKN-28 | IC50 |
6.9 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human MKN-28 cells assessed as inhibition of cell growth by MTT assay
Antiproliferative activity against human MKN-28 cells assessed as inhibition of cell growth by MTT assay
|
[PMID: 36893627] |
| MKN-28 | IC50 |
2.5 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of MKN-28 tumor cell line from stomach.
Compound was tested for its inhibitory effect on the growth of MKN-28 tumor cell line from stomach.
|
10.1016/0960-894X(96)00339-3 |
| MKN-45 | IC50 |
3.6 x 10-1 μg/mL
Compound: fluorouracil
|
Cytotoxicity against human MKN45 cells by MTT assay
Cytotoxicity against human MKN45 cells by MTT assay
|
[PMID: 22011319] |
| MKN-45 | IC50 |
41.73 μM
Compound: Fluorouracil
|
Cytotoxicity against human MKN45 cells after 48 hrs by MTT assay
Cytotoxicity against human MKN45 cells after 48 hrs by MTT assay
|
[PMID: 22809558] |
| MKN-45 | IC50 |
8.89 μM
Compound: 5-FU
|
Antiproliferative activity against human MKN45 cells after 48 hrs by MTT assay
Antiproliferative activity against human MKN45 cells after 48 hrs by MTT assay
|
[PMID: 28838695] |
| MKN-45 | IC50 |
8.89 μM
Compound: 5-FU
|
Antiproliferative activity against human MKN45 cells after 48 hrs by MTT assay
Antiproliferative activity against human MKN45 cells after 48 hrs by MTT assay
|
[PMID: 28863355] |
| MKN-45 | IC50 |
8.89 μM
Compound: 5-Fu
|
Antiproliferative activity against human MKN45 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MKN45 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 29113745] |
| MKN-45 | IC50 |
6.9 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human MKN45 cells by MTT assay
Antiproliferative activity against human MKN45 cells by MTT assay
|
[PMID: 31546197] |
| MKN-45 | IC50 |
21.4 μM
Compound: 5-FU
|
Cytotoxicity against human MNK45 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Cytotoxicity against human MNK45 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 33740546] |
| MKN-45 | IC50 |
6.9 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human MKN-45 cells assessed as inhibition of cell growth by MTT assay
Antiproliferative activity against human MKN-45 cells assessed as inhibition of cell growth by MTT assay
|
[PMID: 36893627] |
| MKN-45 | IC50 |
3 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of MKN-45 tumor cell line from stomach.
Compound was tested for its inhibitory effect on the growth of MKN-45 tumor cell line from stomach.
|
10.1016/0960-894X(96)00339-3 |
| MOLT-3 | ED50 |
2.14 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human TMOLT3 cells after 3 days by trypan blue exclusion technique
Cytotoxicity against human TMOLT3 cells after 3 days by trypan blue exclusion technique
|
[PMID: 1800632] |
| MOLT-3 | IC50 |
1.2 μg/mL
Compound: 5-F-Ura
|
In vitro antitumor activity in MOLT-3 cell lines
In vitro antitumor activity in MOLT-3 cell lines
|
[PMID: 8648611] |
| MOLT-4 | IC50 |
23 μM
Compound: 5-Fluorouracil
|
Concentration required to inhibit 50% of cell growth on human Molt 4/C8 cells.
Concentration required to inhibit 50% of cell growth on human Molt 4/C8 cells.
|
[PMID: 11052798] |
| MOLT-4 | IC50 |
2.9 μg/mL
Compound: 5-FU
|
Evaluated for the inhibition of tumor cell growth of Human T-Lymphocyte cells (Molt4/C8)
Evaluated for the inhibition of tumor cell growth of Human T-Lymphocyte cells (Molt4/C8)
|
[PMID: 11123990] |
| MOLT-4 | IC50 |
23 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human Molt4/C8 cells
Cytostatic activity against human Molt4/C8 cells
|
[PMID: 17931862] |
| MOLT-4 | IC50 |
20 μM
Compound: 5-FU
|
Antiproliferative activity against human Molt4/C8 cells after 3 days by MTT assay
Antiproliferative activity against human Molt4/C8 cells after 3 days by MTT assay
|
[PMID: 18424155] |
| MOLT-4 | IC50 |
3.8 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of cell growth of MOLT-4 leukemic cell lines in human.
Concentration required for 50% inhibition of cell growth of MOLT-4 leukemic cell lines in human.
|
[PMID: 1992123] |
| MOLT-4 | IC50 |
3.8 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human T-cell acute lymphoblastic leukemia (MOLT-4) cell line.
In vitro inhibitory activity against Human T-cell acute lymphoblastic leukemia (MOLT-4) cell line.
|
[PMID: 1995905] |
| MOLT-4 | IC50 |
0.03 μM
Compound: 5-FU
|
Antitumor activity against human MOLT4 cells after 24 hrs by MTT assay
Antitumor activity against human MOLT4 cells after 24 hrs by MTT assay
|
[PMID: 20211564] |
| MOLT-4 | IC50 |
3.2 μM
Compound: 5-Fu
|
Antiproliferative activity against human MOLT4 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human MOLT4 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 22424614] |
| MOLT-4 | GI50 |
0.35 μM
Compound: 5-FU
|
Growth inhibition of human MOLT4 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human MOLT4 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| MOLT-4 | ED50 |
15.07 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MOLT4 cells after 6 hrs by Alamar Blue assay
Cytotoxicity against human MOLT4 cells after 6 hrs by Alamar Blue assay
|
[PMID: 24020806] |
| MOLT-4 | ED50 |
7.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MOLT4 cells by Alamar blue assay
Cytotoxicity against human MOLT4 cells by Alamar blue assay
|
[PMID: 24128077] |
| MOLT-4 | IC50 |
6.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MOLT4 cells incubated for 72 hrs by alamar blue assay
Cytotoxicity against human MOLT4 cells incubated for 72 hrs by alamar blue assay
|
[PMID: 28648460] |
| MOLT-4 | IC50 |
3.8 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of human T-cell acute lymphoblastic leukemic MOLT 4 cell lines.
In vitro inhibitory effect on growth of human T-cell acute lymphoblastic leukemic MOLT 4 cell lines.
|
[PMID: 3373480] |
| MOLT-4 | GI50 |
0.35 μM
Compound: 5-FU
|
Anticancer activity against human MOLT-4 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human MOLT-4 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| MOLT-4 | IC50 |
0.35 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human MOLT-4 cells assessed as cell growth inhibition
Cytotoxicity against human MOLT-4 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| Mononuclear cell line | IC50 |
429.8 μM
Compound: 5-FU
|
Cytotoxicity against patient-derived human mononuclear cells assessed as cell growth inhibition incubated for 72 hrs by FMCA assay
Cytotoxicity against patient-derived human mononuclear cells assessed as cell growth inhibition incubated for 72 hrs by FMCA assay
|
[PMID: 36018000] |
| MRC5 | GI50 |
>100 μM
Compound: 5-FU
|
Growth inhibition of human MRC5 cells after 48 hrs by SRB assay
Growth inhibition of human MRC5 cells after 48 hrs by SRB assay
|
[PMID: 28400235] |
| MRC5 | IC50 |
245.65 μM
Compound: 5-FU
|
Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 36758308] |
| N2a | IC50 |
1.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse Neuro2a cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against mouse Neuro2a cells assessed as cell growth inhibition by MTT assay
|
[PMID: 26629861] |
| N592 | IC50 |
5.4 μM
Compound: 5-FluoroUracil
|
Cytotoxicity against human small-cell lung cancer (SCLC)
Cytotoxicity against human small-cell lung cancer (SCLC)
|
[PMID: 8258835] |
| NCI/ADR-RES | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Cytotoxicity against multidrug-resistant human MCF7/ADR cells after 48 hrs by MTT assay
Cytotoxicity against multidrug-resistant human MCF7/ADR cells after 48 hrs by MTT assay
|
[PMID: 22537362] |
| NCI/ADR-RES | GI50 |
0.31 μM
Compound: 5-FU
|
Growth inhibition of human NCI-ADR-RES cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human NCI-ADR-RES cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| NCI/ADR-RES | IC50 |
512.78 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7/ADR cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7/ADR cells after 72 hrs by MTT assay
|
[PMID: 30677614] |
| NCI/ADR-RES | IC50 |
54.72 μM
Compound: 5-FU
|
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 31673307] |
| NCI/ADR-RES | GI50 |
0.31 μM
Compound: 5-FU
|
Anticancer activity against human NCI/ADR-RES cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI/ADR-RES cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| NCI/ADR-RES | IC50 |
0.31 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human NCI/ADR-RES cells assessed as cell growth inhibition
Cytotoxicity against human NCI/ADR-RES cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| NCI-H1299 | IC50 |
8.91 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay
|
[PMID: 28152430] |
| NCI-H1299 | IC50 |
3.53 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H1299 cells
Antiproliferative activity against human NCI-H1299 cells
|
[PMID: 35944853] |
| NCI-H1650 | IC50 |
12.52 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H1650 cells after 72 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells after 72 hrs by MTT assay
|
[PMID: 28456031] |
| NCI-H1650 | IC50 |
14.25 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H1650 cells after 48 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells after 48 hrs by MTT assay
|
[PMID: 28838695] |
| NCI-H1650 | IC50 |
14.25 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H1650 cells after 48 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells after 48 hrs by MTT assay
|
[PMID: 28863355] |
| NCI-H1650 | IC50 |
14.25 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H1650 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 29113745] |
| NCI-H1650 | IC50 |
14.63 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H1650 cells after 72 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells after 72 hrs by MTT assay
|
[PMID: 29407946] |
| NCI-H1650 | IC50 |
12.52 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H1650 cells after 72 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells after 72 hrs by MTT assay
|
[PMID: 30108876] |
| NCI-H1650 | IC50 |
>10 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H1650 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
Cytotoxicity against human NCI-H1650 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
|
[PMID: 32659087] |
| NCI-H1975 | IC50 |
2.67 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 32682202] |
| NCI-H1975 | IC50 |
9.37 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 34302974] |
| NCI-H1975 | IC50 |
1.98 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H1975 cells
Antiproliferative activity against human NCI-H1975 cells
|
[PMID: 35944853] |
| NCI-H226 | GI50 |
54.7 μM
Compound: 5-FU
|
Growth inhibition of human NCI-H226 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human NCI-H226 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| NCI-H226 | GI50 |
54.7 μM
Compound: 5-FU
|
Anticancer activity against human NCI-H226 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H226 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| NCI-H226 | IC50 |
54.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human NCI-H226 cells assessed as cell growth inhibition
Cytotoxicity against human NCI-H226 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| NCI-H23 | GI50 |
0.33 μM
Compound: 5-FU
|
Growth inhibition of human NCI-H23 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human NCI-H23 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| NCI-H23 | GI50 |
0.33 μM
Compound: 5-FU
|
Anticancer activity against human NCI-H23 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H23 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| NCI-H23 | IC50 |
0.33 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human NCI-H23 cells assessed as cell growth inhibition
Cytotoxicity against human NCI-H23 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| NCI-H358 | IC50 |
6.9 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human NCI-H358 cells assessed as decrease in cell viability after 96 hrs
Cytotoxicity against human NCI-H358 cells assessed as decrease in cell viability after 96 hrs
|
[PMID: 29673982] |
| NCI-H358 | IC50 |
>20 μM
Compound: 5-Fu
|
Cytotoxicity against human NCI-H358 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human NCI-H358 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| NCI-H460 | IC50 |
2 μM
Compound: 5-FU
|
Growth inhibition of human H460 cells after 72 hrs by MTT assay
Growth inhibition of human H460 cells after 72 hrs by MTT assay
|
[PMID: 18640746] |
| NCI-H460 | GI50 |
4.1 μM
Compound: 5FU
|
Cytotoxicity against human H460 cells after 48 hrs
Cytotoxicity against human H460 cells after 48 hrs
|
[PMID: 18798609] |
| NCI-H460 | IC50 |
2 μM
Compound: 5-FU
|
Antitumor activity against human H460 cells after 24 hrs by MTT assay
Antitumor activity against human H460 cells after 24 hrs by MTT assay
|
[PMID: 20211564] |
| NCI-H460 | GI50 |
2.3 μM
Compound: 5FU
|
Cytotoxicity against human NCI-H460 cells
Cytotoxicity against human NCI-H460 cells
|
[PMID: 20356752] |
| NCI-H460 | IC50 |
2.7 μM
Compound: 5-FU
|
Antiproliferative activity against human H460 cells after 24 hrs by trypan blue exclusion assay
Antiproliferative activity against human H460 cells after 24 hrs by trypan blue exclusion assay
|
[PMID: 20403701] |
| NCI-H460 | IC50 |
8.5 μM
Compound: Fluorouracil
|
Cytotoxicity against human NCI-H460 cells
Cytotoxicity against human NCI-H460 cells
|
[PMID: 21774474] |
| NCI-H460 | IC50 |
3 μM
Compound: 5-FU
|
Cytotoxicity against human H460 cells after 72 hrs by MTT assay
Cytotoxicity against human H460 cells after 72 hrs by MTT assay
|
[PMID: 22130132] |
| NCI-H460 | IC50 |
8 μM
Compound: 5-Fu
|
Cytotoxicity against human NCI-H460 cells
Cytotoxicity against human NCI-H460 cells
|
[PMID: 22283451] |
| NCI-H460 | IC50 |
29 μM
Compound: 5-fu
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 22304344] |
| NCI-H460 | IC50 |
3 μM
Compound: 5-Fluorouracil
|
Cytostatic activity against human NCI-H460 cells after 72 hrs by MTT assay
Cytostatic activity against human NCI-H460 cells after 72 hrs by MTT assay
|
[PMID: 22405290] |
| NCI-H460 | GI50 |
6.5 μM
Compound: 5-Fu
|
Growth inhibition of human NCI-H460 cells after 48 hrs by SRB assay
Growth inhibition of human NCI-H460 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| NCI-H460 | IC50 |
7.2 μg/mL
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
|
[PMID: 22647218] |
| NCI-H460 | IC50 |
2.4 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
|
[PMID: 22727445] |
| NCI-H460 | IC50 |
26.7 μM
Compound: 5-FU
|
Cytotoxicity against human H460 cells after 48 hrs by MTT assay
Cytotoxicity against human H460 cells after 48 hrs by MTT assay
|
[PMID: 23867385] |
| NCI-H460 | GI50 |
0.05 μM
Compound: 5-FU
|
Growth inhibition of human NCI-H460 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human NCI-H460 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| NCI-H460 | IC50 |
44.04 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 23988357] |
| NCI-H460 | IC50 |
2.48 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 24021891] |
| NCI-H460 | IC50 |
44.04 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 3 days by MTT assay
Cytotoxicity against human NCI-H460 cells after 3 days by MTT assay
|
[PMID: 24095745] |
| NCI-H460 | IC50 |
8.5 μM
Compound: Fluorouracil
|
Cytotoxic activity against human NCI-H460 cells
Cytotoxic activity against human NCI-H460 cells
|
[PMID: 24195466] |
| NCI-H460 | IC50 |
23.32 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
|
[PMID: 24211021] |
| NCI-H460 | IC50 |
36.04 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 24565905] |
| NCI-H460 | IC50 |
45.14 μM
Compound: 5-Fu
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 24953029] |
| NCI-H460 | IC50 |
44.04 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 25151580] |
| NCI-H460 | IC50 |
36.04 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 25462253] |
| NCI-H460 | IC50 |
46.15 μM
Compound: 5-Fu
|
Cytotoxicity against human NCI-H460 cells after 2 days by MTT assay
Cytotoxicity against human NCI-H460 cells after 2 days by MTT assay
|
[PMID: 25841196] |
| NCI-H460 | GI50 |
0.3 μg/mL
Compound: 5FU
|
Cytotoxicity against human H460 cells assessed as growth inhibition after 48 hrs by SRB assay method
Cytotoxicity against human H460 cells assessed as growth inhibition after 48 hrs by SRB assay method
|
[PMID: 26383125] |
| NCI-H460 | IC50 |
35.52 μM
Compound: 5-FU
|
Cytotoxic activity against human NCI-H460 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxic activity against human NCI-H460 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26706349] |
| NCI-H460 | IC50 |
36 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H460 cells after 48 hrs by MTT assay
Antiproliferative activity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 28756264] |
| NCI-H460 | IC50 |
8.5 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H460 cells after 48 h by hrs MTT assay
Antiproliferative activity against human NCI-H460 cells after 48 h by hrs MTT assay
|
[PMID: 29305189] |
| NCI-H460 | IC50 |
8.5 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H460 cells after 48 by hrs MTT assay
Antiproliferative activity against human NCI-H460 cells after 48 by hrs MTT assay
|
[PMID: 29305189] |
| NCI-H460 | IC50 |
45.44 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 30092368] |
| NCI-H460 | IC50 |
45.44 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay
|
[PMID: 30108826] |
| NCI-H460 | IC50 |
11.75 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay
|
[PMID: 30318440] |
| NCI-H460 | IC50 |
0.54 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability by SRB assay
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability by SRB assay
|
[PMID: 30660827] |
| NCI-H460 | IC50 |
9.9 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
|
[PMID: 32659087] |
| NCI-H460 | IC50 |
7.03 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell growth by CCK8 assay
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell growth by CCK8 assay
|
[PMID: 33964443] |
| NCI-H460 | IC50 |
26.34 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H460 cells
Antiproliferative activity against human NCI-H460 cells
|
[PMID: 34655985] |
| NCI-H460 | GI50 |
0.05 μM
Compound: 5-FU
|
Anticancer activity against human NCI-H460 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H460 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| NCI-H460 | IC50 |
7.03 μM
Compound: 5-Fu
|
Antiproliferative activity against human NCI-H460 cells
Antiproliferative activity against human NCI-H460 cells
|
[PMID: 35944853] |
| NCI-H460 | IC50 |
0.05 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human NCI-H460 cells assessed as cell growth inhibition
Cytotoxicity against human NCI-H460 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| NCI-H460 | IC50 |
24.84 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 36758308] |
| NCI-H460 | GI50 |
5.95 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay
|
10.1007/s00044-013-0798-7 |
| NCI-H508 | IC50 |
8.8 μM
Compound: 5-FU
|
Antiproliferative activity against human NCI-H508 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human NCI-H508 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32127259] |
| NCI-H522 | GI50 |
7.28 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H522 cells after 48 hrs by SRB assay
Cytotoxicity against human NCI-H522 cells after 48 hrs by SRB assay
|
[PMID: 22305543] |
| NCI-H522 | IC50 |
56.76 μM
Compound: 5-FU
|
Cytotoxicity against human NCI-H522 cells after 24 hrs by MTT assay
Cytotoxicity against human NCI-H522 cells after 24 hrs by MTT assay
|
[PMID: 23202484] |
| NCI-H522 | GI50 |
7.27 μM
Compound: 5-FU
|
Growth inhibition of human NCI-H522 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human NCI-H522 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| NCI-H522 | IC50 |
55.6 μM
Compound: 5-FU
|
Growth inhibition of human NCI-H522 cells after 24 hrs by MTT assay
Growth inhibition of human NCI-H522 cells after 24 hrs by MTT assay
|
[PMID: 28011220] |
| NCI-H522 | GI50 |
7.27 μM
Compound: 5-FU
|
Anticancer activity against human NCI-H522 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human NCI-H522 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| NCI-H522 | IC50 |
7.27 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human NCI-H522 cells assessed as cell growth inhibition
Cytotoxicity against human NCI-H522 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| NCI-H69 | GI50 |
100 μM
Compound: 5-Fu
|
Growth inhibition of human NCI-H69 cells after 48 hrs by SRB assay
Growth inhibition of human NCI-H69 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| NCI-H69 | IC50 |
0.28 mg/mL
Compound: 5-Fu
|
Cytotoxicity against human NCI-H69 cells after 3 days MTT assay
Cytotoxicity against human NCI-H69 cells after 3 days MTT assay
|
[PMID: 22796042] |
| NCM460 | EC50 |
43.32 μM
Compound: 5-FU
|
Cytotoxicity against human NCM460 cells assessed as cell viability measured after 72 hrs in presence of 5-FU by MTT assay
Cytotoxicity against human NCM460 cells assessed as cell viability measured after 72 hrs in presence of 5-FU by MTT assay
|
[PMID: 34411894] |
| NCM460 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human NCM460 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
Antiproliferative activity against human NCM460 cells assessed as reduction in cell viability measured after 48 to 72 hrs by MTT assay
|
[PMID: 37659196] |
| NCM460 | IC50 |
7.95 μM
Compound: 5-FU
|
Cytotoxicity against human NCM460 cells incubated for 72 hrs by MTS assay
Cytotoxicity against human NCM460 cells incubated for 72 hrs by MTS assay
|
[PMID: 38843656] |
| NHDF | IC50 |
14.67 μM
Compound: 5-FU
|
Antiproliferative activity against NHDF expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against NHDF expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| NHDF | IC50 |
30 μM
Compound: 5-FU
|
Antiproliferative activity against NHDF expressing p53 after 72 hrs by celltiter-glo assay
Antiproliferative activity against NHDF expressing p53 after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| NHDF | GI50 |
62.02 nM
Compound: 5FU
|
Growth inhibition of human NHDF cells after 48 hrs by SRB assay
Growth inhibition of human NHDF cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| NHDF | IC50 |
7.02 μM
Compound: FUra
|
Cytotoxicity against HDF assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
Cytotoxicity against HDF assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay
|
[PMID: 27501415] |
| NHDF | IC50 |
7.38 μM
Compound: 5-FU
|
Antiproliferative activity against NHDF after 72 hrs by MTT assay
Antiproliferative activity against NHDF after 72 hrs by MTT assay
|
[PMID: 29223098] |
| NHDF | IC50 |
>25 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human NHDF cells incubated for 72 hrs by MTS assay
Cytotoxicity against human NHDF cells incubated for 72 hrs by MTS assay
|
[PMID: 31158748] |
| NHDF | IC50 |
>50 μM
Compound: 5-FU
|
Cytotoxicity against human NHDF cells assessed as reduction in cell viability
Cytotoxicity against human NHDF cells assessed as reduction in cell viability
|
[PMID: 32127259] |
| NHDF | IC50 |
70.4 μM
Compound: 1; 5-FU
|
Cytotoxicity against NHDF assessed as reduction in cell viability measured after 48 hrs by SRB assay
Cytotoxicity against NHDF assessed as reduction in cell viability measured after 48 hrs by SRB assay
|
[PMID: 33819035] |
| NHDF | IC50 |
>50 μM
Compound: 5-FU
|
Cytotoxicity against human NHDF cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human NHDF cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 37098306] |
| NIH3T3 | GI50 |
<1.54 μM
Compound: 5FU
|
Cytotoxicity against BALB mouse 3T3 cells after 48 hrs
Cytotoxicity against BALB mouse 3T3 cells after 48 hrs
|
[PMID: 18798609] |
| NIH3T3 | GI50 |
<3 μM
Compound: 5FU
|
Cytotoxicity against BALB mouse 3T3 cells
Cytotoxicity against BALB mouse 3T3 cells
|
[PMID: 20356752] |
| NIH3T3 | IC50 |
22.36 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against mouse NIH/3T3 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
Antiproliferative activity against mouse NIH/3T3 cells assessed as inhibition of cell proliferation incubated for 48 hrs by CCK8 assay
|
[PMID: 25959813] |
| NSCLC | GI50 |
>100 μM
Compound: 5-FU
|
Growth inhibition of human NSCLC cells after 48 hrs
Growth inhibition of human NSCLC cells after 48 hrs
|
[PMID: 18950904] |
| NSCLC | GI50 |
>100 μM
Compound: 5-FU
|
Cytotoxicity against human NSCLC cells after 48 hrs by coulter counting
Cytotoxicity against human NSCLC cells after 48 hrs by coulter counting
|
[PMID: 22056277] |
| NSCLC | GI50 |
>100 μM
Compound: 5-FU
|
Growth inhibition of human NSCLC cells after 48 hrs by coulter counter method
Growth inhibition of human NSCLC cells after 48 hrs by coulter counter method
|
[PMID: 22119151] |
| NUGC-3 | IC50 |
4.4 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of NUGC-3 tumor cell line from stomach.
Compound was tested for its inhibitory effect on the growth of NUGC-3 tumor cell line from stomach.
|
10.1016/0960-894X(96)00339-3 |
| Ovarian cancer cell line | IC50 |
562.8 μM
Compound: 5-FU
|
Anticancer activity against patient-derived human Ovarian tumor cells assessed as tumor growth inhibition incubated for 72 hrs by FMCA assay
Anticancer activity against patient-derived human Ovarian tumor cells assessed as tumor growth inhibition incubated for 72 hrs by FMCA assay
|
[PMID: 36018000] |
| OVCAR-3 | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Cytotoxicity in human OVCAR3 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity in human OVCAR3 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21250700] |
| OVCAR-3 | GI50 |
0.01 μM
Compound: 5-FU
|
Growth inhibition of human OVCAR3 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human OVCAR3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| OVCAR-3 | GI50 |
0.01 μM
Compound: 5-FU
|
Anticancer activity against human OVCAR-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| OVCAR-3 | IC50 |
0.01 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human OVCAR-3 cells assessed as cell growth inhibition
Cytotoxicity against human OVCAR-3 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| OVCAR-3 | IC50 |
18.86 μM
Compound: 5-FU
|
Antiproliferative activity against human OVCAR-3 cells
Antiproliferative activity against human OVCAR-3 cells
|
[PMID: 38716896] |
| OVCAR-4 | GI50 |
4.43 μM
Compound: 5-FU
|
Growth inhibition of human OVCAR4 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human OVCAR4 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| OVCAR-4 | GI50 |
4.43 μM
Compound: 5-FU
|
Anticancer activity against human OVCAR-4 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-4 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| OVCAR-4 | IC50 |
4.43 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human OVCAR-4 cells assessed as cell growth inhibition
Cytotoxicity against human OVCAR-4 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| OVCAR-5 | GI50 |
20 μM
Compound: 5-Fu
|
Growth inhibition of human OVCAR5 cells after 48 hrs by SRB assay
Growth inhibition of human OVCAR5 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| OVCAR-5 | GI50 |
26.4 nM
Compound: 5FU
|
Growth inhibition of human OVCAR5 cells after 48 hrs by SRB assay
Growth inhibition of human OVCAR5 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| OVCAR-5 | GI50 |
10.9 μM
Compound: 5-FU
|
Growth inhibition of human OVCAR5 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human OVCAR5 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| OVCAR-5 | GI50 |
10.9 μM
Compound: 5-FU
|
Anticancer activity against human OVCAR-5 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-5 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| OVCAR-5 | IC50 |
10.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human OVCAR-5 cells assessed as cell growth inhibition
Cytotoxicity against human OVCAR-5 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| OVCAR-8 | IC50 |
96.37 μM
Compound: 5-FU
|
Antiproliferative activity against p53 deficient human OVCAR8 cells after 72 hrs by proliferative assay
Antiproliferative activity against p53 deficient human OVCAR8 cells after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| OVCAR-8 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient OVCAR8 cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient OVCAR8 cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| OVCAR-8 | GI50 |
1.74 μM
Compound: 5-FU
|
Growth inhibition of human OVCAR8 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human OVCAR8 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| OVCAR-8 | GI50 |
1.74 μM
Compound: 5-FU
|
Anticancer activity against human OVCAR-8 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human OVCAR-8 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| OVCAR-8 | IC50 |
1.74 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human OVCAR-8 cells assessed as cell growth inhibition
Cytotoxicity against human OVCAR-8 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| P388 | IC50 |
0.02 μg/mL
Compound: 5-fluorouracil
|
Antitumor activity against mouse P388 cells
Antitumor activity against mouse P388 cells
|
[PMID: 10579858] |
| P388 | IC50 |
0.49 μM
Compound: 5-Fluorouracil
|
Concentration required to inhibit 50% of cell growth on murine P388 D1 cells.
Concentration required to inhibit 50% of cell growth on murine P388 D1 cells.
|
[PMID: 11052798] |
| P388 | ED50 |
0.075 μg/mL
Compound: 5-FU
|
Growth inhibition of mouse P388 cells
Growth inhibition of mouse P388 cells
|
[PMID: 12502333] |
| P388 | GI50 |
0.073 μg/mL
Compound: 5-FU
|
Growth inhibition of mouse P388 cells
Growth inhibition of mouse P388 cells
|
[PMID: 16562827] |
| P388 | ED50 |
0.073 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 17067147] |
| P388 | ED50 |
0.08 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 1812210] |
| P388 | IC50 |
1.7 pM
Compound: 5-FU
|
Cytotoxicity against mouse P388 cells after 72 hrs by MTT assay
Cytotoxicity against mouse P388 cells after 72 hrs by MTT assay
|
[PMID: 21640594] |
| P388 | ED50 |
6.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse P388 cells by Alamar blue assay
Cytotoxicity against mouse P388 cells by Alamar blue assay
|
[PMID: 24128077] |
| P388 | IC50 |
609 nM
Compound: Fluorouracil
|
Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay
Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay
|
[PMID: 2778449] |
| P388 | IC50 |
5.8 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against mouse P388 cells incubated for 72 hrs by alamar blue assay
Cytotoxicity against mouse P388 cells incubated for 72 hrs by alamar blue assay
|
[PMID: 28648460] |
| P388 | ED50 |
3.72 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 3443857] |
| P388 | IC50 |
0.0219 mM
Compound: 5-FU
|
Cytotoxicity against Mus musculus (mouse) P388 cells assessed as growth inhibition after 72 hr by MTT assay
Cytotoxicity against Mus musculus (mouse) P388 cells assessed as growth inhibition after 72 hr by MTT assay
|
10.1007/s00044-012-0181-0 |
| PA-1 | IC50 |
5 μM
Compound: 5-FU
|
Antiproliferative activity against human PA1 cells after 48 hrs by resazurin reduction test
Antiproliferative activity against human PA1 cells after 48 hrs by resazurin reduction test
|
[PMID: 21530016] |
| PA-1 | IC50 |
39.5 μM
Compound: 5-FU
|
Cytotoxicity against human PA1 cells after 24 hrs by MTT assay
Cytotoxicity against human PA1 cells after 24 hrs by MTT assay
|
[PMID: 23202484] |
| PA-1 | IC50 |
7.59 μM
Compound: 5-FU
|
Anticancer activity against human PA1 cells after 48 hrs by MTT assay
Anticancer activity against human PA1 cells after 48 hrs by MTT assay
|
[PMID: 26413726] |
| PA-1 | IC50 |
8.51 μM
Compound: F
|
Cytotoxicity against human PA1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human PA1 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 27210438] |
| PA-1 | IC50 |
39.5 μM
Compound: 5-FU
|
Growth inhibition of human PA1 cells after 24 hrs by MTT assay
Growth inhibition of human PA1 cells after 24 hrs by MTT assay
|
[PMID: 28011220] |
| PANC-1 | IC50 |
0.22 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human pancreas epitheloid carcinoma (PANC-1) cells
In vitro inhibitory activity against growth of Human pancreas epitheloid carcinoma (PANC-1) cells
|
[PMID: 1995901] |
| PANC-1 | IC50 |
3.94 μM
Compound: 5-FU
|
Cytotoxicity against human PANC1 cells by crystal violet staining
Cytotoxicity against human PANC1 cells by crystal violet staining
|
[PMID: 20930123] |
| PANC-1 | IC50 |
54.1 μM
Compound: 5-fluorouracil
|
Cytotoxicity in human PANC1 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity in human PANC1 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21250700] |
| PANC-1 | IC50 |
50 μM
Compound: 5-FU
|
Cytotoxicity against human PANC1 cells assessed as inhibition of cell viability after 6 days by MTT assay
Cytotoxicity against human PANC1 cells assessed as inhibition of cell viability after 6 days by MTT assay
|
[PMID: 23360104] |
| PANC-1 | IC50 |
50 μM
Compound: 5-FU
|
Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay
Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay
|
[PMID: 25124114] |
| PANC-1 | IC50 |
3.7 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human PANC1 cells after 72 hrs by WST8 assay
Antiproliferative activity against human PANC1 cells after 72 hrs by WST8 assay
|
[PMID: 25919052] |
| PANC-1 | IC50 |
0.4 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human PANC1 cells after 72 hrs by WST-8 assay
Antiproliferative activity against human PANC1 cells after 72 hrs by WST-8 assay
|
[PMID: 26606140] |
| PANC-1 | IC50 |
47.83 μM
Compound: 5-Fu
|
Antiproliferative activity against human PANC1 cells after 48 hrs by MTT assay
Antiproliferative activity against human PANC1 cells after 48 hrs by MTT assay
|
[PMID: 28110871] |
| PANC-1 | IC50 |
62.303 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human PANC1 cells incubated for 24 hrs by MTT assay
Cytotoxicity against human PANC1 cells incubated for 24 hrs by MTT assay
|
[PMID: 30904782] |
| PANC-1 | IC50 |
15 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human PANC1 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human PANC1 cells incubated for 72 hrs by MTT assay
|
[PMID: 31829592] |
| PANC-1 | IC50 |
4.3 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human Panc-1 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human Panc-1 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay
|
[PMID: 32007666] |
| PANC-1 | IC50 |
100 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human PANC-1 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
Cytotoxicity against human PANC-1 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
|
[PMID: 36970146] |
| PANC-1 | IC50 |
48.24 μM
Compound: 5-Fu
|
Antiproliferative activity against human PANC-1 cells by CCK8 assay
Antiproliferative activity against human PANC-1 cells by CCK8 assay
|
[PMID: 37939862] |
| PANC-1 | IC50 |
44.11 μM
Compound: 5-FU
|
Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 39016216] |
| PANC-1 | IC50 |
180.033 μM
Compound: 5-Fu
|
Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human PANC-1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 39163776] |
| PANC-1 | IC50 |
>78 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of PANC-1 tumor cell line from pancreas.
Compound was tested for its inhibitory effect on the growth of PANC-1 tumor cell line from pancreas.
|
10.1016/0960-894X(96)00339-3 |
| Panel NCI-60 (60 carcinoma cell lines) | GI50 |
22.6 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human Panel NCI-60 (60 carcinoma cell lines) cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B assay
Anticancer activity against human Panel NCI-60 (60 carcinoma cell lines) cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B assay
|
[PMID: 31881454] |
| Panel NCI-60 (60 carcinoma cell lines) | GI50 |
18000 μM
Compound: 5-fluorouracil
|
Growth inhibition of human Panel NCI-60 (60 carcinoma cell lines) incubated for 48 hrs by sulforhodamine B assay
Growth inhibition of human Panel NCI-60 (60 carcinoma cell lines) incubated for 48 hrs by sulforhodamine B assay
|
[PMID: 33766762] |
| Panel NCI-60 cells | GI50 |
22.6 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human Panel NCI-60 (60 carcinoma cell lines) cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B assay
Anticancer activity against human Panel NCI-60 (60 carcinoma cell lines) cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B assay
|
[PMID: 31881454] |
| Panel NCI-60 cells | GI50 |
18000 μM
Compound: 5-fluorouracil
|
Growth inhibition of human Panel NCI-60 (60 carcinoma cell lines) incubated for 48 hrs by sulforhodamine B assay
Growth inhibition of human Panel NCI-60 (60 carcinoma cell lines) incubated for 48 hrs by sulforhodamine B assay
|
[PMID: 33766762] |
| PaTu 8988t | IC50 |
2.08 μM
Compound: 5-FU
|
Cytotoxicity against human Patu-T cells by crystal violet staining
Cytotoxicity against human Patu-T cells by crystal violet staining
|
[PMID: 20930123] |
| PaTu 8988t | IC50 |
33.2 μM
Compound: 5-FU
|
Cytotoxicity against human 5-FU-resistant Patu-T cells by crystal violet staining
Cytotoxicity against human 5-FU-resistant Patu-T cells by crystal violet staining
|
[PMID: 20930123] |
| PBMC | IC50 |
>50 μM
Compound: 5-Fu
|
Cytotoxicity against human PBMC assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human PBMC assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992] |
| PBMC | IC50 |
>50 μM
Compound: 5-Fu
|
Cytotoxicity against human PBMC cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human PBMC cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 31877536] |
| PBMC | IC50 |
>40 μM
Compound: 5-Fu
|
Cytotoxicity against human PBMC assessed as reduction in cell growth after 72 hrs by MTT assay
Cytotoxicity against human PBMC assessed as reduction in cell growth after 72 hrs by MTT assay
|
[PMID: 31883693] |
| PC10 | IC50 |
>100 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of human lung squamous cell carcinoma PC10 solid cell lines.
Concentration required for 50% inhibition of human lung squamous cell carcinoma PC10 solid cell lines.
|
[PMID: 1992123] |
| PC10 | IC50 |
>100 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human lung squamous cell carcinoma (PC-10) cell line.
In vitro inhibitory activity against Human lung squamous cell carcinoma (PC-10) cell line.
|
[PMID: 1995905] |
| PC10 | IC50 |
>100 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of human lung squamous cell carcinoma cell lines (PC10).
In vitro inhibitory effect on growth of human lung squamous cell carcinoma cell lines (PC10).
|
[PMID: 3373480] |
| PC10 | IC50 |
42 μg/mL
Compound: 5-FU
|
Concentration at 50 percent inhibition of cell growth against human cancer PC10 cell line in vitro
Concentration at 50 percent inhibition of cell growth against human cancer PC10 cell line in vitro
|
10.1016/S0960-894X(01)81041-6 |
| PC-14 | IC50 |
10 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of human lung squamous cell carcinoma PC14 solid cell lines.
Concentration required for 50% inhibition of human lung squamous cell carcinoma PC14 solid cell lines.
|
[PMID: 1992123] |
| PC-14 | IC50 |
10 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human lung adenocarcinoma (PC-14) cell line.
In vitro inhibitory activity against Human lung adenocarcinoma (PC-14) cell line.
|
[PMID: 1995905] |
| PC-3 | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against PC-3 cells
Tested in vitro for anticancer activity against PC-3 cells
|
[PMID: 10072683] |
| PC-3 | IC50 |
12 μM
Compound: 5-FU
|
Concentration required to inhibit proliferation of PC-3 prostate cancer cell lines
Concentration required to inhibit proliferation of PC-3 prostate cancer cell lines
|
[PMID: 15341952] |
| PC-3 | IC50 |
12 μM
Compound: 5-FU
|
Antiproliferative activity was evaluated against human prostate PC-3 cancer cell lines using the sulforhodamine B (STB) assay
Antiproliferative activity was evaluated against human prostate PC-3 cancer cell lines using the sulforhodamine B (STB) assay
|
[PMID: 15454213] |
| PC-3 | IC50 |
12 μM
Compound: 5-FU
|
Antiproliferative activity against prostate cancer PC-3 cell line using sulforhodamine B(SRB) assay
Antiproliferative activity against prostate cancer PC-3 cell line using sulforhodamine B(SRB) assay
|
[PMID: 15801848] |
| PC-3 | IC50 |
12 μM
Compound: 5-FU
|
Antiproliferative activity against human prostate cancer PC-3 cell line by sulforhodamine B assay
Antiproliferative activity against human prostate cancer PC-3 cell line by sulforhodamine B assay
|
[PMID: 16005217] |
| PC-3 | IC50 |
13.77 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against human PC3 cells expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| PC-3 | GI50 |
14.6 μM
Compound: 5FU
|
Cytotoxicity against human PC3 cells after 48 hrs
Cytotoxicity against human PC3 cells after 48 hrs
|
[PMID: 18798609] |
| PC-3 | IC50 |
0.016 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 19423198] |
| PC-3 | IC50 |
2.48 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 20800480] |
| PC-3 | IC50 |
30 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient PC3 cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient PC3 cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| PC-3 | IC50 |
12 μM
Compound: 5-fluorouracil
|
Anticancer activity against human PC3 cells assessed as cell viability after 48 hrs by SRB assay
Anticancer activity against human PC3 cells assessed as cell viability after 48 hrs by SRB assay
|
[PMID: 21074444] |
| PC-3 | IC50 |
29.3 μM
Compound: 5-Fu
|
Antitumor activity against human PC3 cells after 72 hrs by MTT assay
Antitumor activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 21486694] |
| PC-3 | IC50 |
15.69 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human PC3 after 48 hrs by MTT assay
Cytotoxicity against human PC3 after 48 hrs by MTT assay
|
[PMID: 21486698] |
| PC-3 | GI50 |
12 μM
Compound: 5FU
|
Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| PC-3 | IC50 |
2.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human PC3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 22424614] |
| PC-3 | GI50 |
21 μM
Compound: 5-Fu
|
Growth inhibition of human PC3 cells after 48 hrs by SRB assay
Growth inhibition of human PC3 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| PC-3 | IC50 |
35.75 μM
Compound: 5-Fu
|
Cytotoxicity against human PC3 cells by MTT assay
Cytotoxicity against human PC3 cells by MTT assay
|
[PMID: 22801644] |
| PC-3 | GI50 |
10.45 nM
Compound: 5FU
|
Growth inhibition of human PC3 cells after 48 hrs by SRB assay
Growth inhibition of human PC3 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| PC-3 | IC50 |
27.07 μM
Compound: 5-Fu
|
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 23353743] |
| PC-3 | IC50 |
2.2 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human PC3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23501113] |
| PC-3 | IC50 |
27.07 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells expressing SKP2 after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells expressing SKP2 after 72 hrs by MTT assay
|
[PMID: 23735281] |
| PC-3 | IC50 |
31.44 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells expressing PCDNA after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells expressing PCDNA after 72 hrs by MTT assay
|
[PMID: 23735281] |
| PC-3 | IC50 |
24.76 μM
Compound: 5-Fu
|
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 23792764] |
| PC-3 | GI50 |
2.36 μM
Compound: 5-FU
|
Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| PC-3 | IC50 |
24.76 μM
Compound: 5-Fu
|
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 24077182] |
| PC-3 | IC50 |
4.68 μM
Compound: 5-Fu
|
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 24798098] |
| PC-3 | IC50 |
2.2 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 24910974] |
| PC-3 | IC50 |
12 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 24956552] |
| PC-3 | IC50 |
2.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay
Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by sulphorhodamine B assay
|
[PMID: 26222449] |
| PC-3 | IC50 |
22.63 μM
Compound: 5-Fu
|
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 26363869] |
| PC-3 | IC50 |
68.28 μM
Compound: 5-FU
|
Anticancer activity against human PC3 cells after 48 hrs by MTT assay
Anticancer activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 26413726] |
| PC-3 | IC50 |
42.5 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 26595184] |
| PC-3 | IC50 |
4.9 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
Antiproliferative activity against human PC3 cells assessed as cellular DNA content after 72 hrs by CyQUANT NF fluorescence assay
|
[PMID: 26731300] |
| PC-3 | IC50 |
1.44 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 26735909] |
| PC-3 | IC50 |
2.76 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 27092413] |
| PC-3 | IC50 |
0.03 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay
Cytotoxicity against human PC3 cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay
|
[PMID: 27156770] |
| PC-3 | IC50 |
57.04 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells measured after 48 hrs by MTT assay
|
[PMID: 27287368] |
| PC-3 | IC50 |
106.26 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human PC-3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC-3 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| PC-3 | IC50 |
72.07 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27448774] |
| PC-3 | IC50 |
13.3 μM
Compound: 5 Fluorouracil
|
Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212] |
| PC-3 | GI50 |
4.1 μM
Compound: 5-FU
|
Growth inhibition of human PC3 cells measured after 72 hrs by MTT assay
Growth inhibition of human PC3 cells measured after 72 hrs by MTT assay
|
[PMID: 27504537] |
| PC-3 | IC50 |
42.5 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells measured after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells measured after 72 hrs by MTT assay
|
[PMID: 27537924] |
| PC-3 | IC50 |
45.32 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 27614408] |
| PC-3 | IC50 |
1.8 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human PC3 cells assessed as cell growth inhibition by MTT assay
Cytotoxicity against human PC3 cells assessed as cell growth inhibition by MTT assay
|
[PMID: 27720296] |
| PC-3 | IC50 |
1.2 mM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27847140] |
| PC-3 | IC50 |
15.31 μM
Compound: 5-Fu
|
Cytotoxic activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
|
[PMID: 28011223] |
| PC-3 | IC50 |
29.31 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay
|
[PMID: 28038329] |
| PC-3 | IC50 |
38.61 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells incubated for 48 to 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells incubated for 48 to 72 hrs by MTT assay
|
[PMID: 28395218] |
| PC-3 | IC50 |
1.2 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 28431881] |
| PC-3 | IC50 |
24.33 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 28458133] |
| PC-3 | IC50 |
24.3 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 28494251] |
| PC-3 | IC50 |
1.6 μM
Compound: 5-Fu
|
Cytotoxic activity against human PC3 cells
Cytotoxic activity against human PC3 cells
|
[PMID: 28697923] |
| PC-3 | IC50 |
13.7 μM
Compound: 5-Fu
|
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 28759877] |
| PC-3 | IC50 |
12.87 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 28763643] |
| PC-3 | GI50 |
11.7 μM
Compound: 5-Fluorouracil
|
Growth inhibition of human PC3 cells after 48 hrs by SRB assay
Growth inhibition of human PC3 cells after 48 hrs by SRB assay
|
[PMID: 28898082] |
| PC-3 | IC50 |
1.2 μM
Compound: 5-FU
|
Cytotoxicity in human PC3 cells incubated for 48 hrs by MTT assay
Cytotoxicity in human PC3 cells incubated for 48 hrs by MTT assay
|
[PMID: 28923381] |
| PC-3 | IC50 |
23.94 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells treated for 24 hrs measured after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells treated for 24 hrs measured after 72 hrs by MTT assay
|
[PMID: 29037951] |
| PC-3 | IC50 |
22.02 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells by MTT assay
Antiproliferative activity against human PC3 cells by MTT assay
|
[PMID: 29131616] |
| PC-3 | IC50 |
19.87 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 29133049] |
| PC-3 | IC50 |
4.75 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 29133051] |
| PC-3 | IC50 |
>30 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 29133061] |
| PC-3 | IC50 |
0.53 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 29254641] |
| PC-3 | IC50 |
27.61 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 29407946] |
| PC-3 | IC50 |
23.86 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 29407983] |
| PC-3 | IC50 |
6.27 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 29475156] |
| PC-3 | IC50 |
23.86 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 29524728] |
| PC-3 | IC50 |
12.33 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 29635165] |
| PC-3 | IC50 |
8.45 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 29958763] |
| PC-3 | IC50 |
23.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 30527868] |
| PC-3 | IC50 |
49.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 30737134] |
| PC-3 | IC50 |
20.45 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757] |
| PC-3 | IC50 |
21.4 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human PC3 cells
Cytotoxicity against human PC3 cells
|
[PMID: 31200236] |
| PC-3 | IC50 |
63.8 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human PC3 cells after 24 hrs by MTT assay
Cytotoxicity against human PC3 cells after 24 hrs by MTT assay
|
[PMID: 31401008] |
| PC-3 | IC50 |
1.6 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 31546197] |
| PC-3 | IC50 |
2.42 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197] |
| PC-3 | IC50 |
18.42 μM
Compound: 5-FU
|
Anticancer activity against human PC-3 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Anticancer activity against human PC-3 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 31577977] |
| PC-3 | IC50 |
20.42 μM
Compound: 5-FU
|
Antiproliferative activity against human PC3 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay
|
[PMID: 31740251] |
| PC-3 | IC50 |
8.3 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human PC-3 cells
Cytotoxicity against human PC-3 cells
|
[PMID: 31761383] |
| PC-3 | IC50 |
6.8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability measured for 24 hrs
Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability measured for 24 hrs
|
[PMID: 31945642] |
| PC-3 | IC50 |
17.31 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-3 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human PC-3 cells measured after 48 hrs by MTT assay
|
[PMID: 32135407] |
| PC-3 | IC50 |
5.32 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
|
[PMID: 32619887] |
| PC-3 | IC50 |
18.4 μM
Compound: 5-FU
|
Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32682200] |
| PC-3 | IC50 |
1.64 μM
Compound: 5-FU
|
Anticancer activity against PTEN null human PC-3 cells assessed as inhibition of cell proliferation
Anticancer activity against PTEN null human PC-3 cells assessed as inhibition of cell proliferation
|
[PMID: 32750679] |
| PC-3 | IC50 |
2.88 μM
Compound: 5-fluoro uracil
|
Cytotoxicity against human PC-3 cells incubated for 3 days by MTT assay
Cytotoxicity against human PC-3 cells incubated for 3 days by MTT assay
|
[PMID: 33152379] |
| PC-3 | IC50 |
9.5 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human PC-3 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
Cytotoxicity against human PC-3 cells assessed as reduction in cell viability measured upto 72 hrs by MTT assay
|
[PMID: 33799070] |
| PC-3 | IC50 |
6.23 μM
Compound: 5-FU
|
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 34302974] |
| PC-3 | IC50 |
10.4 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 34455358] |
| PC-3 | IC50 |
10.36 μM
Compound: 5-FU
|
Antiproliferative activity against human PC-3 cells
Antiproliferative activity against human PC-3 cells
|
[PMID: 34655985] |
| PC-3 | IC50 |
32.87 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 34715305] |
| PC-3 | GI50 |
2.36 μM
Compound: 5-FU
|
Anticancer activity against human PC-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human PC-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| PC-3 | IC50 |
8.41 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 35259487] |
| PC-3 | IC50 |
9.09 μM
Compound: 5-FU
|
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
|
[PMID: 35290844] |
| PC-3 | IC50 |
15.12 μM
Compound: 5-Fu
|
Antitumor activity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36216031] |
| PC-3 | IC50 |
2.5 μM
Compound: 5-FU
|
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 36242987] |
| PC-3 | IC50 |
27.64 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell proliferation by MTT assay
Antiproliferative activity against human PC-3 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36336316] |
| PC-3 | IC50 |
2.36 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human PC-3 cells assessed as cell growth inhibition
Cytotoxicity against human PC-3 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| PC-3 | IC50 |
8.41 μM
Compound: 5-Fu
|
Antitumor activity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 36931124] |
| PC-3 | IC50 |
10.3 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human PC-3 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
Cytotoxicity against human PC-3 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
|
[PMID: 36970146] |
| PC-3 | IC50 |
8.46 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-3 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human PC-3 cells measured after 72 hrs by MTT assay
|
[PMID: 37379957] |
| PC-3 | IC50 |
6.7 μM
Compound: 5-FU
|
Cytotoxicity against human PC-3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity against human PC-3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 37859725] |
| PC-3 | IC50 |
10.23 μM
Compound: 5-fluorouracil
|
Inhibition of cell proliferation in human PC-3 cells incubated for 72 hrs by MTT assay
Inhibition of cell proliferation in human PC-3 cells incubated for 72 hrs by MTT assay
|
[PMID: 39285177] |
| PC-3 | IC50 |
46 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
10.1039/C5MD00382B |
| PC-3 | IC50 |
12.23 μM
Compound: 5-FU
|
Cytotoxicity against human PC3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
10.1039/C6MD00061D |
| PC-3M | IC50 |
22.63 μM
Compound: Fluorouracil
|
Cytotoxicity against human PC3M cells after 48 hrs by MTT assay
Cytotoxicity against human PC3M cells after 48 hrs by MTT assay
|
[PMID: 22809558] |
| PC-8 | IC50 |
0.42 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human lung adenocarcinoma (PC-8) cells
In vitro inhibitory activity against growth of Human lung adenocarcinoma (PC-8) cells
|
[PMID: 1995901] |
| PC-9 | IC50 |
23.47 μM
Compound: 5-FU
|
Cytotoxicity against human PC9 cells after 48 hrs by MTT assay
Cytotoxicity against human PC9 cells after 48 hrs by MTT assay
|
[PMID: 22483608] |
| PC-9 | IC50 |
1.99 μM
Compound: 5-FU
|
Cytotoxicity against human PC9 cells assessed as growth inhibition by MTT assay
Cytotoxicity against human PC9 cells assessed as growth inhibition by MTT assay
|
[PMID: 27769034] |
| PC-9 | IC50 |
4.12 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC9 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
Antiproliferative activity against human PC9 cells assessed as reduction in cell viability after 24 to 72 hrs by MTT assay
|
[PMID: 32619887] |
| PC-9 | IC50 |
>10 μM
Compound: 5-FU
|
Cytotoxicity against human PC-9 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
Cytotoxicity against human PC-9 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay
|
[PMID: 32659087] |
| PC-9 | IC50 |
3.25 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-9 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human PC-9 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 32682202] |
| PC-9 | IC50 |
6.52 μM
Compound: 5-Fu
|
Antiproliferative activity against human PC-9 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human PC-9 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33385852] |
| PHA-Ly | IC50 |
1.4 μg/mL
Compound: 5-F-Ura
|
IIn vitro antitumor activity in PHA-Ly cell lines
IIn vitro antitumor activity in PHA-Ly cell lines
|
[PMID: 8648611] |
| PLC | IC50 |
116.8 μM
Compound: 5-Fu
|
Antiproliferative activity against human PLC cells after 48 hrs by MTT assay
Antiproliferative activity against human PLC cells after 48 hrs by MTT assay
|
[PMID: 30737134] |
| PLC-PRF-5 | IC50 |
38.35 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human PLC-PRF-5 cells after 48 hrs by MTT assay
Antiproliferative activity against human PLC-PRF-5 cells after 48 hrs by MTT assay
|
[PMID: 27322756] |
| PLC-PRF-5 | IC50 |
22.81 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human PLC/PRF/5 cells in presence of ubenimex after 48 hrs by MTT assay
Antiproliferative activity against human PLC/PRF/5 cells in presence of ubenimex after 48 hrs by MTT assay
|
[PMID: 29202398] |
| PLC-PRF-5 | IC50 |
35.66 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human PLC/PRF/5 cells after 48 hrs by MTT assay
Antiproliferative activity against human PLC/PRF/5 cells after 48 hrs by MTT assay
|
[PMID: 29202398] |
| PLC-PRF-5 | IC50 |
2.8 μM
Compound: Fluorouracil
|
Cytotoxicity against human PLC/PRF/5 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human PLC/PRF/5 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 31013087] |
| PNT1A | IC50 |
9.7 μM
Compound: 5-FU
|
Cytotoxicity against human PNT1A cells assessed as reduction in cell viability
Cytotoxicity against human PNT1A cells assessed as reduction in cell viability
|
[PMID: 32750679] |
| PNT1A | IC50 |
192.12 μM
Compound: 5-FU
|
Antiproliferative activity against human PNT1A cells assessed as inhibition of cell growth measured after 48 hrs by Alamar blue dye based assay
Antiproliferative activity against human PNT1A cells assessed as inhibition of cell growth measured after 48 hrs by Alamar blue dye based assay
|
[PMID: 38171252] |
| PPC-1 | IC50 |
6.4 μM
Compound: 5-FU
|
Concentration required to inhibit proliferation of PPC-1 prostate cancer cell lines
Concentration required to inhibit proliferation of PPC-1 prostate cancer cell lines
|
[PMID: 15341952] |
| PPC-1 | IC50 |
6.4 μM
Compound: 5-FU
|
Antiproliferative activity against prostate cancer PPC-1 cell line using sulforhodamine B(SRB) assay
Antiproliferative activity against prostate cancer PPC-1 cell line using sulforhodamine B(SRB) assay
|
[PMID: 15801848] |
| PPC-1 | IC50 |
6.4 μM
Compound: 5-FU
|
Antiproliferative activity against human prostate cancer PPC-1 cell line by sulforhodamine B assay
Antiproliferative activity against human prostate cancer PPC-1 cell line by sulforhodamine B assay
|
[PMID: 16005217] |
| PSN1 | IC50 |
4.4 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human PSN1 cells after 72 hrs by WST8 assay
Antiproliferative activity against human PSN1 cells after 72 hrs by WST8 assay
|
[PMID: 25919052] |
| PSN1 | IC50 |
8.7 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human PSN1 cells after 72 hrs by WST-8 assay
Antiproliferative activity against human PSN1 cells after 72 hrs by WST-8 assay
|
[PMID: 26606140] |
| QG-56 | IC50 |
0.18 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human lung squamous-cell carcinoma (QG-56) cells
In vitro inhibitory activity against growth of Human lung squamous-cell carcinoma (QG-56) cells
|
[PMID: 1995901] |
| QG-90 | IC50 |
0.22 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human lung small cell carcinoma (QG-90) cells
In vitro inhibitory activity against growth of Human lung small cell carcinoma (QG-90) cells
|
[PMID: 1995901] |
| QGY-7703 | IC50 |
15.66 μM
Compound: 5-Fu
|
Cytotoxicity against human QGY7703 cells after 48 hrs by CCK-8 assay
Cytotoxicity against human QGY7703 cells after 48 hrs by CCK-8 assay
|
[PMID: 24013415] |
| QGY-7703 | IC50 |
14.2 μM
Compound: 5-Fu
|
Antiproliferative activity against human QGY7703 cells after 24 hrs by CCK-8 assay
Antiproliferative activity against human QGY7703 cells after 24 hrs by CCK-8 assay
|
[PMID: 29499490] |
| RKO | IC50 |
4.39 μM
Compound: 5-Fu
|
Cytotoxicity against human RKO cells after 3 days by SRB assay
Cytotoxicity against human RKO cells after 3 days by SRB assay
|
[PMID: 24704691] |
| RKO | IC50 |
>50 μM
Compound: 5-FU
|
Anticancer activity against human RKO cells assessed as inhibition of cell growth after 24 hrs by MTT assay
Anticancer activity against human RKO cells assessed as inhibition of cell growth after 24 hrs by MTT assay
|
[PMID: 26922233] |
| RKO | IC50 |
41.1 μM
Compound: 5-FU
|
Anticancer activity against human RKO cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Anticancer activity against human RKO cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26922233] |
| RKO | IC50 |
6.8 μM
Compound: 5-FU
|
Anticancer activity against human RKO cells assessed as inhibition of cell growth after 72 hrs by MTT assay
Anticancer activity against human RKO cells assessed as inhibition of cell growth after 72 hrs by MTT assay
|
[PMID: 26922233] |
| RKO | IC50 |
10.2 μM
Compound: 5-FU
|
Growth inhibition of human RKO cells after 48 hrs by CCK-8 assay
Growth inhibition of human RKO cells after 48 hrs by CCK-8 assay
|
[PMID: 30106289] |
| RKO | IC50 |
2.9 μM
Compound: 5-FU
|
Antiproliferative activity against human RKO cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human RKO cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32127259] |
| RKO | IC50 |
>10 μM
Compound: 5-FU
|
Cytotoxicity against human RKO cells after 24 hrs by MTT assay
Cytotoxicity against human RKO cells after 24 hrs by MTT assay
|
[PMID: 32223193] |
| RKO | IC50 |
10.09 μM
Compound: 5-FU
|
Antitumor activity against human RKO cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human RKO cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 35777102] |
| RKO | IC50 |
12.71 μM
Compound: 5-FU
|
Anticancer activity against human RKO cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human RKO cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| RKO | IC50 |
12 μM
Compound: 5-FU
|
Cytotoxicity against human RKO cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
Cytotoxicity against human RKO cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
|
[PMID: 37243616] |
| RKO | IC50 |
3.43 μM
Compound: 5-Fu
|
Cytotoxicity against human RKO cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human RKO cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| RKO | IC50 |
3.96 μM
Compound: 5-FU
|
Cytotoxicity against human RKO cells incubated for 72 hrs by MTS assay
Cytotoxicity against human RKO cells incubated for 72 hrs by MTS assay
|
[PMID: 38843656] |
| RL | IC50 |
3.2 μM
Compound: 5-FU
|
Antiproliferative activity against human RL cells after 72 hrs by MTT assay
Antiproliferative activity against human RL cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| RPMI-8226 | IC50 |
3.55 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human RPMI8226 cells
Cytotoxicity against human RPMI8226 cells
|
[PMID: 16996657] |
| RPMI-8226 | IC50 |
0.07 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human myeloma (RPMI 8226) cells
In vitro inhibitory activity against growth of Human myeloma (RPMI 8226) cells
|
[PMID: 1995901] |
| RPMI-8226 | GI50 |
0.04 μM
Compound: 5-FU
|
Growth inhibition of human RPMI8226 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human RPMI8226 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| RPMI-8226 | IC50 |
3.55 μM
Compound: 5-Fluorouracil
|
Antileukemic activity against human RPMI8226 cells assessed as inhibition of tumor growth after 24 hrs
Antileukemic activity against human RPMI8226 cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| RPMI-8226 | GI50 |
0.04 μM
Compound: 5-FU
|
Anticancer activity against human RPMI-8226 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human RPMI-8226 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| RPMI-8226 | IC50 |
0.04 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human RPMI-8226 cells assessed as cell growth inhibition
Cytotoxicity against human RPMI-8226 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| RT-112 | IC50 |
7.4 μM
Compound: 5-FU
|
Antiproliferative activity against human RT-112 cells
Antiproliferative activity against human RT-112 cells
|
[PMID: 34655985] |
| RXF 393 | GI50 |
2.61 μM
Compound: 5-FU
|
Growth inhibition of human RXF393 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human RXF393 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| RXF 393 | GI50 |
2.61 μM
Compound: 5-FU
|
Anticancer activity against human RXF 393 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human RXF 393 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| RXF 393 | IC50 |
28.23 μM
Compound: 5-FU
|
Cytotoxicity against human RXF 393 cells assessed as inhibition of cell viability incubated for 72 hrs under hypoxia condition by MTT assay
Cytotoxicity against human RXF 393 cells assessed as inhibition of cell viability incubated for 72 hrs under hypoxia condition by MTT assay
|
[PMID: 35182815] |
| RXF 393 | IC50 |
2.61 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human RXF 393 cells assessed as cell growth inhibition
Cytotoxicity against human RXF 393 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SAOS-2 | IC50 |
0.78 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human osteogenic sarcoma (Saos-2) cells
In vitro inhibitory activity against growth of Human osteogenic sarcoma (Saos-2) cells
|
[PMID: 1995901] |
| SCC-9 | IC50 |
12.7 μg/mL
Compound: 5-FU
|
Antiproliferative activity against human SCC-9 cells assessed as cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human SCC-9 cells assessed as cell viability measured after 72 hrs by MTT assay
|
[PMID: 34463097] |
| SCLC | IC50 |
8.4 μM
Compound: 5-FluoroUracil
|
Cytotoxicity against human SCLC cells resistant to cisplatin (SCLC/CDDP)
Cytotoxicity against human SCLC cells resistant to cisplatin (SCLC/CDDP)
|
[PMID: 8258835] |
| SF-268 | IC50 |
87.96 μM
Compound: 5-FU
|
Antiproliferative activity against p53 deficient human SF268 cells after 72 hrs
Antiproliferative activity against p53 deficient human SF268 cells after 72 hrs
|
[PMID: 18469809] |
| SF-268 | IC50 |
>100 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient SF268 cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient SF268 cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| SF-268 | GI50 |
1.62 μM
Compound: 5-FU
|
Growth inhibition of human SF268 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SF268 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SF-268 | GI50 |
1.62 μM
Compound: 5-FU
|
Anticancer activity against human SF-268 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SF-268 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SF-268 | IC50 |
1.62 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SF-268 cells assessed as cell growth inhibition
Cytotoxicity against human SF-268 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SF-268 | GI50 |
49.21 μM
Compound: 5-FU
|
Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
|
10.1007/s00044-013-0798-7 |
| SF-295 | GI50 |
76 μM
Compound: 5-Fu
|
Growth inhibition of human SF295 cells after 48 hrs by SRB assay
Growth inhibition of human SF295 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| SF-295 | GI50 |
0.22 μM
Compound: 5-FU
|
Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SF-295 | IC50 |
0.49 μM
Compound: 5-FU
|
Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition in presence of piperlongumine
Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition in presence of piperlongumine
|
[PMID: 33930801] |
| SF-295 | IC50 |
2.33 μM
Compound: 5-FU
|
Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition
Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition
|
[PMID: 33930801] |
| SF-539 | IC50 |
50.09 μM
Compound: 5-FU
|
Antiproliferative activity against human SF539 cells expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against human SF539 cells expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| SF-539 | IC50 |
43 μM
Compound: 5-FU
|
Antiproliferative activity against human SF539 cells expressing p53 after 72 hrs by celltiter-glo assay
Antiproliferative activity against human SF539 cells expressing p53 after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| SF-539 | GI50 |
0.06 μM
Compound: 5-FU
|
Growth inhibition of human SF539 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SF539 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SF-539 | GI50 |
0.06 μM
Compound: 5-FU
|
Anticancer activity against human SF-539 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SF-539 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SF-539 | IC50 |
0.06 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SF-539 cells assessed as cell growth inhibition
Cytotoxicity against human SF-539 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SGC-7901 | IC50 |
2.95 μM
Compound: 5-FU
|
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 20494492] |
| SGC-7901 | IC50 |
7.38 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 after 48 hrs by MTT assay
|
[PMID: 20538457] |
| SGC-7901 | IC50 |
7.38 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 20800480] |
| SGC-7901 | IC50 |
7.36 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 20947362] |
| SGC-7901 | IC50 |
31.46 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 after 48 hrs by MTT assay
|
[PMID: 21486698] |
| SGC-7901 | IC50 |
76 μM
Compound: 5-FU
|
Cytotoxicity against human SGC7901 cells after 2 days by alamar blue assay
Cytotoxicity against human SGC7901 cells after 2 days by alamar blue assay
|
[PMID: 22093761] |
| SGC-7901 | IC50 |
7.11 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 22405648] |
| SGC-7901 | IC50 |
6.04 μM
Compound: 5-Fu
|
Cytotoxicity against human SGC7901 cells by after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells by after 48 hrs by MTT assay
|
[PMID: 22579780] |
| SGC-7901 | IC50 |
8.7 μg/mL
Compound: 5-FU
|
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 22647218] |
| SGC-7901 | IC50 |
14.49 μM
Compound: 5-Fu
|
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| SGC-7901 | IC50 |
6.3 μM
Compound: 5-FU
|
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 22727445] |
| SGC-7901 | IC50 |
28.5 μM
Compound: 5-Fu
|
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 23279864] |
| SGC-7901 | IC50 |
46.35 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human SGC7901 cells assessed as cell survival measured after 48 hrs by MTT assay
Anticancer activity against human SGC7901 cells assessed as cell survival measured after 48 hrs by MTT assay
|
[PMID: 23312949] |
| SGC-7901 | IC50 |
28.9 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 23490159] |
| SGC-7901 | IC50 |
6.04 μM
Compound: 5-Fu
|
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 23920246] |
| SGC-7901 | IC50 |
7.37 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 24119869] |
| SGC-7901 | IC50 |
59.9 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 25164762] |
| SGC-7901 | IC50 |
6.56 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 25554922] |
| SGC-7901 | IC50 |
6.12 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human SGC7901 cells assessed as cell survival after 48 hrs by MTT assay
Anticancer activity against human SGC7901 cells assessed as cell survival after 48 hrs by MTT assay
|
[PMID: 25812966] |
| SGC-7901 | IC50 |
11.9 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 26595184] |
| SGC-7901 | EC50 |
7.03 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 26883149] |
| SGC-7901 | IC50 |
56.12 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 27503679] |
| SGC-7901 | IC50 |
11.9 μM
Compound: 5-FU
|
Cytotoxicity against human SGC7901 cells measured after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells measured after 72 hrs by MTT assay
|
[PMID: 27537924] |
| SGC-7901 | IC50 |
13.25 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells incubated for 48 to 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells incubated for 48 to 72 hrs by MTT assay
|
[PMID: 28395218] |
| SGC-7901 | IC50 |
16.03 μg/mL
Compound: 5-fluorouracil
|
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 28988624] |
| SGC-7901 | IC50 |
10.98 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 29133051] |
| SGC-7901 | IC50 |
34.4 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 29232583] |
| SGC-7901 | IC50 |
19.84 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 29635169] |
| SGC-7901 | IC50 |
12 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SGC7901 cells after 6 days by MTT assay
Cytotoxicity against human SGC7901 cells after 6 days by MTT assay
|
[PMID: 29786436] |
| SGC-7901 | IC50 |
36.4 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells after 48 hrs by MTT assay
|
[PMID: 30108895] |
| SGC-7901 | IC50 |
11.96 μM
Compound: 5-FU
|
Cytotoxicity against human SGC7901 assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human SGC7901 assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30709651] |
| SGC-7901 | IC50 |
53.58 μM
Compound: 5-FU
|
Cytotoxicity against human SGC7901 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 30826506] |
| SGC-7901 | IC50 |
6.46 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 30921757] |
| SGC-7901 | IC50 |
21 μM
Compound: 5-FU
|
Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 31029946] |
| SGC-7901 | IC50 |
6.38 μM
Compound: 5-Fu
|
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 31202992] |
| SGC-7901 | IC50 |
2.96 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC7901 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells incubated for 72 hrs by MTT assay
|
[PMID: 31404863] |
| SGC-7901 | IC50 |
5.54 μM
Compound: 5-FU
|
Anticancer activity against human SGC-7901 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Anticancer activity against human SGC-7901 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 31577977] |
| SGC-7901 | IC50 |
6.8 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human SGC-7901 cells assessed as reduction in cell viability measured for 24 hrs
Antiproliferative activity against human SGC-7901 cells assessed as reduction in cell viability measured for 24 hrs
|
[PMID: 31945642] |
| SGC-7901 | IC50 |
>30 μM
Compound: 5-FU
|
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852] |
| SGC-7901 | IC50 |
53.58 μM
Compound: 5-FU
|
Cytotoxicity against human SGC-7901 cells by MTT assay
Cytotoxicity against human SGC-7901 cells by MTT assay
|
[PMID: 33831559] |
| SGC-7901 | IC50 |
69.81 μM
Compound: 5-Fu
|
Cytotoxicity against human SGC-7901 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human SGC-7901 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34628244] |
| SGC-7901 | IC50 |
13.1 μM
Compound: 5-Fu
|
Cytotoxicity against human SGC-7901 cells assessed as cell inhibition measured after 72 hrs by MTT assay
Cytotoxicity against human SGC-7901 cells assessed as cell inhibition measured after 72 hrs by MTT assay
|
[PMID: 36774698] |
| SGC-7901 | IC50 |
26.3 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36893627] |
| SGC-7901 | IC50 |
0.58 μg/mL
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) SGC7901 cells by MTT assay
Cytotoxicity against Homo sapiens (human) SGC7901 cells by MTT assay
|
10.1007/s00044-009-9193-9 |
| SGC-7901 | IC50 |
2.19 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) SGC7901 cells by MTT assay
Cytotoxicity against Homo sapiens (human) SGC7901 cells by MTT assay
|
10.1007/s00044-010-9395-1 |
| SGC-7901 | IC50 |
29.19 μM
Compound: 5-Fu
|
Cytotoxicity against Homo sapiens (human) SGC7901 cells after 72 hr by MTT assay
Cytotoxicity against Homo sapiens (human) SGC7901 cells after 72 hr by MTT assay
|
10.1007/s00044-011-9549-9 |
| SGC-7901 | IC50 |
0.86 μM
Compound: 5-Fu
|
Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Cytotoxicity against human SGC7901 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
|
10.1039/C4MD00209A |
| SH-SY5Y | IC50 |
1.09 μM
Compound: 5-Fu
|
Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| SH-SY5Y | IC50 |
0.97 μM
Compound: 5-Fu
|
Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
|
[PMID: 23685571] |
| SH-SY5Y | GI50 |
1.5 μM
Compound: 5-FU
|
Antiproliferative activity against human SH-SY5Y cells after 72 hrs by MTT-based Mosmann assay relative to control
Antiproliferative activity against human SH-SY5Y cells after 72 hrs by MTT-based Mosmann assay relative to control
|
[PMID: 26539626] |
| SH-SY5Y | IC50 |
3.26 μM
Compound: 5-Fu
|
Antiproliferative activity against human SH-SY5Y cells assessed as cell growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human SH-SY5Y cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27105028] |
| SH-SY5Y | GI50 |
12 μM
Compound: 5-Fu
|
Antiproliferative activity against human SH-SY5Y cells after 48 hrs by MTT assay
Antiproliferative activity against human SH-SY5Y cells after 48 hrs by MTT assay
|
[PMID: 28763647] |
| SH-SY5Y | GI50 |
11.9 μM
Compound: 5-FU
|
Antiproliferative activity against human SH-SY5Y cells after 48 hrs by MTT assay
Antiproliferative activity against human SH-SY5Y cells after 48 hrs by MTT assay
|
[PMID: 29040954] |
| SiHa | GI50 |
6.3 μM
Compound: 5FU
|
Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SiHa cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
| SiHa | IC50 |
218 μM
Compound: 5-Fu
|
Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
Cytotoxicity against human SiHa cells after 48 hrs by MTT assay
|
[PMID: 22244588] |
| SK-BR-3 | GI50 |
3 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against estrogen receptor deficient human SKBR3 cells after 48 hrs by SRB assay
Antiproliferative activity against estrogen receptor deficient human SKBR3 cells after 48 hrs by SRB assay
|
[PMID: 20438092] |
| SK-BR-3 | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Cytotoxicity in human SK-BR-3 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity in human SK-BR-3 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21250700] |
| SK-BR-3 | IC50 |
>20 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human SK-BR-3 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human SK-BR-3 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 21381696] |
| SK-BR-3 | IC50 |
38.25 μM
Compound: 5-FU
|
Antiproliferative activity against human SKBR3 cells after 72 hrs by MTT assay
Antiproliferative activity against human SKBR3 cells after 72 hrs by MTT assay
|
[PMID: 21524829] |
| SK-BR-3 | IC50 |
38.88 μM
Compound: 5-FU
|
Cytotoxicity against human SKBR3 cells overexpressing HER2 assessed as cell growth inhibition after 48 hrs by WST-1 assay
Cytotoxicity against human SKBR3 cells overexpressing HER2 assessed as cell growth inhibition after 48 hrs by WST-1 assay
|
[PMID: 25466196] |
| SK-BR-3 | IC50 |
10 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SKBR3 cells
Cytotoxicity against human SKBR3 cells
|
[PMID: 31200236] |
| SK-HEP1 | GI50 |
6.3 μM
Compound: 5-Fu
|
Growth inhibition of human SKHEP1 cells after 48 hrs by SRB assay
Growth inhibition of human SKHEP1 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| SK-HEP1 | GI50 |
7.6 nM
Compound: 5FU
|
Growth inhibition of human SKHEP1 cells after 48 hrs by SRB assay
Growth inhibition of human SKHEP1 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| SK-HEP1 | IC50 |
4.95 μM
Compound: 5-Fu
|
Antiproliferative activity against human SK-HEP1 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
Antiproliferative activity against human SK-HEP1 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
|
[PMID: 35797896] |
| SK-HEP1 | IC50 |
12.5 μM
Compound: 5-FU
|
Anticancer activity against human SK-HEP1 cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human SK-HEP1 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| SK-HEP1 | IC50 |
>40 μM
Compound: 5-FU
|
Antiproliferative activity against human SK-HEP1 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human SK-HEP1 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 37182331] |
| SK-MEL | IC50 |
6.3 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human SK-MEL cells after 2 to 7 days by neutral red assay
Cytotoxicity against human SK-MEL cells after 2 to 7 days by neutral red assay
|
[PMID: 11374943] |
| SK-MEL-2 | IC50 |
0.63 μg/mL
Compound: 5-FU
|
Inhibitory concentration of compound for cytotoxicity against SK-MEL-2 human melanoma cells was determined
Inhibitory concentration of compound for cytotoxicity against SK-MEL-2 human melanoma cells was determined
|
[PMID: 11814824] |
| SK-MEL-2 | GI50 |
56.7 μM
Compound: 5-FU
|
Growth inhibition of human SK-MEL-2 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SK-MEL-2 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SK-MEL-2 | GI50 |
56.7 μM
Compound: 5-FU
|
Anticancer activity against human SK-MEL-2 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-MEL-2 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SK-MEL-2 | IC50 |
6.52 μM
Compound: 5-Fu
|
Antiproliferative activity against human SK-MEL-2 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
Antiproliferative activity against human SK-MEL-2 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 assay
|
[PMID: 35797896] |
| SK-MEL-2 | IC50 |
56.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SK-MEL-2 cells assessed as cell growth inhibition
Cytotoxicity against human SK-MEL-2 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SK-MEL-28 | IC50 |
4.5 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against SK-MEL-28 cells
Tested in vitro for anticancer activity against SK-MEL-28 cells
|
[PMID: 10072683] |
| SK-MEL-28 | IC50 |
0.1 μg/mL
Compound: 5-fluorouracil
|
Antitumor activity against human SK MEL28 cells
Antitumor activity against human SK MEL28 cells
|
[PMID: 10579858] |
| SK-MEL-28 | IC50 |
10.7 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human melanoma (P-36) cell line.
In vitro inhibitory activity against Human melanoma (P-36) cell line.
|
[PMID: 1995905] |
| SK-MEL-28 | GI50 |
1.03 μM
Compound: 5-FU
|
Growth inhibition of human SK-MEL-28 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SK-MEL-28 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SK-MEL-28 | GI50 |
1.03 μM
Compound: 5-FU
|
Anticancer activity against human SK-MEL-28 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-MEL-28 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SK-MEL-28 | IC50 |
14.64 μM
Compound: 5-FU
|
Cytotoxicity against human SK-MEL-28 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Cytotoxicity against human SK-MEL-28 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35635947] |
| SK-MEL-28 | IC50 |
1.03 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SK-MEL-28 cells assessed as cell growth inhibition
Cytotoxicity against human SK-MEL-28 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SK-MEL-28 | IC50 |
10.23 μM
Compound: 5-FU
|
Antiproliferative activity against human SK-MEL-28 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human SK-MEL-28 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 38107169] |
| SK-MEL-28 | IC50 |
11 μg/mL
Compound: 5-FU
|
The compound was evaluated for antitumoral activity against human melanoma cell line P36 after 72 hr of incubation
The compound was evaluated for antitumoral activity against human melanoma cell line P36 after 72 hr of incubation
|
10.1016/S0960-894X(01)80742-3 |
| SK-MEL-5 | GI50 |
0.46 μM
Compound: 5-FU
|
Growth inhibition of human SK-MEL-5 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SK-MEL-5 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SK-MEL-5 | GI50 |
0.46 μM
Compound: 5-FU
|
Anticancer activity against human SK-MEL-5 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-MEL-5 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SK-MEL-5 | IC50 |
15.31 μM
Compound: 5-FU
|
Cytotoxicity against human SK-MEL-5 cells assessed as inhibition of cell viability incubated for 72 hrs under hypoxia condition by MTT assay
Cytotoxicity against human SK-MEL-5 cells assessed as inhibition of cell viability incubated for 72 hrs under hypoxia condition by MTT assay
|
[PMID: 35182815] |
| SK-MEL-5 | IC50 |
0.46 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SK-MEL-5 cells assessed as cell growth inhibition
Cytotoxicity against human SK-MEL-5 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SK-MES-1 | IC50 |
13.1 μM
Compound: 5-fluorouracil
|
Tested in vitro for anticancer activity against SK-MES-1 cells
Tested in vitro for anticancer activity against SK-MES-1 cells
|
[PMID: 10072683] |
| SK-MES-1 | IC50 |
0.31 μM
Compound: 5-fluorouracil
|
Antitumor activity against lung carcinoma cell line (SK-MES-1)
Antitumor activity against lung carcinoma cell line (SK-MES-1)
|
[PMID: 2547068] |
| SK-N-SH | IC50 |
9.84 μM
Compound: 5-FU
|
Cytotoxicity against human SK-N-SH cells assessed as cell growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human SK-N-SH cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27423479] |
| SK-N-SH | IC50 |
7.22 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SK-N-SH cells by MTT assay
Antiproliferative activity against human SK-N-SH cells by MTT assay
|
[PMID: 31546197] |
| SK-N-SH | IC50 |
10.32 μM
Compound: 5-Fu
|
Antiproliferative activity against human SK-N-SH cells after 72 hrs by MTT assay
Antiproliferative activity against human SK-N-SH cells after 72 hrs by MTT assay
|
10.1039/C6MD00169F |
| SK-OV-3 | IC50 |
>10 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human SKOV3 cells after 2 to 7 days by neutral red assay
Cytotoxicity against human SKOV3 cells after 2 to 7 days by neutral red assay
|
[PMID: 11374943] |
| SK-OV-3 | IC50 |
0.03 μg/mL
Compound: 5-FU
|
Inhibitory concentration of compound for cytotoxicity against SK-OV-3 human ovarian cells was determined
Inhibitory concentration of compound for cytotoxicity against SK-OV-3 human ovarian cells was determined
|
[PMID: 11814824] |
| SK-OV-3 | GI50 |
21.8 μM
Compound: 5-FU
|
Growth inhibition of human SKOV3 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SKOV3 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SK-OV-3 | IC50 |
24.43 μM
Compound: 5-FU
|
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
|
[PMID: 23988357] |
| SK-OV-3 | IC50 |
24.43 μM
Compound: 5-FU
|
Cytotoxicity against human SKOV3 cells after 3 days by MTT assay
Cytotoxicity against human SKOV3 cells after 3 days by MTT assay
|
[PMID: 24095745] |
| SK-OV-3 | IC50 |
24.43 μM
Compound: 5-FU
|
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
|
[PMID: 24565905] |
| SK-OV-3 | IC50 |
27.34 μM
Compound: 5-Fu
|
Cytotoxicity against human SKOV3 cells after 2 days by MTT assay
Cytotoxicity against human SKOV3 cells after 2 days by MTT assay
|
[PMID: 25841196] |
| SK-OV-3 | IC50 |
22.43 μM
Compound: 5-FU
|
Cytotoxic activity against human SKOV3 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
Cytotoxic activity against human SKOV3 cells assessed as inhibition of cell growth after 48 hrs by MTT assay
|
[PMID: 26706349] |
| SK-OV-3 | IC50 |
23.11 μM
Compound: 5-Fu
|
Cytotoxic activity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
|
[PMID: 28011223] |
| SK-OV-3 | IC50 |
32.5 μM
Compound: 5-FU
|
Antiproliferative activity against human SKOV3 cells after 48 hrs by MTT assay
Antiproliferative activity against human SKOV3 cells after 48 hrs by MTT assay
|
[PMID: 28756264] |
| SK-OV-3 | IC50 |
20.8 μM
Compound: 5-Fu
|
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 28759877] |
| SK-OV-3 | IC50 |
26.34 μM
Compound: 5-FU
|
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
|
[PMID: 30092368] |
| SK-OV-3 | IC50 |
26.34 μM
Compound: 5-FU
|
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
Cytotoxicity against human SKOV3 cells after 48 hrs by MTT assay
|
[PMID: 30108826] |
| SK-OV-3 | IC50 |
26.34 μM
Compound: 5-FU
|
Antiproliferative activity against human SK-OV-3 cells by MTT assay
Antiproliferative activity against human SK-OV-3 cells by MTT assay
|
[PMID: 33109400] |
| SK-OV-3 | IC50 |
26.34 μM
Compound: 5-FU
|
Antiproliferative activity against human SK-OV-3 cells
Antiproliferative activity against human SK-OV-3 cells
|
[PMID: 34655985] |
| SK-OV-3 | IC50 |
21.6 μM
Compound: 5-Fu
|
Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 35092899] |
| SK-OV-3 | GI50 |
21.8 μM
Compound: 5-FU
|
Anticancer activity against human SK-OV-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SK-OV-3 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SK-OV-3 | IC50 |
21.8 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SK-OV-3 cells assessed as cell growth inhibition
Cytotoxicity against human SK-OV-3 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SK-OV-3 | IC50 |
47.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SK-OV-3 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
Cytotoxicity against human SK-OV-3 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
|
[PMID: 36970146] |
| SK-OV-3 | IC50 |
25 μM
Compound: 5-FU
|
Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 37859725] |
| SK-OV-3 | IC50 |
26.34 μM
Compound: 5-FU
|
Antiproliferative activity against human SK-OV-3 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells incubated for 48 hrs by MTT assay
|
[PMID: 37972528] |
| SK-OV-3 | IC50 |
10.85 μM
Compound: 5-Fu
|
Cytotoxicity against human SK-OV-3 cells assessed as cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as cell viability measured after 48 hrs by MTT assay
|
[PMID: 38964974] |
| SMMC-7721 | IC50 |
51 μM
Compound: 5-FU
|
Cytotoxicity against SMMC7721 cells after 48 hrs by MTT assay
Cytotoxicity against SMMC7721 cells after 48 hrs by MTT assay
|
[PMID: 17604394] |
| SMMC-7721 | IC50 |
13 μM
Compound: fluorouracil
|
Cytotoxicity against human SMMC7721 cells
Cytotoxicity against human SMMC7721 cells
|
[PMID: 21495659] |
| SMMC-7721 | IC50 |
2.3 x 10-2 μg/mL
Compound: fluorouracil
|
Cytotoxicity against human SMMC7721 cells by MTT assay
Cytotoxicity against human SMMC7721 cells by MTT assay
|
[PMID: 22011319] |
| SMMC-7721 | IC50 |
15 μM
Compound: 5-Fu
|
Cytotoxicity against human SMMC7721 cells
Cytotoxicity against human SMMC7721 cells
|
[PMID: 22283451] |
| SMMC-7721 | IC50 |
>100 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human SMMC7721 cells after 48 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 48 hrs by MTT assay
|
[PMID: 22537362] |
| SMMC-7721 | IC50 |
26.71 μM
Compound: 5-Fu
|
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
|
[PMID: 23644193] |
| SMMC-7721 | IC50 |
9.78 μM
Compound: 5-Fu
|
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
|
[PMID: 23792764] |
| SMMC-7721 | IC50 |
14.55 μM
Compound: 5-Fu
|
Cytotoxicity against human SMMC7721 cells after 48 hrs by CCK-8 assay
Cytotoxicity against human SMMC7721 cells after 48 hrs by CCK-8 assay
|
[PMID: 24013415] |
| SMMC-7721 | IC50 |
9.78 μM
Compound: 5-Fu
|
Cytotoxicity against human SMMC7721 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 24077182] |
| SMMC-7721 | IC50 |
67.7 μM
Compound: 5-FU
|
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
|
[PMID: 25164762] |
| SMMC-7721 | IC50 |
5.62 μM
Compound: 5-FU
|
Antiproliferative activity against human SMMC7721 cells assessed as inhibition of cell proliferation by CCK8 assay
Antiproliferative activity against human SMMC7721 cells assessed as inhibition of cell proliferation by CCK8 assay
|
[PMID: 25442303] |
| SMMC-7721 | IC50 |
20.4 μM
Compound: 5-Fu
|
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
|
[PMID: 25707012] |
| SMMC-7721 | IC50 |
4.87 μM
Compound: 5-Fluorouracil
|
Anticancer activity against human SMMC7721 cells assessed as cell survival after 48 hrs by MTT assay
Anticancer activity against human SMMC7721 cells assessed as cell survival after 48 hrs by MTT assay
|
[PMID: 25812966] |
| SMMC-7721 | IC50 |
5.62 μM
Compound: 5-Fu
|
Antiproliferative activity against human SMMC7721 cells after 48 hrs by CCK8 assay
Antiproliferative activity against human SMMC7721 cells after 48 hrs by CCK8 assay
|
[PMID: 26786698] |
| SMMC-7721 | IC50 |
5.62 μM
Compound: 5-FU
|
Antiproliferative activity against human SMMC7721 cells after 48 hrs by CCK-8 assay
Antiproliferative activity against human SMMC7721 cells after 48 hrs by CCK-8 assay
|
[PMID: 27542307] |
| SMMC-7721 | IC50 |
19.25 μg/mL
Compound: 5-fluorouracil
|
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells after 48 hrs by MTT assay
|
[PMID: 28988624] |
| SMMC-7721 | IC50 |
37.8 μM
Compound: 5-FU
|
Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay
|
[PMID: 29232583] |
| SMMC-7721 | IC50 |
13.7 μM
Compound: 5-Fu
|
Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay
Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay
|
[PMID: 29475156] |
| SMMC-7721 | IC50 |
12.47 μM
Compound: 5-Fu
|
Antiproliferative activity against human SMMC7721 cells after 24 hrs by CCK-8 assay
Antiproliferative activity against human SMMC7721 cells after 24 hrs by CCK-8 assay
|
[PMID: 29499490] |
| SMMC-7721 | IC50 |
37.8 μM
Compound: 5-FU
|
Antiproliferative activity against human SMMC-7721 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human SMMC-7721 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 30739827] |
| SMMC-7721 | IC50 |
2.5 μM
Compound: Fluorouracil
|
Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 31013087] |
| SMMC-7721 | IC50 |
15.32 μM
Compound: 5-FU
|
Antiproliferative activity against human SMMC-7721 cells by MTT assay
Antiproliferative activity against human SMMC-7721 cells by MTT assay
|
[PMID: 33109400] |
| SMMC-7721 | IC50 |
9.7 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SMMC-7721 cells
Antiproliferative activity against human SMMC-7721 cells
|
[PMID: 33421712] |
| SMMC-7721 | IC50 |
20 μM
Compound: 5-FU
|
Antiproliferative activity against human SMMC-7721 cells measured after 48 hrs
Antiproliferative activity against human SMMC-7721 cells measured after 48 hrs
|
[PMID: 34128674] |
| SMMC-7721 | IC50 |
1.59 μM
Compound: 5-Fu
|
Antiproliferative activity against human SMMC-7721 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
Antiproliferative activity against human SMMC-7721 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay
|
[PMID: 37360398] |
| SMMC-7721 | IC50 |
14.2 μM
Compound: 5-Fu
|
Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
10.1039/C5MD00240K |
| SN12C | GI50 |
0.49 μM
Compound: 5-FU
|
Growth inhibition of human SN12C cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SN12C cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SN12C | IC50 |
6.5 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human SN12C cells assessed as decrease in cell viability after 96 hrs
Cytotoxicity against human SN12C cells assessed as decrease in cell viability after 96 hrs
|
[PMID: 29673982] |
| SN12C | GI50 |
0.49 μM
Compound: 5-FU
|
Anticancer activity against human SN12C cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SN12C cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SN12C | IC50 |
0.49 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SN12C cells assessed as cell growth inhibition
Cytotoxicity against human SN12C cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SNB-19 | GI50 |
3.81 μM
Compound: 5-FU
|
Growth inhibition of human SNB19 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SNB19 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SNB-19 | GI50 |
3.81 μM
Compound: 5-FU
|
Anticancer activity against human SNB-19 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SNB-19 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SNB-19 | IC50 |
3.81 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SNB-19 cells assessed as cell growth inhibition
Cytotoxicity against human SNB-19 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SNB-75 | GI50 |
78.7 μM
Compound: 5-FU
|
Growth inhibition of human SNB75 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SNB75 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SNB-75 | GI50 |
78.7 μM
Compound: 5-FU
|
Anticancer activity against human SNB-75 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SNB-75 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SNB-75 | IC50 |
78.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition
Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SNU-16 | EC50 |
6.4 μM
Compound: 5FU
|
Cytotoxicity against human SNU-16 cells assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
Cytotoxicity against human SNU-16 cells assessed as inhibition of proliferation measured after 24 to 72 hrs by CCK-8 assay
|
[PMID: 35939803] |
| SNU-423 | IC50 |
7.4 μM
Compound: 5-FU
|
Antiproliferative activity against human SNU-423 cells
Antiproliferative activity against human SNU-423 cells
|
[PMID: 34655985] |
| SNU-C2A | IC50 |
2.7 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of SUN-C2A tumor cell line from colon.
Compound was tested for its inhibitory effect on the growth of SUN-C2A tumor cell line from colon.
|
10.1016/0960-894X(96)00339-3 |
| SR | IC50 |
60.3 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human SR cells
Cytotoxicity against human SR cells
|
[PMID: 16996657] |
| SR | GI50 |
0.0238 μM
Compound: 5-FU
|
Cytotoxicity against human SR cells after 48 hrs by SRB assay
Cytotoxicity against human SR cells after 48 hrs by SRB assay
|
[PMID: 22305543] |
| SR | GI50 |
0.02 μM
Compound: 5-FU
|
Growth inhibition of human SR cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SR cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SR | IC50 |
60.3 μM
Compound: 5-Fluorouracil
|
Antileukemic activity against human SR cells assessed as inhibition of tumor growth after 24 hrs
Antileukemic activity against human SR cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| SR | IC50 |
7.38 μM
Compound: 5-FU
|
Antiproliferative activity against human SR cells assessed as inhibition of cell growth incubated for 2 to 4 hrs by MTT assay
Antiproliferative activity against human SR cells assessed as inhibition of cell growth incubated for 2 to 4 hrs by MTT assay
|
[PMID: 38389871] |
| SW 1116 | IC50 |
37 μM
Compound: 5-fluorouracil
|
Cytotoxicity against SW1116 cells by MTT colometric method
Cytotoxicity against SW1116 cells by MTT colometric method
|
[PMID: 17253861] |
| SW 1116 | EC50 |
28.52 μg/mL
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
|
[PMID: 21889345] |
| SW 1116 | IC50 |
95.17 μM
Compound: 5-FU
|
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
|
[PMID: 21962523] |
| SW 1116 | IC50 |
2.41 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT method
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT method
|
[PMID: 23018096] |
| SW 1116 | IC50 |
5.26 μM
Compound: 5-FU
|
Cytotoxicity against human SW1116 cells after 48 hrs by MTT assay
Cytotoxicity against human SW1116 cells after 48 hrs by MTT assay
|
[PMID: 24286761] |
| SW 1116 | IC50 |
18.52 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
Antiproliferative activity against human SW1116 cells after 48 hrs by MTT assay
|
[PMID: 28363444] |
| SW 1116 | IC50 |
76.92 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human SW1116 cells by disk diffusion soft agar colony formation assay
Cytotoxicity against human SW1116 cells by disk diffusion soft agar colony formation assay
|
[PMID: 31117520] |
| SW13 | IC50 |
>20 μM
Compound: 5-Fu
|
Cytotoxicity against human SW13 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human SW13 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| SW1573 | GI50 |
4.1 μM
Compound: 5-FU
|
Growth inhibition of human SW1573 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SW1573 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 19664930] |
| SW1573 | GI50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW1573 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human SW1573 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 25752525] |
| SW1573 | GI50 |
4.3 μM
Compound: 5-FU
|
Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
|
[PMID: 28728108] |
| SW1573 | GI50 |
4.3 μM
Compound: 5-FU
|
Antiproliferative activity against human SW1573 cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human SW1573 cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 31376562] |
| SW1573 | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW1573 cells by MTT assay
Antiproliferative activity against human SW1573 cells by MTT assay
|
[PMID: 31546197] |
| SW1573 | GI50 |
3.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW1573 cells assessed as reduction in cell growth
Antiproliferative activity against human SW1573 cells assessed as reduction in cell growth
|
[PMID: 34847410] |
| SW1573 | GI50 |
4.3 μM
Compound: 5-FU
|
Growth inhibition of human SW1573 cells measured after 48 hrs by SRB colorimetric assay
Growth inhibition of human SW1573 cells measured after 48 hrs by SRB colorimetric assay
|
[PMID: 37137247] |
| SW1990 | IC50 |
120 μM
Compound: Fluorouracil
|
Cytotoxicity against human SW1990 cells
Cytotoxicity against human SW1990 cells
|
[PMID: 21226488] |
| SW1990 | IC50 |
121 μM
Compound: Fluorouracil
|
Cytotoxicity against human SW1990 cells
Cytotoxicity against human SW1990 cells
|
[PMID: 21774474] |
| SW1990 | IC50 |
123 μM
Compound: 5-Fu
|
Cytotoxicity against human SW1990 cells
Cytotoxicity against human SW1990 cells
|
[PMID: 22283451] |
| SW1990 | IC50 |
45 μM
Compound: 5-fu
|
Cytotoxicity against human SW1990 cells after 48 hrs by MTT assay
Cytotoxicity against human SW1990 cells after 48 hrs by MTT assay
|
[PMID: 22304344] |
| SW1990 | IC50 |
126.4 μM
Compound: 5-Fu
|
Cytotoxicity against human SW1990 cells after 48 hrs by MTT assay
Cytotoxicity against human SW1990 cells after 48 hrs by MTT assay
|
[PMID: 26714048] |
| SW48 | IC50 |
5.3 μM
Compound: 5-FU
|
Antiproliferative activity against human SW48 cells after 72 hrs
Antiproliferative activity against human SW48 cells after 72 hrs
|
[PMID: 17548198] |
| SW48 | IC50 |
4.4 μM
Compound: 5-FU
|
Antiproliferative activity against human SW48 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW48 cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| SW48 | IC50 |
5.7 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of SW-48 tumor cell line from colon.
Compound was tested for its inhibitory effect on the growth of SW-48 tumor cell line from colon.
|
10.1016/0960-894X(96)00339-3 |
| SW480 | IC50 |
8.1 μM
Compound: 5-FU
|
Antiproliferative activity against human SW480 cells after 72 hrs by MTT method
Antiproliferative activity against human SW480 cells after 72 hrs by MTT method
|
[PMID: 17524655] |
| SW480 | IC50 |
3.5 μM
Compound: 5-FU
|
Antiproliferative activity against human SW480 cells after 72 hrs
Antiproliferative activity against human SW480 cells after 72 hrs
|
[PMID: 17548198] |
| SW480 | ED50 |
3.09 μg/mL
Compound: 5-fluorouracil
|
Cytotoxicity against human SW480 cells after 3 days by trypan blue exclusion technique
Cytotoxicity against human SW480 cells after 3 days by trypan blue exclusion technique
|
[PMID: 1800632] |
| SW480 | IC50 |
26.26 μM
Compound: 5-FU
|
Antiproliferative activity against p53 deficient human SW480 cells after 72 hrs by proliferative assay
Antiproliferative activity against p53 deficient human SW480 cells after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| SW480 | IC50 |
13.16 μM
Compound: 5-FU
|
Cytotoxicity against human SW480 cells by MTT assay
Cytotoxicity against human SW480 cells by MTT assay
|
[PMID: 18644718] |
| SW480 | IC50 |
2.1 μM
Compound: 5-FU
|
Antiproliferative activity against human SW480 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW480 cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| SW480 | IC50 |
3.3 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of human lung squamous cell carcinoma SW 480 solid cell lines.
Concentration required for 50% inhibition of human lung squamous cell carcinoma SW 480 solid cell lines.
|
[PMID: 1992123] |
| SW480 | IC50 |
3.3 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human colon adenocarcinoma (SW-480) cell line.
In vitro inhibitory activity against Human colon adenocarcinoma (SW-480) cell line.
|
[PMID: 1995905] |
| SW480 | IC50 |
57 μM
Compound: 5-FU
|
Antiproliferative activity against human p53 deficient SW480 cells after 72 hrs by celltiter-glo assay
Antiproliferative activity against human p53 deficient SW480 cells after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| SW480 | IC50 |
15.71 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells after 24 hrs by MTT assay
Cytotoxicity against human SW480 cells after 24 hrs by MTT assay
|
[PMID: 22182926] |
| SW480 | IC50 |
15.71 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells by after 48 hrs by MTT assay
Cytotoxicity against human SW480 cells by after 48 hrs by MTT assay
|
[PMID: 22579780] |
| SW480 | IC50 |
158.2 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells after 48 hrs by MTT assay
Cytotoxicity against human SW480 cells after 48 hrs by MTT assay
|
[PMID: 23356786] |
| SW480 | IC50 |
8.1 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells after 72 hrs by MTT assay
Cytotoxicity against human SW480 cells after 72 hrs by MTT assay
|
[PMID: 23792763] |
| SW480 | IC50 |
15.71 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells after 48 hrs by MTT assay
Cytotoxicity against human SW480 cells after 48 hrs by MTT assay
|
[PMID: 23920246] |
| SW480 | IC50 |
3.69 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells after 3 days by SRB assay
Cytotoxicity against human SW480 cells after 3 days by SRB assay
|
[PMID: 24704691] |
| SW480 | IC50 |
12.4 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human SW480 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 32987314] |
| SW480 | IC50 |
13.1 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human SW480 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 32987314] |
| SW480 | IC50 |
15.3 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
Cytotoxicity against human SW480 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay
|
[PMID: 32987314] |
| SW480 | IC50 |
9.7 μM
Compound: 5-FU
|
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33538581] |
| SW480 | IC50 |
3.3 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of human colon adenocarcinoma cell lines (SW480).
In vitro inhibitory effect on growth of human colon adenocarcinoma cell lines (SW480).
|
[PMID: 3373480] |
| SW480 | IC50 |
>30 μM
Compound: 5-FU
|
Antitumor activity against human SW480 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
Antitumor activity against human SW480 cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay
|
[PMID: 35777102] |
| SW480 | IC50 |
21.93 μM
Compound: 5-FU
|
Anticancer activity against human SW480 cells assessed as inhibition of cell proliferation by MTT assay
Anticancer activity against human SW480 cells assessed as inhibition of cell proliferation by MTT assay
|
[PMID: 36439975] |
| SW480 | IC50 |
12 μM
Compound: 5-FU
|
Cytotoxicity against human SW480 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
Cytotoxicity against human SW480 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
|
[PMID: 37243616] |
| SW480 | IC50 |
217.5 μM
Compound: 5-FU
|
Antiproliferative activity against human SW480 cells assessed as inhibition of cell growth measured after 48 to 72 hrs by XTT assay
Antiproliferative activity against human SW480 cells assessed as inhibition of cell growth measured after 48 to 72 hrs by XTT assay
|
[PMID: 37902628] |
| SW480 | IC50 |
37.5 μM
Compound: 1; 5-FU
|
Growth inhibition of human SW480 cells incubated for 1.5 hrs by MTT assay
Growth inhibition of human SW480 cells incubated for 1.5 hrs by MTT assay
|
[PMID: 38107178] |
| SW480 | IC50 |
12.56 μM
Compound: 5-Fu
|
Cytotoxicity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| SW480 | IC50 |
6 μg/mL
Compound: 5-FU
|
The compound was evaluated for antitumoral activity against human cancer cell line SW480 after 72 hr of incubation
The compound was evaluated for antitumoral activity against human cancer cell line SW480 after 72 hr of incubation
|
10.1016/S0960-894X(01)80742-3 |
| SW480 | IC50 |
32.72 μM
Compound: 5-Fu
|
Antiproliferative activity against human SW480 cells after 48 hrs by MTT assay
Antiproliferative activity against human SW480 cells after 48 hrs by MTT assay
|
10.1039/C5MD00163C |
| SW-620 | IC50 |
18.6 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human SW620 cells
Cytotoxicity against human SW620 cells
|
[PMID: 16996657] |
| SW-620 | IC50 |
8.7 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells after 3 days by MTT assay
Antiproliferative activity against human SW620 cells after 3 days by MTT assay
|
[PMID: 18424155] |
| SW-620 | IC50 |
9 μM
Compound: 5-FU
|
Growth inhibition of human SW620 cells after 72 hrs by MTT assay
Growth inhibition of human SW620 cells after 72 hrs by MTT assay
|
[PMID: 18640746] |
| SW-620 | IC50 |
9 μM
Compound: 5-FU
|
Antitumor activity against human SW620 cells after 24 hrs by MTT assay
Antitumor activity against human SW620 cells after 24 hrs by MTT assay
|
[PMID: 20211564] |
| SW-620 | IC50 |
>100 μM
Compound: 5-FU
|
Anticancer activity against human SW620 cells
Anticancer activity against human SW620 cells
|
[PMID: 21449610] |
| SW-620 | IC50 |
3.38 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
|
[PMID: 21524829] |
| SW-620 | IC50 |
380 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SW620 cells
Cytotoxicity against human SW620 cells
|
[PMID: 22409967] |
| SW-620 | IC50 |
6.68 μM
Compound: 5-Fluoruracil
|
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
|
[PMID: 22555152] |
| SW-620 | GI50 |
0.92 μM
Compound: 5-FU
|
Growth inhibition of human SW620 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human SW620 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| SW-620 | IC50 |
18.6 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SW620 cells assessed as inhibition of tumor growth after 24 hrs
Cytotoxicity against human SW620 cells assessed as inhibition of tumor growth after 24 hrs
|
[PMID: 24657568] |
| SW-620 | IC50 |
5.3 μM
Compound: 5-FU
|
Cytotoxicity against human SW620 cells after 72 hrs by MTS assay
Cytotoxicity against human SW620 cells after 72 hrs by MTS assay
|
[PMID: 25066282] |
| SW-620 | EC50 |
>50 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells after 24 hrs by MTT assay
Antiproliferative activity against human SW620 cells after 24 hrs by MTT assay
|
[PMID: 25198997] |
| SW-620 | IC50 |
0.79 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW620 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells incubated for 72 hrs by MTT assay
|
[PMID: 26291038] |
| SW-620 | IC50 |
0.79 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
|
[PMID: 26617970] |
| SW-620 | CC50 |
>2512 μM
Compound: 5-Fu
|
Cytotoxicity against human SW620 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human SW620 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| SW-620 | IC50 |
14.8 μM
Compound: 5-Fu
|
Cytotoxicity against human SW620 cells after 48 hrs by sulforhodamine B assay
Cytotoxicity against human SW620 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 26727215] |
| SW-620 | IC50 |
0.08 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
|
[PMID: 27875779] |
| SW-620 | IC50 |
0.08 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
|
[PMID: 28525845] |
| SW-620 | IC50 |
0.08 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay
|
[PMID: 29133046] |
| SW-620 | IC50 |
0.08 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells incubated for 72 hrs by MTT assay
|
[PMID: 31734024] |
| SW-620 | IC50 |
>10 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32127259] |
| SW-620 | IC50 |
6.96 μM
Compound: 5-FU
|
Cytotoxicity against human SW-620 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human SW-620 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32203786] |
| SW-620 | IC50 |
10 μM
Compound: 5-FU
|
Cytotoxicity against human SW620 cells after 24 hrs by MTT assay
Cytotoxicity against human SW620 cells after 24 hrs by MTT assay
|
[PMID: 32223193] |
| SW-620 | IC50 |
15.29 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell viability measured after 72 hrs by MTT assay
|
[PMID: 32387836] |
| SW-620 | GI50 |
0.92 μM
Compound: 5-FU
|
Anticancer activity against human SW-620 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human SW-620 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| SW-620 | IC50 |
13.25 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 36269639] |
| SW-620 | IC50 |
0.92 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human SW620 cells assessed as cell growth inhibition
Cytotoxicity against human SW620 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| SW-620 | IC50 |
32.5 μM
Compound: 5-FU
|
Cytotoxicity against human SW620 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human SW620 cells assessed inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 37098306] |
| SW-620 | IC50 |
12 μM
Compound: 5-FU
|
Cytotoxicity against human SW620 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
Cytotoxicity against human SW620 cells assessed as decrease in cell viability incubated for 48 hrs by SRB assay
|
[PMID: 37243616] |
| SW-620 | IC50 |
102.6 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells assessed as inhibition of cell growth measured after 48 to 72 hrs by XTT assay
Antiproliferative activity against human SW620 cells assessed as inhibition of cell growth measured after 48 to 72 hrs by XTT assay
|
[PMID: 37902628] |
| SW-620 | IC50 |
43 μM
Compound: 5-FU
|
Cytotoxicity against human SW620 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
Cytotoxicity against human SW620 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay
|
[PMID: 38536967] |
| SW-620 | IC50 |
13.84 μM
Compound: 5-Fu
|
Cytotoxicity against human SW620 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human SW620 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 38634707] |
| SW-620 | IC50 |
9.01 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38677112] |
| SW-620 | IC50 |
17.01 μM
Compound: 5-Fu
|
Antiproliferative activity against human SW-620 cells incubated for 72 hrs by SRB method
Antiproliferative activity against human SW-620 cells incubated for 72 hrs by SRB method
|
[PMID: 39054645] |
| SW620/5-FU | EC50 |
>1000 μM
Compound: 5-FU
|
Reversal of 5-FU resistance against human SW620/5-FU cells assessed as inhibition of cell proliferation measured after 72 hrs in presence of 5-FU by MTT assay
Reversal of 5-FU resistance against human SW620/5-FU cells assessed as inhibition of cell proliferation measured after 72 hrs in presence of 5-FU by MTT assay
|
[PMID: 34411894] |
| SW620/5-FU | EC50 |
>1000 μM
Compound: 5-FU
|
Antiproliferative activity against human SW620/5-FU cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human SW620/5-FU cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 34688013] |
| SW780 | IC50 |
6.99 μM
Compound: 5-FU
|
Cytotoxicity against human SW780 cells assessed as growth inhibition after 72 hrs by CCK8 assay
Cytotoxicity against human SW780 cells assessed as growth inhibition after 72 hrs by CCK8 assay
|
[PMID: 27597411] |
| T-24 | IC50 |
6.1 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of human lung squamous cell carcinoma T24 solid cell lines.
Concentration required for 50% inhibition of human lung squamous cell carcinoma T24 solid cell lines.
|
[PMID: 1992123] |
| T-24 | IC50 |
6.1 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human bladder transitional-cell carcinoma (T-24) cell line.
In vitro inhibitory activity against Human bladder transitional-cell carcinoma (T-24) cell line.
|
[PMID: 1995905] |
| T-24 | IC50 |
40.57 μM
Compound: 5-Fu
|
Cytotoxicity against human T24 cells after 2 days by MTT assay
Cytotoxicity against human T24 cells after 2 days by MTT assay
|
[PMID: 25841196] |
| T-24 | IC50 |
37.56 μM
Compound: 5-FU
|
Cytotoxicity against human T24 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human T24 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25841199] |
| T-24 | IC50 |
40.14 μM
Compound: 5-FU
|
Cytotoxicity in human T24 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human T24 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 28754470] |
| T-24 | IC50 |
40.14 μM
Compound: 5-FU
|
Antiproliferative activity against human T-24 cells by MTT assay
Antiproliferative activity against human T-24 cells by MTT assay
|
[PMID: 33109400] |
| T-24 | IC50 |
6.1 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of human bladder transitional-carcinoma cell lines (T24).
In vitro inhibitory effect on growth of human bladder transitional-carcinoma cell lines (T24).
|
[PMID: 3373480] |
| T-24 | IC50 |
12.89 μM
Compound: 5-FU
|
Cytotoxicity against human T24 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
Cytotoxicity against human T24 cells assessed as inhibition of cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 33740546] |
| T-24 | IC50 |
39.4 μM
Compound: 5-Fu
|
Antiproliferative activity against human T24 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human T24 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 35092899] |
| T-24 | IC50 |
25.23 μM
Compound: 5-FU
|
Antiproliferative activity against human T24 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
Antiproliferative activity against human T24 cells assessed as reduction in cell viability measured for 24 hrs by MTT assay
|
[PMID: 37122546] |
| T-24 | IC50 |
40.14 μM
Compound: 5-FU
|
Antiproliferative activity against human T24 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human T24 cells incubated for 48 hrs by MTT assay
|
[PMID: 37972528] |
| T-24 | IC50 |
0.5 μg/mL
Compound: 5-FU
|
Tested for cytotoxicity against antigen negative T-24 bladder carcinoma cells having only 3-5% antigen expression
Tested for cytotoxicity against antigen negative T-24 bladder carcinoma cells having only 3-5% antigen expression
|
[PMID: 8496926] |
| T-24 | IC50 |
4.1 μM
Compound: 5-FU
|
Tested for cytotoxicity against antigen negative T-24 bladder carcinoma cells having only 3-5% antigen expression
Tested for cytotoxicity against antigen negative T-24 bladder carcinoma cells having only 3-5% antigen expression
|
[PMID: 8496926] |
| T-24 | IC50 |
22 μM
Compound: 5-FU (5-fluorouracil)
|
Compound was tested for its inhibitory effect on the growth of T24 tumor cell line from bladder.
Compound was tested for its inhibitory effect on the growth of T24 tumor cell line from bladder.
|
10.1016/0960-894X(96)00339-3 |
| T-24 | IC50 |
6 μg/mL
Compound: 5-FU
|
The compound was evaluated for antitumoral activity against human cancer cell line T24 after 72 hr of incubation
The compound was evaluated for antitumoral activity against human cancer cell line T24 after 72 hr of incubation
|
10.1016/S0960-894X(01)80742-3 |
| T47D | GI50 |
29 μM
Compound: 5-FU
|
Growth inhibition of human T47D cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human T47D cells after 48 hrs by sulforhodamine B assay
|
[PMID: 19664930] |
| T47D | IC50 |
0.6 μM
Compound: 5-FU
|
Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| T47D | GI50 |
47 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human T47D cells expressing estrogen receptor after 48 hrs by SRB assay
Antiproliferative activity against human T47D cells expressing estrogen receptor after 48 hrs by SRB assay
|
[PMID: 20438092] |
| T47D | IC50 |
8.91 μM
Compound: 5FU
|
Cytotoxicity against human T47D cells incubated for 72 hrs by SRB assay
Cytotoxicity against human T47D cells incubated for 72 hrs by SRB assay
|
[PMID: 22867707] |
| T47D | IC50 |
51.8 μM
Compound: 5-FU
|
Cytotoxicity against human T47D cells after 24 hrs by MTT assay
Cytotoxicity against human T47D cells after 24 hrs by MTT assay
|
[PMID: 23202484] |
| T47D | GI50 |
8.12 μM
Compound: 5-FU
|
Growth inhibition of human T47D cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human T47D cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| T47D | ED50 |
50.2 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human T47D cells after 3 hrs by Alamar Blue assay
Cytotoxicity against human T47D cells after 3 hrs by Alamar Blue assay
|
[PMID: 24020806] |
| T47D | IC50 |
10.56 μM
Compound: 5-Fu
|
Cytotoxicity against human T47D cells after 3 days by SRB assay
Cytotoxicity against human T47D cells after 3 days by SRB assay
|
[PMID: 24704691] |
| T47D | IC50 |
7.9 μM
Compound: 5-FU
|
Cytotoxicity against human T47D cells after 72 hrs by SRB assay
Cytotoxicity against human T47D cells after 72 hrs by SRB assay
|
[PMID: 25462277] |
| T47D | GI50 |
47 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human T47D cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells after 48 hrs by sulforhodamine B assay
|
[PMID: 25752525] |
| T47D | IC50 |
51.7 μM
Compound: 5-FU
|
Growth inhibition of human T47D cells after 24 hrs by MTT assay
Growth inhibition of human T47D cells after 24 hrs by MTT assay
|
[PMID: 28011220] |
| T47D | IC50 |
12.1 μM
Compound: 5-FU
|
Antiproliferative activity against human T47D cells after 48 hrs by MTT assay
Antiproliferative activity against human T47D cells after 48 hrs by MTT assay
|
[PMID: 28400238] |
| T47D | GI50 |
47 μM
Compound: 5-FU
|
Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
|
[PMID: 28728108] |
| T47D | IC50 |
171.06 μM
Compound: Fluorouracil
|
Cytotoxicity against human T47D cells after 48 hrs by MTT assay
Cytotoxicity against human T47D cells after 48 hrs by MTT assay
|
[PMID: 28789892] |
| T47D | GI50 |
47 μM
Compound: 5-FU
|
Antiproliferative activity against human T47D cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human T47D cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 31376562] |
| T47D | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human T47D cells by MTT assay
Antiproliferative activity against human T47D cells by MTT assay
|
[PMID: 31546197] |
| T47D | IC50 |
6.7 μM
Compound: 5-FU
|
Antiproliferative activity against human T47D cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells assessed as reduction in cell viability incubated for 24 hrs by sulforhodamine B assay
|
[PMID: 34847409] |
| T47D | GI50 |
43 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human T47D cells assessed as reduction in cell growth
Antiproliferative activity against human T47D cells assessed as reduction in cell growth
|
[PMID: 34847410] |
| T47D | GI50 |
8.12 μM
Compound: 5-FU
|
Anticancer activity against human T47D cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human T47D cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| T47D | IC50 |
8.12 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human T47D cells assessed as cell growth inhibition
Cytotoxicity against human T47D cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| T47D | GI50 |
47 μM
Compound: 5-FU
|
Growth inhibition of human T47D cells measured after 48 hrs by SRB colorimetric assay
Growth inhibition of human T47D cells measured after 48 hrs by SRB colorimetric assay
|
[PMID: 37137247] |
| T84 | IC50 |
6.2 μM
Compound: 5-FU
|
Antiproliferative activity against human T84 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
Antiproliferative activity against human T84 cells assessed as cellular DNA content after 96 hrs by CyQUANT NF fluorescence assay
|
[PMID: 26731300] |
| T84 | IC50 |
3.4 μM
Compound: 5-Fu
|
Antiproliferative activity against human T84 cells after 3 days by sulforhodamine B assay
Antiproliferative activity against human T84 cells after 3 days by sulforhodamine B assay
|
[PMID: 30248657] |
| T84 | IC50 |
>10 μM
Compound: 5-FU
|
Antiproliferative activity against human T84 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human T84 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 32127259] |
| T98G | IC50 |
>50 μM
Compound: 5-FU
|
Antiproliferative activity against human T98G cells assessed as inhibition of cell growth
Antiproliferative activity against human T98G cells assessed as inhibition of cell growth
|
[PMID: 36089111] |
| TE-1 | IC50 |
17.32 μM
Compound: 5-FU
|
Cytotoxicity against human TE1 cells assessed as growth inhibition after 72 hrs by CCK8 assay
Cytotoxicity against human TE1 cells assessed as growth inhibition after 72 hrs by CCK8 assay
|
[PMID: 27597411] |
| TE-1 | IC50 |
16.53 μM
Compound: 5-Fu
|
Antiproliferative activity against human TE1 cells after 72 hrs by MTT assay
Antiproliferative activity against human TE1 cells after 72 hrs by MTT assay
|
[PMID: 29635165] |
| TE-1 | IC50 |
16.53 μM
Compound: 5-Fu
|
Cytotoxicity against human TE1 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Cytotoxicity against human TE1 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 30388465] |
| TE-1 | IC50 |
7.73 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human TE-1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human TE-1 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36893627] |
| TE-2 | IC50 |
3.9 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of human lung squamous cell carcinoma TE2 solid cell lines.
Concentration required for 50% inhibition of human lung squamous cell carcinoma TE2 solid cell lines.
|
[PMID: 1992123] |
| TE-2 | IC50 |
3.9 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human esophagus adenocarcinoma (TE-2) cell line.
In vitro inhibitory activity against Human esophagus adenocarcinoma (TE-2) cell line.
|
[PMID: 1995905] |
| TE-2 | IC50 |
3.9 μg/mL
Compound: 5-FU
|
In vitro inhibitory effect on growth of human esophagus adenocarcinoma cell lines (TE2).
In vitro inhibitory effect on growth of human esophagus adenocarcinoma cell lines (TE2).
|
[PMID: 3373480] |
| THP-1 | IC50 |
0.54 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
Cytotoxicity against human THP1 cells after 24 hrs by MTT assay
|
[PMID: 23352638] |
| THP-1 | IC50 |
1 μM
Compound: 5-FU
|
Antiproliferative activity against human THP1 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human THP1 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23501113] |
| THP-1 | IC50 |
0.04 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human THP1 cells after 48 hrs by SRB assay
Cytotoxicity against human THP1 cells after 48 hrs by SRB assay
|
[PMID: 25259515] |
| THP-1 | IC50 |
1.7 μM
Compound: 5-FU
|
Cytotoxicity against human THP1 cells after 48 hrs by MTT assay
Cytotoxicity against human THP1 cells after 48 hrs by MTT assay
|
[PMID: 26854375] |
| THP-1 | IC50 |
4.87 μM
Compound: 5-FU
|
Antiproliferative activity against human THP1 cells treated for 24 hrs measured after 72 hrs by MTT assay
Antiproliferative activity against human THP1 cells treated for 24 hrs measured after 72 hrs by MTT assay
|
[PMID: 29037951] |
| THP-1 | IC50 |
0.01 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human THP1 cells assessed as inhibition of cell growth after 48 hrs by sulforhodamine B assay
Cytotoxicity against human THP1 cells assessed as inhibition of cell growth after 48 hrs by sulforhodamine B assay
|
10.1039/C5MD00289C |
| TIG-3 | IC50 |
8.4 μM
Compound: 5-fluorouracil
|
Antiproliferative activity against human TIG3 cells after 72 hrs by WST8 assay
Antiproliferative activity against human TIG3 cells after 72 hrs by WST8 assay
|
[PMID: 25919052] |
| TK-10 | GI50 |
1.12 μM
Compound: 5-FU
|
Growth inhibition of human TK10 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human TK10 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| TK-10 | GI50 |
1.12 μM
Compound: 5-FU
|
Anticancer activity against human TK-10 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human TK-10 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| TK-10 | IC50 |
1.12 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human TK-10 cells assessed as cell growth inhibition
Cytotoxicity against human TK-10 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| TSU | IC50 |
3.6 μM
Compound: 5-FU
|
Concentration required to inhibit proliferation of TSU prostate cancer cell lines
Concentration required to inhibit proliferation of TSU prostate cancer cell lines
|
[PMID: 15341952] |
| U-251 | GI50 |
82 μM
Compound: 5-Fu
|
Growth inhibition of human U251 cells after 48 hrs by SRB assay
Growth inhibition of human U251 cells after 48 hrs by SRB assay
|
[PMID: 22512908] |
| U-251 | GI50 |
69.6 nM
Compound: 5FU
|
Growth inhibition of human U251 cells after 48 hrs by SRB assay
Growth inhibition of human U251 cells after 48 hrs by SRB assay
|
[PMID: 23094992] |
| U-251 | GI50 |
0.9 μM
Compound: 5-FU
|
Growth inhibition of human U251 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human U251 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| U-251 | IC50 |
24.69 μM
Compound: 5-Fu
|
Cytotoxicity against human U251 cells after 48 hrs by MTT assay
Cytotoxicity against human U251 cells after 48 hrs by MTT assay
|
[PMID: 27133593] |
| U-251 | IC50 |
38.68 μM
Compound: 5-Fu
|
Cytotoxicity against human U251 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Cytotoxicity against human U251 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 27400887] |
| U-251 | IC50 |
48.68 μM
Compound: 5FU
|
Cytotoxicity against human U251 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
Cytotoxicity against human U251 cells assessed as decrease in cell proliferation after 48 hrs by MTT colorimetric assay
|
[PMID: 28038327] |
| U-251 | IC50 |
0.54 μM
Compound: 5-fluorouracil
|
Cytotoxicity against human U251 cells assessed as reduction in cell viability by SRB assay
Cytotoxicity against human U251 cells assessed as reduction in cell viability by SRB assay
|
[PMID: 30660827] |
| U-251 | GI50 |
30.1 μM
Compound: 5-Fu
|
Antiproliferative activity against human U251 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human U251 cells incubated for 48 hrs by MTT assay
|
[PMID: 32832031] |
| U-251 | GI50 |
0.92 μM
Compound: 5-FU
|
Anticancer activity against human U-251 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human U-251 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| U-251 | IC50 |
0.92 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human U-251 cells assessed as cell growth inhibition
Cytotoxicity against human U-251 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| U-251 | IC50 |
29.49 μM
Compound: 5-Fu
|
Antiproliferative activity against human U-251 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human U-251 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 39163776] |
| U-266 | IC50 |
43.48 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human U266 cells in presence of ubenimex after 48 hrs by MTT assay
Antiproliferative activity against human U266 cells in presence of ubenimex after 48 hrs by MTT assay
|
[PMID: 29202398] |
| U-266 | IC50 |
66.22 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human U266 cells after 48 hrs by MTT assay
Antiproliferative activity against human U266 cells after 48 hrs by MTT assay
|
[PMID: 29202398] |
| U2OS | IC50 |
13.18 μM
Compound: 5-FU
|
Antiproliferative activity against human U2OS cells expressing p53 gene after 72 hrs by proliferative assay
Antiproliferative activity against human U2OS cells expressing p53 gene after 72 hrs by proliferative assay
|
[PMID: 18469809] |
| U2OS | IC50 |
16 μM
Compound: 5-FU
|
Antiproliferative activity against human U2OS cells expressing p53 after 72 hrs by celltiter-glo assay
Antiproliferative activity against human U2OS cells expressing p53 after 72 hrs by celltiter-glo assay
|
[PMID: 20873740] |
| U2OS | IC50 |
7.2 μg/mL
Compound: 5-FU
|
Cytotoxicity against human U2OS cells after 36 hrs by MTT assay
Cytotoxicity against human U2OS cells after 36 hrs by MTT assay
|
[PMID: 20961091] |
| U2OS | IC50 |
13.02 μM
Compound: 5-Fu
|
Antiproliferative activity against human U2OS cells after 72 hrs by MTT assay
Antiproliferative activity against human U2OS cells after 72 hrs by MTT assay
|
[PMID: 35609396] |
| U2OS | IC50 |
>20 μM
Compound: 5-FU
|
Cytotoxicity against human U2OS cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Cytotoxicity against human U2OS cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36331508] |
| U-87MG ATCC | IC50 |
38.2 μM
Compound: 5-Fu
|
Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay
|
[PMID: 25453794] |
| U-87MG ATCC | IC50 |
3.61 μM
Compound: 5-FU
|
Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 26735909] |
| U-87MG ATCC | IC50 |
18.25 μM
Compound: 5-FU
|
Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Z2 coulter counter method
Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Z2 coulter counter method
|
[PMID: 27081742] |
| U-87MG ATCC | IC50 |
219.6 μM
Compound: 5-FU
|
Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by Z2 coulter counter method
Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by Z2 coulter counter method
|
[PMID: 27081742] |
| U-87MG ATCC | IC50 |
49298 μM
Compound: 5-FU
|
Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by Z2 coulter counter method
Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by Z2 coulter counter method
|
[PMID: 27081742] |
| U-87MG ATCC | IC50 |
3.65 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay
Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay
|
[PMID: 27092413] |
| U-87MG ATCC | IC50 |
5.61 μM
Compound: 5-Fu
|
Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay
Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay
|
[PMID: 27105028] |
| U-87MG ATCC | IC50 |
15.48 μM
Compound: F
|
Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 27210438] |
| U-87MG ATCC | GI50 |
13 μM
Compound: 5-FU
|
Neurotoxicity against human U87 cells assessed as growth inhibition measured after 48 hrs by MTT assay
Neurotoxicity against human U87 cells assessed as growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 27688184] |
| U-87MG ATCC | IC50 |
22 μM
Compound: 5-Fu
|
Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay
|
[PMID: 30568759] |
| U-87MG ATCC | IC50 |
45.3 μM
Compound: 5-FU
|
Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 30739827] |
| U-87MG ATCC | IC50 |
2.42 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197] |
| U-87MG ATCC | IC50 |
>50 μM
Compound: 5-FU
|
Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33538581] |
| U-87MG ATCC | IC50 |
4.94 μM
Compound: 5-Fu
|
Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by SRB assay
|
[PMID: 39054645] |
| U-937 | IC50 |
3.5 μg/mL
Compound: 5-FU
|
Concentration required for 50% inhibition of cell growth of U937 leukemic cell lines in human.
Concentration required for 50% inhibition of cell growth of U937 leukemic cell lines in human.
|
[PMID: 1992123] |
| U-937 | IC50 |
0.11 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against growth of Human histocytic lymphoma (U937) cells
In vitro inhibitory activity against growth of Human histocytic lymphoma (U937) cells
|
[PMID: 1995901] |
| U-937 | IC50 |
3.5 μg/mL
Compound: 5-FU
|
In vitro inhibitory activity against Human histiocytic lymphoma (U-937) cell line.
In vitro inhibitory activity against Human histiocytic lymphoma (U-937) cell line.
|
[PMID: 1995905] |
| U-937 | IC50 |
1.07 μM
Compound: 5-FU
|
Cytotoxicity against human U937 cells after 72 hrs by MTT assay
Cytotoxicity against human U937 cells after 72 hrs by MTT assay
|
[PMID: 22959518] |
| U-937 | IC50 |
0.87 μg/mL
Compound: 5-Fluorouracil
|
Cytotoxicity against human U937 cells after 24 hrs by MTT assay
Cytotoxicity against human U937 cells after 24 hrs by MTT assay
|
[PMID: 23352638] |
| U-937 | IC50 |
23.93 μM
Compound: 5-Fu
|
Cytotoxicity against human U937 cells after 48 hrs by MTT assay
Cytotoxicity against human U937 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| U-937 | IC50 |
23.93 μM
Compound: 5-Fu
|
Growth inhibition against human U937 cells after 48 hrs by MTT assay
Growth inhibition against human U937 cells after 48 hrs by MTT assay
|
[PMID: 23999046] |
| U-937 | IC50 |
28.76 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
|
[PMID: 29202398] |
| U-937 | IC50 |
9.56 μM
Compound: 2; 5-FU
|
Antiproliferative activity against human U937 cells in presence of ubenimex after 48 hrs by MTT assay
Antiproliferative activity against human U937 cells in presence of ubenimex after 48 hrs by MTT assay
|
[PMID: 29202398] |
| U-937 | IC50 |
56.28 μM
Compound: 5-Fu
|
Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
Antiproliferative activity against human U937 cells after 48 hrs by MTT assay
|
[PMID: 29958763] |
| U-937 | IC50 |
0.5 μg/mL
Compound: 5-F-Ura
|
In vitro antitumor activity in U-937 cell lines
In vitro antitumor activity in U-937 cell lines
|
[PMID: 8648611] |
| U-937 | IC50 |
4.7 μM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) U937 cells after 96 hr by MTT assay
Cytotoxicity against Homo sapiens (human) U937 cells after 96 hr by MTT assay
|
10.1007/s00044-011-9778-y |
| UACC-257 | GI50 |
3.55 μM
Compound: 5-FU
|
Growth inhibition of human UACC257 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human UACC257 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| UACC-257 | GI50 |
3.55 μM
Compound: 5-FU
|
Anticancer activity against human UACC-257 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human UACC-257 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| UACC-257 | IC50 |
3.55 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human UACC-257 cells assessed as cell growth inhibition
Cytotoxicity against human UACC-257 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| UACC-62 | GI50 |
0.52 μM
Compound: 5-FU
|
Growth inhibition of human UACC62 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human UACC62 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| UACC-62 | IC50 |
264 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human UACC62 cells after 48 hrs by MTT assay
Cytotoxicity against human UACC62 cells after 48 hrs by MTT assay
|
[PMID: 24177365] |
| UACC-62 | GI50 |
0.52 μM
Compound: 5-FU
|
Anticancer activity against human UACC-62 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human UACC-62 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| UACC-62 | IC50 |
0.52 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human UACC-62 cells assessed as cell growth inhibition
Cytotoxicity against human UACC-62 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| UACC-812 | IC50 |
3.1 μM
Compound: 5-FU
|
Antiproliferative activity against human UACC-812 cells after 72 hrs by MTT assay
Antiproliferative activity against human UACC-812 cells after 72 hrs by MTT assay
|
[PMID: 19743863] |
| UO-31 | GI50 |
1.42 μM
Compound: 5-FU
|
Growth inhibition of human UO31 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human UO31 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 23887055] |
| UO-31 | GI50 |
1.42 μM
Compound: 5-FU
|
Anticancer activity against human UO-31 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
Anticancer activity against human UO-31 cells assessed as cell growth inhibition incubated for 48 hrs by SRB assay
|
[PMID: 35182815] |
| UO-31 | IC50 |
1.42 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human UO-31 cells assessed as cell growth inhibition
Cytotoxicity against human UO-31 cells assessed as cell growth inhibition
|
[PMID: 36470105] |
| Vero | IC50 |
6.81 μM
Compound: 5-fluorouracil
|
Tested in vitro for cytotoxicity against Vero cells
Tested in vitro for cytotoxicity against Vero cells
|
[PMID: 10072683] |
| Vero | IC50 |
0.2 μM
Compound: 5-fluorouracil
|
Cytotoxicity against Vero cells
Cytotoxicity against Vero cells
|
[PMID: 17234303] |
| Vero | IC50 |
6.5 μg/mL
Compound: 5-Fu
|
Cytotoxicity against african green monkey Vero cells assessed as loss of cell monolayers after 96 hrs
Cytotoxicity against african green monkey Vero cells assessed as loss of cell monolayers after 96 hrs
|
[PMID: 21130542] |
| Vero | IC50 |
6.5 μg/mL
Compound: 5-Fu
|
Cytotoxicity against african green monkey Vero cells after 96 hrs by MTT assay
Cytotoxicity against african green monkey Vero cells after 96 hrs by MTT assay
|
[PMID: 22204901] |
| Vero | IC50 |
>100 μM
Compound: 5-Fu
|
Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay
|
[PMID: 22687745] |
| Vero | IC50 |
6.4 μg/mL
Compound: 5-FU
|
Cytotoxicity against African green monkey Vero cells after 96 hrs by MTT assay
Cytotoxicity against African green monkey Vero cells after 96 hrs by MTT assay
|
[PMID: 23022735] |
| Vero | IC50 |
4.5 μM
Compound: 1, 5-FU
|
Growth inhibition of african green monkey Vero cells by crystal violet assay
Growth inhibition of african green monkey Vero cells by crystal violet assay
|
[PMID: 23075414] |
| Vero | IC50 |
9.71 μM
Compound: 5-Fu
|
Cytotoxicity against African green monkey Vero cells after 72 hrs by MTT assay
Cytotoxicity against African green monkey Vero cells after 72 hrs by MTT assay
|
[PMID: 23685571] |
| Vero | IC50 |
8 μM
Compound: 5-FU
|
Antiproliferative activity against african green monkey Vero cells after 48 hrs by MTT assay
Antiproliferative activity against african green monkey Vero cells after 48 hrs by MTT assay
|
[PMID: 23800391] |
| Vero | IC50 |
0.05 mM
Compound: 5-FU
|
Cytotoxicity against Chlorocebus aethiops (African green monkey) Vero cells assessed as inhibition of cell survival after 96 hr
Cytotoxicity against Chlorocebus aethiops (African green monkey) Vero cells assessed as inhibition of cell survival after 96 hr
|
10.1007/s00044-012-0201-0 |
| WI-38 | IC50 |
10 μM
Compound: 5-FU
|
Cytotoxicity against human WI38 cells after 3 days by MTT assay
Cytotoxicity against human WI38 cells after 3 days by MTT assay
|
[PMID: 18424155] |
| WI-38 | IC50 |
3.2 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human WI38 cells assessed as loss of cell monolayers after 96 hrs
Cytotoxicity against human WI38 cells assessed as loss of cell monolayers after 96 hrs
|
[PMID: 21130542] |
| WI-38 | IC50 |
18.5 μM
Compound: 5-FU
|
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
|
[PMID: 21524829] |
| WI-38 | IC50 |
3.2 μg/mL
Compound: 5-Fu
|
Cytotoxicity against human WI38 cells after 96 hrs by MTT assay
Cytotoxicity against human WI38 cells after 96 hrs by MTT assay
|
[PMID: 22204901] |
| WI-38 | IC50 |
24.66 μM
Compound: 5-Fluoruracil
|
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
|
[PMID: 22555152] |
| WI-38 | IC50 |
4 μg/mL
Compound: 5-FU
|
Cytotoxicity against human WI38 cells after 96 hrs by MTT assay
Cytotoxicity against human WI38 cells after 96 hrs by MTT assay
|
[PMID: 23022735] |
| WI-38 | IC50 |
10 μM
Compound: 5-FU
|
Antiproliferative activity against human WI38 cells after 48 hrs by MTT assay
Antiproliferative activity against human WI38 cells after 48 hrs by MTT assay
|
[PMID: 23800391] |
| WI-38 | IC50 |
38.91 μM
Compound: 5-FU
|
Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 26873416] |
| WI-38 | IC50 |
4 μM
Compound: 5-FU
|
Cytotoxicity against human WI38 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against human WI38 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 27343853] |
| WI-38 | IC50 |
0.94 μM
Compound: 5-FU
|
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
|
[PMID: 27875779] |
| WI-38 | IC50 |
9.3 μM
Compound: 5-FU
|
Cytotoxicity against human WI38 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Cytotoxicity against human WI38 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 27951487] |
| WI-38 | IC50 |
0.051 mM
Compound: 5-Fluorouracil
|
Cytotoxicity in human WI38 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity in human WI38 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 28334654] |
| WI-38 | IC50 |
0.94 μM
Compound: 5-FU
|
Cytotoxicity against human WI38 cells after 72 hrs by MTT assay
Cytotoxicity against human WI38 cells after 72 hrs by MTT assay
|
[PMID: 28525845] |
| WI-38 | IC50 |
6.8 μM
Compound: 5-FU
|
Cytotoxicity against human WI38 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human WI38 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
|
[PMID: 28558970] |
| WI-38 | IC50 |
5.73 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human W138 cells assessed as decrease in cell viability after 48 hrs by MTT assay
Cytotoxicity against human W138 cells assessed as decrease in cell viability after 48 hrs by MTT assay
|
[PMID: 28623814] |
| WI-38 | IC50 |
5.7 μM
Compound: 5-Fluorouracil
|
Cytotoxicity in human WI38 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
Cytotoxicity in human WI38 cells assessed as inhibition of cell viability incubated for 48 hrs by MTT assay
|
[PMID: 28926764] |
| WI-38 | IC50 |
0.94 μM
Compound: 5-FU
|
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
Antiproliferative activity against human WI38 cells after 72 hrs by MTT assay
|
[PMID: 29133046] |
| WI-38 | IC50 |
8.4 μM
Compound: 5-FU
|
Cytotoxicity activity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
Cytotoxicity activity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
|
[PMID: 30856408] |
| WI-38 | IC50 |
201.9 μM
Compound: 5-FU
|
Cytotoxicity in human W138 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
Cytotoxicity in human W138 cells assessed as growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 31128448] |
| WI-38 | IC50 |
4.1 μM
Compound: 5-Fu
|
Cytotoxicity against human WI38 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human WI38 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 31276896] |
| WI-38 | IC50 |
78.5 μM
Compound: 5-FU
|
Cytotoxicity against human WI-38 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxicity against human WI-38 cells assessed as reduction in cell viability after 72 hrs by SRB assay
|
[PMID: 32485532] |
| WI-38 | IC50 |
>40 μM
Compound: 5-Fu
|
Antiproliferative activity against human WI-38 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human WI-38 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 35092899] |
| WI-38 | IC50 |
3.325 μM
Compound: 5-FU
|
Cytotoxicity against human WI-38 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human WI-38 cells incubated for 72 hrs by MTT assay
|
[PMID: 36335743] |
| WI-38 | IC50 |
0.192 μM
Compound: 5-FU
|
Cytotoxicity in human WI-38 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Cytotoxicity in human WI-38 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 36921275] |
| WI-38 | IC50 |
62 μM
Compound: 5-Fluorouracil
|
Cytotoxicity against human WI-38 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
Cytotoxicity against human WI-38 cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay
|
[PMID: 36970146] |
| WI-38 | IC50 |
0.02 mM
Compound: 5-FU
|
Cytotoxicity against Homo sapiens (human) WI38 cells assessed as inhibition of cell survival after 96 hr
Cytotoxicity against Homo sapiens (human) WI38 cells assessed as inhibition of cell survival after 96 hr
|
10.1007/s00044-012-0201-0 |
| WiDr | GI50 |
50 μM
Compound: 5-FU
|
Growth inhibition of human WiDr cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human WiDr cells after 48 hrs by sulforhodamine B assay
|
[PMID: 19664930] |
| WiDr | GI50 |
49 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human WiDr cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human WiDr cells after 48 hrs by sulforhodamine B assay
|
[PMID: 25752525] |
| WiDr | GI50 |
49 μM
Compound: 5-FU
|
Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
|
[PMID: 28728108] |
| WiDr | GI50 |
49 μM
Compound: 5-FU
|
Antiproliferative activity against human WiDr cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human WiDr cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 31376562] |
| WiDr | IC50 |
4.3 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human WiDr cells by MTT assay
Antiproliferative activity against human WiDr cells by MTT assay
|
[PMID: 31546197] |
| WiDr | IC50 |
10.5 μM
Compound: 5-FU
|
Anticancer activity against human WiDr cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Anticancer activity against human WiDr cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 34425478] |
| WiDr | GI50 |
49 μM
Compound: 5-Fluorouracil
|
Antiproliferative activity against human WiDr cells assessed as reduction in cell growth
Antiproliferative activity against human WiDr cells assessed as reduction in cell growth
|
[PMID: 34847410] |
| WiDr | GI50 |
49 μM
Compound: 5-FU
|
Growth inhibition of human WiDr cells measured after 48 hrs by SRB colorimetric assay
Growth inhibition of human WiDr cells measured after 48 hrs by SRB colorimetric assay
|
[PMID: 37137247] |
| WISH | IC50 |
7.1 μM
Compound: 5-FU
|
Cytotoxicity against human WISH cells assessed as reduction in cell viability after 24 hrs by MTT assay
Cytotoxicity against human WISH cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 27951487] |
| WM 266-4 | GI50 |
28.76 μM
Compound: 5-Fu
|
Antiproliferative activity against human WM266.4 cells after 24 hrs by MTT assay
Antiproliferative activity against human WM266.4 cells after 24 hrs by MTT assay
|
[PMID: 24934992] |
| ZR-75-1 | GI50 |
2.3 μM
Compound: 5FU
|
Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human ZR-75-1 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 21489802] |
5-Fluorouracil (5-Fu) and NSC 123127 (Dox) show synergistic anticancer efficacy. The IC50 value of 5-Fu/Dox-DNM toward human breast cancer (MDA-MB-231) cells is 0.25 μg/mL, presenting an 11.2-fold and 6.1-fold increase in cytotoxicity compared to Dox-DNM and 5-Fu-DNM, respectively[1]. In 5-fluorouracil (5-FU) and CDDP treated NFBD1-inhibited NPC cells, the NFBD1 expression in NPC CNE1 cell lines is depleted using lentivirus-mediated short hairpin RNA, and the sensitivity of these cells is elevated. NFBD1 knockdown leads to an obvious induction of apoptosis in CDDP- or 5-FU-treated CNE1 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 51-21-8
-
Appearance Solid
-
Molecular Weight 130.08
-
Formula C4H3FN2O2
-
Color White to off-white
-
SMILES
O=C(N1)NC=C(F)C1=O
-
Synonyms
5-FU
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (344)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responses. [Abstract]2025 Dec 15;10(1):406. PMID: 41392286 -
Cancer Cell
Chemotherapy triggers immune evasion by fostering LEPR+ Kupffer cell differentiation in liver metastases. [Abstract]2026 Mar 9;44(3):658-675.e12. PMID: 41687606 -
Cancer Cell
Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches. [Abstract]2025 Sep 25:S1535-6108(25)00393-9. PMID: 41005303 -
Nature
2024 Oct;634(8036):1229-1237. PMID: 39322678 -
Nat Med
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma. [Abstract]2024 Mar;30(3):749-761. PMID: 38287168
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Nat Med. 2024 Mar;30(3):749-761. [Abstract]
The relative cell viability of shCtl-, shNDUFB8-, and shCEMIP2-transfected cells was detected by XTT assay after paclitaxel plus gemcitabine treatment (A+G), single-agent 5-Fu (5-FU), and the FOLFIRINOX chemotherapy cocktail [FU+IRI+OXA: 5-FU (5 μM)+Irinotecan (SN-38) +Oxaliplatin] for 48h.
-
Cell
Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells. [Abstract]2024 Apr 25;187(9):2288-2304.e27. PMID: 38565142
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Cell. 2024 Apr 25;187(9):2288-2304.e27. [Abstract]
SP1 and SLC6A6 levels in SGC7901 cells treated with fluorouracil (0.5 μg/mL) for the indicated times.
-
Mol Cancer
Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma. [Abstract]2024 Jan 10;23(1):12. PMID: 38200517 -
Mol Cancer
LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM. [Abstract]2024 Jan 24;23(1):23. PMID: 38263157
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Jan 24;23(1):23. [Abstract]
A CCK-8 assay was used to investigate the effects of LINC01852 overexpression and knockdown on the sensitivity of CRC cells to 5-FU and L-OHP. CRC cells were exposed to gradually increasing concentrations of 5-FU (1-3 μM) and L-OHP for 48 h
-
Immunity
Small-molecule CBP/p300 histone acetyltransferase inhibition mobilizes leukocytes from the bone marrow via the endocrine stress response. [Abstract]2024 Feb 13;57(2):364-378.e9. PMID: 38301651 -
Gastroenterology
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53. [Abstract]2021 Nov;161(5):1601-1614.e23. PMID: 34303658
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Gastroenterology. 2021 Nov;161(5):1601-1614.e23. [Abstract]
Bar graphs show the GI50 of 5-fluoruracil (48 h), irinotecan (48 h), gemcitabine (48 h), paclitaxel (48 h), and oxaliplatin (48 h) in PDAC cells in combination with bioactive hexapeptides (NTAIYY and PTTIYY) or controls (saline and NTAIYA).
-
Adv Mater
Efficacy and Safety Assessment of 5-Fluorouracil, Irinotecan and Oxaliplatin-Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy. [Abstract]2026 Mar 15:e22617. PMID: 41834342 -
Adv Mater
Epigenetic Remodeling Hydrogel Patches for Multidrug-Resistant Triple-Negative Breast Cancer. [Abstract]2021 May;33(18):e2100949. PMID: 33792093 -
Cancer Commun (Lond)
N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer. [Abstract]2024 Apr;44(4):469-490. PMID: 38512764 -
JAMA Oncol
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. [Abstract]2022 Jan 1;8(1):e215445. PMID: 34792531 -
Cell Stem Cell
2026 Apr 2;33(4):660-675.e5. PMID: 41895281 -
Cancer Res
METTL3 Methylation Induces Decay of Endogenous Retroelement Transcripts to Promote Tumor Immune Evasion. [Abstract]2026 Mar 5. PMID: 41784625 -
Cancer Res
SMARCA4 loss increases RNA Polymerase II pausing and elevates R-loops to inhibit BRCA1-mediated repair in ovarian cancer. [Abstract]2025 May 14. PMID: 40366633 -
Cancer Res
A RIPK3-PGE2 Circuit Mediates Myeloid-Derived Suppressor Cell-Potentiated Colorectal Carcinogenesis. [Abstract]2018 Oct 1;78(19):5586-5599. PMID: 30012671 -
Drug Resist Updat
FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis. [Abstract]2023 Mar:67:100926. PMID: 36682222 -
Autophagy
HMBOX1 reverses autophagy mediated 5-fluorouracil resistance through promoting HACE1-induced ubiquitination and degradation of ATG5 in colorectal cancer. [Abstract]2025 Jul;21(7):1556-1577. PMID: 40126194 -
Nat Commun
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. [Abstract]2026 May 11. PMID: 42115161 -
-
ACS Nano
MicroRNA-200 Loaded Lipid Nanoparticles Promote Intestinal Epithelium Regeneration in Canonical MicroRNA-Deficient Mice. [Abstract]2023 Nov 28;17(22):22901-22915. PMID: 37939210
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: ACS Nano. 2023 Nov 28;17(22):22901-22915. [Abstract]
5-FU (120 mg/kg; i.p.; once daily for 2 consecutive days) induces increased infiltration of CD45+ immune cells into the intestinal lumen of Dgcr8-deficient mice, accompanied by elevated levels of the pro-inflammatory cytokines IFNγ and pNF-κB.
-
Redox Biol
p53 and fatty acids collaborate to trigger ferroptosis via the FBXO2-FABP5 axis in colorectal cancer. [Abstract]2026 Mar:90:104043. PMID: 41604941 -
Mol Cell
Lactylation of XLF promotes non-homologous end-joining repair and chemoresistance in cancer. [Abstract]2025 Jul 17;85(14):2654-2672.e7. PMID: 40680721 -
Gut Microbes
Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway. [Abstract]2024 Jan-Dec;16(1):2333790. PMID: 38533566 -
Theranostics
Metastasis-on-a-chip mimicking the progression of kidney cancer in the liver for predicting treatment efficacy. [Abstract]2020 Jan 1;10(1):300-311. PMID: 31903121 -
Theranostics
Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagy. [Abstract]2019 Jul 9;9(17):4878-4892. PMID: 31410188 -
-
Acta Pharm Sin B
Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier. [Abstract]2024 Apr;14(4):1677-1692. PMID: 38572095 -
Acta Pharm Sin B
A biomimetic liver cancer on-a-chip reveals a critical role of LIPOCALIN-2 in promoting hepatocellular carcinoma progression. [Abstract]2023 Nov;13(11):4621-4637. PMID: 37969730 -
J Clin Invest
DNA topoisomerase II inhibition potentiates osimertinib's therapeutic efficacy in EGFR-mutant non-small cell lung cancer models. [Abstract]2024 Mar 7;134(10):e172716. PMID: 38451729
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Mar 7;134(10):e172716. [Abstract]
The given cell lines were treated with 250 nM osimertinib (Osim), 1.25 μM Etoposide (VP-16), 125 nM Doxorubicin (DXR), 5 nM Paclitaxel, 10 μM Cisplatin, 25 μM Carboplatin, 25 nM Gemcitabine, 20 nM 5-Fluorouracil (5-FU), 25 μM Cyclophosphamide, 25 μM Capecitabine, or 10 nM Vincristine alone or in combination for 3 days. Cell numbers were then measured using the SRB assay.
-
J Exp Clin Cancer Res
ZBTB28 induces autophagy by regulation of FIP200 and Bcl-XL facilitating cervical cancer cell apoptosis. [Abstract]2021 Apr 30;40(1):150. PMID: 33931087
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2021 Apr 30;40(1):150. [Abstract]
Inhibition rate of proliferation in pcDNA3.1 or ZBTB28 transfected cells treated with gradient concentration of 5-FU for 72 hours.
-
J Exp Clin Cancer Res
Tubeimoside-I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation. [Abstract]2019 Aug 14;38(1):353. PMID: 31412953 -
Adv Sci (Weinh)
Loss of VMP1 Impairs Tight Junction Recycling and Aggravates Intestinal Barrier Dysfunction in Inflammatory Bowel Disease. [Abstract]2026 May;13(25):e21681. PMID: 41757559 -
Adv Sci (Weinh)
PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti-TIGIT Therapy in Microsatellite-Stable Colorectal Cancer. [Abstract]2025 Jul;12(27):e2500271. PMID: 40344511 -
Adv Sci (Weinh)
2025 Mar;12(12):e2408845. PMID: 39888307 -
Adv Sci (Weinh)
Synthetic Retinoid Sulfarotene Selectively Inhibits Tumor-Repopulating Cells of Intrahepatic Cholangiocarcinoma via Disrupting Cytoskeleton by P-Selectin/PSGL1 N-Glycosylation Blockage. [Abstract]2025 Jan;12(3):e2407519. PMID: 39605300 -
Adv Sci (Weinh)
Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients. [Abstract]2023 Sep;10(27):e2302640. PMID: 37485650 -
Adv Sci (Weinh)
Primary Human Pancreatic Cancer Cells Cultivation in Microfluidic Hydrogel Microcapsules for Drug Evaluation. [Abstract]2023 Apr;10(12):e2206004. PMID: 36808707 -
Adv Sci (Weinh)
Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR-Mediated Base Editors. [Abstract]2022 Oct;9(30):e2200717. PMID: 36045417
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2022 Oct;9(30):e2200717. [Abstract]
A transient upregulation and subsequent downregulation of RSK2 phosphorylation at Thr577 by 5-Fluorouracil (5-FU), which is accompanied by the accumulation of γ‐H2AX phosphorylation in a time‐dependent manner.
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2022 Oct;9(30):e2200717. [Abstract]
In Hct116 cells, the inhibitory effects of 5-Fluorouracil (5-FU on cell growth at 2-10 μM are significantly enhanced by RSK2 or PAK4 inhibitors in short‐term and long‐term assays.
-
Adv Sci (Weinh)
A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer. [Abstract]2021 Nov;8(21):e2101936. PMID: 34605226
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2021 Nov;8(21):e2101936. [Abstract]
Cell viability upon treatment with 5-Fluorouracil (5-FU; 60 μM), SR140333, or Aprepitant either as single agents or in combination at 24 h in HCT116 cells.
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2021 Nov;8(21):e2101936. [Abstract]
Western blotting of drug-resistant proteins in HCT116/5-FU cells treated with 5-Fluorouracil (5-FU; 80 μM) at 48 h.
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2021 Nov;8(21):e2101936. [Abstract]
ER stress pathways in HCT116/5-FU cells treated with 5-Fluorouracil (5-FU; 60 μM) with SR140333 or Aprepitant either as single agents or in combination at 24 h.
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2021 Nov;8(21):e2101936. [Abstract]
The combination of SR140333 or aprepitant and 5-Fluorouracil (5-FU; mg/kg) decreases the expression levels of ABCC1, ABCG2, p-ERK1/2, and c-Myc and increased those of p-PERK, ATF4, and CHOP compared with 5-FU treatment alone.
-
MedComm (2020)
Demethylzeylasteral inhibits proliferation, migration, and invasion through FBXW7/c-Myc axis in gastric cancer. [Abstract]2021 Jun 3;2(3):467-480. PMID: 34766156 -
Cell Rep Med
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomes. [Abstract]2026 May 19;7(5):102757. PMID: 42013847 -
Cell Rep Med
FBXO3-mediated DUSP9 ubiquitination promotes leukemia stem cell maintenance and tyrosine kinase inhibitor resistance in chronic myeloid leukemia. [Abstract]2026 Mar 17;7(3):102686. PMID: 41850237 -
Cell Rep Med
Single-cell profiles delineate immune cell remodeling and enhanced tumor-fibroblast interaction of hepatoblastoma after chemotherapy. [Abstract]2025 Oct 21;6(10):102401. PMID: 41038160 -
Cell Rep Med
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer. [Abstract]2025 Apr 15;6(4):102053. PMID: 40187357 -
Cell Death Differ
p53 transcriptionally activates DCP1B to suppress tumor progression and enhance tumor sensitivity to PI3K blockade in non-small cell lung cancer. [Abstract]2025 Apr 9. PMID: 40200093 -
Biomaterials
Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway. [Abstract]2024 Oct:310:122625. PMID: 38820768 -
Plant Cell
The chromatin remodeler ERCC6 and the histone chaperone NAP1 are involved in apurinic/apyrimidinic endonuclease-mediated DNA repair. [Abstract]2024 May 29;36(6):2238-2252. PMID: 38367203 -
Carbohydr Polym
Chitosan/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo/immuno-resistance in unresectable metastatic melanoma. [Abstract]2024 Dec 15:346:122645. PMID: 39245506 -
Research (Wash D C)
Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer. [Abstract]2025 Aug 25:8:0838. PMID: 40862051 -
-
J Transl Int Med
Anti-SIA-cIgG enhances chemotherapy effectiveness through PTPN13-regulated tumor stemness in head and neck squamous cell carcinoma. [Abstract]2026 Mar 26;14(2):237-258. PMID: 42046805 -
-
-
Cell Death Dis
Glutamine metabolic stress induces SLC25A6-dependent mitofission via MIC60-MIC19 complex disassembly in colorectal cancer. [Abstract]2026 Apr 23;17(1):537. PMID: 42020360 -
Cell Mol Biol Lett
2025 Nov 7;30(1):133. PMID: 41204108 -
Pharmacol Res
CDC7 stabilized by KRAS signaling reactivation impairs chemosensitivity in KRAS-mutant colorectal cancer. [Abstract]2025 Dec:222:108027. PMID: 41207349 -
Cell Death Dis
Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer. [Abstract]2025 Mar 12;16(1):170. PMID: 40075071 -
Cell Death Dis
Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells. [Abstract]2025 Jan 18;16(1):28. PMID: 39827156 -
Cell Death Dis
2024 Oct 1;15(10):720. PMID: 39353904 -
Cell Death Dis
Sensing of endogenous retroviruses-derived RNA by ZBP1 triggers PANoptosis in DNA damage and contributes to toxic side effects of chemotherapy. [Abstract]2024 Oct 27;15(10):779. PMID: 39465258 -
Cell Death Dis
Nanog mediated by FAO/ACLY signaling induces cellular dormancy in colorectal cancer cells. [Abstract]2022 Feb 17;13(2):159. PMID: 35177584 -
Cell Death Dis
2021 Apr 1;12(4):338. PMID: 33795638
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2021 Apr 1;12(4):338. [Abstract]
SW620, CACO2, and HCT15 cells are treated with different concentrations of UTD1 and 5-Fluorouracil (5-FU), and cell viability is measured by CCK-8.
-
Pharmacol Res
Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism. [Abstract]2021 Jan:163:105232. PMID: 33027716 -
Cell Death Dis
Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway. [Abstract]2020 Jun 15;11(6):464. PMID: 32541902 -
Pharmacol Res
MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2. [Abstract]2020 Jun:156:104774. PMID: 32220639 -
Cell Death Dis
MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling. [Abstract]2019 Aug 13;10(8):615. PMID: 31409796 -
Cancer Lett
Targeting C/EBPβ/SCD1/C16:1 loop-driven macrophage M2 polarization by Bruceine D improves anti-PD-1 immunotherapy in colorectal cancer. [Abstract]2026 Sep 28:656:218655. PMID: 42250753 -
Cancer Lett
Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma. [Abstract]2025 Dec 1:634:218064. PMID: 41015267 -
Cancer Lett
2026 Jan 28:638:218156. PMID: 41265630 -
Cancer Lett
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy. [Abstract]2024 Oct 10:602:217214. PMID: 39218291 -
Cancer Lett
FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients. [Abstract]2023 May 28:562:216145. PMID: 36997107 -
Cancer Lett
Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways. [Abstract]2021 Nov 1:520:361-373. PMID: 34389435 -
J Immunother Cancer
Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response. [Abstract]2026 Jun 8;14(6):e015109. PMID: 42259601 -
J Immunother Cancer
2025 Nov 19;13(11):e012652. PMID: 41260904 -
J Immunother Cancer
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC. [Abstract]2022 Aug;10(8):e004006. PMID: 36002188
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2022 Aug;10(8):e004006. [Abstract]
Hep3B and Huh7 cells are treated with 5-Fluorouracil for 24 h, then the cellular protein expression of p-IRF3 and pP65 is detected by immunoblotting.
-
Int J Biol Sci
CIRBP-OGFR axis safeguards against cardiomyocyte apoptosis and cardiotoxicity induced by chemotherapy. [Abstract]2022 Apr 11;18(7):2882-2897. PMID: 35541895
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Int J Biol Sci. 2022 Apr 11;18(7):2882-2897. [Abstract]
Representative immunoblots assessing apoptosis induced by 5-Fluorouracil (5-FU) in immortalized human ventricular myocytes (AC16).
-
Int J Biol Sci
2022 Feb 7;18(4):1724-1736. PMID: 35280673 -
Cell Commun Signal
The aggressive colorectal cancer subtype marker HTR2B has a dual role depending on the tumor microenvironment. [Abstract]2025 Oct 1;23(1):403. PMID: 41034989 -
Cell Commun Signal
Mechanisms of electroacupuncture-induced neuroprotection in acute stroke rats: the role of astrocyte-mediated mitochondrial transfer. [Abstract]2025 Jul 1;23(1):316. PMID: 40598228 -
Cell Commun Signal
Prkci promotes colorectal cancer metastasis by phosphorylating and stabilizing Tgfbr1 to activate TGF-β signaling. [Abstract]2025 May 17;23(1):230. PMID: 40382656 -
Phytomedicine
Daphnoretin targeted binding to HSP90AA1 to promote P53 UFMylation and stability thereby inducing apoptosis in colorectal cancer. [Abstract]2026 Jul:156:158180. PMID: 42034025 -
Phytomedicine
Modified Fuzheng Yiliu Decoction chemosensitizes colorectal cancer by inhibiting cancer stem cell metabolism and stemness through CAV1/ZNF460/GRP78 signaling. [Abstract]2026 Jul 25:157:158317. PMID: 42177885 -
Phytomedicine
GSTM2 as the molecular linking of depression-driven colon cancer progression and chemoresistance: Reversal by Sinisan. [Abstract]2026 Jun:155:158113. PMID: 41962265 -
Phytomedicine
Multi-omics analysis and experimental verification reveal the role of dihydrocaffeic acid against 5-fluorouracil-induced intestinal mucositis. [Abstract]2026 Mar:152:157837. PMID: 41564518 -
Phytomedicine
Targeting tumor metabolism: The dual attack of emodin on glycolysis and oxidative phosphorylation in esophageal squamous cell carcinoma. [Abstract]2025 Aug:144:156958. PMID: 40513325 -
Phytomedicine
Pentagalloyl glucose targets the JAK1/JAK3-STAT3 pathway to inhibit cancer stem cells and epithelial-mesenchymal transition in 5-fluorouracil-resistant colorectal cancer. [Abstract]2025 Jul:142:156773. PMID: 40378534 -
Phytomedicine
Ponicidin triggered ferroptosis in esophageal squamous cell carcinoma by suppressing the SLC7A11/Glutathione/GPX4 signalling axis. [Abstract]2025 Jul 25:143:156925. PMID: 40456202 -
Phytomedicine
The role of the natural compound naringenin in AMPK-mitochondria modulation and colorectal cancer inhibition. [Abstract]2024 Aug:131:155786. PMID: 38875812 -
Phytomedicine
Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells. [Abstract]2024 Jan:122:155079. PMID: 37863004 -
Phytomedicine
Neobavaisoflavone induces pyroptosis of liver cancer cells via Tom20 sensing the activated ROS signal. [Abstract]2023 Jul 25:116:154869. PMID: 37196512 -
Phytomedicine
Curcumin treatment suppresses cachexia-associated adipose wasting in mice by blocking the cAMP/PKA/CREB signaling pathway. [Abstract]2023 Jan:109:154563. PMID: 36610148 -
Phytomedicine
Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p. [Abstract]2021 Aug:89:153603. PMID: 34175590 -
Phytomedicine
Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer. [Abstract]2021 Jun:86:153553. PMID: 33906076 -
Acta Biomater
Mechanically heterogeneous nanofibrous hydrogel drives Piezo1-mediated cell aggregation and collective migration. [Abstract]2026 Jul:218:244-260. PMID: 42270027 -
Acta Pharmacol Sin
Metabolic checkpoint blockade of IL4I1 by ZY-MY-111 reactivates CD8+ T cell immunity and suppresses tumor growth. [Abstract]2026 Jun 8. PMID: 42252303 -
Cell Death Discov
A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis. [Abstract]2022 May 2;8(1):238. PMID: 35501301 -
NPJ Precis Oncol
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer. [Abstract]2024 Sep 30;8(1):214. PMID: 39349771 -
Proc Natl Acad Sci U S A
2021 Jul 20;118(29):e2026813118. PMID: 34266953
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2026813118. [Abstract]
Overexpression of RMRP impairs 5-FU-induced p53 activation determined by IB.
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2026813118. [Abstract]
Overexpression of RMRP impairs 5-FU–induced p53 activation determined by RT-qPCR.
-
Oncogene
Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability. [Abstract]2026 Jun 15. PMID: 42298179 -
Oncogene
TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling. [Abstract]2021 Dec;40(49):6666-6679. PMID: 34642500 -
Int J Biol Macromol
A novel recombinant peptide, rAnguillin, induces ferroptosis in nasopharyngeal carcinoma by promoting FOXM1 degradation and disrupting the FOXM1-PABPC1L-tryptophan metabolism axis. [Abstract]2026 May:361:151988. PMID: 41985819 -
Int J Nanomedicine
2024 Jul 19:19:7353-7365. PMID: 39050869 -
Int J Nanomedicine
SiRNF8 Delivered by DNA Framework Nucleic Acid Effectively Sensitizes Chemotherapy in Colon Cancer. [Abstract]2024 Jan 6:19:171-188. PMID: 38204601 -
Int J Mol Med
Ailanthone suppresses the activity of human colorectal cancer cells through the STAT3 signaling pathway. [Abstract]2022 Feb;49(2):21. PMID: 34958109 -
Int J Mol Med
XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway. [Abstract]2020 Jul;46(1):201-210. PMID: 32377720 -
Mol Med
Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcinoma. [Abstract]2025 Feb 19;31(1):62. PMID: 39972282 -
Arch Pharm Res
Pharmacological targeting of HDAC/BET pathway enhances 5-FU efficacy in esophageal squamous cancer cells. [Abstract]2025 Dec;48(11-12):1362-1381. PMID: 41258372 -
Phytother Res
Platycodin D2 Mediates Incomplete Autophagy and Ferroptosis in Breast Cancer Cells by Regulating Mitochondrial ROS. [Abstract]2025 Feb;39(2):581-592. PMID: 39581858 -
-
Drug Deliv
Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy. [Abstract]2026 Dec 31;33(1):2604086. PMID: 41404765 -
Clin Transl Med
H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling. [Abstract]2023 Nov;13(11):e1481. PMID: 37983931 -
Clin Transl Med
Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1-Wnt/β-catenin-TFE3 feedback loop signalling. [Abstract]2022 Apr;12(4):e752. PMID: 35485210 -
ACS Appl Mater Interfaces
Primary Human Gastric Cancer Cells Integrated Hydrogel Microcapsules for Personalized Drug Screening. [Abstract]2026 Feb 11;18(5):7900-7909. PMID: 41615381 -
ACS Appl Mater Interfaces
Highly Strong and Transparent Hydrogel Elastomers Microfabricated for 3D Microphysiological Systems. [Abstract]2025 Jul 23;17(29):42394-42406. PMID: 40637032 -
Cell Rep
Gasdermin C reprograms metabolism through the CAMKK2-AMPK axis to promote lung adenocarcinoma progression and radioresistance. [Abstract]2026 May 22;45(6):117427. PMID: 42176271 -
Cell Rep
Structural basis for the reversal of human MRP4-mediated multidrug resistance by lapatinib. [Abstract]2025 Mar 25;44(4):115466. PMID: 40138312 -
Cell Rep
mTORC1 regulates the pyrimidine salvage pathway by controlling UCK2 turnover via the CTLH-WDR26 E3 ligase. [Abstract]2025 Jan 13;44(1):115179. PMID: 39808525 -
Cell Rep
p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. [Abstract]2023 Nov 14;42(11):113426. PMID: 37967006 -
Cell Rep
The deubiquitinase OTUD1 noncanonically suppresses Akt activation through its N-terminal intrinsically disordered region. [Abstract]2023 Jan 31;42(1):111916. PMID: 36640312 -
Cell Rep
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. [Abstract]2022 Dec 20;41(12):111826. PMID: 36543138 -
Cell Rep
S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway. [Abstract]2022 Aug 16;40(7):111194. PMID: 35977495 -
Cell Rep
Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer. [Abstract]2021 Nov 30;37(9):110069. PMID: 34852234 -
Cell Prolif
2021 May;54(5):e13038. PMID: 33793020 -
-
Chin J Nat Med
Two cardenolide glycosides from the seed fairs of Asclepias curassavica and their cytotoxic activities. [Abstract]2022 Mar;20(3):202-209. PMID: 35369964 -
Chin Med
Integrative network pharmacology, transcriptomics, and proteomics reveal the material basis and mechanism of the Shen Qing Weichang Formula against gastric cancer. [Abstract]2025 Mar 29;20(1):42. PMID: 40155922 -
Int J Radiat Oncol Biol Phys
Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells. [Abstract]2023 Feb 1;115(2):440-452. PMID: 35918054 -
Anal Chem
Viability-Informed Single-Cell Mass Spectrometry for More Comprehensive Metabolic Analysis. [Abstract]2026 Jan 23. PMID: 41574827 -
Int J Oncol
Discovery of the late autophagy inhibitor FZU‑0045‑053 and its anti‑breast cancer and immunomodulatory effects. [Abstract]2026 Jan;68(1):10. PMID: 41312734 -
Int J Oncol
2022 Nov;61(5):139. PMID: 36169178 -
Int J Oncol
Isoorientin induces the apoptosis and cell cycle arrest of A549 human lung cancer cells via the ROS‑regulated MAPK, STAT3 and NF‑κB signaling pathways. [Abstract]2020 Aug;57(2):550-561. PMID: 32626938 -
Anal Chem
Modular Nuclease-Responsive DNA Three-Way Junction-Based Dynamic Assembly of a DNA Device and Its Sensing Application. [Abstract]2016 Apr 5;88(7):3817-25. PMID: 26943244 -
Cancer Cell Int
Establishment and characteristic analysis of a novel patient derived cell line of intrahepatic cholangiocarcinoma. [Abstract]2025 Oct 15;25(1):357. PMID: 41094661 -
Cancer Cell Int
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis. [Abstract]2021 Jul 19;21(1):384. PMID: 34281530 -
Cancer Cell Int
YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway. [Abstract]2019 Jul 12:19:179. PMID: 31337986 -
Mol Cancer Ther
Mosperafenib, a novel paradox breaker BRAF inhibitor with potent preclinical activity in BRAF mutated colorectal cancer. [Abstract]2025 Dec 4. PMID: 41340484 -
Redox Rep
Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways. [Abstract]2024 Dec;29(1):2313366. PMID: 38318818 -
Mol Cancer Ther
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199. [Abstract]2021 Dec;20(12):2483-2494. PMID: 34711645 -
Mol Cancer Ther
PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers. [Abstract]2020 Mar;19(3):906-919. PMID: 31879364 -
J Ethnopharmacol
Xianlian Jiedu Decoction induces apoptosis in colorectal cancer via modulation of sphingosine-1-phosphate-dependent JNK/p38 MAPK signaling. [Abstract]2026 Nov 15:370:121987. PMID: 42276393 -
Cell Biosci
2025 Jul 4;15(1):95. PMID: 40615893 -
Cell Mol Life Sci
Neutrophil-centric analysis of gastric cancer: prognostic modeling and molecular insights. [Abstract]2024 Nov 14;81(1):452. PMID: 39540948 -
-
Biomater Sci
Tumor signal amplification and immune decoy strategy using bacterial membrane-coated nanoparticles for immunotherapy. [Abstract]2025 Mar 19. PMID: 40104961 -
Drug Des Devel Ther
Exploration of the Active Component and Mechanisms of Shengyu Decoction Against Myelosuppression Using Network Pharmacology and in vitro Experimental Validation. [Abstract]2024 Jun 20:18:2405-2420. PMID: 38915868 -
Gastric Cancer
Anthracycline chemicals with anthracyclinone structure exert antitumor effects by inhibiting angiogenesis and lymphangiogenesis in a xenografted gastric tumor model. [Abstract]2023 Nov;26(6):863-877. PMID: 37344705 -
J Cell Biol
2023 Jan 2;222(1):e202202110. PMID: 36282216 -
Cells
Machine Learning-Driven Multi-Omics Analysis Identifies CHP2 as a Key PANoptosis-Related Dual-Function Biomarker in Colorectal Cancer. [Abstract]2026 Feb 28;15(5):430. PMID: 41827864 -
Cells
A Comprehensive Adenoid Cystic Carcinoma-Derived Organoid Platform for Disease Modeling and Drug Screening Captures Interpatient Heterogeneity. [Abstract]2026 Feb 23;15(4):383. PMID: 41744826 -
ACS Biomater Sci Eng
Three-Dimensional-Printed In Vitro Model of Colorectal Cancer with Immune Microenvironment and Reprogramming Capabilities. [Abstract]2025 Oct 13;11(10):5991-6003. PMID: 41032858 -
Foods
The Quality and Bioactive Properties of Mulberry Wine Under Different Fermentation Conditions. [Abstract]2025 Sep 30;14(19):3393. PMID: 41097561 -
Oncogenesis
Spindle function and Wnt pathway inhibition by PBX1 to suppress tumor progression via downregulating DCDC2 in colorectal cancer. [Abstract]2023 Feb 4;12(1):3. PMID: 36739270 -
Pharm Biol
Gnetum montanum extract induces apoptosis by inhibiting the activation of AKT in SW480 human colon cancer cells. [Abstract]2022 Dec;60(1):915-930. PMID: 35587342 -
Foods
Comparison of an Artificial Neural Network and a Response Surface Model during the Extraction of Selenium-Containing Protein from Selenium-Enriched Brassica napus L. [Abstract]2022 Nov 27;11(23):3823. PMID: 36496631 -
J Biomed Inform
2023 Jun:142:104383. PMID: 37196989 -
Commun Biol
Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays. [Abstract]2024 Dec 3;7(1):1612. PMID: 39627437 -
Cell Rep Methods
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [Abstract]2023 Oct 23;3(10):100599. PMID: 37797618 -
Front Bioeng Biotechnol
β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest. [Abstract]2020 May 8:8:378. PMID: 32457882 -
Pharmaceuticals (Basel)
Inflammation-Driven JNK Activation Promotes EMT and Metastasis in Gastric Cancer and Is Attenuated by Huangjin Shuangshen Granules. [Abstract]2026 Apr 17;19(4):636. PMID: 42075891 -
Eur J Pharmacol
Arenobufagin induces ferroptosis in gastric cancer stem cells via the HCAR1-GPX4/SLC7A11 antioxidant axis. [Abstract]2026 Apr 10:1020:178785. PMID: 41856196 -
Eur J Pharmacol
ROS-mediated senescence and autophagy inhibition drive 5-FU/Aumolertinib synergy in colorectal cancer. [Abstract]2026 Jan 12:1011:178448. PMID: 41352706 -
Eur J Pharmacol
VOPP1, a determinant of the sensitivity of non-small cell lung cancer cells to NAE inhibitors. [Abstract]2025 Sep 15:1003:177942. PMID: 40651787 -
Pharmaceuticals (Basel)
A Mechanism of Isoorientin-Induced Apoptosis and Migration Inhibition in Gastric Cancer AGS Cells. [Abstract]2022 Dec 12;15(12):1541. PMID: 36558992 -
Int J Mol Sci
LRRC8A Inhibition Overcomes Chemoresistance by Downregulating MRP3 and CYP3A4 in the 3D Spheroid Model of Human Breast Cancer Cells. [Abstract]2026 Mar 13;27(6):2646. PMID: 41898509 -
Int Immunopharmacol
Lycium barbarum polysaccharide LBP3 alleviates 5-Fluorouracil-induced intestinal injury via a mechanism associated with activating Nrf2 and improving mitochondrial function. [Abstract]2026 Jan 1;168(Pt 2):115879. PMID: 41314045 -
Int Immunopharmacol
RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer. [Abstract]2025 Sep 6:165:115445. PMID: 40915184 -
Int J Mol Sci
Study on the Mechanism of Formononetin Against Hepatocellular Carcinoma: Regulating Metabolic Pathways of Ferroptosis and Cell Cycle. [Abstract]2025 Mar 13;26(6):2578. PMID: 40141219 -
Int Immunopharmacol
Capecitabine mitigates cardiac allograft rejection via inhibition of TYMS-Mediated Th1 differentiation in mice. [Abstract]2024 Nov 15:141:112955. PMID: 39163685 -
Int Immunopharmacol
A novel Senescence-Based prognostic model unveils tumor interactions and drug resistance in colorectal cancer. [Abstract]2024 Jun 15:134:112197. PMID: 38733826 -
Int Immunopharmacol
Metronomic capecitabine with rapamycin exerts an immunosuppressive effect by inducing ferroptosis of CD4+ T cells after liver transplantation in rat. [Abstract]2023 Aug 23;124(Pt A):110810. PMID: 37625370 -
Mikrochim Acta
Highly sensitive and accurate detection of dam MTase activity via G-switch-activated AgNCs fluorescence. [Abstract]2025 Dec 27;193(1):49. PMID: 41454998 -
Front Pharmacol
Transcriptomics and Metabolomics Identify Drug Resistance of Dormant Cell in Colorectal Cancer. [Abstract]2022 Apr 8;13:879751. PMID: 35462906 -
Front Pharmacol
Repurposing Ziyuglycoside II Against Colorectal Cancer via Orchestrating Apoptosis and Autophagy. [Abstract]2020 Sep 18:11:576547. PMID: 33071789 -
J Enzyme Inhib Med Chem
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy. [Abstract]2019 Dec;34(1):117-123. PMID: 30362384 -
ACS Omega
A LRELHLNNN-Gal‑3 Modified Adipose Decellularized Scaffold To Construct Colorectal Cancer Model for Anticancer Drug Screening and Immunotherapy. [Abstract]2025 Oct 30;10(44):52931-52943. PMID: 41244442 -
Chem Biol Interact
New naphthalene derivatives induce human lung cancer A549 cell apoptosis via ROS-mediated MAPKs, Akt, and STAT3 signaling pathways. [Abstract]2019 May 1:304:148-157. PMID: 30871965 -
Molecules
2'-Fucosyllactose Suppresses Angiogenesis and Alleviates Toxic Effects of 5-Fu in a HCT116 Colon Tumor-Bearing Model. [Abstract]2022 Oct 26;27(21):7255. PMID: 36364081 -
BMC Chem
Insights into an NEk2 inhibitory profile of nitidine chloride by molecular docking and biological evaluation. [Abstract]2022 Oct 9;16(1):75. PMID: 36210464 -
Molecules
Atractylodin Induces Apoptosis and Inhibits the Migration of A549 Lung Cancer Cells by Regulating ROS-Mediated Signaling Pathways. [Abstract]2022 May; 27(9): 2946. PMID: 35566297 -
Molecules
Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating TP53 Protein Expression. [Abstract]2020 Mar 5;25(5):1162. PMID: 32150865 -
Mol Med Rep
Identification of the clinical value and biological effects of TTN mutation in liver cancer. [Abstract]2025 Jun;31(6):165. PMID: 40242970 -
Mol Med Rep
Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β‑catenin. [Abstract]2021 Dec;24(6):862. PMID: 34676872 -
Mol Med Rep
Quinalizarin induces ROS‑mediated apoptosis via the MAPK, STAT3 and NF‑κB signaling pathways in human breast cancer cells. [Abstract]2019 Nov;20(5):4576-4586. PMID: 31702038 -
J Mol Med (Berl)
2019 Aug;97(8):1183-1193. PMID: 31201471 -
Sci Rep
Targeting colorectal cancer with pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides: comprehensive in vitro evaluation. [Abstract]2026 May 31. PMID: 42225755 -
Sci Rep
Cancer-Associated fibroblasts regulate the development of cholangiocarcinoma through IL-6/STAT3/AKR1C3 signaling axis. [Abstract]2026 Feb 25;16(1):10467. PMID: 41735359 -
Biol Proced Online
Establishment of a mouse lung cancer organoid model and its applications for therapeutic screening. [Abstract]2025 Jun 16;27(1):21. PMID: 40524168 -
Sci Rep
Synthesis, anticancer evaluation, and electrochemical investigation of new chiral pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides. [Abstract]2025 May 28;15(1):18640. PMID: 40436919 -
Sci Rep
The synergistic antitumour effect of Carrimycin combined with 5-fluorouracil on colorectal cancer. [Abstract]2025 Mar 17;15(1):9155. PMID: 40097541 -
Sci Rep
Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6. [Abstract]2024 Nov 29;14(1):29661. PMID: 39613883 -
Transl Oncol
Cinobufacini enhances the therapeutic response of 5-Fluorouracil against gastric cancer by targeting cancer stem cells via AKT/GSK-3β/β-catenin signaling axis. [Abstract]2024 Sep:47:102054. PMID: 38970916 -
Int J Cancer
Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells. [Abstract]2020 Mar 15;146(6):1700-1716. PMID: 31381140 -
Sci Rep
Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models. [Abstract]2020 Feb 19;10(1):2935. PMID: 32076068 -
Sci Rep
Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species. [Abstract]2016 Dec 1:6:38267. PMID: 27905569 -
Bioelectrochemistry
Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol. [Abstract]2016 Jun:109:31-40. PMID: 26775206 -
Eur J Med Res
Potential role of CFLAR in enhancing 5-FU sensitivity and modulating immune cell infiltration in breast cancer. [Abstract]2025 Apr 10;30(1):265. PMID: 40211399 -
Cancers (Basel)
Drug Repurposing Applications to Overcome Male Predominance via Targeting G2/M Checkpoint in Human Esophageal Squamous Cell Carcinoma. [Abstract]2022 Nov 28;14(23):5854. PMID: 36497337 -
Cell Signal
ARTN drives ABCB1-mediated chemoresistance in gastric cancer cells by promoting ELK4 phosphorylation. [Abstract]2026 Oct:146:112668. PMID: 42285190 -
Oncol Rep
2025 Oct;54(4):133. PMID: 40776759 -
Oncol Rep
DEPP1: A prognostic biomarker linked to stroma‑rich and immunosuppressive microenvironment, promoting oxaliplatin resistance in gastric cancer. [Abstract]2025 Jul;54(1):82. PMID: 40376989 -
J Cell Mol Med
TIMP-2 Modulates 5-Fu Resistance in Colorectal Cancer Through Regulating JAK-STAT Signalling Pathway. [Abstract]2025 Mar;29(6):e70470. PMID: 40118773 -
Oncol Rep
Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma. [Abstract]2021 Jan;45(1):107-118. PMID: 33155663 -
Oncol Res
Esketamine Enhances the Chemosensitivity of Colorectal Adenocarcinoma Cells to 5-Fluorouracil via AMPK/mTOR/HMMR Signaling Pathway. [Abstract]2026 Jan 19;34(2):22. PMID: 41613804 -
Mol Oncol
Patient therapy outcome modeling in cancer organoids is improved by cancer-associated fibroblasts and organoid assembly convolution. [Abstract]2026 Jun 5. PMID: 42246237 -
iScience
Screening and molecular mechanism research on bile microRNAs associated with chemotherapy efficacy in perihilar cholangiocarcinoma. [Abstract]2024 Dec 4;27(12):111437. PMID: 39717085 -
iScience
Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine. [Abstract]2022 Sep 6;25(10):105081. PMID: 36204272 -
Biomedicines
Combinatorial Virtual Screening Revealed a Novel Scaffold for TNKS Inhibition to Combat Colorectal Cancer. [Abstract]2022 Jan 10;10(1):143. PMID: 35052822 -
BMC Complement Med Ther
Exploring the effect of Huangqi Fuling Decoction on gastric cancer based on UPLC-MS, network pharmacology and experiments in vitro. [Abstract]2025 Nov 3;25(1):405. PMID: 41184845 -
BMC Complement Med Ther
PLGA-based herb Toosendanin delivery system for efficient therapy of oral squamous cell carcinoma. [Abstract]2025 Jul 2;25(1):217. PMID: 40604940 -
FASEB J
2019 Apr;33(4):5520-5534. PMID: 30668917 -
Cancer Res Treat
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients. [Abstract]2023 Oct;55(4):1077-1086. PMID: 37309112 -
Drug Dev Res
Peimine-induced apoptosis and inhibition of migration by regulating reactive oxygen species-mediated MAPK/STAT3/NF-κB and Wnt/β-catenin signaling pathways in gastric cancer MKN-45 cells. [Abstract]2022 Nov;83(7):1683-1696. PMID: 36048972 -
Fish Shellfish Immunol
PI3K/AKT/p53 pathway inhibits infectious spleen and kidney necrosis virus infection by regulating autophagy and immune responses. [Abstract]2022 Jan:120:648-657. PMID: 34968710 -
Drug Dev Res
Quinalizarin induces cycle arrest and apoptosis via reactive oxygen species-mediated signaling pathways in human melanoma A375 cells. [Abstract]2019 Dec;80(8):1040-1050. PMID: 31432559 -
Drug Dev Res
Glycitein induces reactive oxygen species-dependent apoptosis and G0/G1 cell cycle arrest through the MAPK/STAT3/NF-κB pathway in human gastric cancer cells. [Abstract]2019 Aug;80(5):573-584. PMID: 30916421 -
Drug Dev Res
The compound 2-(naphthalene-2-thio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via reactive oxygen species-regulated mitogen-activated protein kinase, protein kinase B, and signal transducer and activator of transcription 3 signaling in human gastric cancer cells. [Abstract]2018 Sep;79(6):295-306. PMID: 30222185 -
Epigenomes
2026 Feb 23;10(1):14. PMID: 41892363 -
BMC Cancer
Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor xenograft. [Abstract]2025 Dec 31. PMID: 41469951 -
Microbiol Spectr
Survival mechanism of pancreatic tumor bacteria and their ability to metabolize chemotherapy drugs. [Abstract]2025 Sep 2;13(9):e0182025. PMID: 40792508 -
Curr Issues Mol Biol
The Molecular Mechanism of Craniofacial Cartilage Deformity Induced by High Glucose in Zebrafish. [Abstract]2025 Aug 26;47(9):687. PMID: 41020809 -
Microbiol Spectr
Mandarin Fish (Siniperca chuatsi) p53 Regulates Glutaminolysis Induced by Virus via the p53/miR145-5p/c-Myc Pathway in Chinese Perch Brain Cells. [Abstract]2022 Apr 27;10(2):e0272721. PMID: 35286150 -
Naunyn Schmiedebergs Arch Pharmacol
Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway. [Abstract]2020 Oct;393(10):1987-1999. PMID: 31956937 -
BMC Oral Health
Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3. [Abstract]2023 Nov 9;23(1):846. PMID: 37946196 -
Drug Metab Dispos
Neddylation inhibition sensitizes gastric cancer to 5-fluorouracil by targeting the post-translational stability of the metabolic enzyme dihydropyrimidine dehydrogenase. [Abstract]2026 Apr;54(4):100274. PMID: 41962314 -
J Biochem Mol Toxicol
The Study of the Antitumor Effects and Molecular Mechanisms of Byakangelicol on HepG2 Cells. [Abstract]2026 Apr;40(4):e70819. PMID: 41891544 -
J Biochem Mol Toxicol
Evodiamine Enhances Chemosensitivity in Colorectal Cancer by Targeting Ribonucleotide Reductase M2. [Abstract]2025 Nov;39(11):e70541. PMID: 41121956 -
PLoS Negl Trop Dis
Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti. [Abstract]2019 Aug 20;13(8):e0007681. PMID: 31430351 -
Cancer Med
Metronomic Capecitabine Triggers Ferroptosis in Hepatocellular Carcinoma Cells Through Inhibition of TYMS. [Abstract]2026 May;15(5):e71898. PMID: 42108395 -
Mol Carcinog
Tumor-derived extracellular vesicles confer 5-fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery. [Abstract]2022 Dec;61(12):1177-1190. PMID: 36239547 -
Arch Biochem Biophys
FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis. [Abstract]2022 Jun 15;722:109216. PMID: 35421356 -
Arch Pharm (Weinheim)
Synthesis and biological evaluation of 3,5-diaryl-pyrazole derivatives as potential antiprostate cancer agents. [Abstract]2021 Dec;354(12):e2100225. PMID: 34467575 -
BMC Pharmacol Toxicol
Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma. [Abstract]2021 Jan 6;22(1):1. PMID: 33407916 -
Exp Cell Res
Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia. [Abstract]2020 Aug 1;393(1):112054. PMID: 32376287 -
Mol Carcinog
2020 May;59(5):512-519. PMID: 32124501 -
Bioorg Med Chem
The design of 1,4-naphthoquinone derivatives and mechanisms underlying apoptosis induction through ROS-dependent MAPK/Akt/STAT3 pathways in human lung cancer cells. [Abstract]2019 Apr 15;27(8):1577-1587. PMID: 30846406 -
Int J Biochem Cell Biol
Novel 1,4-naphthoquinone derivatives induce apoptosis via ROS-mediated p38/MAPK, Akt and STAT3 signaling in human hepatoma Hep3B cells. [Abstract]2018 Mar:96:9-19. PMID: 29326072
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Int J Biochem Cell Biol. 2018 Mar:96:9-19. [Abstract]
Hep3B cells are treated with 2 μmol Shikonin, 5-FU, BSNQ or OSNQ for different times (3, 6, 12 and 24 h), and stained with Annexin V and PI. The apoptotic cells are detected by fluorescence microscopy and quantified as percentages.
-
Invest New Drugs
A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer. [Abstract]2025 Jun;43(3):728-741. PMID: 40478388 -
Reprod Toxicol
2025 May:134:108895. PMID: 40097051 -
Front Oncol
Gut virome dysbiosis impairs antitumor immunity and reduces 5-fluorouracil treatment efficacy for colorectal cancer. [Abstract]2024 Dec 19:14:1501981. PMID: 39791120 -
J Cancer
Tanshinone IIA inhibits cell viability and promotes PUMA-mediated apoptosis of oral squamous cell carcinoma. [Abstract]2023 Aug 6;14(13):2481-2490. PMID: 37670974 -
Front Oncol
Lnc-PKD2-2-3/miR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance. [Abstract]2022 Jul 29;12:871281. PMID: 35965521 -
Front Oncol
Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine. [Abstract]2021 Jul 13:11:704042. PMID: 34327143 -
Chem Biol Drug Des
Madecassoside Induces Apoptosis and Inhibits Migration by Regulating ROS-Mediated Signaling Pathways in MDA-MB-231 Breast Cancer Cells. [Abstract]2025 Nov;106(5):e70197. PMID: 41195615 -
J Cancer Res Clin Oncol
2023 Aug;149(10):7235-7246. PMID: 36905423 -
BMC Gastroenterol
Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer. [Abstract]2025 Jan 30;25(1):46. PMID: 39885392 -
J Immunol Res
ATXN2-Mediated PI3K/AKT Activation Confers Gastric Cancer Chemoresistance and Attenuates CD8+ T Cell Cytotoxicity. [Abstract]2022 Sep 28;2022:6863240. PMID: 36213324 -
Food Chem Toxicol
Apigenin 7-O-glucoside promotes cell apoptosis through the PTEN/PI3K/AKT pathway and inhibits cell migration in cervical cancer HeLa cells. [Abstract]2020 Dec:146:111843. PMID: 33152472 -
Tissue Cell
Gancao Xiexin decoction alleviates 5-fluorouracil-induced intestinal mucositis by inhibiting ACSL4 and activating Keap1-Nrf2 pathway. [Abstract]2026 May 28:103:103646. PMID: 42235381 -
Chin J Integr Med
Hydroxychavicol in Combination with 5-Fluorouracil Induced Apoptosis by Inhibiting Purine Metabolism in HT-29 and DLD-1 Cell Lines. [Abstract]2025 May 13. PMID: 40358878 -
Oral Dis
Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma. [Abstract]2025 Feb;31(2):468-481. PMID: 39039738 -
J Appl Toxicol
Inorganic arsenic exposure promotes malignant progression by HDAC6-mediated down-regulation of HTRA1. [Abstract]2023 Aug;43(8):1214-1224. PMID: 36861143 -
In Vitro Model
Colorectal carcinoma organoid and cancer-associated fibroblasts co-culture system for drug evaluation. [Abstract]2025 Mar 5;4(1):31-44. PMID: 40160212 -
J Cell Biochem
2019 May;120(5):8447-8456. PMID: 30485509
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: J Cell Biochem. 2019 May;120(5):8447-8456. [Abstract]
MKN45 and MKN28 cells transfected with empty and DEC2 vectors are incubated in control medium or 5-Fu of 10 μM for 48 hours, then proliferation ratio of these cells is figured by EdU incorporation assay.
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: J Cell Biochem. 2019 May;120(5):8447-8456. [Abstract]
The expressions of apoptotic-related proteins, cleaved-PARP, caspase-3-active and survivin are detected in MKN45, MKN45+5-Fu, MKN45-EV, MKN45-DEC2, MKN45-DEC2+5-Fu, MKN28, MKN28+5-Fu, MKN28-EV, MKN28-DEC2, MKN28-DEC2+5-Fu cells using Western blot analysis.
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: J Cell Biochem. 2019 May;120(5):8447-8456. [Abstract]
The expressions of apoptotic-related proteins, cleaved-PARP, caspase-3-active are detected in control, STAT5A, STAT5A+5-Fu, DEC2+5-Fu, DEC2/STAT5A+5-Fu of MKN45 and MKN28 cell lines using Western blot analysis.
-
Int J Colorectal Dis
ERO1α regulates colon cancer progression and 5-FU resistance through the miR-451a/ARF1 axis. [Abstract]2025 Aug 21;40(1):184. PMID: 40835727 -
PeerJ
Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma. [Abstract]2024 May 13:12:e17296. PMID: 38756442 -
Biomed Res Int
10-HDA Induces ROS-Mediated Apoptosis in A549 Human Lung Cancer Cells by Regulating the MAPK, STAT3, NF- κ B, and TGF- β 1 Signaling Pathways. [Abstract]2020 Dec 8:2020:3042636. PMID: 33376719 -
Discov Oncol
Relationship between AQP5 and chemotherapy resistance in colorectal cancer cells and its mechanism. [Abstract]2025 Aug 4;16(1):1468. PMID: 40760228 -
-
Technol Cancer Res Treat
Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles. [Abstract]2020 Jan-Dec:19:1533033820962114. PMID: 33267716 -
Biotechniques
A simple electrical stimulation cell culture system on the myelination of dorsal root ganglia and Schwann cells. [Abstract]2019 Jul;67(1):11-15. PMID: 31124698 -
Cancer Manag Res
UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway. [Abstract]2019 Mar 22:11:2339-2348. PMID: 30962721 -
Ther Clin Risk Manag
Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo. [Abstract]2017 Feb 7:13:117-130. PMID: 28223815 -
J Chromatogr B Analyt Technol Biomed Life Sci
2026 Jun 16:1281:125188. PMID: 42322757 -
Cancer Rep
2025 Dec;8(12):e70401. PMID: 41308696 -
Biochem Biophys Res Commun
Non-cytotoxic nanomolar concentration of arctigenin protects neuronal cells from chemotherapy-induced ferroptosis by regulating SLC7A11-cystine-cysteine axis. [Abstract]2024 May 28:710:149895. PMID: 38593620 -
Biochem Biophys Res Commun
MESP1-knockdown inhibits the proliferation and epithelial mesenchymal transition of hepatocellular carcinoma and enhances the tumor-suppressive effect of 5-fluorouracil. [Abstract]2023 Aug 30:670:1-11. PMID: 37271034 -
Biochem Biophys Res Commun
2023 Jan 1:638:94-102. PMID: 36442237 -
Anal Cell Pathol
Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer. [Abstract]2022 Jun 16:2022:4484211. PMID: 35757014 -
Biochem Biophys Res Commun
miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway. [Abstract]2020 Nov 12;532(3):329-335. PMID: 32977944 -
Biochem Biophys Res Commun
Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer. [Abstract]2020 Sep 3;529(4):1086-1093. PMID: 32819569 -
Biochem Biophys Res Commun
2020 Jan 15;521(3):596-602. PMID: 31679697 -
Med Sci Monit
2018 Sep 21:24:6666-6672. PMID: 30240386
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Med Sci Monit. 2018 Sep 21:24:6666-6672. [Abstract]
Expression of protein of OPA1, Mfn1, Mfn2, Drp1 and Fis1 in heart mitochondria of rats treated with different 5-FU concentrations. The control group is intraperitonealled injection with same amount of physiological saline.
-
Biochem Biophys Res Commun
Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line. [Abstract]2018 Jun 27;501(3):636-642. PMID: 29738772
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2018 Jun 27;501(3):636-642. [Abstract]
Immunoblot analysis of the expression levels of BCL-2 and BAX after treatment of HCT116 TP53-/- cells with 20 μM 5-FU and 1.25 μM DHA alone or in combination for 48 h. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as a loading control.
-
Med Sci Monit
Quinalizarin Induces Apoptosis through Reactive Oxygen Species (ROS)-Mediated Mitogen-Activated Protein Kinase (MAPK) and Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathways in Colorectal Cancer Cells. [Abstract]2018 Jun 3:24:3710-3719. PMID: 29860266 -
Onco Targets Ther
18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells. [Abstract]2021 Oct 22;14:5131-5144. PMID: 34712051 -
Onco Targets Ther
Zeaxanthin Induces Apoptosis via ROS-Regulated MAPK and AKT Signaling Pathway in Human Gastric Cancer Cells. [Abstract]2020 Oct 29:13:10995-11006. PMID: 33149614 -
Arch Oral Biol
Triggering mitotic catastrophe by podophyllotoxin induces apoptosis in oral squamous cell carcinoma. [Abstract]2025 Sep 15:179:106396. PMID: 40966849 -
Transl Cancer Res
Corylin inhibits liver cancer cell growth through the endogenous apoptosis and mitophagy. [Abstract]2026 Mar 31;15(3):190. PMID: 41969474 -
J Pharmacol Toxicol Methods
Establishment of drug screening in human embryonic stem cells based on a high-content screening system. [Abstract]2020 Nov-Dec:106:106913. PMID: 32822830 -
Oncol Lett
2019 Aug;18(2):1337-1343. PMID: 31423195 -
J Chemother
2-(4-methoxyphenylthio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via ROS-mediated MAPK and STAT3 signaling pathway in human gastric cancer cells. [Abstract]2019 Jul;31(4):214-226. PMID: 31074342 -
-
J Med Food
Ginkgolic Acid Suppresses Nasopharyngeal Carcinoma Growth by Inducing Apoptosis and Inhibiting AKT/NF-κB Signaling. [Abstract]2021 Aug;24(8):806-816. PMID: 34382859 -
J Int Med Res
Paris polyphylla 26 triggers G2/M phase arrest and induces apoptosis in HepG2 cells via inhibition of the Akt signaling pathway. [Abstract]2019 Apr;47(4):1685-1695. PMID: 30819018 -
Turk J Biol
Combinatorial effect of epirubicin and 5-fluorouracil in the treatment of temozolomide-resistant glioblastoma cells. [Abstract]2026 Mar 13;50(2):170-184. PMID: 42058124 -
-
Mol Cell Toxicol (2019) 15:209-219
-
-
-
bioRxiv
Ferrous Iron Accumulation Is a Hallmark and Therapeutic Vulnerability of Therapy-Induced Senescence. [Abstract]2026 May 23:2026.05.20.726695. PMID: 42239384 -
-
-
-
-
-
-
-
-
-
-
Environ Toxicol
Hypoxia-Associated GPNMB+ Macrophages Promote Malignant Progression of Colorectal Cancer and Its Related Risk Signature Are Powerful Predictive Tool for the Treatment of Colorectal Cancer Patients. [Abstract]2025 Feb;40(2):204-221. PMID: 39367576 -
-
-
Biomed Pharmacother
Expediting the development of robust 5-FU-resistant colorectal cancer models using innovative combined in vivo and in vitro strategies. [Abstract]2024 Nov:180:117576. PMID: 39442235 -
bioRxiv
All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer. [Abstract]2024 Oct 23:2024.10.20.619300. PMID: 39484589 -
Biomed Pharmacother
Deapioplatycodin D promotes cell senescence induced by P21 through the mediation of incomplete mitophagy via BNIP3L. [Abstract]2024 Sep:178:117215. PMID: 39084076 -
Comput Biol Med
Deep pan-cancer analysis and multi-omics evidence reveal that ALG3 inhibits CD8+ T cell infiltration by suppressing chemokine secretion and is associated with 5-fluorouracil sensitivity. [Abstract]2024 Jul:177:108666. PMID: 38820773 -
-
Heliyon
HMGA2 promotes resistance against paclitaxel by targeting the p53 signaling pathway in colorectal cancer cells. [Abstract]2024 May 20;10(11):e31431. PMID: 38845972 -
-
Biomed Pharmacother
Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU. [Abstract]2024 Jan:170:116086. PMID: 38159377 -
-
-
-
Biomed Pharmacother
Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing. [Abstract]2023 Jul:163:114751. PMID: 37105073 -
-
-
Heliyon
The roles and molecular mechanisms of long non-coding RNA WT1-AS in the maintenance and development of gastric cancer stem cells. [Abstract]2023 Mar 21;9(4):e14655. PMID: 37025896 -
-
-
-
Biomed Pharmacother
Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma. [Abstract]2022 Sep:153:113465. PMID: 36076577 -
-
-
-
-
J Oncol
Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF- κ B/BCL-2 Signaling Pathway In Vitro and In Vivo. [Abstract]2021 Nov 9:2021:9355555. PMID: 34795760 -
-
-
-
Environ Toxicol
Molecular mechanisms of quinalizarin induces apoptosis and G0/G1 cell cycle of human esophageal cancer HCE-4 cells depends on MAPK, STAT3, and NF-κB signaling pathways. [Abstract]2021 Feb;36(2):276-286. PMID: 33030807 -
-
-
Biomed Pharmacother
Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice. [Abstract]2020 Aug:128:110262. PMID: 32447214 -
Aging (Albany NY)
CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis. [Abstract]2020 Jul 20;12(16):16270-16293. PMID: 32688344 -
-
-
Biomed Pharmacother
Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells. [Abstract]2018 Jul:103:729-737. PMID: 29684851 -
Oncotarget
2017 Dec 15;8(70):115398-115412. PMID: 29383168 -
Tumour Biol
Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells. [Abstract]2016 Jul;37(7):8811-24. PMID: 26747179
5-Fluorouracil purchased from MedChemExpress. Usage Cited in: Tumour Biol. 2016 Jul;37(7):8811-24. [Abstract]
Assays for autophagy activity. Immunoblot analysis for LC3B. Compared with the Lenti-NC cells, the Lenti-CD44v6 cells display a higher intensity of autophagy flux but not steady-state levels when treated with 5-FU (*P<0.001).
-
Solvent & Solubility
DMSO : 50 mg/mL (384.38 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
1 M Ammonium hydroxide : 50 mg/mL (384.38 mM; Need ultrasonic)
H2O : 10 mg/mL (76.88 mM; ultrasonic and warming and heat to 60°C)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (19.22 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (19.22 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Add each solvent one by one: 5% DMSO 95% Saline
Solubility: 2.5 mg/mL (19.22 mM); Clear solution; Need ultrasonic
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 25 mg/mL (192.19 mM); Clear solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
Mice receive intraperitoneal injections of 5-FU (23 mg/kg), 3 times a week via a 26 gauge needle. 5-FU is dissolved in 100% dimethyl sulfoxide (DMSO) to make 1 M/L stock solution refrigerated at −20°C. The stock is then defrosted and diluted with sterile water to make 0.1 M/L (10% DMSO) solutions for intraperitoneal injections. The dose of 5-FU is calculated to be equivalent to standard human dose per body surface area. The low doses of 5-FU (10-40 mg/kg) have been shown to have antitumor efficacy in mouse models of cancer. Sham-treated mice received 10% DMSO in sterile water via intraperitoneal injection three times a week via a 26 gauge needle. The injected volumes are calculated to the body weight; the maximum volume does not exceed 200 μL per injection. Mice are euthanized via cervical dislocation at 3 (2 treatments), 7 (3 treatments), and 14 (6 treatments) days after the first injection and colon is collected for in vitro experiments.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (285 KB)
-
SDS (644 KB)
- English - EN (644 KB)
- Français - FR (644 KB)
- Deutsch - DE (644 KB)
- Norwegian - NO (644 KB)
- Español - ES (644 KB)
- Swedish - SV (644 KB)
- Italian - IT (644 KB)
- Korean - KR (644 KB)
- Portuguese - PT (644 KB)
-
Handling Instructions (2659 KB)
References
[1]. Han R, et al. Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and NSC 123127 for enhanced therapeutic efficacy. J Drug Target. 2016 Jun 29:1-28. [Epub ahead of print] [Content Brief]
[2]. Zeng Q, et al. Knockdown of NFBD1/MDC1 enhances chemosensitivity to NSC 119875 or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells. Mol Cell Biochem. 2016 Jul;418(1-2):137-46. [Content Brief]
[3]. Jones DH, et al. Ten-Year and Beyond Follow-up After Treatment With Highly Purified Liquid-Injectable Silicone for HIV-Associated Facial Lipoatrophy: A Report of 164 Patients. Dermatol Surg. 2019 Jul;45(7):941-948. [Content Brief]
[4]. McQuade RM, et al. Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil. Neurogastroenterol Motil. 2016 Jun 28. [Content Brief]
[5]. Yin L, et al. Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo. Ther Clin Risk Manag. 2017 Feb 7;13:117-130. [Content Brief]
[6]. Snyder SM, et al. Initial Experience with Topical Fluorouracil for Treatment of HIV-Associated Anal Intraepithelial Neoplasia. J Int Assoc Physicians AIDS Care (Chic). 2011;10(2):83-88. [Content Brief]
[7]. Pek Yee Lum, et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell. 2004 Jan 9;116(1):121-37. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO / 1 M Ammonium hydroxide | 1 mM | 7.6876 mL | 38.4379 mL | 76.8758 mL | 192.1894 mL |
| 5 mM | 1.5375 mL | 7.6876 mL | 15.3752 mL | 38.4379 mL | |
| 10 mM | 0.7688 mL | 3.8438 mL | 7.6876 mL | 19.2189 mL | |
| 15 mM | 0.5125 mL | 2.5625 mL | 5.1251 mL | 12.8126 mL | |
| 20 mM | 0.3844 mL | 1.9219 mL | 3.8438 mL | 9.6095 mL | |
| 25 mM | 0.3075 mL | 1.5375 mL | 3.0750 mL | 7.6876 mL | |
| 30 mM | 0.2563 mL | 1.2813 mL | 2.5625 mL | 6.4063 mL | |
| 40 mM | 0.1922 mL | 0.9609 mL | 1.9219 mL | 4.8047 mL | |
| 50 mM | 0.1538 mL | 0.7688 mL | 1.5375 mL | 3.8438 mL | |
| 60 mM | 0.1281 mL | 0.6406 mL | 1.2813 mL | 3.2032 mL | |
| DMSO / 1 M Ammonium hydroxide | 80 mM | 0.0961 mL | 0.4805 mL | 0.9609 mL | 2.4024 mL |
| 100 mM | 0.0769 mL | 0.3844 mL | 0.7688 mL | 1.9219 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.